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Preface
The main focus of this thesis is the characterisation of the aggregation and mem-
brane interaction of the 34-amino acid peptide SerADan, a modified variant of
the ADan peptide, which is the primary component of protein deposits in Famil-
ial Danish dementia (FDD).  The main bulk of the thesis work is presented in the
two papers. Paper 1 focuses on biophysical characterisation by spectroscopic
and microscopic methods of SerADan. Paper 2 describes development and docu-
mentation of a novel method for secondary structure characterisation of protein
aggregates by vacuum-ultra violet circular dichroism spectroscopy. In chapter 1,
I will summarise current knowledge of protein misfolding for the amyloid dis-
eases, characteristics of the deposited polypeptides and the prevailing hypoth-
eses of disease. Chapter 2 describes FDD, FBD and the deposited proteins in
more detail while chapter 3 presents and discusses the two central papers. Addi-
tionally, chapter 4 (appendix) covers additional work on expression and purifica-
tion of precursor proteins to ADan and ABri, which is deposited in Familial Brit-
ish dementia (FBD).
The majority of the PhD study time was devoted to characterisation of SerADan,
ADan and the precursor proteins, for which the bulk of the work was carried out
in the laboratories of Professor Daniel E. Otzen (Department of Molecular Biol-
ogy, Interdisciplinary Nanoscience Centre, Aarhus University, Denmark, previ-
ously Department of Life Sciences, Aalborg University, Denmark). Electron
microscopy was carried out at the Institute of Medical Microbiology and Immu-
nology, Aarhus University, in collaboration with Professor Gunna Christiansen.
Concentration-dependent calcein-release was performed by Brian Vad and X-ray
fibre distraction was performed by Christian B. Andersen, Protein Structure and
Biophysics group, Novo Nordisk A/S, Måløv, Denmark. The secondary project
was development and description of dry-phase protein synchrotron radiation cir-
cular dichroism in collaboration with Dr Søren V. Hoffmann at the Institute for
Storage Ring Facilities (ISA), Aarhus University, Denmark. With few exceptions,
the work was performed at the ASTRID storage ring facility, Aarhus University.
The PhD project was funded by pre-doctoral grants from Aalborg University, the
Danish Research Training Council and the BioNET research network, funded by
the Villum Kann Rasmussen Foundation. In addition, I received a COST Short
Term Scientific Mission grant for a visit to Structure and Function of Membrane
Biology Laboratory, Université Libre, Bruxelles, Belgium in collaboration with
Dr Erik Goormaghtigh. The purpose was characterisation of membrane proteins
advanced infrared spectroscopy methods.
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Resumé
Hovedemnet for denne afhandling er biofysisk karakterisering af et peptid knyttet
til the neurodegenerative sygdom Arvelig Dansk Demens. Derudover blev
anvendelsen af synkrotronstrålings cirkulær dikroism undersøgt med hensyn til
karakterisering af protein aggregater.
Arvelig Dansk Demens er associeret med proteolytisk kløvning og aggregering
af det 34-amino syre peptid ADan, der i lighed med andre amyloid-dannende
polypeptider er i stand til at danne transmembrane kanaler og hvis celletoksicitet
kan finde sted gennem vekselvirkning med cellemembranen. Peptidet indeholder
to cysteiner og kan derfor forefindes i en lineær, reduceret eller cirkulær, oxideret
form, blandt hvilke den reducerede form har den højeste celletoksicitet. Vi
karakteriserede the afledte peptid SerADan i hvilket de to cysteiner er udskiftet
med serin for at efterligne det reducerede peptid. Derudover er fenyl-
aminosyrerester i position 15 udskiftet med tryptofan for at inkorporere en
fluorescensmarkør. SerADan aggregerer hurtigt ved pH 5.0 og 7.5 gennem en
serie af konformationelle stadier til en β-rig fibril-lignende struktur. Til trods for
den generelle lighed med amyloid-lignende fibriller viser røntgen fiber diffraktion
ikke det klassiske amyloide kryds-β mønster og SerADan fibre binder ikke amy-
loid-specifikke farvemarkører. Dette kan formentlig tilskrives en mangel på
organiserede kontakter mellem β-plader og tilstedeværelse af bindingssteder.
Aggregering forhindres af negativt ladede lipid vesikler ved neutral/sur pH og
lav ionstyrke mens øget ionstyrke eliminerer effekten af liposomerne, hvilket
tyder på at elektrostatiske vekselvirkninger spiller en vigtig rolle. Lipid/peptid-
kontakten leder til dannelse af stabile β-rige strukturer, som er forskellige fra
aggregater i opløsning, og permeabilisering af liposomerne, der her vises som
frigivelse af den 623 Da fluorefor calcein. Ved ældning af SerADan i opløsning
reduceres den permeabiliserende effekt i først omgang, hvorefter den elimineres.
Det eksperimentelle arbejde, der præsenteres i denne afhandling, viser at
aggregater, der ikke har klassiske amyloide egenskaber, kan samles gennem serie
af trin og danne et hierarki af højere-orden strukturer i tilfælde, hvor hurtig dannelse
af stabile, lokale β-strenge kunne forhindrer omdannelse til klassisk amyloid
struktur. Det viser også at en snæver balance kan findes mellem aggregering og
membran-interaktion med det deraf følgende potentiale for celletoksicitet.
Konkurrencen mellem lipidbinding og aggregering kan tænkes at tilsvare en
tvedeling af aggregeringsmekanismen for ADan in vivo mellem ophobning af
inerte aggregater og dannelse af celletoksiske, permeabiliserende strukturer.
Som et sideprojekt til afhandlingens hovedemne undersøgte jeg anvendelsen af
synkrotronstrålings cirkulær dikroisme til karakterisering af tørrede
proteinaggregater og fibriller. Brugen af synkrotronstråling kan udvide det
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tilgængelige bølgelængdeområde ned til ~130nm for tørrede proteiner, hvilket
potentielt kan give ny strukturel information. For at muliggøre sammenligning
og estimere den strukturelle effekt af tørring på ikke-aggregerede prøver benyttede
vi et udvalg af modelproteiner i våd og tør fase. Der var tale om α-heliske, β-
plade og blandende strukturer. Vi viste at tørringsprocessen ikke leder til store
ændringer i den sekundære struktur og ikke inducerer orienteringseffekter. Vi
observerede et lav-bølgelængde bånd ved 130-160nm hvis intensitet og
topplacering er følsom overfor sekundær struktur og som potentielt kunne
indeholde information om ændringer i super-sekundær struktur. Dette bånd er
tidligere beskrevet for peptider, men ikke for globulære proteiner eller
proteinaggregater, og det er kompatibelt med publicerede teoretiske beregninger
af π-orbitalovergange. Sammen med principal komponent analyse tillader vores
data os at differentiere mellem to typer proteinfibriller; de klassiske fibriller dannet
af lysozym er strukturelt tættere forbundet med ikke-amyloide aggregater af
SerADan end med de klassiske α-synuclein fibriller. Denne analyse tillader os
også at beskrive ellers ukendte forskelle i sekundær struktur mellem SerADan
fibre dannet ved pH 5.0 og 7.5. En mere detaljeret analyse er påkrævet før der er
muligt at drage klare strukturelle konklusioner, men en omfangsrig SRCD-baseret
database over spektre af tørrede proteiner kan måske bidrage til differentiering
mellem forskellige typer super-sekundær struktur og typer af protein-aggregater.
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Summary
The main topic of this thesis is the biophysical characterisation of a peptide asso-
ciated with the neurodegenerative illness Familial Danish Dementia (FDD). Ad-
ditionally, the use of synchrotron radiation circular dichroism on protein aggre-
gates was investigated.
Familial Danish Dementia is linked to proteolytic formation and aggregation of
the 34-residue ADan peptide, which is capable of forming transmembrane chan-
nels in a manner similar to other amyloidogenic polypeptides and whose cyto-
toxicity may be mediated by membrane interactions. The peptide contains two
cysteines and can therefore exits in the linear, reduced and circular, oxidised
form, of which the reduced form is the more cytotoxic in culture. We character-
ised the derived peptide SerADan, in which the two cysteines found in ADan
were substituted with serines to emulate the reduced peptide. Additionally, the
phenyl residue at position 15 was replaced with a tryptophan residue acting as a
fluorescent marker. SerADan aggregates rapidly at pH 5.0 and 7.5 in a series of
conformational transitions to form β-sheet rich fibril-like structures. Despite the
overall morphological similarities with amyloid-like fibrils, X-ray fibre diffrac-
tion does not yield the classical amyloid cross-β pattern, nor do the SerADan
fibres bind amyloid-specific dyes. This is probably due to the absence of organ-
ized β-sheet contacts and surface binding sites. Aggregation is prevented by ani-
onic lipid vesicles at neutral/acidic pH and low ionic strength, while increased
ionic strength abolishes the effect of the anionic liposomes suggesting an impor-
tant role for electrostatic interaction. The lipid/peptide association leads to for-
mation of stable β-sheet structures, which are different from the solution aggre-
gates, and permeabilisation of the liposomes, here demonstrated as the release of
the 623 Da fluorophore calcein. Solution ageing of SerADan first reduces and
then abolishes the ability of the peptide assembly to alter membrane permeabil-
ity. The work presented within this thesis demonstrates that non-fibrillar aggre-
gates can assemble in a series of steps to form a hierarchy of higher-order assem-
blies, where rapid formation of stable local β-sheet structure may prevent rear-
rangement to amyloid proper. It also shows that a fine balance can exist between
non-fibrillar aggregation and membrane interaction with associated potential
cytotoxicity. The competition between lipid binding and aggregation may reflect
bifurcating pathways for the ADan peptide in vivo between accumulation of inert
aggregates and formation of cytotoxic permeabilising species.
As an offshoot of the main thesis subject, I investigated the use of synchrotron
radiation circular dichroism (SRCD) for characterisation of dried protein aggre-
gates and fibrils. The use of synchrotron radiation can extend the spectral range
down to ~130nm for dry proteins and has the potential to provide new structural
Summary
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information. To allow comparison and to estimate the structural effect of drying
on non-aggregated samples, we used a selection of model proteins, including α-
helical, β-sheet, and mixed-structure proteins, in the wet and dried phases. We
showed that drying does not lead to large changes in the secondary structure and
does not induce orientational artefacts. The access to the higher-energy regions
allowed us to observe a low-wavelength band in the range 130-160nm, whose
intensity and peak position is sensitive to secondary structure and may also re-
flect changes in super-secondary structure. This band has previously been ob-
served for peptides but not for globular proteins, and is compatible with previ-
ously published theoretical calculations related to π-orbital transitions. In combi-
nation with principal component analysis, our SRCD data allow us to distinguish
between two different types of protein fibrils, high-lighting that bona fide fibrils
formed by lysozyme are structurally more similar to the nonclassical fibrillar
aggregates formed by the SerADan peptide than with the amyloid formed by α-
synuclein. The analysis also allows us to describe otherwise unidentified differ-
ences in secondary structure between SerADan fibres at pH 5.0 and 7.5. A more
detailed study is required for any firm conclusions to be drawn, but a comprehen-
sive SRCD-based database of dried protein spectra may provide a useful method
to differentiate between various types of super-secondary structure and aggre-
gated protein species.
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Frequently used abbreviations
Ordered alphabetically
Aβ Amyloid β-peptide of Alzheimer’s disease
(Aβ)n Oligomeric form of Aβ
AβPP Aβ precursor protein
ABri Amyloid peptide of Familial British dementia
ABriPP ABri precursor protein
ACBP Acyl-CoA-binding protein
ACP Acylphosphatase
AD Alzheimer’s disease
ADAM10 ADAM metallopeptidase domain 10
ADan Amyloid peptide of Familial Danish dementia
ADan-pE ADan with N-terminal pyroglutamate
ADanPP ADan precursor protein
ADDLs Aβ-derived diffusible ligands
AEC Anion-exchange chromatography
AFM Atomic force microscopy
ALS Amyotrophic lateral sclerosis
APP Gene encoding AβPP
ATR Attenuated total reflection
β2m β2-microglobulin
Bri C-terminal proteolytic fragment of BriPP, wildtype analogue of patho-
genic ABri and ADan peptides
BriPP Bri precursor protein
BriPPEC C-terminal, extra-cellular domain of BriPP
BriPPS Short form of BriPP beginning at position 57
CA Carbonic anhydrase
CAA Cerebral amyloid angiopathy
CD Circular dichroism
CNS Central nervous system
ConA Concanavalin A
CR Congo red
CR Critical concentration of fibrillation
CSF Cerebrospinal fluid
DOPC 1,2-dioleoyl-sn-glycero-3-phosphocholine
DOPG 1,2-dioleoyl-sn-glycero-3-[phospho-rac-(1-glycerol)]
EM Electron microscopy
FBD Familial British dementia
FDD Familial Danish dementia
FFI Fatal familial insomnia
FTIR Fourier-transform infrared spectroscopy
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GAG Glycosaminoglycan
HFIP 1,1,1,3,3,3-hexafluoropropan-2-ol
HSPGs Heparan sulphate proteoglycans
HypF Hydrogenase maturation factor of Escherichia coli
HypF-N N-terminal domain of HypF
IAPP Islet amyloid polypeptide
ITM2A-C Gene encoding integral membrane protein 2 (ITM2) isoform A-C.
ITM2B corresponds to BriPP.
ITM2-LG Integral membrane protein 2-like gene
LTP (Hippocampal) long-term potentiation
MPL Fibril mass-per-length
MTT 3-(4,5-dimethylthiazol-2-yl)-2.5-diphenyltetrazolium bromide
n* Critical fibrillation nucleus
NAC Nickel-affinity chromatography
NFTs Neurofibrillar tangles
NMR Nuclear magnetic resonance spectroscopy
oxABri Oxidised form of ABri by disulphide C5-C22
oxADan Oxidised form of ADan by disulphide C5-C22
oxBri Oxidised form of Bri by disulphide C5-C22
PCA Principle component analysis
PD Parkinson’s disease
PSA Porcine serum albumin
PSEN1, 2 Gene encoding presenilin 1 or 2
redABri Reduced form of ABri
redADan Reduced form of ADan
redBri Reduced form of Bri
rm-III9 The ninth type III domain of fibronectin
ROS Reactive oxygen species
SAP Serum amyloid P-component
SCAA Sporadic cerebral amyloid angiopathy
SDS Sodium dodecylsulphate
SEC Size-exclusion chromatography
SerADan Variant of ADan (C5S, C22S, F15W)
SH3 SH3 domain of phosphatidylinositol-3'-kinase
SPPL2a,b Signal peptidase-like protease 2a, b
SRCD Synchrotron radiation circular dichroism
SSNFOS SDS-stable non-fibrillar oligomeric species
STEM Scanning transmission electron microscopy
TEM Transmission electron microscopy
TFE 2,2,2-trifluoroethanol
ThS Thioflavin S
ThT Thioflavin T
TII27 Titin, Ig repeat 27
Tnfn3 Tenescin, third fibronectin type III repeat
TTR Transthyretin
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1
The interest in protein misfolding has increased over the past decade, partly due
to the importance of maintaining protein structure and function in pharmaceuti-
cal, enzymatic and other industrial protein preparations [1] and partly due to the
emerging significance of protein misfolding in disease including cancer and de-
mentia (table 1) [2]. The underlying mechanism of disease understandably de-
pends on the relevant protein. Protein misfolding results in loss of biological
activity and this loss-of function can have greatly damaging effects on cell and
organ function. This is the case for cystic fibrosis and p53-deficient cancers [3].
Conversely, gain-of-function, or perhaps rather ‘gain-of-cellular-toxicity’, is be-
lieved to be at the basis of many of the protein deposition diseases including the
two well-known neurodegenerative amyloidoses Alzheimer’s disease and Par-
kinson’s disease [4]. Familial Danish dementia (FDD) and the closely related
Familial British dementia (FBD) belong to this latter group and are the focus of
the present work.
Table 1. Examples of
protein misfolding
diseases. Adapted
from [2, 3]. a Fatal
familial insomnia.
Disease Affected proteins
Inability to fold
Cystic fibrosis Cystic fibrosis transmembrane conductance regulator
Marfan syndrome Fibrillin
Amyotrophic lateral sclerosis Superoxide dismutase
Scurvy Collagen
Maple syrup urine disease α-ketoacid dehydrogenase complex
p53-deficient cancer p53
Fabry’s disease α-Galactosidase A
Osteogenesis imperfecta Type I procollagen pro α
Toxic, non-native folds
Scrapie/kuru/Creutzfelt-Jacob/FFI a Prion protein
Parkinson’s disease α-synuclein
Alzheimer’s disease Amyloid precursor protein
Huntington’s disease Huntingtin
Spinocerebellar ataxia Ataxin
Cataracts Crystalins
Mislocation owing to misfolding
Familial hypercholesterolemia LDL receptor
α-antitrypsin deficiency α-antitrypsin
Tay-Sachs disease β-hexosaminidase
Retinitis pigmentosa Rhodopsin
Leprechaunism Insulin receptor
Amyloid: Protein folding,
misfolding and disease
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1.1 Amyloidosis and amyloid characteristics
1.1.1 The protein misfolding disorders and amyloidoses
The amyloid diseases, or amyloidoses, are a diverse group of generally life-threat-
ening protein misfolding disorders with one unifying characteristic: The pres-
ence of systemic or organ-specific extra-cellular deposits of insoluble amyloid
[4, 5]. The first amyloidoses were described in the early 19th century as presence
of abnormal tissues that appeared ‘waxy’ or ‘lardaceous’ upon gross inspection
[6, 7]. Much controversy resulted from the subsequent attempts at characterisa-
tion of the amyloid material, particularly following observations by Virchow in
1853 of the cellulose-like staining properties of ‘waxy’ spleen tissue and of cor-
pora amylacea from human brain tissue. 150 years later, it is commonly accepted
that the deposits, or plaques, are predominantly proteinaceous with a single-spe-
cies fibrous fibril1 as the main component [8]. The iodine-sulphuric acid staining
reaction of Virchow has been replaced by amyloid-specific dyes among which
Congo red (CR) and thioflavin S (ThS) are most commonly used for staining of
tissue while thioflavin T (ThT) is useful for in vitro characterisation [9].
The amyloidoses are a part of the larger group of protein misfolding disorders
and more than 20 amyloid-forming proteins or peptides have been identified to
date [8, 10] (table 2.A) including several associated with well-known diseases
such as type II diabetes mellitus (IAPP) and Alzheimer’s disease (Aβ). Some of
these polypeptides are full-length proteins, e.g. β2-microglobulin (β2m), that lose
their native structure and deposit in a misfolded, β-rich conformation [12]. Oth-
ers are truncated, usually intrinsically unfolded, fragments of longer precursor
proteins, e.g. Aβ, ABri and ADan. Under the definition of amyloid used by pa-
thologists, intra-cellular deposits (table 2.B), as in the case of Lewy bodies of
Parkinson’s disease, are not considered amyloid, but rather amyloid-like [8] al-
though the deposits appear structurally alike. Similarly, fibrils formed in vitro are
more accurately referred to as amyloid-like. The fibril is the central component
of amyloid, but additional non-fibrillar components are consistently present in
biological amyloid, e.g. serum amyloid P-component (SAP), heparan sulphate
proteoglycans (HSPGs) and apolipoprotein E [7]. The roles of these additional
species are as yet unresolved although some studies suggest a role as enhancers
of amyloid formation or protection of plaques from clearance mechanisms [13].
1.1.2 Functional amyloid
Amyloid has not been exclusively linked to disease. Numerous discoveries of
functional amyloid have been made within the past decade highlighting its possi-
ble beneficial functions. Several prion types have been identified in fungi includ-
ing the S. cerevisiae Sup35 [14, 15] which has become an important model sys-
tem. Briefly, Sup35 is a normally soluble member of the yeast translation termi-
1 Derived from Latin fibrilla meaning ‘small fibre’.
Table 2 (opposite). A. Amyloidoses/diseases with amyloid-like deposits and associated proteins
or peptides. B. Examples of inclusions with amyloid-like properties. Adapted from [4, 8, 10, 11]
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A. Proteins and peptides associated with amyloidoses or diseases with amyloid-like deposits in human
Disease Aggregating protein or peptide
Neurodegenerative localised amyloidoses
Alzheimer’s disease a Aβ, proteolytic fragment of Aβ protein precursor (AβPP)
Spongiform encephalopathies a,b Prion protein and fragments thereof
Familial British dementia c ABri, proteolytic fragment of ABri precursor protein (ABriPP)
Familial Danish dementia ADan, proteolytic fragment of ADan precursor protein (ADanPP)
Neurodegenerative diseases with inclusion bodies with amyloid-like properties
Parkinson’s disease a α-synuclein
Dementia with Lewy bodies a α-synuclein
Frontotemporal dementia with Parkinsonism Tau and fragments thereof
Huntington’s disease Huntingtin with polyQ expansion
Spinocerebellar ataxias d Ataxins with polyQ expansion
Spinocerebellar ataxia 17 d TATA box-binding protein with polyQ expansion
Spinal and bulbar muscular atophy d Androgen receptor with polyQ expansion
Hereditary dentatorubral-pallidoluysian atrophy d Atrophin with polyQ expansion
Nonneuropathic systemic amyloidoses
AL amyloidosis a Immunoglobulin light chains or fragments
AA amyloidosis a Fragments of serum amyloid A protein (SAA)
Familial Meditteranean fever a Fragments of serum amyloid A protein
Senile systemic amyloidosis a Wild-type transthyretin (TTR)
Familial amyloidotic polyneuropathy d Mutants of transthyretin
Haemodialysis-related amyloidosis a β2-microglobulin (β2m)
ApoAI amyloidosis d N-terminal fragments of apolipoprotein AI (ApoAI)
ApoAII amyloidosis d N-terminal fragment of apolipoprotein AII (ApoAII)
ApoAIV amyloidosis N-terminal fragment of apolipoprotein AIV (ApoAIV)
Finnish hereditary amyloidosis d Fragments of gelsolin mutants
Lysozyme amyloidosis d Mutants of lysozyme
Fibrinogen amyloidosis d Variants of fibrinogen Aα-chain and fragments thereof
Icelandic hereditary cerebral amyloid angiopathy d Mutant of cystatin C
Nonneuropathic localised diseases
Type II diabetes a Islet amyloid polypeptide (IAPP), also named amylin
Medullary carcinoma of the thyroid a Calcitonin
Atrial amyloidosis a Atrial natriuretic factor (ANF)
Hereditary cerebral haemorrhage with amyloidosis Mutants of Aβ
Pituitary prolactinoma Prolactin
Injection-localised amyloidosis a Insulin
Aortic medial amyloidosis a Medin, fragment of lactadherin
Hereditary lattice corneal dystrophy d Mainly C-terminal fragments of kerato-epithelin
Corneal amyloidosis associated with trichiasis a Lactoferrin
Cataract a γ-Crystallins
Calcifying epithelial odontogenic tumour a Unknown
Pulmonary alveolar proteinosis d Lung surfactant protein C
Inclusion-body myositis a Aβ
Cutaneous lichen amyloidosis a Keratins
Senile seminal vesicle amyloidosis Fragments of semenogelin I
a Predominantly sporadic, in some cases hereditary forms associated with specific mutations are documented. b Five
percent of cases are transmitted (e.g. iatrogenic). c Systemic deposits are documented. d Predominantly hereditary,
although in some cases sporadic forms are documented.
B. Examples of intracellular, amyloid-like inclusions in human and their primary protein component
Inclusion name Main component Site Example of associated disease
Lewy bodies α-synuclein Neurons Parkinson’s disease
(intracytoplasmic) Alzheimer’s disease with Lewy bodies
Huntington bodies polyQ expanded huntingtin Neurons Huntington’s disease
(intranuclear)
Neurofibrillary tangles Hyperphosphorylated protein tau Neurons Alzheimer’s disease
(intracytoplasmic) Frontotemporal dementia
Hirano bodies Actin Neurons Neurodegenerative disorders
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nation complex [16]. Sequestration of Sup35 into insoluble amyloid form results
in decreased concentration and in generation of the dominantly inherited [PSI+]
phenotype, which confers suppression of nonsense mutations by increasing the
read-through rate of nonsense stop codons. The protein-only inherited [PSI+] el-
ement is structurally self-perpetuating in a manner similar to the mammalian PrP
prions [17]. Like prions, several [PSI+] ‘strains’ have been described with differ-
ing morphological and kinetic characteristics [18]. Amyloid-like fibrils have also
been isolated from bacterial biofilms [19, 20]. The fibril structure assist in adher-
ence to surfaces and is biochemically resistant to degradation making it an excel-
lent biofilm component. Protective, functional amyloid has also recently been
described in phyla ranging from fungi to mammals [21-23]. The formation of
melanin, the polymer that confers protection against small toxins, pathogens and
UV-radiation in skin and eyes, is dependent on the generation of insoluble fibres
consisting of the Pmel17 subunit that have strikingly similar properties to dis-
ease-related amyloid. Consequently, amyloid plays protective or functional roles
in bacteria, fungi and higher eukaryotes.
1.1.3 Familial and sporadic, localised and systemic amyloidoses
Some amyloidoses occur sporadically while others are exclusively hereditary
(e.g. British and Danish Familial dementias), transmissible (spongiform encepha-
lopathies) or a result of external factors (e.g. haemodialysis-associated amyloido-
sis) [24]. Several amyloidoses, including Alzheimer’s disease (AD) and Parkin-
son’s disease (PD), arise sporadically as the body ages or as early-onset disease
as a result of an inherited mutation. For AD, numerous variants have been identi-
fied of the AβPP-encoding APP gene and the presenilin genes (PSEN1 and PSEN2)
that are related to early-onset or particularly aggressive variants of the disease
[25]. In contrast, possession of the ε4 allele of the gene encoding apolipoprotein
E is associated with increased susceptibility to late-onset, sporadic AD.
For systemic amyloidoses, protein deposits can be found in several tissues e.g.
heart, liver and kidneys in reactive serum AA amyloidosis and/or skeletal tissue
and joints in haemodialysis-related amyloidosis [26]. In extreme situations, the
deposited mass can reach several kilograms, which in itself can cause organ dam-
age by physical disruption and compression of vasculature. Deposition of smaller
amounts can also cause organ dysfunction, e.g. renal failure resulting from depo-
sition of lysozyme, apolipoproteins AI and AII or fragments of fibrinogen Aα-
chain in renal vasculature or glomeruli [26-28]. For the localised amyloidoses,
the mass of deposited material can be very low and clinical symptoms are associ-
ated with cell death co-localised with protein deposits [29]. The predominant
hypothesis holds that cell death is cause by the presence of toxic protein oligomers
via a number of subtle mechanisms (covered in more detail in section 1.4). De-
posits are restricted to one organ, but the localised amyloidoses have highly var-
ied organ- and cellular specificities, e.g. islets of Langerhans in the pancreas in
type II diabetes mellitus [30]. However, toxicity due to protein deposits rather
than obstruction may also play a role in systemic disease [31].
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1.1.4 Aspects of Alzheimer’s disease
Alzheimer’s disease (AD) is the most common neurodegenerative amyloidosis
and arguably the most studied. It is characterised clinically by progressive de-
mentia, loss of cognitive function and ultimately death. Histopathological ex-
amination shows neuronal loss and plaques composed of Aβ distributed through-
out the central nervous system (CNS) but with particular intensity in the cerebral
cortex [32-34] in addition to neurofibrillar tangles (NFTs) composed of paired
helical filaments of hyperphophorylated microtubule-associated protein tau [35].
The Aβ peptide is proteolytic fragment of the Aβ precursor protein (AβPP), which
contains a single transmembrane helix (figure 1). A small fraction of AβPP is
processed sequentially by the membrane-bound β- and γ-secretases to yield Aβ
[36-38] while the larger fraction is processed by α- and γ-secretases to give non-
pathogenic P3 peptide. Cleavage by γ-secretase results in fragments of variable
length from 39 to 43 residues with Aβ1-40 and Aβ1-42 as the predominant species.
These cleavage sites are positioned midway along the transmembrane helix leav-
ing the soluble Aβ peptide with an exposed hydrophobic C-terminal region. Bio-
physical characterisation of Aβ1-40 and Aβ1-42 has shown that the longer peptides
is the more amyloidogenic [39] and correlations have been observed between
occurrence of disease and elevation of total serum Aβ and Aβ1-42 [40, 41].
The classical amyloid plaque consists of a dense, fibrillar core surrounded by
dystrophic neurites of axonal and dendritic origin, reactive microglia and fibril-
lar astrocytes [42] but Aβ immunostaining has revealed that diffuse CR-negative
deposits is widespread in the cortex and cerebellum [43, 44]. These non-fibrillar
or preamyloid plaques are rarely associated with cellular abnormalities of the
surrounding tissue. Similar non-fibrillar deposits, termed cotton wool plaques
from their distinct appearance, are observed in certain variants of AD with spas-
tic paraparesis [45, 46]. These lack the dense core but have sharply defined bounda-
ries and are primarily composed of Aβ1-42. In addition to the presence of
parenchymal plaques, AD is often accompanied by development of cerebral amy-
loid angiopathy (CAA) [47, 48]. Amyloid accumulates in the walls of cerebral
and leptomeningeal arteries, arterioles and smaller vessels, resulting in severe
cases in loss of smooth muscle cells and degenerative changes progressively
weakening the vessel wall dramatically increasing the risk of haemorrhagic stroke.
Perivascular amyloid deposits can often be observed surrounding affected ves-
sels. Several hereditary forms of CAA exist associated with deposition of Aβ and
AD-unrelated proteins or peptides of which several are associated with other
DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA
  
LVFFAEDVGSNKGAIIGLMVGGVV P3
DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV A1-40
DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA A1-42
Figure 1.  Proteolytic
processing of AβPP by
α-, β- and γ-secretase
and the sequences of
the resulting peptides.
Adapted from [36]
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neurodegenerative amyloidoses (table 3). However, CAA in the absence of AD
or other amyloidoses appears to be an aspect of normal ageing [48, 49]. The
incidence of sporadic CAA increases sharply after the age of 60 and may account
for as many as 15% of cerebral haemorrhagic incidents in the elderly.
1.2 Amyloid and amyloid-like properties and structure
The next question that arises is what are the structural and mechanistic character-
istics that define the fibril component of amyloid. For laboratory purposes and
particularly for in vitro work, the following three detectable characteristics pro-
vide a useful definition of amyloid-like fibrils [7, 50]: i) Affinity for amyloid-
specific stains such as CR and the thioflavin dyes ThS and ThT, ii) β-rich struc-
ture with organisation giving rise to a characteristic cross-β pattern observable
by X-ray fibre diffraction and iii) ultrastructure composed of long fibres with
variable periodicities, branching and curvature, as observed by electron
microscopy (EM) or atomic force microscopy (AFM). Additionally, fibril-for-
mation often proceeds via a characteristic nucleation-dependent mechanism which
may be attenuated by addition of seeds of preformed fibrils [51] (covered in more
detail in section 1.3).
1.2.1 Staining with amyloid-specific dyes
Binding of amyloid-specific dyes has long been central to identification of amy-
loid in post-mortem samples and thereby to the understanding of development
and pathology of amyloidoses. Congo red (CR) is a sulfonated azo dye (figure
2.A) consisting of two negatively charged amine- and sulphonate-substituted naph-
Gene Chromosome Precursor Amyloid protein
Sporadic cerebral amyloid angiopathy (SCAA)
SCAA in AD AβPP 21 AβPP Aβ
Hereditary cerebral angiopathies
HCHWA-D AβPP (E22Q) 21 AβPP Aβ
FAD AβPP, PS1, PS2 21, 14, 1 AβPP Aβ
Flemish AβPP (A21G)
Italian 1 AβPP (E22K)
Arctic AβPP (E22G)
Iowa AβPP (D23N)
Italian 2 AβPP (A42T)
Austrian AβPP (T43I)
Iranian AβPP (T43A)
French AβPP (V44M)
Florida AβPP (I45V)
London AβPP (V46I/F/G/L)
HCHWA-I CYST C 20 Cystatin C ACys
FAP/MVA TTR 18 Transthyretin TTR
FAF GEL 99 Gelsolin AGel
PrP-CAA PRNP 20 Prion protein APrP
FBD ITM2B 13 ABriPP ABri
FDD ITM2B 13 ADanPP ADan
HCHWA-D: Hereditary cerebral haemorrhage with amyloidosis - Dutch type; FAD: Familial
Alzheimer's disease; HCHWA-I: Hereditary cerebral haemorrhage with amyloidosis - Icelandic
type; FAP/MVA: Familial amyloid polyneuropathy/meningo-vascular amyloidosis; FAF: Familial
amyloidoses Finnish type; Prp-CAA: Prion disease with cerebral amyloid angiopathy.
Table 3. Selected
sporadic and
hereditary cerebral
amyloid angiopathies.
Adapted from [48, 49].
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thalene groups separated by a biphenyl group and binds to amyloid-like fibrils
with a visual change in colour from red-orange to pale red [9]. The amyloid-
characteristic apple-green birefringence is thought to arise from linear orienta-
tion of CR molecules along the fibril, but the exact nature of the binding is not
well understood [53-56]. Nonetheless, the resulting spectral shift and increased
absorbance intensity may be used for quantitative analysis of in vitro fibrillation
in the visual range, although the light-scattering from insoluble fibrils and satu-
rable binding demands that care must be taken in determining the appropriate
concentrations and in data interpretation [57]. The binding specificity of CR is
relatively high but whereas the characteristic birefringence appears to be specific
for the continuous β-sheet structure of amyloid, CR also binds all-α, α+β, all-β
and β-helical proteins [58, 59] as well as extended β-sheets of the short-chain
polyamines polyglycine and poly-L-serine albeit with low affinity [60]. An alter-
native to CR for tissue staining is thioflavin S (ThS), which is a blend of several
compounds with diverse properties [9].
Thioflavin T (ThT) is a good choice for studies of fibril formation in vitro. It is a
fluorescent benzoethiazole dye that bind amyloid with higher sensitivity than CR
but somewhat greater nonspecificity [9]. ThT binds poorly to natively folded
proteins and non-fibrillar structures formed along the fibrillation pathway [52,
61] although non-amyloid conformations with ThT-affinity have been described
[62, 63]. The ThT molecule has a well-defined structure (figure 2.B) and con-
tains a single positive charge. Binding of ThT to fibrils elicits a dramatic red-
shift in excitation maximum from ~350nm to ~450nm while the emission maxi-
mum is moderately shifted from ~440nm to ~480nm resulting in minimal back-
ground fluorescence allowing quantitative analysis [64, 65]. ThT is particularly
useful for continuous detection of fibrils in solution, e.g. in assay application,
because it does not interfere appreciably with the formation of fibril structure
[66]. However, the affinity of the charged ThT molecule towards fibrils varies
greatly depending on pH. Differential binding is also observed depending on the
properties of the fibrillating polypeptide making direct quantitative comparison
between fibril species challenging [52, 67]. Several fibril species that bind ThT
poorly or do not bind the dye in detectable amounts have been identified includ-
ing fibrillar structures of poly-L-serine or poly-L-lysine, fibrils formed of β2m
[61] or truncated amylin peptide [68] and ThT-negative, CR-positive fibrils of
N NN N
NH2
NH2
SO3
-
SO3
-
S
N+
N(CH3)2
A. Congo red
B. Thioflavin T
Figure 2. Structure of
the amyloid-binding
dyes Congo red (A)
and thioflavin T (B).
Adapted from [9] and
[52], respectively.
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Aβ1-40 [69]. Several models have been suggested for the binding of ThT to amy-
loid fibrils, including association of ThT micelles [70]. However, recent studies
suggest that ThT binds with its long axis parallel to the fibril within cavities [71,
72], e.g. between protofilaments (see section 1.2.3), and it has been suggested
that CR binds in a similar manner [53]. Lockhart and co-workers [73, 74] identi-
fied three ThT binding site on Aβ fibrils including a high-affinity site with low
binding stoichiometry (1 mole per 300 mole Aβ in fibril from). Groenning et al.
[72] demonstrated two binding sites for insulin fibrils although the high-affinity
site has somewhat higher capacity (1 mole ThT per mole fibrillar insulin). Inter-
estingly, ThT bound to the high-affinity site was found to be responsible for the
increase in ThT fluorescence upon binding.
1.2.2. Morphology of amyloid-like fibrils
The morphology of biological amyloid and amyloid-like fibrils formed in vitro
has been examined comprehensively by AFM, EM and scanning transmission
electron microscopy (STEM). The later method allows measurement of the mass-
per-length (MPL) of fibrils [75]. Despite the seeming overall similarity in fibril
structure, significant morphological differences exist between fibrils composed
of different polypeptides as well as for fibrils of identical polypeptides formed
under different experimental conditions [76-78]. An ensemble of morphologies
within the same sample is also a common find. Fibrils may be found in bundles
or alone, be straight, curled or branched and appear smooth, twisted or as rib-
bons. However, the overall morphology is of highly structured, long, thin fibres
with well-defined dimensions ranging from 6 to 13nm in width [7, 79] and with
varying lengths in the micron range. The mature fibril found in aged samples is
often composed of thinner (2-5nm-wide), laterally associated protofilaments giving
rise to a wide range of possible morphologies (table 4). As such, mature fibrils
can be described based on their dimensions, number of protofilaments and MPL.
Fibril polymorphism and the variability of fibrils structure among closely related
polypeptides sequences were illustrated by Goldsbury et al. [68, 82], who stud-
ied the fibril ensemble of the amyloidogenic hormone IAPP in vitro by EM and
STEM. A common 5nm-wide protofilament (termed protofibril by the authors)
was found with 2.5-3.0 IAPP monomers per nm measured along the filament axis
by STEM. These protofilaments were rarely found in isolation but rather as con-
stituents of twisted rope-like fibrils or arranged sidewise in flat ribbons (figure
3.A, C-F). A shorter fragment (IAPP20-29) covering the amyloidogenic core did
Table 4. Examples of
fibril and protofilament
dimensions. N.A.: Not
available. Adapted
from [80]. a from [68].
b from [81].
Number of Cross-section dimensions (Å)
Amyloid protein Mass(kDa) protofilaments Protofilaments Fibril
TTR (V30M) 15 4   50 120
Immunoglobulin light chain λVI 13 4-6 ~30 90
ApoAI (L60R) ~9 5/6 ~32 100
AA 8.4 5 ~30 100
Lysozyme (D67H) 15 5 ~30 95
TTR10-19 ~1 6 ~28 90
IAPP a 4 2-many ~50 80-higher
Insulin b N.A. 2/4/6 ~35 50-100
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not form twisted fibrils but only flat ribbons of 3.6nm-wide filaments (figure
3.B) signifying the influence of the non-core regions in determining fibril mor-
phology. Twisting of protofilaments and fibrils is predominantly left-handed propa-
gating from the tendency towards inter-stand twisting within β-sheets determined
by amino acid chirality and steric constraints [50]. Correspondingly, fibrils formed
from the D-form have right-handed twists [83, 84]. The diverse appearance of
IAPP fibrils reflects the frequent observation of a wide range of fibril morphologies
[80, 85-88], which include tubular structures with electron-translucent centres
and straight or twisted fibres with occasional branching and frayed ends expos-
ing individual protofilaments.
Growth micro- and macro-conditions can have a strong impact on morphology
and condition-dependent polymorphism is a frequent observation such as pH and
agitation for Aβ1-40 and fragments thereof [89, 90] solution polarity for insulin
[91] or peptide concentration, fibrillation temperature, ionic strength and pres-
ence of ions that may acts as ligands for the pancreatic hormone glucagon [67,
92]. Finally, growth under conditions of high pressure has been shown to lead to
formation of highly curved or circular fibrils for insulin [93] underscoring the
Figure 4. ‘Strain’
behaviour of Aβ fibrils.
The use or absence of
agitation during growth
give rise to two fibril
types. The properties
of the seed determines
the properties of
seeded fibrils [90].
Figure 3. Diversity of
fibril morphology
(polymorphism) for
IAPP (A,C-F) and
IAPP20-29 (B). Adapted
from [68]
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morphological diversity of amyloid-like fibrils. Several of these studies also il-
lustrate the principle of fibril ‘strain’ (figure 4), which parallels the strain-behav-
iour of prions. Solutions seeded with fragments of previously formed fibrils
showed preservation of morphology in populations of daughter- and granddaugh-
ter-fibrils. However, the widespread condition-dependent polymorphism and strain
behaviour has raised questions about the generic nature of the fibril structure,
which will be discussed further below.
1.2.3 The cross-β fibril structure
The wide range of fibril morphologies raises the question of the basic structure of
the protofilament and whether structural polymorphism originate in differences
of protofilament packing or illustrates more fundamental differences in structure.
Early structural studies of amyloid-like fibrils by X-ray fibre diffraction showed
the characteristic diffraction pattern [94, 95] ascribed to the cross-β organisation
of the extended pleated sheets first described by Pauling (figure 5.A-B) [96]. The
individual β-strands are perpendicular to the fibril axis while the β-sheet is paral-
lel to the fibril direction (figure 5.C) resulting in a diffraction pattern consisting
of 4.7-4.8Å meridional and more diffuse 10-11Å equatorial reflections [97]. The
former originates from the distance between the extended β-strands within the β-
sheet while the latter is attributed to the distance between two or more laminated
β-sheet although this distance depends on the type of side chains [98]. X-ray
fibre diffraction does not distinguish well between parallel and anti-parallel ori-
entation nor does it provide information about the register of the individual β-
strands, the direction of twisting of the β-sheets or about regions of the polypep-
tide chain outside the regular structure such as loops or turns. However, Blake
and Serpell [99, 100] used the observation of a repeating unit of 24 β-strands to
construct a basic protofilament structure consisting of four laminated, continu-
ous β-sheets for ex vivo fibrils of transthyretin (TTR) variant V30M (figure 6.A).
The mature fibril consists of 4 such protofilaments. The full rotation of the lami-
nated β-sheets around a central axis result in an inter-strand twist of 15º similar
to the energy-minimising twist observed for β-sheets in globular proteins [102].
An analogous model, constructed from electron-density maps obtained from cryo-
electron microscopy of fibrils of the SH3 domain of phosphatidylinositol-3'-ki-
nase [101], shows a double-helix of two pairs of protofilaments, each consisting
of two laminated β-sheets. Similarly, an ensemble of polymorph fibrils of insulin
Figure 5. Parallel (A)
and anti-parallel (B)
pleated sheets [96].
The cross-β structure
consist of laminated
pleated sheets (shown
as anti-parallel) run-
ning along the fibril di-
rection with strands ori-
ented perpendicular to
the fibril axis. Adapted
from [97].
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[81] was found to consist of 2, 4, 6 or more protofilaments (figure 6.B-C) that
appeared identical under the available resolution.
1.2.4 Sub-protofilament structure
The advances in high-resolution methods, particularly within the field of nuclear
magnetic resonance spectroscopy (NMR), has allowed the collection of more
detailed information about the sub-protofilament structure of both short peptides
and full-length amyloidogenic polypeptides. Using Aβ as an example, if was
found by combination of several methods that the longer peptides Aβ10-35, Aβ1-42
and Aβ1-42 form parallel, in-register β-sheets [103-109] while the shorter Aβ11-25
and Aβ16-22 form β-sheets in anti-parallel conformation [110, 111]. Interestingly,
the latter peptide was found to switch to parallel conformation upon octanoylation
of the N-terminus [112]. This can be rationalised in terms of hydrophobic and
electrostatic interactions. The longer peptides have asymmetrical hydrophobic
segments (residues 17-21 and 29-40) and the parallel, in-register conformation
allows for full overlap between these. For the shorter peptides, the segment at
residues 17-21 occupies a central, symmetrical position that allows for anti-par-
allel conformation and interaction between the opposing terminal charges.
Octanoylation abolishes the electrostatic interaction and adds an additional hy-
drophobic region switching Aβ16-22 to parallel organisation.
It has been suggested that the structural polymorphism observed for identical
peptides at differing growth conditions stems from protofilament surface char-
acteristics [77], e.g. side chains not directly involved in formation of the cross-β
core. The parallel-to-anti-parallel conformational switching suggests that poly-
morphism may correspond to structural difference at the sub-filament level. This
is further supported by the observation of significant differences in protofilament-
substructure observed by solid state NMR for the previously mentioned poly-
morphic Aβ1-40 fibrils grown with or without agitation [90] (figure 4). Quiescent
Figure 6. Model of
TTRV30M (A) and insulin
(B-C) fibril structures.
Adapted from [100]
and [81], respectively.
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samples were found to contain two conformations ratio 2:1, and measurements
of MPL by STEM further suggested that agitated and quiescent protofilaments
contained two and three laminated sheets, respectively. However, monoclonal
antibodies specific for fibrils but not precursors or soluble monomers suggest the
existence of a common fibril-specific structural epitope [113].
A more extensive description of the dependence of sub-filament structural poly-
morphism on fibrillation conditions comes from studies of the 29 amino acid
glucagon peptide [67, 92, 114]. Numerous fibril ‘types’ (table 5) have been de-
scribed exclusively or in mixed populations depending on peptide concentration,
agitation, pH, temperature, ionic strength and presence of specific anions during
fibrillogenesis. The mature fibril types vary not only in morphology (figure 7.A-
D) but also in their stability by thermal or chemical dissociation and their sec-
ondary structure. Fourier transform infrared spectroscopy (FTIR) of dried fibril
samples show some diversity but all display a major β-sheet component in the
1620-1640cm-1 range (figure 7.E). In contrast, circular dichroism (CD) yields
very diverse spectra including typical β-structure as well as spectra with α-heli-
cal or β-turn characteristics (figure 7.F). Using types B and D as examples, growth
in the presence of 250mM NaCl changes the CD spectrum from β-turn-like to a
more typical β-sheet-like spectrum without considerably altering the appearance
Fibril type Conditions Characteristics
A >1g/L glucagon (pH 2.5) Thin flexible fibrils, sometimes as twisted bundles; high
ThT staining.
B <0.5mg/mL (pH 2.5); agitation Untwisted parallel bundles of two or more filaments; low
ThT staining; CD-spectrum fingerprint at 206nm and
characteristic IR peak at ~1635cm-1.
Bquiescent <0.5g/L (pH 2.5); no agitation Twisted thick fibrils; low ThT staining.
C <0.5g/L (pH 2.5); agitation; elevated Low ThT staining; large untwisted parallel bundles of
temperature (50ºC) several filaments; similar molecular structure as type B.
D <0.5g/L (pH 2.5); 100-200μM NaCl; agitation High-pitch twisting; low ThT staining.
S (sulphate type) ~0.5g/L glucagon (pH 2-2.5); 1mM SO4
2-; Regular twisted fibrils; high ThT staining; irregular,
 agitation not required α-helix-like CD spectrum.
Table 5. Summary of
glucagon fibril types.
Adapted from [114].
Figure 7. Morphology
of glucagon fibril types
A-D (A-D) [67]. FTIR
(E) and CD (F) spectra
of selected types [114].
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in FTIR. Similarly, the addition of as little as 1mM sulphate ions favours a fibril
type which contains noticeable amounts of α-helical structure (type S), which is
also observed for freshly dissolved peptide in the presence of higher concentra-
tions of sulphate ions [92] suggestive of a stabilising role of sulphate towards
helical conformation. It thus appears that fibril polymorphism encompasses every
level from secondary structure, which must be probed by spectroscopic methods,
to quaternary structure, commonly observable as differences in gross morphol-
ogy. For a given polypeptide, the structural preferences within this polymorphic
field of possible conformations are determined by physical (e.g. temperature)
and solution (e.g. ionic strength) conditions and these traits are generally con-
ferred to daughter fibrils upon seeding under dissimilar conditions as those used
for parent fibrillation. This speaks against a single generic fibril structure repre-
senting a global energy minimum and the tendency towards a given fibril type or
strain is likely driven by kinetic factors and directed by constraints from solution
conditions and imprinting from seed ‘templates’.
1.2.5 Models of fibril structure
The extensive work on the structural properties of the Aβ peptides have led to a
parallel, in-register structural model of full-length Aβ1-40 [115] (figure 8.A). The
two β-strands are folded so the peptide contributes one β-strand to each of the
two continuous β-sheets that make up the protofilament. This model is in general
agreement with subsequent data obtained from e.g. solution NMR [117], mass
spectrometry [118], cryo-EM [119, 120] and mutagenesis studies [121, 122] al-
though a recent structure of Aβ1-42 [116] obtained from solution NMR combined
with structural constraints from previous studies suggests a staggered arrange-
ment with the laminated sheet leading to partially unpaired β-strands (figure 8.B).
A similar interpretation of the cross-β organisation comes the ability of certain
short, amyloidogenic peptides to form crystalline, fibril-like structures [123, 124].
Two peptides from the N-terminal prion domain of the fungal prion Sup35,
GNNQQNY and NNQQNY, were found to form microcrystals that allowed X-
ray diffraction to 1.8Å and 1.3Å resolution, respectively, revealing continuous,
flat β-sheets with β-strands in parallel, in-register conformation [125]. The inner
core of the laminated β-sheets, or ‘dry face’, is tightly packed with closely nes-
Figure 8. Structural
model of Aβ1-40 (A) con-
sisting of two laminated
sheets from the same
peptide. An alternative
model (B) describes a
staggered arrange-
ment. Adapted from
[115] and [116],
respectively.
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tled, complementary side chains giving the appearance along the protofilament
axis of an interlocked ‘steric zipper’. The tight packing excludes water from the
core, which is compatible with the structural insensitivity of some fibrils towards
hydration [126]. The polar Asn and Gln side chains do not form hydrogen bonds
between β-sheets but rather ‘polar zippers’ along the fibril axis [127]. In the ab-
sence of hydrogen bond stabilisation, the two β-sheets are held together by van
der Waals interactions between the closely packed side chains. Similar structures
have been described for a further eight short peptides from amyloidogenic pro-
teins or peptides [128] classified based on β-strand orientation within the β-sheet
and with respect to the opposite β-sheet and which β-sheet sides, or faces, are in
contact (figure 9). Interestingly, several of the peptides have two conformations
suggesting variability in side chain packing and the less specific van der Waals
interactions could be a basis for fibril polymorphism.
Several alternative model for fibril structure suggest that cross-β organisation
may not be relevant for all fibrils. The late Max Perutz [129] observed that the
10Å equatorial reflection is missing in X-ray fibre diffraction patterns for fibrils
of polyglutamine repeats and proposed that amyloid-like fibrils may be water-
filled nanotubes composed of ~30nm-wide, cylindrical β-helices with 20 residues
per turn. Similar β-helical structures with circular or triangular cross-sections
have been suggested for other fibril types [130-134]. A second group of alterna-
tive structural models is based on preservation of some native structure [135]: i)
‘Gain-of-interaction’ models in which dislocation of a native β-sheet allows inter-
molecular contact between edge strands and direct stacking of monomers pre-
serving residual native structure (e.g. TTR) [136-138], ii) cross-β spine models
in which a central fibril is formed by N- or C-terminal amyloidogenic regions
(e.g. yeast prion Ure2p) or by ‘gain-of-interaction’ association of edge strands
conserving extra-fibrillar domains of native structure (e.g. β2m) [139, 140] and
iii) domain-swapping in which the native structure opens and complementary
domains associate across molecules (e.g. cystatin C) [141, 142].
In summary, despite overall similarities amyloid-like fibrils show a striking de-
gree of polymorphism in their gross morphology and in their underlying struc-
Figure 9. Classes of
steric zippers. Adapted
from [128].
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ture. The self-assembly via hydrogen bonded β-strands into continuous β-sheets
or β-helices may the underlying motif of formation of amyloid-like fibrils. This
might be a reflection of the inherent ability of the polypeptide backbone to con-
form to the extended β-strand conformation.
1.3 The mechanism of protein folding and misfolding
1.3.1 The inherent ability of proteins to form fibrils
Many proteins and peptides have been identified in biological amyloid, but two
observations paved the way to a more fundamental understanding of fibril as-
sembly: i) synthetic disease-related peptides are capable of forming amyloid-like
fibrils in vitro with comparable tinctorial, morphological and structural proper-
ties to their in vivo counterparts [143, 144] and ii) globular proteins unrelated to
disease may by induced to form similar fibrils as in the case of SH3, the ninth
type III domain of fibronectin (rm-III9) and acylphosphatase (ACP) [145-147].
The observation of fibrillogenic potential for natively folded proteins led to the
proposal that any protein sequence may be capable of forming amyloid-like fi-
brils under appropriate conditions and that the capacity to conform to the con-
tinuous β-sheet structure may be an intrinsic ability of the polypeptide backbone
[148]. This is supported by the ever-growing list of proteins and peptides
fibrillating in vitro or in vivo, which includes all-β (SH3, rm-III9, β2m), all-α
(apomyoglobin, cytochrome c552), mixed structures (ACP, hen egg white lysozyme,
stefin B), fragments of transmembrane helices (Aβ, truncated glycophorin A)
and polyamino acids [98, 149-153]. Consequently, the fibril conformation seems
to occupy a permanent place in the energy landscape of folding [154]. While the
native structure encoded within the protein sequence [155] may represent a local
free energy minimum relevant for the isolated polypeptide chain, it has been
suggested that the native fold may be considered a metastable state whereas the
amyloid-like fold represents the global free energy minimum [156].
Formation of intermolecular contacts opens up the alternative aggregation en-
ergy landscape (figure 10) and allows for a range of structures including the
Figure 10. The energy
landscape of folding
and aggregation. The
formation of intermole-
cular interactions al-
lows access to alterna-
tive structures that may
be more energitically
favourable than the
native structure. Adap-
ted from [157].
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highly stable amyloid-like fibril [157]. However, a single common and preserved
amyloid structural motif can hardly be expected in the light of the absence of
evolutionary pressure in the development of fibril structure excluding those few
proteins that constitute the functional amyloid group. The evolutionary pressure
has rather been on prevention of aggregation-promoting non-native interactions
during protein folding, which offers a partial explanation for the relative rarity of
in vivo amyloidogenesis compared to the readiness with which many otherwise
non-pathogenic proteins have been induced to fibrillate in vitro. In light of the
frequent observation of fibril polymorphism, the nucleation and growth of amy-
loid-like fibrils appears to be a competitive process involving a collection of
highly-ordered structures in a ‘survival of the fittest’-like scenario [114]. From a
mechanistic strand-point, the fibrillation process begins from the monomeric state,
which may belong to an ensemble of unfolded or partially folded conformations
[158, 159] or be native-like [135, 160]. The subsequent assembly may involve
formation of oligomeric species, ordered or amorphous aggregates, all of which
have been implicated on- or off-pathway in the fibrillation process [161].
1.3.2 Models for fibril growth
The classical model of fibrillation is a nucleation-dependent assembly mecha-
nism, which ascribes the frequently observed lag phase before growth of mature
fibrils can be detected2 to a rate-limiting formation of a critical fibrillation nu-
cleus (figure 11), defined as the most unstable and therefore least populate spe-
cies along the pathway [162, 163]. The assembly proceeds via step-wise addition
of monomer to the growing fibril [165]. However, the initial equilibria are ther-
modynamically unfavourable until the critical fibrillation nucleus (n*) is reached:
(1) n n 1 n* n* 1A A A A A A+ ++ +…
The end of the observable lag phase corresponds to the end of the initial slow
nucleation phase and formation of the rare critical nucleus (figure 12.A). This is
followed by thermodynamically favoured end-wise elongation leading to observ-
able fibril growth. The addition of available ‘ends’ in the form of seeds of pre-
formed fibrils should abolish the lag phase. The nucleation-elongation model
also implies a critical concentration (CR) below which fibril formation does not
2 Detection can be by e.g. ThT or intrinsic fluorescence or time-lapse AFM.
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Figure 11. Fibril growth
is often characterised
by a lag phase follo-
wed by rapid growth
(A) here shown for
ThT-monitored insulin
fibrillation [169]. (B)
The end of the lag
phase is often ascri-
bed to the formation of
the critical fibrillation
nucleus [162] although
this interpretation is in-
consistent with the low
concentration depen-
dence and rapid onset
of elongation obser-
ved for several fibril
systems.
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occur and a strong concentration dependence of fibrillation kinetics. The addi-
tion of monomers to the growing fibril end may proceed rapidly but can involve
a second rate-limiting step as observed for elongation of Sup35 fibrils [166] or
separate binding and rearrangement steps as observed for Aβ1-40 [167, 168].
Nucleation-dependent models have been used successfully for kinetic interpreta-
tion of experimental fibrillation or aggregation data [88, 169-171]. However, the
duration of the lag phase can be independent of or only weakly dependent on
monomer concentration and the elongation phase may show rapid onset, which is
in disagreement with the parabolic early time-course predicted by the nuclea-
tion-dependent model [165, 166, 172]. Secondary processes for production of
growing ends in the form of branching, nucleus-formation on the fibril surface or
fibril fragmentation may result is such abrupt termination of the lag phase [161].
Fragmentation also explains promotion of growth by sonication or agitation [173,
174] and the importance of fibril ‘brittleness’ for fungal prion phenotypes [175].
Lateral surface recruitment and association of smaller spheroids has been ob-
served for short, rod-like prefibrillar insulin oligomers [176]. The relative inde-
pendence of concentration has been attributed to formation of off-pathway spe-
cies lowering the effective monomer concentration [177-179]. Duration of the
lag phase can also be affected by stabilisation of on-pathway monomeric or oli-
gomeric species [180-184].
Alternatively, fibrillation may take place without formation of a critical nucleus
similar to the process of amorphous aggregation [185]. The aggregation-prone
monomer is the highest energy species (figure 12.B) and each essentially irre-
versible assembly step stabilises the larger species. Consequently, such downhill
polymerisation is characterised by first-order dependence on monomer concen-
tration and whereas addition of seeds may affect the distribution of oligomeric
species, it has no effect on the time-course of the assembly as observed for TTR
under partially denaturing conditions and Aβ covalently modified by aldehyde-
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Figure 12. Proposed
reaction schemes for
the nucleation-depen-
dent fibrillation of Aβ
(A) and the downhill
polymerisation of TTR
(B), which is initiated
by conversion of the
native monomer to an
aggregation-prone con-
formation. In the former
case, the critical
nucleus is the highest-
energy species. In the
latter case, the native
monomer occupies this
position. Adapted from
[164].
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derivatives of cholesterol [164, 186, 187]. Similarly, formation of amorphous but
seeding-competent aggregates of a tandem-repeat of SH3 at neutral pH has been
shown to follow down-hill polymerisation kinetics [188].
1.3.3 Early oligomeric species, on- or off-pathway intermediates
The initial phases of fibrillation, before the appearance of mature fibrils, are of-
ten characterised by nucleation-independent conversion of a portion of the
monomer pool into an ensemble of oligomeric species [189-191]. These early
intermediates are generally classified based on appearance (EM and AFM) and
approximate molecular mass (size-exclusion chromatography [SEC] and gel elec-
trophoresis). A diverse range of structures have been observed including sphe-
roids [69, 192, 193], curvilinear protofibrils [69, 194, 195], ‘micelles’ produced
above a CMC-like threshold monomer concentration [177, 196, 197] and, for
Aβ, Aβ-derived diffusible ligands (ADDLs) [198]. Pore-like structures have also
been observed with striking similarities to pore-forming bacterial toxins suggest-
ing a role in neurodegeneration [199-203].
The presence of oligomeric species and slow disappearance before mature fibrils
can be observed has prompted speculation about their role as potential on-path-
way intermediates. Because of their relative abundance they cannot by definition
be the critical nucleus, but an on-pathway role is supported by structural studies
detecting similar ordered elements for protofibrils as for fibrils [118, 204] and
oligomeric intermediate species have been inferred or identified on-pathway in
several studies [178, 205-207]. Spheroids have been observed to anneal to form
linear or annular structures [200, 203, 208] and participation in fibril elongation
by association of oligomers at fibril ends has been proposed for e.g. Sup35 and
Aβ1-40 [209, 210] although elongation by monomer addition is well-documented
in many cases [166, 197]. However, fibrillation can occur under mildly denatur-
ing conditions that prevent formation of oligomers [211] and Goldsbury et al.
[208] observed that annealed Aβ1-40 spheroids separated before disappearing from
solution as mature fibrils appeared suggesting an off-pathway role. The latter
study also demonstrated protofibrils may originate from spheroids, indicating
internal conformational nucleation, and elongate by monomer addition albeit at a
slower rate than mature fibril growth suggesting structural differences requiring
conformational rearrangement to allow conversion to mature fibrils. The early
curliform protofibrils may be on-pathway intermediates that laterally associated
to form mature fibrils [212] but protofibrils may coexist with spheroids under
conditions that disfavour formation of mature fibrils whereas fibrils are capable
of growing under conditions that disfavour the formation of oligomeric species
[191]. As such, early oligomeric species may be kinetically trapped on pathways
competing with formation of mature fibrils [208, 213, 214] and whereas on-path-
way oligomers can be observed for several systems, they are not generally obli-
gate. This is supported by the observation that several small-molecule inhibitors
selectively reduces oligomerisation of Aβ without affecting fibrillogenesis indi-
cating that oligomerisation and fibrillation can occur by separate pathways [215].
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1.3.4 Formation of aggregation-prone species
Significant work has gone into describing the earliest events in the fibrillation
process, i.e. how the relevant polypeptide chain becomes prone to participating
in aggregation and which factors influence the process. Fibrillation has been ob-
served to occur for globular proteins, intrinsically unfolded proteins or unfolded
proteolytic fragments and the specific formation of the fibrillation-prone monomer
depends on the nature of the precursor polypeptide. Fibrillation of globular pro-
teins generally requires conditions under which fibrillation-prone, partially folded
conformations are populated [10, 158]. This can happen either i) by introduction
of mutations that destabilise the native state or stabilise the partially folded con-
formation [216-218] or ii) via non-native environmental factors [145, 151, 219,
220] such as low or high pH, high temperature or addition of organic solvents to
alter solvent polarity. The unmasking of fibrillation-prone regions allows for in-
teraction with similar regions on other molecules and the formation of higher
order species. An example is dislocation within a native β-sheet, through muta-
tion or environment factors, leading to exposure of edge β-strands already in the
required extended conformation and available for formation of an intermolecular
β-sheet. The importance of such exposed edge β-strands is illustrated in the pro-
tective methods used by globular proteins such as strategically placed charges,
incorporation of prolines and shortening of edge β-strands to prevent such asso-
ciation [221, 222].
Fibrillation also occurs from intrinsically unfolded conformations include full-
length proteins (e.g. α-synuclein), short peptides with low structural propensity
(e.g. IAPP and calcitonin) or proteolytic fragments of longer precursor protein
(e.g. Aβ and medin [223]). In the latter example, the cleaved peptides will be
incapable of folding into a globular shape offering protection of fibrillation-prone
regions. However, mutagenesis studies have demonstrated that fibrillation from
both unfolded [224] or partially folded [225] states occurs through interactions
between a limited number of residues in a manner reminiscent of the native fold-
ing nucleus3 although the residues forming the native and fibrillation nuclei dif-
fer. Additionally, intrinsically unfolded proteins or peptides are capable of adopt-
ing molten globule-like structures with significant secondary structure and the
formation of such transient intermediates, occasionally with significant α-helical
elements, have been observed for e.g. IAPP and Aβ1-40 [226-228].
1.3.5 Factors influencing aggregation propensity
There is no single consensus motif for fibrillation but different sequences have
markedly different fibrillation propensities and rates. The amyloid stretch theory
[229] proposes that the fibril self-assembly occurs through interaction of short
segments within the polypeptide chain and that the properties of these aggrega-
tion-prone regions or ‘hot spots’ that can be used for predictive purposes. Several
intrinsic physiochemical factors have been described as playing a role in deter-
mining aggregation rates [230, 231], e.g. hydrophobicity, β-strand amphiphilicity,
charge and β-sheet propensity.
3 Not to be confused with the critical fibrillation nucleus defined for the nucleation-elongation model.
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The interaction between unmasked hydrophobic patches is an important driving
force in the formation of amyloid-like fibrils as well as amorphous aggregates
[232, 233]. However, short peptide fragments consisting of polar amino acids
(e.g. GNNQQNY [124]) and long polyglutamine also readily form amyloid-like
fibrils in vitro, possible stabilised by polar zippers as proposed by Perutz et al.
[127] and observed for yeast prion Ure2p and several steric zipper structures
[125, 128, 234]. Eisenberg and coworkers [235] used threading of sliding win-
dow hexapeptides of amyloidogenic proteins through the steric zipper structure
obtained from microcystals of the NNQQNY peptide [125] to accurately predict
not only potentially amyloidogenic Asn and Gln-rich segments but also known
predominantly nonpolar amyloidogenic regions including the final GGVVIA
hexapeptide of Aβ1-42 in agreement with the increased fibrillation rate for the
longer Aβ variant [39]. Brack and Orgel [236] and later Hecht and coworkers
[237] studied the secondary structure preferences of patterns of alternating hy-
drophilic and hydrophobic residues and found partiality towards β-structure and
formation of amyloid-like fibrils. Indeed, such patterns are underrepresented in
Nature suggesting an evolutionary disadvantage. However, screening of globular
and amyloidogenic proteins did not yield an overrepresentation of alternating
patterns [222]. Rather, fibril-forming proteins showed an increased frequency of
pure hydrophobic or hydrophilic segments.
The β-branched (VIL) and large aromatic (FYW) residues generally favour β-
sheet structure [238-240] and these amino acids are overrepresented when exam-
ining the deviation of amino acid frequency compared to the average frequencies
in the Swiss-Prot database for a selection of short, amyloidogenic peptides asso-
ciated with disease and with the overall frequencies observed for short fibril-
forming segments (figure 13). Similarly, the α-helix promoting amino acids
(MALEK) are generally underrepresented. In the case of the α-helix promoting
charged amino acids, the low frequencies may arise from the aforementioned net
charge effect leading to overrepresentation of low charge among the amyloidogenic
peptides. Proline is largely excluded, which is in agreement with its role as sec-
ondary structure ‘breaker’. Correspondingly, scanning proline mutagenesis has
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been used to elucidate the thermodynamic stability and structure of fibrils [131,
241]. The effect of proline in amyloidogenic sequences is illustrated in the lack
of amyloid-formation for rat IAPP, which contains a proline-rich segment
(NLGPVLPP) in region corresponding to the human amyloidogenic core
(NFGAILSS) [242]. Conversely, glycine has diverse effects on fibrillation. Con-
served glycine residues have been linked to prevention of ACP-fibrillation by
alanine mutagenesis [243] while the G3A substitution in NFGAIL was shown to
be without effect [244]. In contrast, the small glycine residue was found to be
important in packing of bulky side chains for a fragment of transmembrane, α-
helical glycophorin A [150] and glycine has a similar role in the packing of large
aromatic side chains and in interstrand interaction for antiparallel β-strands [245,
246].
Aromatic residues appears to play an important role in fibril formation in agree-
ment with the general overrepresentation of particularly phenylalanine in the sum-
marised amyloidogenic sequences (figure 13). Indeed, alanine-substitution of phe-
nylalanine in NFGAIL abolishes fibrillation [244] while tyrosine-substitution sig-
nificantly inhibits it [247] indicating structure-specificity in the form of π-stack-
ing of aromatic rings [248]. However, Raleigh and coworkers [249] demonstrated
that phenylalanine is not required to form fibrils although a large effect upon
alanine-substitution and a less dramatic effect of leucine-substitution were ob-
served. The effects ascribed to effects on hydrophobicity and β-structure propen-
sity. Similar observations were made for ACP [250]. However, a microcrystal
structure of a designed 12-mer (KFFEAAAKKFFE) showed stabilisation of the
packing of parallel β-sheets by means of π-stacking of rows of phenylalanine
termed a phenylalanine zipper by the authors [251] and similar packing of aro-
matic side chains has been described for a pentapeptide of human calcitonin [252].
The role of charge in fibril-formation seemingly involve competition between
opposite mechanisms. Chiti and co-workers found that mutations that reduces
the net charge promote aggregation of ACP and the N-terminal domain of HypF
from E. coli (HypF-N) from an ensemble of partially denatured states signifying
an inhibitory effect of charge repulsion [232, 253]. Similarly, the tetrapeptide
KFFE fibrillates while KFFK and EFFE do not [254] in agreement with the ob-
servation that intrinsically unfolded proteins have lower net hydrophobicity and
higher net charge than native folded proteins [255]. In contrast, a study of de
novo designed hexapeptides showed that a charge of +/-1 was essential for fibril-
formation to proceed over amorphous aggregation [256] supporting the both im-
portance of charge-interactions in fibril stabilisation and the tendency towards
formation of amorphous aggregates at neutral net charge or by charges-screening
at high ionic strength [85, 185, 257]. The competition between amorphous β-
aggregation and formation of ordered amyloid-like fibrils is reasonable since
hydrophobicity and propensity for β-structure are important for both processes
[258]. Despite the overlap between β-aggregation and fibrillogenesis, some cau-
tious generalisations can be made about the relationship between the two proc-
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esses. Although amorphous, β-rich aggregates do contain significant amounts of
ordered structure, their structural flexibility can result in faster kinetics com-
pared to fibrillogenesis [258]. For highly hydrophobic sequences with high β-
sheet propensity, the tendency will be towards fast amorphous aggregation while
more polar sequences will be more favourable for formation of ordered fibril
structure. However, the two processes commonly occur simultaneous and com-
petitively, exemplified by the frequent observation of transient amorphous ag-
gregates during fibrillogenesis.
In recent years, several methods for prediction of aggregation or fibrillation pro-
pensity of denatured polypeptides have been developed based on individual amino
acids properties within the sequence. Using aggregation propensities obtained
from mutagenesis of Aβ [259, 260] (table 6.A) and sliding window analysis,
Conchillo-Sole et al. [262] developed the AGGRESCAN method for predicition
of aggregation ‘hot spots’ for several amyloidogenic proteins. The Zyggregator
algorithm, developed by Vendruscolo and co-workers [261], also uses position-
specific aggregational propensities (table 6.B) to calculate aggregation scores,
but these are based on α- and β-structure propensities, a score for patterns of
alternating polar and nonpolar side chains, hydrophobicity and charge. Aggrega-
tion-prone regions are identified by comparison to aggregation scores of a ran-
dom protein of similar length. The algorithm was recently [263] expanded to
allow prediction of aggregation-prone regions in native proteins by incorpora-
tion of the CamP method for calculation of flexibility and solvent accessibility
[264]. For the TANGO method, Fernandez-Escamilla et al. [265] used similar
physiochemical factors in combined with the assumption that a given amino acid
is fully buried in the fibril fold. The protein is divided into segments and the
partitioning within a conformation space including α-helix, β-aggregate and other
conformations is calculated to predict aggregation-prone segments. A different
approach was chosen by Seno and co-workers [266] for the PASTA method. Se-
Table 6. Aggregation
propensities of the 20
natural amino acids
used for AGGRESCAN
(A, [260]) and
Zyggregator (B, [261])
methods.
A. Aggregation propensities, de Groot et al. B. Aggregation propensities, Pawar et al.
Residue Residue pH 2 pH 7 pH 13
W 1.037 W 2.92 2.92 2.92
F 1.754 F 2.80 2.80 2.80
C 0.604 C 1.61 1.61 -3.44
Y 1.259 Y 1.03 1.03 1.03
I 1.822 I 0.93 0.93 0.93
V 1.594 V 0.49 0.49 0.49
L 1.380 L -0.25 -0.25 -0.25
M 0.910 M -1.06 -1.06 -1.06
T -0.159 T -2.12 -2.12 -2.12
A -0.036 A -3.31 -3.31 -3.31
G -0.535 G -3.96 -3.96 -3.96
H -1.033 H -9.36 -4.31 -4.31
S -0.294 S -5.08 -5.08 -5.08
Q -1.231 Q -6.00 -6.00 -6.00
N -1.302 N -6.02 -6.02 -6.02
D -1.836 D -4.38 -9.42 -9.42
K -0.931 K -9.55 -9.55 -9.47
E -1.412 E -6.73 -10.93 -10.93
R -1.240 R -11.93 -11.93 -11.85
P -0.334 P -11.96 -11.96 -11.96
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quence-specific strand-strand interaction energies were calculated from a library
of globular proteins to give parallel and anti-parallel pairing matrices. The pre-
diction algorithm calculates pairing aggregation scores for combinations of po-
tentially interacting regions in parallel and anti-parallel conformations to pre-
dict aggregation-prone segments and their orientation as minimal interaction en-
ergies. This list of prediction methods is by no means exhaustive but merely
represent the methods used in the present work. It is worth mentioning that the
close relationship between β-aggregation and fibrillation can limit the predictive
power of such methods. A sequence may be predicted as aggregation-prone based
on high β-strand propensity, high hydrophobicity and low net charge but this is
not in itself indicative of aggregation in the fibrillar form.
1.4 Molecular basis of cellular toxicity
A detailed description of the pathological mechanism of neurodegenerative amy-
loidoses and diseases with amyloid-like deposits has remained an elusive target.
Certainly, the clinical characteristics do not suggest a single, simple underlying
mechanism. The diseases have very diverse cardinal symptoms, e.g. bradyki-
nesia, rest tremor, rigidity and postural instability of Parkinson’s disease, insom-
nia and autonomic nervous system dysfunction of Fatal Familial Insomnia (FFI)
and uncontrolled body movements, personality changes and dementia of Hunt-
ington’s disease [267-269]. However, the underlying progressive neuronal dys-
function and apoptosis shows similarities on the cellular level and the diverse
symptoms are rather associated with selectivity for specific populations of neu-
rons [270]: Hippocampal and cortical neurons are the primary targets in AD
whereas PD is associated with loss of dopaminogenic neurons of the substantia
nigra [271, 272]. Likewise, different mutations in the same gene can lead to dis-
tinct clinical forms such for mutations in the prion protein gene where Creutzfeldt-
Jacob disease is associated with widespread spongiform changes while neuronal
loss is limited to the thalamus in FFI [269, 273]. It is likely that numerous of
inherited or environmental factors play a role in pathogenesis and that the spe-
cific factors and the interplay between may differ for the various neurodegenerative
diseases. A number of theses factors will be covered in the following with par-
ticular emphasis on the effect of the amyloidogenic protein species and the iden-
tification of the primary toxic species among these.
1.4.1 The amyloid and oligomeric hypotheses
The presence of insoluble amyloid co-localised with areas most affected by dis-
ease is a general observation of neurodegenerative amyloidoses [274]. This, cou-
pled with the discovery of mutations in the APP gene associated with early onset-
AD and the inevitable development of AD in individuals with trisomy 21/Down’s
syndrome who live beyond the age of 404 [275], led to the amyloid hypothesis of
Alzheimer’s disease (figure 14): The accumulation and deposition of amyloid is
the primary event of disease leading to a cascade of tau hyperphosphorylation
and neuronal death [42, 276]. Additional support for the amyloid hypothesis comes
4 The extra copy of APP in trisomy 21 causes life-long overexpression of AβPP and widespread deposition of Aβ [275].
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from AD as well as other neurodegenerative amyloidoses in the form of disease-
associated phenotypes observed for animal models over-expressing amyloidogenic
proteins [277-279], from identification of mutations linked to hereditary disease
forms [32, 268] as well as biophysical characterisation of the in vitro aggregational
tendency of the mutant proteins and peptides [32, 39]. Nevertheless, several fac-
tors speak against the validity of the this simple amyloid cascade hypothesis. The
correlation between accumulation of amyloid plaques and the severity of AD
symptoms is poor [280, 281] whereas the soluble population of Aβ, consisting of
monomers and low-molecular mass oligomers, is more predictive for the sever-
ity of neurodegeneration [41, 282, 283]. Neurological deposits is a common post-
mortem find in the non-demented elderly [284] and symptoms may conversely
develop in the absence of extensive deposition such as in the case of juvenile
autosomal recessive PD [285, 286]. Correspondingly, symptoms have been shown
to precede formation if amyloid plaques in Aβ- or α-synuclein-expressing mouse
and Drosophila models [287-291]. Disease progression may therefore be inde-
pendent of formation of mature amyloid plaques and it is plausible that a shared
mechanism may exist that unify not only the neurodegenerative amyloidoses but
also neurodegenerative disease such as amyotrophic lateral sclerosis (ALS, [292])
that progress in the absence of amyloid plaques but shows formation of similar
oligomeric structures.
The presence of non-amyloid aggregates can be demonstrated in the early
presymptomatic stage for mouse and Drosophila models [293-295] and the emerg-
ing view of the relationship between protein structure and progression of disease
focuses on the formation of oligomeric species [5, 193, 296], which may be simi-
lar to those observed in in vitro studies, e.g. spheroid and linear or annular
protofibrils. This view is supported by the study of the E693G or ‘Arctic’ variant
of AD for which dementia develops in the absence of compact amyloid plaques.
The mutation causes decreased plasma levels of Aβ1-40 and the more amyloidogenic
Aβ1-42 but increases protofibril formation [297]. While the common observation
of oligomeric structures in vitro may not correspond to biologically relevant spe-
cies, soluble Aβ oligomers have been isolated from human cerebrospinal fluid
(CSF), cultured cells or transgenic mouse models [298-301]. Memory-impair-
ment in the absence of neuronal loss correlated to extra-cellular accumulation of
a 56kDa oligomer5 has been demonstrated in mouse model over-expressing AβPP
and comparable reversible memory impairment was observed when the oligomer
was injected in rat brain [302]. Similarly, samples from cases of multiple system
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5 The 56kDa oligomer theoretically corresponds to a dodecamer of Aβ1-42.
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atrophy were found to contain annular α-synuclein oligomers [303] with simi-
larities to the annular species observed for recombinant α-synuclein [200].
The detection and characterisation of oligomers in humans is limited but much
information has been gleaned from studies on cultured neurons. Mature fibrils
can be neurotoxic but commonly at significant higher concentrations than for
oligomers, which also speaks against the mature fibril as the primary toxic spe-
cies in vivo [24]. Sub-micromolar concentrations of oligomers are capable of
inducing apoptosis with associated calcium homeostasis alterations, unspecific
membrane permeabilisation and depolarisation, Golgi and chromatin fragmenta-
tion and increased oxidative stress [192, 304-308]. The toxicity of oligomers in
cell culture appears to be a general phenomenon [32, 309] and has been reported
for proteins or peptides with no association with clinical disease as well as those
associated with neurodegenerative and other localised amyloidoses, e.g. Aβ [198,
310], α-synuclein [311, 312], PrP [313], IAPP [314, 315], TTR [316, 317], equine
lysozyme [318, 319], SH3 and E.coli hydrogenase maturation factor (HypF) [320,
321]. Oligomer-cytotoxicity has also been implicated in the systemic immu-
noglobulin light chain amyloidosis [31] and may be a contributing factor in other
systemic amyloidoses [322].
In recent years, studies have also shed light on the effect of oligomers in vivo.
Selkoe and coworkers [323-326] have identified Aβ1-42 over-expressing cell lines
that form intra-cellular and secreted di-, tri- and tetramers, which are potent
neurotoxins at picomolar concentration. Direct cerebellar injection in rat caused
inhibition of hippocampal long-term potentiation (LTP), cognitive disruption and
impairment of complex learned behaviour. Studies of organotypical hippocam-
pal slices in vivo also showed inhibition of hippocampal LTP as well as pro-
nounced but reversible effects on dendritic spine density. In all, these results
suggest that the mechanism behind the memory and learning deficits of dementia
is does not merely involve cell death but also subtle effects on neuron function.
Similarly, injection of oligomers of the non-pathogenic HypF into rat brain led to
dose-dependent impairment of function although to a lesser degree than in cul-
tured cells suggesting the presence of protective mechanisms [309]. Further sup-
port for the role of oligomers in disease process comes from antibody and immu-
nisation studies. Antibodies raised against soluble Aβ1-42 oligomers or a molecu-
lar mimic of spherical Aβ oligomers have little or no immunoreactivity against
low-molecular weight Aβ or fibrils but effectively inhibit the neurotoxicity in
cell culture of Aβ1-40 and Aβ1-42 oligomers [327-329], which is in agreement with
the marked improvement in transgenic mice upon immunisation and that neuro-
logical improvement can be independent of reduced presence of mature amyloid
[330]. However, the oligomer-specific antibodies also inhibit neurotoxicity of
oligomers of very diverse sequences including α-synuclein, IAPP, polyglutamine,
lysozyme, insulin and PrP106-126 [327] suggesting a shared oligomeric structure
and common pathological mechanism. The supposed shared structure is interest-
ing in the light of the proposed generic nature of mature fibril structure.
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1.4.2 Membrane permeabilisation by amyloidogenic proteins or peptides
The seeming importance of early oligomeric forms of the amyloidogenic pro-
teins combined with the common observations of membrane permeabilisation
and depolarisation suggest that the cytotoxic mechanism may include membrane-
associated processes [331]. It has been hypothesised that cell death is closely
associated with or caused by membrane perturbations through formation of chan-
nels by the amyloidogenic protein, changes in membrane fluidity or lipid
peroxidation due to increased levels of free radicals or possibly a combination of
these factors [332-335]. In vitro permeabilisation has been demonstrated for sev-
eral amyloidogenic system [336-339] using artificial liposomes of neutral and
anionic lipids and in- or efflux of Ca2+ and various probes. As expected from the
available observations of cytotoxicity, the early oligomeric forms have the high-
est membrane activity, which decreases as mature fibrils are formed [306, 338,
340].
The ability of an amyloidogenic peptide to form transmembrane pores in vitro
was first demonstrated in 1993 for Aβ1-40 [341]. The pores were voltage-inde-
pendent, moderately cation-selective, Ca2+-permable, of varied conductance in
the pS-range and all susceptible to blockage by Al3+ (irreversible) and tris
(tromethamine, reversible). Further work demonstrated formation of channels
with unusually high conductance in the 0.4-4nS range and the authors suggested
that the incorporation of such channels in neuronal membranes could alter Ca2+
homeostasis and depolarise the membrane within seconds and induce apoptosis
[342] leading to the channel hypothesis of Aβ cell toxicity [343]. Indeed, Aβ1-40
and Aβ1-42 have been shown to kill fibroblasts and to form channels in rat cortical
neurons, hNT cells and patches of gonadotropin-releasing neurons [344-347].
Studies have demonstrated formation of several dissimilar and reproducible chan-
nel types distinguishable by their conductivity, ion selectivity, voltage activation
and kinetic characteristics [341, 342, 348-350], which is consistent with a range
of oligomeric assemblies and thereby channels rather than a single well-defined
transmembrane structure. The channel hypothesis has since been supported by in
Peptide Voltage Single-channel Ion Blockade Inhibition by
dependence conductance selectivity by zinc Congo red
Aβ25-35 Dependent 
b 10-400pS Cation + +
Aβ1-40 Independent 10-2000pS Cation + N.D.
Independent 50-4000pS Cation + N.D.
Aβ1-42 Independent 10-2000pS Cation + +
CT105 a Independent 120pS Cation + +
IAPP Dependent c 7.5pS Cation + +
PrP106-126 Independent 10-400pS Cation + +
Independent 140, 900, 1444pS Cation N.D. N.D.
PrP82-146 Independent Cation N.D. N.D.
SAA Independent 10-1000pS Cation + +
ANF Independent 21, 63pS Cation + +
β2m Independent 0.5-120pS Non-selective + +
Transthyretin Independent Variable Cation (variable) + +
Polyglutamine Independent 19-220pS Non-selective - -
Independent 17pS Cation N.D. N.D.
α-synuclein65-95 Independent 10-300pS + +
Table 7. Examples of
channel-formation by
amyloidogenic proteins
and peptides. Adapted
from [335]. a C-terminal
fragment of APP.
b Channels open at
negative voltages and
close at positive volta-
ges. c Channels close
at positive voltages.
N.D. Not determined.
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vitro observation of similar pores for several other amyloidogenic proteins and
polypeptides (table 7, figure 15) [199, 202]. Despite very varied conductivities
and differences in cation-selectivity, the channels have remarkably similar char-
acteristics including blocking by Zn2+ and inhibition of channel formation by
CR, which is a known inhibitor of fibrillation [335, 351]. In contrast, conditions
that favour oligomerisation generally enhance channel formation, which is also
the effect of increasing membrane charge and low concentration of cholesterol
[352, 353] illustrating the importance of aggregational state, electrostatic inter-
action and membrane fluidity on membrane activity.
In all, the observations of channel-like permeabilisation suggest the toxicity is
linked to the formation of a collection of channels with overall similar structure.
However, other mechanisms of membrane permeabilisation have been described.
Glabe and co-workers [304] described generalised permeabilisation by oligomers
of Aβ, IAPP, polyglutamine and lysozyme while Kayed et al. [354] described
alterations in membrane conductance by oligomers of Aβ1-40, Aβ1-42, α-synuclein,
polyglutamine, PrP106-126 and IAPP that could not be explained by channel forma-
tion. IAPP has also been shown to induce non-channel defects in supported lipid
bilayers monitored by time-lapse AFM [355] while α-synuclein and the G4R
variant of human stefin B cause membrane fragmentation [336, 339]. Interest-
ingly, both the wild type and the more amyloidogenic stB-Y31 isoforms of stefin
B permeabilises liposomes by a channel-like mechanism. A different effect has
been observed for growing fibrils of e.g. IAPP, endostatin and Aβ in vitro, for
which alteration of bilayer structure or extraction of lipid into the forming fibril
was associated with loss of membrane integrity and increased permeability [356-
358]. It is possible that such non-specific alteration of membrane structure could
play a direct role in inducing apoptosis in vivo.
1.4.3 Membrane modulation of fibril growth
As described previously, the current hypothesis for fibrillogenesis under mem-
brane-free conditions consists of several steps: i) Destabilisation and partial un-
folding of globular proteins or partial folding/stabilisation of natively unfolded
proteins/peptides yielding a fibrillation-prone conformation, ii) association of
monomers into a critical fibrillation nucleus or seed and iii) endwise elongation/
addition of monomers to the seed and growing fibril, possibly combined with
shearing of fibrils to create additional growing ends. Formation of a variety of
morphologically distinct oligomers may or may not be an on-pathway phenom-
enon and the growing fibril may undergo further maturation. Based on current
knowledge, a similar mechanism can be outlined for on-membrane fibrillogenesis
Figure 15.High-
resolution AFM images
of oligomeric channels.
Adapted from [202].
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although significant structural differences may exist between solution- and mem-
brane-associated assemblies [359]: i) Association of the monomer with the mem-
brane, generally but not solely by electrostatic attraction, ii) structural transitioning
to a fibrillation-prone conformation, iii) oligomerisation of the bound monomers,
which for IAPP and α-synuclein appears to proceed in a nucleation-dependent
manner and iv) fibril growth by monomer addition.
The unique environment afforded by the lipid bilayer may induce and act as a
catalyst of fibrillogenesis. Whereas zwitterionic membranes have little or not
effect, acceleration of fibrillation by anionic lipids has demonstrated for pro-
teins/peptides associated with disease, e.g. Aβ [360], α-synuclein [361], IAPP
[362], lysozyme, transthyretin, as well as proteins without known in vivo
amyloidogenic activity, e.g. cytochrome c, insulin, myoglobin and endostatin [357,
363]. Effects on oligomerisation of Aβ have also been described for mixed mem-
branes of zwitterionic lipid and gangliosides or cholesterol [364], suggesting that
lipids may influence fibrillogenesis by a complex interplay of factors that influ-
ence physiochemical characteristics (e.g. charge, interfacial pH and dielectric
constant, bilayer thickness and lateral pressure) and that these factors are protein/
peptide specific. Destabilisation and partial unfolding at the water-membrane
interface has been observed for a variety of globular proteins such as cytochrome
c, phospholipase A2 and acetylcholinesterase [365-367]. Similarly, membrane
interaction may stabilise partially folded conformations of natively unfolded pro-
teins or peptides. Aβ is unfolded in solution but recognises and binds to clusters
of GM1 gangliosides on the cell membrane, the formation of which is modulated
by cholesterol [368]. The unfolded peptide transitions to an α-helical structure at
low Aβ:GM1 ratios, whereas higher ratios result in a β-rich conformation, which
is hypothesised to facilitate nucleation and fibrillation in vivo [369]. Similarly, α-
synuclein assumes an α-helical conformation when bound to negatively charged
membranes [370].
Preferential membrane binding can increase the local concentration [371] and/or
result in regular orientation of the polypeptide chain normal to the membrane
plane by e.g. asymmetric charge distribution or partial insertion into the bilayer.
An illustrative examples comes from human IAPP. While the peptide binds to
zwitterionic liposomes in a β-rich conformation [372], Miranker and co-workers
[373] showed that human IAPP partly insert into anionic membranes in an α-
helical conformation, which after a lag phase transitions to a β-rich conformation
synchronous with fibril formation. The formed α-helix has a highly cationic N-
terminus and the authors speculated that the interaction with the anionic lipid
headgroups masks the charges allowing the α-helix to form and permits cluster-
ing of individual helices in bundles. Random helix-coil sampling then leads to
cooperative transition to the β-rich conformation and nucleation of fibril forma-
tion (figure 16) yielding fibrils of parallel strand orientation. Such interstrand
orientation has been described for IAPP [374] while parallel, in-register align-
ment appears to be a favoured conformation for fibrils of several Aβ-variants in
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solution [375]. Curiously, membrane permeabilisation is observed for the α-heli-
cal rather than later states, which offers a possible structural model for non-pore
permeabilisation observed for IAPP [304, 354]. The importance of charge in
membrane-associated IAPP fibrillogenesis is also illustrated by the observation
of an optimal surface charge density of anionic:zwitterionic vesicles for rapid
fibril assembly [362].
The anionic head groups play an important role in preferentially binding the pro-
tein or peptide [376] but the properties of the hydrophobic core region of the
bilayer have significance for those proteins or peptides that partially inserts into
the bilayer and intercalates between the densely packed acyl chains [377-379].
The interaction can inhibit fibrillation but also enhance nucleation and fibril for-
mation. Wild type α-synuclein primarily associate with the polar lipid headgroups
where it can act as a heterologous seed for fibrillation in the cytosol whereas the
A53T mutant penetrates deeper into the non-polar bilayer core thereby masking
the hydrophobic protein regions and inhibiting nucleation [380]. Membrane as-
sociation and penetration also appears to be of importance for Aβ. The ability of
Aβ to insert into mixed zwitterionic lipid/cholesterol monolayers and vesicles
increases with increasing cholesterol content [381]. At cholesterol levels the pep-
tide adopts a predominantly α-helical conformation and is effectively protected
against fibril formation. Similarly, decreasing cholesterol content of brain lipid
liposomes resulted in increased nucleation, surface fibril formation and toxicity
for PC-12 and SY5Y cells whereas high cholesterol levels allowed membrane
association but not insertion and inhibited fibril formation [382]. The nucleation-
and fibrillation-enhancing effect of Aβ associated with anionic membrane sur-
faces was also demonstrated by Bokvist et al. [360] who showed that anionic
lipids could stabilise an α-helical, transmembrane conformation of the recently
cleaved peptide thereby preventing its release and subsequent fibrillation through
surface-associated nucleation. However, an exiting recent study by Rousseau and
co-workers [383] revealed a complementary effect of zwitterionic and anionic
lipids as well as cholesterol and gangliosides. Vesicles of these lipids converted
mature Aβ fibrils into soluble oligomers similar to those formed by ‘forward’
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oligomerisation. The ‘backward’ oligomers were cytotoxic in culture and induced
cognitive deficits in rats suggesting that a highly dynamic equilibrium exists for
lipid-associated oligomers and fibrils and that lipids play an important role in
modulation of oligomerisation and thereby toxicity in vivo.
1.4.4 Mechanism behind cell death may be complex and involve many factors
There is compelling evidence for oligomers formed during the early steps in
fibrillogenesis as the primary toxic species in vivo, which allows formulation of
a tentative mechanism of cytotoxicity (figure 17.A). In the healthy cell, misfolded
proteins should be refolded by chaperone intervention or cleared by the ubiquitin-
proteasome system [384]. Similarly, oligomeric assemblies and insoluble aggre-
gates should be degraded via the autophagy-lysozyme pathway. However, insuf-
ficiency or outright malfunction of these system allows accumulation of misfolded
monomers, oligomers and, eventually, mature fibrils. The oligomers most likely
have a number of deleterious effects such as membrane destabilisation, mito-
chondrial dysfunction and alterations in the Ca2+ homeostasis [24, 331]. Some or
all of these eventually leads to cells dysfunction and death, which present as
clinical symptoms although significant cell loss can be required [385].
The focus on oligomers as the neurotoxic agent proposes a useful but somewhat
narrow perspective, which may be too simplistic in vivo, as demonstrated by the
observation of protective mechanisms in rat brain against HypF oligomers. The
question also remains what leads to misfolding of proteins and formation of
oligomers in tissue in excess of the capacity of cellular clearance pathways. One
likely scenario is an interplay of numerous causes (figure 17.B) related to aging,
disease or inherited factors including, but not limited to, increased concentration
of the amyloidogenic protein or peptide, increased oligomerisation tendency,
decreased clearance of misfolded protein or aggregates and increased oxidative
stress [5, 311].
The available cellular concentration of the amyloidogenic protein or peptide is
determined by synthesis and clearance rates and, in the case of amyloidogenic
protein fragments, by alterations of the proteolytic processing of the precursor
protein consistent with the correlation between elevated of ‘soluble’ Aβ, i.e.
monomeric and low-molecular mass oligomeric, and disease in AD. Decreasing
efficiency and capacity of cellular clearance pathway and increasing oxidative
stress are both associated with ageing [384, 386, 387], which offers a possible
explanation for why neurodegenerative diseases predominantly are diseases of
late life. Oxidative stress arises from the accumulation of reactive oxygen spe-
cies (ROS) in excess of what the cellular antioxidant systems and has been impli-
cated in pathogenesis of a number of neurodegenerative and other amyloidoses
[268, 388], e.g. lipid peroxidation known to induce membrane perturbations and
other cellular injuries prompting cell death [389, 390] or accumulation of misfolded
proteins [272, 391, 392]. The tendency towards misfolding, oligomerisation and
fibrillation can also be driven by pathogenic mutations exemplified by the E693G
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Arctic variant of AD described above. Any of these factors could contribute to
the accumulation of misfolded protein but amyloidogenic proteins can in turn
influence both the oxidative state of the cell and proteasomal efficacy. Binding of
metal ions such as Cu2+ and Fe3+ to Aβ results in production of ROS, peptide
oxidation and reduction of the metal ions by reaction with O2 [393, 394]. Simi-
larly, amyloid plaques are efficient redox catalysts [395] and co-localise with
elevated levels of transition metals [396] suggesting that direct production of
ROS by Aβ oxidation plays a role in pathogenesis. Interaction with transition
metals have also been described as an effective catalyst of oligomerisation [397,
398]. However, Aβ, α-synuclein and polyglutamate have also been implicated
directly in mitochondrial dysfunction [399] and enhanced permeability of mito-
chondrial membranes with channel-like characteristics or through localised
oxidative damage to the membrane [400-403]. It is likely that mitochondrial dys-
function will affect the ATP dependent ubiquitin-proteasome system [404] but
oligomers of α-synuclein have also been directly linked to proteasome impair-
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ment [405, 406]. Consequently, the pathogenesis of neurodegenerative amy-
loidoses is complex and may be driven by self-propagating factors.
Activation of components of the immune system may play an important role in
the clinical progression of neurodegenerative amyloidoses. Activation of micro-
glia and astrocytes leading to overexpression of cytokines is a known cause of
neuronal tissue loss and can, in the chronic inflammatory state of AD, act in a
self-propagating fashion [407]. Additionally, activation of complement through
the classical and alternative pathways occurs early in disease progression. Acti-
vation appears to occur at the site of plaques leading to insertion of the mem-
brane-perforating MAC complex in surrounding neurons probably leading to fur-
ther neuronal death [408]. It remains unknown to what degree immune activation
and inflammation actively participates in driving the emergence of clinical symp-
toms, but they arguable play an important part in the progression of disease [409].
A final potential contributor to neurological abnormalities is cerebral amyloid
angiopathy (described in section 1.1.4). The exact role of CAA in the pathology
of AD and other neurodegenerative amyloidoses is not known, but CAA has in
some cases been linked directly to the development of dementia [410]. CAA-
related strokes, micro-haemorrhages and vascular degeneration appears to play a
significant role with ischemic lesions as a common post-mortem find in e.g. AD.
It is possible that the progressive damage to vasculature arises from direct toxic-
ity of the deposited species [411]. However, the argument can also be made that
the pathology of CAA also bears semblance to the systemic amyloidoses in that
vascular disruption appears to play an important part in disease development.
1.4.5 Potential therapeutic approaches
Unsurprisingly, much effort has gone into development of therapeutic strategies
for intervention in neurodegenerative and other amyloidoses. The current treat-
ment options do not address the underlying cause of disease but are rather fo-
cused on alleviating symptoms e.g. by inhibitions of acetylcholinesterase in AD
(tacrine, donepezil and rivastigmine approved for treatment) [412, 413] or
dopamine-replacement therapy in PD (levodopa, co-careldopa and co-beneldopa)
[414]. Disease-modifying treatment requires that the cause of disease be addressed.
Considering the case of AD and using the current limited understanding of its
pathology, a simplistic sequence of events can be drawn up (figure 18) [5]. Briefly,
the full-length AβPP is processed (1) yielding a number of Aβ variants of which
Aβ1-42 is the most amyloidogenic. Aβ is in dynamic equilibrium with toxic
oligomers, (Aβ)n, (2) and mature fibrils in amyloid plaques (3). The presence of
oligomers give rise to disease by a complex mechanism (4). Prevention of clini-
cal symptoms require intervention at any of these steps or by depletion of
monomeric Aβ (5, 6). Selected therapeutic approaches are summarised in table 8.
The initial processing of AβPP (1) is a prime candidate for intervention e.g. via
inhibition or modulation of γ-secretase and shifting of the proteolytic cleavage
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from Aβ1-42 to less amyloidogenic peptide variants. Recent years have seen sev-
eral potentially effective candidates. The γ-secretase modulator R-flurbiprofen
(Flurizan) showed promise in animal and phase II trials, but was discarded after
lack of effect at phase III [415-417]. Recently, an alternative, LY451039, has
entered phase III [418-420].
Assuming that the soluble oligomers that are observed for most amyloidoses in-
deed are the toxic species, the prevention of this step is essential, either by bind-
ing of the monomer thereby preventing self-association (5) or by stabilisation of
a non-toxic oligomeric assembly (2). The initial view that the mature fibril is the
toxic species led to a focus on the prevention of fibrillation rather than formation
of oligomers and diverse small molecule inhibitors were identified in vitro in-
cluding benzoflurans, sulphated or sulphonated compounds, apomorphine, anti-
oxidants, antibiotics, chemotherapeutic agents and natural products such as
curcumin from tumeric [421-435]. Several of these compounds also prevent cell
death in culture [423, 424, 427, 432, 435]. However, inhibition of oligomerisation
or of oligomerisation and fibrillation can only be demonstrated for a subset of the
general inhibitors [215]. An example of an oligomerisation inhibitor is tramiprosate
(3APS), which is currently in phase III trials. The approach utilises the in vivo
binding of glycosaminoglycan (GAG) to amyloid. The compound is a sulpho-
Table 8. Examples of
compounds being de-
veloped for treatment
of AD.
Compound name(s) Clinical trial no.a Phase Remarks
Inhibition of γ-secretase
R-flurbiprofen, Flurizan NCT00105547 III Lack of effect in phase III, discontinued
LY450139 NCT00244322 II
NCT00471211 II
NCT00594568 III
Inhibition/modulation of oligomerisation
Tramiprosate, 3APS NCT00314912 III Sulphonated GAC-mimic
NCT00088673 III
NCT00217763 III
ELND005, AZD103 NCT00568776 II Scyllo stereoisomer of inositol
Antibody-based approaches
AN1792 NCT00021723 II Active immunisation, discontinued
after severe adverse effects
Bepaneuzimab, ELN115727 NCT00574132 III Passive immunisation with monoclonal
NCT00575055 III antibody
NCT00676143 III
NCT00667810 III
a http://clinicaltrial.gov
Figure 18. Summary of
Aβ processing and
fibrillation with possible
sites of intervention.
Obviously, activity in
the CNS requires
prospective drugs to be
able to cross the blood
brain barrier. Adapted
from [5].
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nated GAG mimic, which selectively binds monomeric Aβ (5), maintains it in an
α-helical/random coil conformation and thereby prevents formation of toxic
oligomers [436-439]. An alternative approach, utilising the scyllo stereoisomer
of inositol (ELND005, formerly known as AZD-103), targets the equilibrium
formation of oligomeric (Aβ)n (2). The compound stabilises a non-toxic oligo-
meric Aβ assembly [440-442] and is being investigated in phase II.
Antibody-mediated removal of the amyloidogenic monomer from the brain (6) is
a potentially very powerful alternative. Binding of monomeric Aβ and transport
across the blood-brain barrier followed by remote degradation would deplete the
soluble peptide pool and, via the equilibrium, oligomers and higher aggregates.
Consistent with this, animal studies have demonstrated that active or passive
immunisation against Aβ can result in reduction of amyloid plaques and some
reversibility of cognitive deficits [330, 443-447]. A phase II study using pre-
aggregated Aβ (AN1792) was prematurely stopped after 6% of participants de-
veloped aseptic meningoencephalitis, possibly due to T-cell activation [448, 449]
and despite observations of lower levels of aggregated Aβ in test subjects [450],
concern remains over the severe adverse effects. An alternative small study using
passive immunisation with total human IgG from healthy individuals showed
effect in human subjects [451] and several remodelled antigens or monoclonal
antibodies are in development [452-455] including the AN1792-derived
monoclonal antibody bepaneuzimab [456, 457], which is currently in phase III.
An alternative to inhibition of toxic oligomer formation is intervention at step (4)
by e.g. neuroprotective agents such as the antihistamine dimebolin [458, 459],
which has been described as an effective blocker of Ca2+ channels [460], or metal-
protein attenuating compounds such as the quinoline derivative PBT2 [461], which
also potentially targets Cu2+-mediated oligomerisation. A consequence of the oli-
gomer toxicity hypothesis is that conversion to mature fibrils could function as a
clearing mechanism allowing sequestering of toxic oligomers in relatively be-
nign deposits [462, 463]. Consequently, inhibitors that prevent this step (3) could
exacerbate rather than alleviate disease. A compound that catalyses fibril forma-
tion could have clinical effect although some studies indicate that mature fibrils
may be toxic as well [464, 465]. However, intervention at steps (3) and (4) are
associated with progressing build-up of aggregated material, which may lead to
tissue damage and disease, particularly considering the pathology of the sys-
temic amyloidoses and CAA.
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Paper 1 is focused on characterisation of the aggregational behaviour of a modi-
fied peptide linked to Familial Danish dementia. This recently described
neurodegenerative disease belongs to the chromosome 13 group of rare familial
amyloidoses, which also comprises Familial British dementia (FBD). These dis-
eases share a common precursor protein, BriPP, which is located on the long arm
of chromosome 13, and constitute an alternative model for neurodegenerative
amyloid pathology. Central aspects of these diseases are summarised in the fol-
lowing with emphasis on pathophysiology and the properties of the associated
proteins and peptides.
2.1 Aspects of chromosome 13 dementias
2.1.1 Familial British dementia
Familial British dementia was first described by Worster-Drought and collabora-
tors in 1933 as a novel form of familial presenile dementia with spastic paralysis
in members of a family residing in South London [466, 467]. The original Worster-
Drought pedigree has since been expanded to encompass more than 300 indi-
viduals including 36 known cases dating back to the late eighteenth century [468-
471]. An additional pedigree containing two cases without clear relation to the
main pedigree has been described [472] and could potentially represent an unre-
lated emergence of the disease-causing mutation although relation to the expanded
Worster-Drought pedigree could exist through several members that remain un-
accounted for.
FBD is an early-onset autosomal dominant disorder with a median age of onset
of 48 years (range 40-60) [469, 473]. Clinically, it initially presents with person-
ality changes and impairment of memory, which progresses to global amnesia.
The patients display gradually worsening spastic tetraparesis and cerebellar ataxia.
The median length of illness is 9 years with median age of death at 56 years of
age (range 48-70). Histopathologic examination of post-mortem samples shows
CR and ThS positive parenchymal plaques composed of 10nm-wide fibrils of
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varying density and entanglement throughout the central nervous system but par-
ticularly affecting the hippocampus and cerebellum with lesser involvement of
the amygdala and hypothalamic nuclei [474]. Neurofibrillar tangles are observed
with severe pathology in the limbic system associated with plaques in a manner
similar to AD. In addition of amyloid plaques, diffuse CR- and ThS-negative
non-fibrillar or preamyloid deposits are present in most areas of the CNS. These
are composed of amorphous, electron-dense material with sparse fibril presence.
CR-negative amorphous material is also found bordering amyloid plaques. Addi-
tionally, many amyloid plaques are of the perivascular type and associated with
severe CAA throughout the brain and spinal cord affecting white and grey mat-
ter. Cerebral haemorrhage is observed rarely in FBD, but stroke-like episode
have been described in some cases and ischemic lesions is a common post-mortem
find [468]. Overall, the neuropathology of FBD is similar to that observed for
AD, but FBD also shows widespread systemic amyloid or non-amyloid,
parenchymal and vascular deposits, indistinguishable from those found in the
CNS, in organs and skeletal muscle [475, 476]. Systemic, non-amyloid presence
of Aβ has been demonstrated for AD [477] while systemic amyloid has been
identified for HCHWA-I, for which CNS parenchymal amyloid is absent, but
neither shows both neurological and systemic presence of amyloid [478, 479].
The main constituent of FBD amyloid plaques, perivascular plaques, vascular
and diffuse deposits has been identified as a ~4kDa peptide, termed ABri, which
is a C-terminal proteolytic degradation product of the BriPP protein [480]. The
presence of amyloid-associated proteins or other additional components has also
been demonstrate including SAP, apolipoproteins E and J, HSPGs [481] and,
curiously, C-terminal fragments of α- and β-tubulin [482].
2.1.2 Familial Danish dementia
Familial Danish Dementia was first described in 1970 by Strömgren and collabo-
rators under the name heredopathia ophthalmo-oto-encephalica in a family from
Djursland, Denmark [483]. The 48 person pedigree is smaller than that of FBD
with 13 identified cases spanning five generations [473, 484]. Like FBD, FDD is
an autosomal dominant disease but with earlier age of onset, which can be before
the age of 30 and median age of death at 58 years. The first clinical symptom is
gradual loss of vision from cataract formation and accumulation of amyloid in
the retina and in walls of retinal capillaries leading to loss of glial cells and reti-
nal neovascularisation, vitreous haemorrhage and neovascular glaucoma [485].
Severe or total central hearing loss develops 10-20 years after the initial symp-
toms followed by gradually worsening cerebellar ataxia [473]. The final decade
of life is marked by development of paranoid psychosis and progressive demen-
tia.
One of the major histopathological finds in FDD is severe cerebral amyloid an-
giopathy throughout the CNS with particularly abundant deposits found in the
hippocampus, subiculum and cerebellar cortex where some capillaries appear
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completely occluded [484, 486] and with associated volume loss and small areas
of infarction. However, unlike FBD and Alzheimer’s disease, amyloid plaques
rare and principally perivascular with the exception of retinal and subpial
paranchymal plaques. Paranchymal deposits are predominantly non-neuritic and
observed throughout the CNS with highest concentration in the hypothalamus,
midbrain tectum and periaqueductal grey, locus ceruleus, retina, hippocampal
formation and other limbic structures. These deposits do not stain with CR or
ThS but do bind antibodies to AAPs with particularly high intensity for SAP
[481]. The absence of staining with amyloid-specific dyes indicate a lack of fi-
brillar structure and these possibly preamyloid deposits can be divided into two
groups: 1) Compact plaques that appear morphologically similar to cotton-wool
plaques observed for spastic paraparesis variants of Alzheimer’s disease and 2)
ill-defined ‘cloudy’ deposits that are often peri-neuronal. Neurofibrillar tangles,
particularly within the hippocampus, are similar to the neuropathology observed
for FBD and AD. The predominance of non-fibrillar deposits highlights the prob-
able importance of oligomeric species in disease progress and suggests that the
eventual presence of fibrillar or non-fibrillar, insoluble deposits may be inciden-
tal. Similar to other neurodegenerative amyloidoses, immune activation appears
to be an important factor in FBD and FDD. Complement activation in FBD and
FDD occurs by both the classical and alternative pathways with membrane at-
tack complex activation on level with the activation observed for Aβ1-42 [487].
The amyloid, but not the defuse deposits in FBD and FDD, are associated with
markers of glial activation and local inflammation [474, 484] and show co-lo-
calisation with α-1-antichymotrypsin and cystatin C indicating local inflamma-
tion [481].
A novel, 34-amino acid peptide, ADan, has been identified in circulation and in
plaques in post-mortem samples [486]. Like ABri, it is a C-terminal proteolytic
fragment of BriPP albeit arising from a different mutation. An interesting aspect
of FDD is the colocalisation but without complete overlap between deposits of
ADan and Aβ by immunostaining [484, 488]. Co-deposition is primarily vascu-
lar or within perivascular amyloid plaques and occur predominantly in the hip-
pocampus, limbic structures, neocortex, thalamus and cerebellum while other
areas are solely affected by ADan deposition. The most prevalent deposited form
is Aβ1-42 with N-terminal degradation to position 3-4 [489]. It is possible that Aβ
is deposited as an ‘innocent bystander’ due to interaction with ADan or the pre-
cursor protein or that FDD is associated with early-onset Alzheimer’s disease
through some unknown mechanism. However, the exact mechanism behind such
co-localisation remains unknown although overlapping deposition is a well-known
phenomenon as exemplified by cystatin C, which co-localises with Aβ in AD
brain [490] and with amyloid deposits in FBD and FDD. CST3, encoding cystatin
C, has also recently been implicated as a AD susceptibility gene [491] and whereas
mutant variants of cystatin C is linked to hereditary amyloidosis and CAA, the
wild type has also been shown to inhibit fibrillation in vitro [492].
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2.2 The precursor proteins
2.2.1 Characteristics of BriPP
The Bri precursor protein (termed BriPP, ABriPP or ADanPP depending on pres-
ence of FBD or FDD-related mutation) is a 266AA protein encoded by the ITM2B
gene on the long arm of chromosome 13 [486]. The gene contains six exons and
five introns of which the first is long and possibly contains regulatory elements.
The ITM2 gene family span at least three isoforms (ITM2A, ITM2B and ITM2C)
in human and mouse [489], but ITM2B, ITM2C and ITM2-like genes (ITM2-
LGs) have been identified in a wide range of vertebras and non-vertebras (table 9
and figure 19). The family is highly conserved. Human ITM2B shared 41% and
47% similarity with human ITM2A and ITM2C, respectively, and 60% identity
with fruit fly Q9VPT9, the most distant identified relative.
The ITM2 family shows distinct differences in expression profile. Expression or
up-regulation of ITM2A has been associated with development of bone and carti-
lage in mouse and with haemopoiesis and T-cell selection with expression re-
stricted to these tissues [493, 494]. ITM2C is expressed in brain and other tissues
[495, 496], but not with as wide an expression profile as ITM2B, which appears
ubiquitous [497]. In human and mouse CNS, it is expressed in smooth muscle
and endothelial cells of the cerebral vasculature and in microglia, astrocytes and
neurons with presence in the neuron body, axons and dendrites [498, 499]. It is
A. Vertebras
Class Organism No. Gene name, SwissProt ID
Actinopterygii a Zebrafish (Danio rerio) 1 ITM2B_DANRE, Q803H7
2 ITM2C_DANRE, Q7SYK5
Amphibia African clawed frog (Xenopus laevis) 3 ITM2B_XENLA, Q8AVF1
Western clawed frog (Xenopus tropicalis) 4 ITM2B_XENTR, Q6P3P6
Aves Chicken (Gallus gallus) 5 ITM2B_CHICK, O42204
Mammalia Chimpanzee (Pan troglodytes) 6 ITM2B_PANTR, A5A6H8
Cow (Bos taurus) 7 ITM2B_BOVIN, Q3T0P7
8 ITM2C_BOVIN, A2VDN0
Crab-eating macaque (Macaca fascicularis) 9 ITM2B_MACFA, Q60HC1
10 ITM2C_MACFA, Q4R540
Human (Homo sapiens) 11 ITM2A_HUMAN, O43736
12 ITM2B_HUMAN, Q9Y287
13 ITM2C_HUMAN, Q9NQX7
Mouse (Mus musculus) 14 ITM2A_MOUSE, Q61500
15 ITM2B_MOUSE, O89051
16 ITM2C_MOUSE, Q91VK4
Pig (Sus scrofa) 17 ITM2B_PIG, Q52N47
18 ITM2C_PIG, Q06AV4
Rat (Rattus norvegicus) 19 ITM2B_RAT, Q5XIE8
20 ITM2C_RAT, Q5PQL7
Sumatran orang-utan (Pongo abelii) 21 ITM2B_PONAB, Q5R876
22 ITM2C_PONAB, Q5NVC3
B.  Invertebras
Class Organism No. Abbreviation / SwissProt ID
Insecta Common fruit fly (Drosophila melanogaster) 23 Q9VPT9_DROME,Q9VPT9
Secernentea b Caenorhabditis briggsae 24 Q17302_CAEBR, Q17302
Caenorhabditis elegans 25 Q967F7_CAEEL, Q967F7
Table 9. Examples of
ITM2 and ITM2-like
genes from vertebras
(A) and invertebras (B).
a Ray-finned fish. b Ne-
matodes.
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present throughout both white and grey matter but is particularly abundant in the
hippocampus and cerebellum, which parallels the most intense sites of neuronal
loss in FBD and FDD.
Little experimental evidence exists for the domain organisation of the proteins
encoded by the ITM2 genes, but the overall structure appears shared by all mem-
bers [495, 497, 500]. Using BriPP as a representative example, the ITM2-type
protein is putative type II transmembrane protein (figure 20.A) with a
proteolytically protected region spanning positions 52 to 76 [504]. Transmem-
brane helix prediction algorithms Phobius [501, 502] and PHDhtm [505] both
predict a single transmembrane helix at positions 51-74 and 58-75 (figure 20.B),
respectively. This partitions the protein into three domains with the short N-ter-
minal domain located intra-cellularly, a transmembrane region and a larger, pos-
sibly globular, extra-cellular C-terminal domain (BriPPEC). Using the ScanProsite
motif scanning tool [506], a single N-glycosylation site is predicted at position
170. This has been reported previously [497] and is supported by the observation
of glycosylation at a similar, conserved site in mouse ITM2A [507]. ScanProsite
also predicts a number of potential phosphorylation sites6 and two N-
myristoylation sites at position 48 and 67, which are interesting in light of the
predicted membrane localisation.
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Figure 19. Unrooted
phylogenetic tree of
selected ITM2 and
ITM2-like genes (see
table 9 for key). Made
using the Phylip server
(bioweb2.pasteur.fr/
phylogeny/intro-
en.html)
6 Casein kinase II: 22, 114. cAMP- and cGMP-dependent protein kinase: 151, 233. Protein kinase C: 206, 228, 236.
Tyrosine kinase: 221.
Figure 20. The primary
structure of BriPP (A)
adapted from [497].
Phobius prediction of a
single transmembrane
helix (B) [501, 502].
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2.2.2 Proteolytic processing of BriPP
FBD and FDD are associated with mutations that elongate the C-terminal of BriPP
creating the two variants ABriPP and ADanPP. In the case of FBD, a T-to-A
mutation in the TGA stop codon results in the introduction of an Arg codon and
10 additional amino acids (RTVKKNIIEEN) before the sequence terminates at a
pre-existing stop codon [480]. For FDD, a 10bp insertion/deletion (tttaatttgt) in
codon 265 results in S266F mutation and an 11 amino acid elongation ((S-to-
F)NLFLNSQEKHY) and termination at a previously out-of-frame stop codon
[486]. Consequently, both variant proteins contain 277 residues but with drasti-
cally different C-terminal elongations.
BriPP, ABriPP and ADanPP are all cleaved before position 244 to release the C-
terminal Bri, ABri and ADan peptides, respectively (figure 21). The proprotein
convertase furin colocalises with ABri amyloid in FBD [508]. Furin also cleaves
BriPP, ABriPP and ADanPP effectively in cell culture of which a fraction occurs
intracellulary in the trans-Golgi [504, 509, 510]. Other members of the subtili-
sin/kexin-like proprotein convertase family also cleaves the precursor proteins
but with less efficiency [509]. Interestingly, the release of ABri is elevated com-
pare to release of the wild-type Bri peptide. The production of ADan is also in-
creased but this peptide appears to accumulate intra-cellularly. The observation
by Kim et al. that furin is ‘both necessary and sufficient’ for processing of the
precursor proteins contrasts somewhat with work by Choi and co-workers [511].
This group found that cleavage is not prevented by inhibition of cellular furin or
expression in furin-deficient cells and that processing takes place in the cis- or
medial-Golgi indicating that while furin has proteolytic activity, another pro-
tease may be responsible for processing in vivo. Additionally, they observed a
novel proteolytic variant arising from cleavage N-terminally to the N-glycosylation
site at position 170. This is in agreement with a recent study by Haass and co-
workers [512] that demonstrates proteolytic processing by the ADAM
metallopeptidase domain 10 (ADAM10) and release of the C-terminal BriPPEC
domain to the extra-cellular space. The cleavage is independent of prior removal
of the Bri peptide. The N-terminal domain further undergoes intramembrane pro-
teolysis by signal peptidase-like proteases 2a and 2b (SPPL2a and SPPL2b).
2.2.3 Structure of BriPP, extra-cellular domain
The structure and function of BriPPEC is highly interesting in light of the proteo-
lytic cleavage and the disease-associate peptides that result. The 191AA domain
is sufficiently long to allow for folding. The DISPro [513], FoldIndex [514], IUPred
[515, 516] and DisEMBL [517] methods all indicated that BriPPEC is folded into
a compact globular shape although the DisEMBL method did return several po-
Figure 21. The proteo-
lytic processing of
BriPP (C) and the three
resulting peptides Bri,
ABri and ADan [503,
512].
Bri: EASNCFAIRH FENKFAVETL ICS
ABri: EASNCFAIRH FENKFAVETL ICS
ADan: EASNCFAIRH FENKFAVETL IC
RTVKKNI IEEN
FNLFLNSQ EKHY
# * *-------- ----
ADAM10SPPL2a/b Furin (244)
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tentially unfolded regions by the loops/coils definition (figure 22.A). However,
none of these were sufficiently long to indicate that the domain is intrinsically
unfolded. To further elucidate the possible structure of the precursor protein, five
neural network-based secondary prediction servers were chosen: HNN [518],
SSPro [519, 520], PROF [521], PSIPred [522, 523] and Jpred [524]. The pres-
ence of the N-terminal and transmembrane regions did not significantly influ-
ence the predictions and these were omitted for clarity. The resulting predictions
were not in general agreement (figure 22.B), but a consensus prediction was built
by demanding three or more positives per position and three or more consecutive
residues. The consensus is robust for several regions of the sequence and BriPPEC
appears to be a mixed α/β protein with alternating helices and strands although
several regions lacked agreement between the used methods. Overall, the predic-
tion is too poor to allow comprehensive structural analysis, particularly in light
of the absence of evolutionary conserved homologues outside the ITM2 family.
2.2.4 Biological function of BriPP
BLAST and FastA homology searches return only identified members of the ITM2
family. However, BriPP does contain a conserved BRICHOS domain (position
137-231) which is also found in such functionally distant proteins as
chondromodulin and lung surfactant C [525]. The specific function of the
BRICHOS domain remains unknown, but given that the identified BRICHOS
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Figure 22. Prediction of
folding (A) by DisEMBL
[506] and prediction of
secondary structure (B)
[517-523] of the BriPP
extra-cellular domain.
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proteins all are type II membrane proteins and all are proteolytically cleaved, it
has been speculated that the domain may be involved in secretory targeting or
intra-cellular protease processing. BriPP and lung surfactant C are both prone to
aggregation and BRICHOS could also have evolved to function as an intramo-
lecular chaperone.
Finally, Fleischer and co-workers [526] identified a preserved BH3 domain in a
short form of BriPP beginning at position 57 (BriPPS). The BH3 domain is one
among several domains preserved among the Bcl-2 family of proapoptotic or
prosurvival proteins and BriPPS was found to be capable of caspase-3 and caspase-
9 activation and of inducing p53-independent apoptosis in cell culture [527, 528].
The shortening of the protein affects the transmembrane helix and could poten-
tially involve solvent exposure of the highly hydrophobic region. It is interesting
to speculate that this property of BriPPS could be related to the proapoptotic ef-
fect observed for Aβ, which is also characterised by an exposed, partial trans-
membrane helix [411, 529].
Induction of apoptosis is not the only potential function ascribed to BriPP. ITM2B
is located in the 13q14.3 region of chromosome 13 and loss of heterozygosity in
this region has been connected to head and neck squamous cell carcinoma, pitui-
tary tumours and ovarian carcinoma [530-532]. ITM2B is one of several genes
down-regulated in primary prostate cancer [533] suggesting a role in tumour sup-
pression. Interestingly in the light of the strong link between prostate cancer and
testosterone level, ITM2B was found to be strongly regulated by testosterone in
rat reproductive tissue [534]. Expression was significantly down-regulated upon
castration of mature rats and up-regulate upon testosterone replacement.
The perhaps most interesting putative function of BriPP is in the regulation of
AβPP processing. A region of BriPP stretching from V46 to S104 and including
the first 24 residues of BriPPEC was found to interact in cis with AβPP648-719 in
transfected cells [535, 536]. This region includes the uncleaved Aβ sequence, the
transmembrane helix and the cleavage sites for the three secretases. Indeed, BriPP
was found to strongly modulate secretase activity and production of Aβ. The
activity of β-secretase increased while the α- and γ-secretases were inhibited
resulting in decreased release of Aβ. This interaction could explain the observed
colocalisation of ADan and Aβ in FDD. The high expression of BriPP in the CNS
also suggests a role in neuron function. Immunostaining of healthy brain tissue
and tissue from pathological cases reveals that ITM2B expression is upregulated
near ischemic or hypoxic lesions and in dystrophic neurites in AD [498]. Similar
to AβPP [537], BriPP or its proteolytic fragments appear to be transported in
axons [511] and expression of the protein was also found to induce neuron out-
growth suggesting a role in plasticity of neuronal processes.
A part of the aim of the present work was biophysical characterisation of BriPP,
ABriPP and ADanPP. While the C-terminal globular domain could be effectively
The Molecular Basis of Familial Danish Dementia
57
expressed in E. coli and purified by a combination of methods, the high number
of cysteines made the following refolding difficult. The applied methods and
relevant observations are summarised in annex 1.
2.3 Amyloidogenic and aggregation-prone ABri and ADan
peptides
2.3.1 Heterogeneity of circulating and deposited forms
The proteolytic cleavage of the pre-proteins releases the amyloidogenic subunits
ABri and ADan to circulation where they are found in serum, CNS deposits and,
for FBD, systemic deposits [475, 488]. ABri was initially identified in leptome-
ningeal vascular amyloid extracted by formic acid with Mr 3935.5Da and in a
form that prevented N-terminal sequencing [480]. This suggests an intramolecu-
lar disulphide bond between cysteines 5 and 22 and N-terminal cyclisation of
glutamate to form pyroglutamyl. ABri isolated from systemic and CNS deposits
are indistinguishable. The peptide was also identified in serum at an estimated
concentration of 20ng/mL (5nM) and with an unmodified N-terminal glutamate
[475]. Studies of ADan gave similar findings [486, 488]. The circulating form
was not N-terminally modified while deposits of rising complexity contained
peptide of increasing diversity (figure 23). Soluble fractions in PBS or 2% so-
dium dodecylsulphate (SDS) contained monomers and dimers with pyroglytamyl
(ADan-pE) and unmodified N-terminals in a ratio of 60:40. The monomeric form
dominated PBS and SDS-solubilised vascular samples while the dimer prevailed
in parenchymal SDS fractions. However, deposits solubilised in formic acid
showed only extensively oligomerised ADan-pE, which was N- and C-termi-
nally truncated at positions 3 and 27, 28, 30 and 33, respectively. ADan1-33-pE,
ADan1-28-pE and ADan1-34-pE were more prevalent. Similarly, formic acid-solu-
bilised ABri was highly oligomerised but with less extensive internal cleavage. It
is not known whether the pattern of truncation demonstrates peptide variability
the time of deposition or the body’s attempt at clearing the deposits.
The absence of ABri-pE and ADan-pE in serum and the gradual conversion with
increasing deposit complexity could indicate increased aggregation-susceptibil-
ity of the pE forms but it is equally likely that circulating peptide does not origi-
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and mass spectrometry
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Adapted from [473].
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nate from cleared deposits and that the cyclisation of glutamate happens in situ as
deposits age. N-terminal blocking by pyroglutamyl has been described in forms
of Aβ truncated at position 4 and for several hormones and neuropeptides [538-
542]. For the latter two, the reaction is an enzymatic deamination catalysed by
glutaminyl cyclase with glutamine as substrate [543, 544] whereas the substrate
is glutamate for ABri, ADan and Aβ4-x. Although cyclisation of Glu has been
demonstrate in Aplysia neurons [545], the specific pathway has not been identi-
fied. Interestingly, the presence of ABri-pE in systemic deposits suggests that the
catalysing enzyme or enzymes are not restricted to the CNS in activity.
2.3.2 In vitro aggregation and fibrillation of ABri and ADan
Despite their differences in the C-terminal elongation, ABri and ADan both ag-
gregate readily in vitro although important differences can be observed. Early
studies on ABri aggregation suggested that the intramolecular disulphide bond
was essential for fibrillation [546]. Neither reduced ABri (redABri) nor wild-
type Bri peptide oligomerised or displayed appreciable cytotoxicity in human
neuroblastoma SHSY-5Y cells [547]. In contrast, the oxidised form (oxABri)
formed dimers and an extensive array of SDS-stable, DTT-sensitive higher
oligomers (SDS-stable non-fibrillar oligomeric species, SSNFOS) at pH 9.0. The
predicted pI is 6.9 and the high pH-value was chosen to avoid this region of low
solubility. Upon ageing over a period of three weeks short, curly protofibrils
(2.5-8.5nm-wide and 10-60nm-long) and later long, intertwined, CR-birefrin-
gent fibrils (5-9nm-wide) were produced. Fresh samples containing SSNFOS
showed significantly higher concentration-dependent toxicity than aged samples
in SHSY-5Y cells measured by lactate dehydrogenase-release, inhibition of MTT7
reduction and positive staining with of apoptotic cells with annexin A5. How-
ever, the later finding that the intramolecular disulphide bond is labile and prone
formation of intermolecular covalent species [548] at pH 9 suggests that the
oligomerisation pattern may be an artefact of the experimental procedure. OxABri
is does indeed appear aggregation-prone in the absence of reducing agents as
shown by circular dichroism of aged samples in the absence or presence of cysteine
[549]. Under reducing conditions, the peptide remained in solution in a β-rich
conformation but precipitates in the absence of reducing agent.
Zagorski and coworkers [548] used disaggregation with hexafluoropropan-2-ol
(HFIP) prior to use to prevent disulphide scrambling for a systematic investiga-
tion of the pH and concentration-dependence of oxABri structure. At low pH
(3.1) the peptide is predominantly random coil, which converts to a β-rich form
as the pH is raised incrementally to pH 8.9. At low peptide concentration signifi-
cant random coil is retained throughout the interval whereas high concentration
(44μM) decreased the tipping point from random coil to β-rich conformation to
between pH 4.7 and 5.9. Aging at pH 4.9 for 48 hours leads to formation of
spherical aggregates (0.5-1.5nm diameter) and 1.5-2.2nm-wide curved or branched
protofilaments (termed protofibrils by the authors) with 20-30nm periodicity (fig-
ure 24). The protofibrils may appear as beaded chains, ring-like or pore-like struc-
7 MTT: 3-(4,5-dimethylthiazol-2-yl)-2.5-diphenyltetrazolium bromide.)
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tures with symmetry indicative of a tetramer [550] as previously observed by
Quist et al. [202]. After two weeks, longer 4-6nm-wide fibrils with 37-45nm
periodicity emerge [548]. These are composed of several protofilaments, which
retain the curving and branching of the thinner filaments. When followed by ThT
fluorescence, the emission reaches a plateau after approximately 80 hours sug-
gesting that the protofilaments are structurally similar to mature fibrils. Higher
pH- values (pH 7.3-8.4) favours production of amorphous species. Spherical ag-
gregates (2-8nm diameter) form within a day and slowly coalesce into dense,
amorphous structures with 100-200nm dimensions. The addition of fibrils formed
at pH 4.9 to solutions at higher pH seeds protofilaments but not mature fibrils
suggesting that the assembly of mature fibrils from protofilaments may be influ-
ences by the charge state of the peptide. These finding are in agreement with the
previous studies where spherical aggregates coalescing into denser structures
were observed at similar concentrations and basic pH [546, 547].
The pH-sensitivity of ABri fibrillation suggests that the charge state of the pep-
tide plays a significant part in the thermodynamic and kinetic partitioning be-
tween solution-stable species, aggregation and fibrillation. The peptide contains
multiple glutamate residues (figure 25) and the presence of stable monomeric
species at low pH is likely attributable to charge repulsion. Examination of the
charge state of the peptide suggests that the narrow pH range for fibrillation is
dependent upon the deprotonation of the single histidine residue with nominal
pKa at pH 6. Above this value, ABri is neutral and faster β-aggregation is likely
favoured. The absence of aggregation for redABri could suggest that gradual
deprotonation of the free cysteines play a role. However, a different interpreta-
tion of the available data is that the disulphide bond for oxABri restricts the
peptide chain and efficiently brings together the misfolding nucleus tipping the
balance from a soluble monomer to an aggregation- or fibrillation-prone species.
ADan has the same net charge as ABri at pH 5.0 despite containing significantly
fewer charged residues (figure 25) and fibrillation of oxidised ADan (oxADan)
has similar pH preference as oxABri [551]. Fibrillation occurs over a broad con-
centration range from 18 to 140 μM and comparable timescale. At pH 4.8, freshly
Figure 24. AFM images
of ageing samples of
56μM oxABri at pH 4.9
for 48 (A), 144 (B) and
336 (C) hours. Adapted
from [547].
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Figure 25. Charge
distribution of ABri and
ADan at either side (pH
5 and 7) of the predic-
ted isoelectric points.
Red, negative; blue,
positive; green, histidi-
ne; yellow: cysteine.
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prepared oxADan contains a low-molecular weight species, which could be a
mono- or dimer, and a ~35kDa oligomer. Protofibrils and then filaments and
mature fibrils are formed over 10-15 days as the low-molecular weight species
disappears. Unlike oxABri, for which increasing concentration results in faster
kinetics [548], ThT-monitored oxADan fibrillation shows increasing lag time with
increasing peptide concentration from 22 hours at 35μM to 94 hours at 140μM
suggestive of one or more kinetically favoured off-pathway oligomeric species
stabilised at higher peptide concentrations. EM and AFM of the mature fibrils
reveals slender, straight approximately 4nm-wide fibrils without observable pe-
riodicity and composed of thinner, ~2nm-wide protofilaments (figure 26). In ad-
dition, the samples occasionally show annular forms with average diameters of
100nm diameter and 8-9nm in height, which is lower than observed for e.g. oxABri
and α-synuclein although the morphology do not appear ‘beaded’ from lateral
association of spheroids.
The similar pH-preference for oxidised ABri and ADan is interesting in the light
of the distinct C-terminal elongations. ABri is predominantly polar with multiple
charged side chains whereas ADan combines a hydrophobic stretch (figure 27)
containing several phenylalanines with a charge-rich C-terminus. The shorter Bri
peptide does not readily aggregate and is not related to any human disease sug-
gesting that the elongations are solely responsible for the increased aggregation
propensity. However, the fact that the two disease-related peptides form amy-
loid-like fibrils, albeit over a narrow pH range, despite their dissimilar properties
implies that the wild type peptide contains latent amyloidogenic potential. This
is consistent with the presence of two predicted aggregation-prone regions by the
Figure 26. TEM images
of ageing oxADan at
pH 4.9 for 2 (A), 10 (B,
C) and 30 (D) days.
Adapted from [550].
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Figure 27. Hydrophobi-
city of ABri and ADan
estimated using the
ProtScale tool [551]
(www.expasy.org/tools/
protscale.html) with the
Kyte-Doolittle scale
[552] and a sliding win-
dow of 7. The Eisen-
berg scale [553] gives
similar results.
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Zyggregator method [263, 555, 556] (figure 28.A) at positions 3-8 and 18-23 that
are shared with the ADan peptide.
Whereas oxADan does form amyloid-like fibrils over a narrow pH-range, re-
duced ADan (redADan) has not been induced to form fibrils. Freshly prepared
samples at pH 4.8 contain a range low-molecular mass oligomers [551]. Ageing
results in formation of spherical amorphous aggregates that are 30-40nm in height
and lack structural features. Simultaneously, the oligomeric species disappear.
However, even fresh samples contain insoluble material. As expected, the forma-
tion of amorphous aggregates by redADan occurs significantly faster than or-
dered fibril formation by oxADan. At higher pH (7.4), a non-covalent dimer and
a higher-molecular mass oligomer (Mr ~70kDa) dominate for both oxADan and
redADan. Over several weeks, spherical species and later electron-dense larger
aggregates are formed in a manner similar to oxABri (figure 29) although aggre-
gated oxADan shows mild birefringence after CR binding [557].
In contrast to the similar aggregational properties of the oxidised forms, reduced
ABri and ADan have remarkable differences. redADan readily aggregates at
slightly acidic and neutral pH whereas redABri remains in solution [548, 551].
ADan contains fewer charged residues than ABri despite a similar net charge and
the presence of two histidine residues likely results in a more abrupt charge tran-
sition around pH 6. As a consequence, the aggregation appears to be chiefly driven
by the presence of the extended hydrophobic region at positions 17-27 that, com-
Figure 29. TEM images
of ageing oxADan and
redADan at pH 7.4.
Adapted from [556].
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β-aggregation-prone
regions by the
Zyggregator method at
pH 7.5 [263, 554, 555].
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bined with high β-structure propensity, results in either β-aggregation or fibrilla-
tion. The presence of the disulphide bond appears to favour fibrillation over seg-
regation in amorphous aggregates in competition with charge effects in a similar
manner as for ABri, possibly due to formation of a similar misfolding nucleus.
Perhaps the most striking difference between ADan and ABri is that while redABri
is snows minimal toxicity in SHSY-5Y assays, redADan is more toxic than oxADan
at low concentration in both SHSY-5Y and neuro2a cell assays and induces marked
caspase activation [551, 557]. At higher concentration, the oxidised and reduced
form appear equally toxic. Additionally, redADan is also more toxic than oxABri.
The low or absent cytotoxicity for non-oligomerising and non-aggregating spe-
cies, Bri and redABri, and the higher toxicity for fresh samples containing pre-
dominantly oligomeric species is in agreement with the oligomer hypothesis of
cytotoxicity. The absence of the restricting disulphide bond for redADan allows
higher conformational freedom and the high toxic potential of redADan could be
ascribed to an alternative, more toxic conformation.
DISCUSSION
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3Presentation and discussionof Papers 1 and 2
3.1 Introduction to Paper 1
Nesgaard, L., Vad, B., Christiansen, G., Otzen, D. Kinetic partitioning between aggregation and
vesicle permeabilization by modified ADan. Biochim Biophys Acta (2009) 1794 p.  84-93.
The identification of the ABri and ADan peptides in FBD and FDD deposits is a
very recent discovery, which may explain why our understanding of their bio-
physical characteristics is still relatively limited. Certainly, when compared to
the volume of work on Aβ and α-synuclein, chromosome 13 dementias appear
decidedly underrepresented although it must be admitted that they are not only
rare diseases but, in the case of FDD, among the rarest of diseases. Nonetheless,
they offer an interesting alternative to Aβ as model systems of aggregational
behaviour. Chromosome 13 dementias and AD share many similarities such as
parenchymal preamyloid and amyloid deposits, neurofibrillar tangles, cerebral
amyloid angiopathy and extensive inflammation. Despite being dissimilar in se-
quence, ABri/ADan and Aβ can associate to oligomers and fibrils through a com-
parable series of events and are capable of forming transmembrane channels.
Of the two peptides, ADan is by far the least investigated despite having a number
of highly interesting properties. Firstly, despite being the most likely causative
agent of a highly aggressive amyloid disease with remarkably early onset, ADan
does not fibrillate readily in vitro. Secondly, while the in vivo redox state of ADan
is not known, it has been speculated that it is the reduced form of the peptide
(redADan), which circulate in plasma. redADan is also the most toxic to cultured
neurons. Conversely, only the oxidised peptide (oxADan) has been induced to
form amyloid-like fibrils. Accordingly, the conditions under which ADan can be
induced to form fibrils are associated with significantly lower cytotoxicity than
conditions that favour production of oligomers and large, presumably amorphous
aggregates. This is entirely in keeping with the hypothesis that amyloid toxicity
is mediated by toxic oligomers and in line with the observation of transmem-
brane channels with similar properties as those described for Aβ and other well-
known amyloidogenic peptides [5, 558]. The cyclisation of cysteines 5 and 22
effectively constrains the structure while the linear peptide has a wider field of
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available conformations. It is likely that the variation in aggregational propensity
for oxADan and redADan reflects structural differences at the monomer level.
However, the structural properties of redADan along the assembly pathway and
of the mature aggregates themselves are largely unknown. A number of questions
can be posed as a consequence of these reflections: Is it possible to delineate a
mechanism of assembly for the non-amyloid aggregates of the linear ADan pep-
tide? What morphologies can be observed during aggregation and what are their
structural properties? What, if any, similarities exist with other know fibrillation
or aggregation processes? Finally, in light of the higher cytotoxicity, is redADan
able to interact with or permeabilise membranes and in which form of the peptide
does such interaction take place? The aim of the present work was to answer
these questions in part or in full, but initial observations of the redox behaviour
of the redADan peptide in solution led me to alter my approach somewhat.
3.1.1 SerADan, a linear ADan variant
The experimental protocol called for ageing of samples over a period of days to
weeks prompting concern that prolonged ageing and frequent aliquot removal
could result in intramolecular oxidation or intermolecular cross-linking. Stock
solutions of redADan were prepared in 10M urea or 6M guanidine to limit the
presence of aggregate seeds prior to use, but despite the presence of powerful
chaotropes, the concentration of redADan steadily dropped as small amounts of
insoluble aggregates formed. Their low concentration and the presence of urea or
guanidine prevented examination of secondary structure or morphology, but the
addition of dithiothreitol (DTT) limited aggregation without abolishing it en-
tirely suggesting that the aggregates were cross-linked via intermolecular disul-
phide bonds. To ensure that the peptide remained in the linear form, thereby pre-
venting artefacts brought on by small amounts of oxidised monomer or cross-
linked oligomers, I designed an alternative peptide termed SerADan (figure 30)
by replacement of the two cysteines with serine (C5S, C22S), which decisively
eliminated the intramolecular disulphide bond. Additionally, phenylalanine 15
(F15W) was substituted with tryptophan. The aim was to obtain a higher intrinsic
fluorescence and to incorporate a polarity-sensitive probe in the central region of
the peptide where packing into large aggregates could conceivable be monitored.
As discussed in section 1.3.5, the importance of phenylalanine in stabilisation of
the fibril structure has been observed for fibril of NFGAIL and ACP due to π-
stacking or its inherent β-sheet propensity and hydrophobicity. However, the β-
sheet propensity is essentially preserved and the previously described redADan
aggregates are amorphous so the additional bulkiness of the larger tryptophan
side chain could conceivably be accommodated within the structure.
The cysteine-to-serine and phenylalanine-to-tryptophan substitutions are largely
conservative under the assumption that cysteine is uncharged, but lead to an overall
Figure 30. Primary
structure of SerADan
peptide. Red, negative
charge; blue, positive
charge; green, neutral
or positive in the mid-
pH region; yellow, cys-
tein; *, asparagine and
glutamine; underlined,
hydrophobic region.
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reduction in hydrophobicity and β-sheet propensity, which could alter the aggre-
gation propensity. To estimate the effect of the substitutions, the original and
substituted variants were assessed using the four prediction methods Zyggregator
[263, 555, 556], TANGO [258, 265, 559], AGGRESCAN [262] and PASTA [266,
560] (figure 31.A, B-C, D and table 10, respectively). The three predictors of
aggregation-prone regions give strikingly similar results for ADan, predicting a
low-value region at approximately positions 3-8 (SNCFAI) and a region of higher
propensity at positions 18-27 (ETLICFNLFL) with the exception of TANGO,
which does not predict the former region. As expected, the substitutions lower
the predicted aggregation propensity for both regions, although Zyggregator elimi-
nates the first region altogether. The predictions show little variance with pH and
similar observations can be made for variations in concentration (10-50μM) and
ionic strength (0.05-0.15M) when using the TANGO algorithm for which these
values can be specified (not shown).
For SerADan, the predicted aggregation-prone region (ETLISFNLFL) overlaps
with the hydrophobic region (VETLISFNLF, see also section 2.3.2), which is
asymmetrical and surrounded by charged and polar stretches containing several
Table 10. Prediction of
aggregation-prone
SerADan segments by
the PASTA algorithm.
Pairing Energy Length Segment 1 Segment 2 Orientation
1 -6.99347 23 6-28 6-28 parallel
2 -6.84909 12 17-28 17-28 parallel
3 -6.84653 22 6-27 6-27 parallel
Figure 31. Prediction of
aggregation-prone re-
gions in SerADan by
various prediction met-
hods: Zyggregator (A),
TANGO (B-C),
AGGRESCAN (D).
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asparagines and a single glutamine residue. These amino acids have been impli-
cated in stabilisation of continuous β-sheets through the ‘polar zipper’. By com-
parison, the PASTA algorithm return parallel orientations of similar energies sug-
gesting a preference for β-sheet self-association in the parallel orientation. Inter-
estingly, the asymmetric position of the non-polar region shows similarities to
the properties of longer Aβ peptides, which assemble into fibrils with parallel
interstrand orientation. Overall, SerADan appears to retain a strong if somewhat
lower propensity for β-aggregation when compared to the linear redADan.
3.1.2 Methods for characterisation of aggregation
Describing the mechanistic and structural characteristics of SerADan aggrega-
tion required observation of secondary and tertiary structure by time-resolved
and static techniques as well as particle size and overall morphology of the formed
species (table 11). The F15W substitution allowed the use of intrinsic peptide
fluorescence as a probe of peptide environment and thereby indirectly of tertiary
structure in solution [561]. The situation is somewhat more complex in the pres-
ence of lipids since spectral changes observed during shielding of the Trp from
the aqueous environment may be ascribed to structural changes or burial of the
aromatic residue within the membrane. Intrinsic Trp fluorescence was monitored
either by recording full emission spectra at a fixed excitation wavelength (290nm)
at various time-points during aggregation or as time-resolved measurements in
second- or minute increments at fixed excitation and emission (290 and 350nm,
respectively). Similarly, information regarding particle size was obtained by dy-
namic light scattering [562] by measurements in minute intervals although this
method is particularly sensitive to particulate matter, e.g. dust, which occasion-
ally led to excessive noise despite careful buffer filtering and centrifugation of
peptide stocks.
Secondary structure was monitored by a combination of three techniques. At-
tenuated total reflection FTIR (ATR-FTIR) is a powerful tools for secondary struc-
ture analysis [563, 564], but was used exclusively for end-point measurements of
mature aggregates because of its poor suitability for time-resolved studies8. CD
is useful for time-resolved single-wavelength measurements as well as estima-
tion of secondary structure from spectra [564-566] but ill-suited for large aggre-
gates due to non-uniform concentration throughout solution and light scattering
effects. When applied to SerADan aggregates, the method showed significant
variability in signal intensity and noise between individual scans for aged sam-
ples. In addition, the acquisition of spectral information at high energies is lim-
ited by the presence of salts, urea and other contaminants. While some inferences
could be made about secondary structure from spectra obtained from the com-
mercially available Jasco J-810 instrument (Jasco, Hachioji, Tokyo, Japan), in-
sufficient spectral data prevented an actual estimate of secondary structure con-
tent. The use of synchrotron UV radiation, with its much higher intensity, allows
spectral acquisition at higher energies and the results obtained by this method
8 Due to interference from urea and salts, aggregates were washed in milliQ water prior to spectral acquisition. The
aggregates were stable in structure and morphology over several days under these conditions.
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will be discussed further in section 3.4. The secondary and supramolecular struc-
ture of mature fibre-like aggregates were also examined by X-ray fibre diffrac-
tion [97], which was kindly performed by Christian Beyschau Andersen at the
Protein Structure and Biophysics group, Novo Nordisk A/S. However, the pres-
ence of salts and the relatively low signal intensity limited the data quality.
The morphology of amorphous and structured aggregates was observed by EM
at several time points during assembly. The extended time (~10 minutes) required
for sample preparation at each time point results in poor resolution in time, but
the method does nonetheless offer a snapshot of the aggregate population during
assembly. AFM was used for corroboration of morphological properties. EM and
AFM are both powerful methods, but while the shapes and sizes of aggregates
can be observed at good resolution [77, 567], it must be stressed that the images
offer little or no information about the exact nature the structures. The methods
are therefore susceptible to numerous artefacts from presence of salts, lipids,
dust and other contaminants as well as method-specific concerns, e.g. sample
deformation and tip broadening effects for AFM. The interpretation of images
must be performed with careful consideration of such artefacts.
The interaction of peptide and lipids was examined using extruded large unilamillar
vesicles of the zwitterionic 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC)
and anionic 1,2-dioleoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] (DOPG) via
Trp fluorescence, DLS, AFM and calcein release. The latter method utilised the
the fluorophore calcein, which is trapped within the liposomes at high, self-quench-
ing concentrations [568]. Permabilisation of the vesicles led to release of the
fluorophore into the surrounding solution and increased intensity. For compari-
son, total release was obtained using the detergent Triton X-100 and the
permeabilisation efficiency expressed as the percentage of total calcein release.
Early in the experimental phase it became clear that an efficient protocol was
required for disaggregation of the SerADan peptide prior to use. The presence of
small pre-formed nuclei capable of effectively seeding fibrillation makes the ag-
Method What is detected? Ref.
Intrinsic tryptophan fluorescence Changes in Trp environment. Reports on tertiary structure. [561]
Liposome calcein release Calcein trapped in liposomes at self-quenching concentration. Release [568]
into solution by liposome permeabiliation abolishes self-quenching.
Congo Red absorbance Amount of CR bound to fibril. Specific for amyloid. [9]
Thioflavin T fluorescence Amount of ThT bound to fibril. Specific for amyloid. [52, 53]
Electron microscopy (EM) Morphology. [567]
Atomic force microscopy (AFM) Morphology. Always run in contact mode on washed and dried samples. [77]
Dynamic light scattering (DLS) Particle size. Sensitive to pollutants, e.g. dust particles. [562]
Fourier transform IR (FTIR) Secondary structure. Practical for dried, insoluble samples but sensitive [563-564]
to salt and other solutes.
Circular dichroism (CD) Secondary structure. Sensitive to some solutes. Scattering effects from [564-566]
large particles.
Synchrotron radiation CD (SRCD) Secondary structure. High-intensity light source yields good signal/noise [607]
ratio and spectral acquisition at higher energies.
X-ray fibre diffraction Secondary and supramolecular organisation. Sensitive to presence of [97]
salts and other solutes.
Table 11. Methods for
characterisation of
SerADan aggregation
and lipid interaction.
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gregation process highly stochastic [165, 569]. Indeed, the time-course of aggre-
gation of SerADan freshly dissolved from powder form was observed to vary
greatly. The halogenated alcohol 1,1,1,3,3,3-hexafluoropropan-2-ol (HFIP) has
been used for disaggregation of the ABri and ADan peptides [548, 551] but proved
insufficient for suppression of the stochastic aggregation of SerADan. Instead,
disaggregation was accomplished by overnight incubation in 10M urea, which
was highly effective. However, urea decomposes in solution to isocyanic acid
with resulting carbamylation of arginine, lysine and the polypeptide N-terminus
[570, 571]. Consequently, urea was prepared fresh, the peptide stocks fast-frozen
in aliquots of appropriate size and only thawed immediately prior to usage.
Irrespective of the used technique, the aggregation process was in all cases initi-
ated by dilution of the peptide from 10M to 0.2M urea in sodium phosphate or
Tris buffer at pH 5.0 and 7.5, respectively. It should be mentioned acceleration of
fibrillation by urea has been described [572], but at significantly higher concen-
trations (5M). The lower pH value was chosen with reference to the pH interval
where oxADan has been induced to form fibrils. The predicted charge is +1 at pH
5.0 and the higher pH value was chosen to give an overall peptide charge of -1
after examination of the theoretical titration curve (figure 32).
Figure 32. Theoretical
titration curve of
SerADan (www.iut-
arles.up.univ-mrs.fr/
w3bb/d_abim/compo-
p.html).
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The neurodegenerative illness Familial Danish Dementia (FDD) is linked to formation and aggregation of the
34-residue ADan peptide, whose cytotoxicity may be mediated by membrane interactions. Here we
characterize the derived peptide SerADan, in which the two cysteines found in ADan have been changed to
serines to emulate the reduced peptide. SerADan aggregates rapidly at pH 5.0 and 7.5 in a series of
conformational transitions to form β-sheet rich fibril-like structures, which nevertheless do not bind
amyloid-specific dyes, probably due to the absence of organized β-sheet contacts. Aggregation is prevented
at neutral/acidic pH and low ionic strength by anionic lipid vesicles. These vesicles are permeabilized by
monomeric SerADan assembling on the membrane to form stable β-sheet structures which are different
from the solution aggregates. In contrast, solution ageing of SerADan first reduces and then abolishes
permeabilization properties. The competition between lipid binding and aggregation may reflect bifurcating
pathways for the ADan peptide in vivo between accumulation of inert aggregates and formation of cytotoxic
permeabilizing species. Our work demonstrates that non-fibrillar aggregates can assemble in a series of steps
to form a hierarchy of higher-order assemblies, where rapid formation of stable local β-sheet structure may
prevent rearrangement to amyloid proper.
© 2008 Elsevier B.V. All rights reserved.
1. Introduction
Familial Danish Dementia, first described in 1970 [1] as heredo-
pathia ophthalmo-oto-encephalica, is an example of a degenerating
neurofibrillar disease of the same type as the more common and
better characterized Alzheimer's disease (AD) [2]. The illness involves
progressive dementia and is fatal with death occurring at the age of
50–60. The earliest clinical manifestation is cataract formation before
the age of thirty followed by progressive hearing loss and cerebellar
ataxia. A 34-amino acid peptide, ADan, has been identified in
circulation and in plaques in post-mortem tissue samples [2]. In
contrast to the Aβ aggregates formed in AD, these plaques appear to
be predominantly pre-amyloid in nature with amorphous morpho-
logy containing sparse and disperse fibrils, and are negative for
staining with the amyloid-specific dyes Congo red and thioflavin S [3].
The ADan peptide is formed due to a decamer duplication in the 3′-
end of the Bri gene causing a frameshift and generating a larger-than-
normal precursor protein [2]. C-terminal degradation of the precursor
by furin yields the 34-amino acid ADan peptide rather than the native
23-amino acid Bri peptide [4] (Fig. 1). Both wild-type Bri and mutant
ADan peptide circulate in plasma, but only ADan has been found to
accumulate in tissue [5]. The oxidation state of the two cysteines in
serum-circulating and plaque-deposited ADan is controversial, with
some groups claiming it to be reduced [6] and others oxidized
between Cys5 and Cys22 [7]. The deposited form of the peptide is
highly heterogeneous [7], with the N-terminal glutamate modified to
pyroglutamate in a large percentage of the peptide chains, which are
also N- and C-terminally processed at position 3, 28 and 33.
Previous studies of the aggregational tendencies of ADan in both
the reduced and oxidized forms [8,9] did not observe classical fibril-
formation of the type routinely observed for Aβ and similar fibrillation
protein peptides under physiological conditions. Formation of amy-
loid-like material was only possible for the oxidized form of ADan
under mildly acidic conditions (pH 4.8) and after extensive ageing
(10–15 days). At other experimental condition, including a wide range
of pH values and peptide concentrations, oxidized and reduced ADan
were found to readily aggregate into various amorphous structures.
However, studies using SH-SY5Yor neuro2a cell lines showed that the
reduced form of ADan had higher cytotoxicity than the oxidized form
and led to marked caspase activation [8]. The distinct prevalence of
pre-amyloid over amyloid deposits makes ADan an interesting case
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study, that may provide further insight into the nature of aggregate
cytotoxicity. Here we examine the aggregational properties of a
modified ADan-like peptide, termed SerADan, designed to prevent any
oxidation by replacing Cys5 and Cys22 with Ser. Besides mimicking
the reduced state which has been shown to be more neurotoxic than
the oxidized state in cell cultures [8], it also avoids the formation of
covalent crosslinks that complicate in vitro studies of ADan. Addition-
ally, the phenylalanine in position 14 was replaced with the
fluorescent probe tryptophan, which may also be considered a
conservative mutation. To address charge effects, the peptide was
investigated at both the approximately neutral pH-value 7.5 and the
slightly acidic pH 5.0, which is similar to the pH-value at which the
oxidized variant form amyloid-like structures. These two pH values
are on either side of the estimated isoelectric point of pH 6.05.
In order to elucidate the possible mechanism of cytotoxicity, we
investigated the direct interaction of SerADan with lipid membranes.
Several fibrillation-prone peptides are known to interact with anionic
lipid membranes but with different outcomes. Anionic membranes
stimulate fibrillation of Islet Amyloid Polypeptide (IAPP) [10,11], while
Aβ40 is protected from fibrillation when fully inserted in anionic
membranes but experiences accelerated fibrillation when surface
bound [12]. Interestingly, zwitterionic lipids may also reverse
fibrillation of amyloid and lead to cytotoxic species [13]. The anionic
lipid phosphatidylserine has been shown to trigger fibril formation for
a number of peptides and proteins including lysozyme, insulin and
transthyretin [14]. In contrast, annular structures that exhibit
heterogeneous single-channel conductance have been observed for
ADan bound to zwitterionic phosphatidylcholine membranes in a
manner highly similar to those of other fibrillation-prone peptides e.g.
α-synuclein and Aβ [15]. We consequently examined peptide-
membrane interactions using fluorescence spectroscopy and calcein
release assays for vesicles of anionic and zwitterionic phospholipids.
2. Materials and methods
2.1. Materials
SerBri (EASNSFAIRH FENKWAVETL ISS) and SerADan (EASNSFAIRH
FENKWAVETL ISFNLFLNSQ EKHY, in which Cys5 and Cys22 found in
ADan are replaced by Ser) peptides were obtained N90% pure
(EZBiolab Inc., Westfield, IN, USA). 1,2-Dioleoyl-sn-glycero-3-phos-
phocoline (DOPC) and 1,2-Dioleoyl-sn-glycero-3-[phospho-rac-(1-
glycerol)] (DOPG) were from Avanti Polar Lipids (Alabaster, AL).
Thioflavin T and other chemicals were from Sigma (Sigma-Aldrich, St.
Louis, MO).
2.2. Preparation of SerADan samples
Freeze-dried SerADan peptide was dissolved in 10 M urea and
allowed to disaggregate overnight at room temperature to obtain a
monodisperse monomeric population in the random coil conforma-
tion according to circular dichroism. Concentration was monitored by
absorbance at 280 nm (extinction coefficient estimate obtained using
the ProtParam tool at http://www.expasy.org) and found to be within
5% of the weighed amount. Stock concentration was adjusted to
2.5 mM. Stock aliquots were flash frozen and stored at −80 °C. They
were thawed and centrifuged immediately before use. Samples for
aggregation were prepared by freshly thawed peptide stock to the
appropriate concentration (10–75 μM) in either 50 mM sodium
acetate (pH 5.0) or 50 mM Tris (pH 7.5) with or without 100 mMNaCl.
2.3. Preparation of liposomes and calcein release assay
Vesicles were prepared from stock solutions of lipids dissolved in
chloroform and dried overnight in vacuum. Lipids were then
resuspended by vortexing in milliQ water to a final concentration
of 10 g/L (∼14 mM), exposed to at least seven cycles of freezing in
liquid nitrogen, followed by thawing in a 50 °C water bath, before
extrusion through a 100 nm pore filter 12 times using a 10 mL
thermo barrel extruder (Northern Lipids, Vancouver, Canada).
Vesicle size was verified by DLS and vesicles were used the same
day they were made.
Calcein-containing vesicles, which were made immediately before
each experiment, were prepared similarly, except that lipid was
dispersed in 1.5 mL calcein-containing buffer (70 mM calcein, 50 mM
Tris, pH 7.5) prior to freeze–thawing and extrusion. Vesicles were
isolated from the calcein buffer by filtration through a pre-equili-
brated Pharmacia PD-10 column and small aliquots of the collected
fractions were monitored by fluorescence (excitation 490 nm, emis-
sion 500–600 nm) using Triton X-100 to obtain release of calcein and
thereby increased fluorescence of vesicle-containing fraction(s). Those
with the highest signal-to-background ratio were selected for further
use. The fluorescence measurements were conducted on a Cary
Eclipse Fluorescence Spectrophotometer (Varian, Palo Alto, CA) using
a 10 mm quartz cuvette with magnetic stirring. The vesicles were
diluted in 50 mM Tris buffer pH 7.5 to a concentration of ∼0.017 mg/
mL (21 μM), yielding a maximum signal of around 90 U under these
settings. For ageing experiments, SerADan was diluted from a 2.5 mM
stock in 10 M urea to 10 μM peptide and 0.04 M urea in 50 mM Tris
buffer pH 7.5. At different time points, 10 μL of this solution was
diluted 10-fold to 1 μMSerADan in the presence of 21 μMcalcein-filled
vesicles and calcein release was monitored bymeasuring fluorescence
emission intensity at 515 nm (excitation at 490 nm, 5 nm slits for both
monochromators) every 11 s until it reached a plateau. Spectra were
normalized with regards to maximum fluorescence, i.e. the fluores-
cence level achieved when 1% of Triton X-100 is added. For
permeabilization experiments with different concentrations of Ser-
ADan, the peptidewas first diluted from 2.5mM stock in urea to 50 μM
peptide and immediately diluted to the appropriate concentration in
the presence of 21 μM calcein vesicles.
2.4. Circular dichroism
Circular dichroism (CD) spectra were recorded on a Jasco J-810
spectropolarimeter (Jasco, Hachioji, Tokyo, Japan; 110QS cuvette,
Hellma, Müllheim, Germany) using averaging over 10 scans, resolu-
tion 0.1 nm and 10–50 μM peptide.
2.5. Fourier transform infrared spectroscopy
Spectra were recorded on a Bruker Tensor 27 infrared spectro-
meter (Bruker Optik GmbH, Ettlingen, Germany) with a Specac Golden
Gate single-reflection ATR unit (Specac Ltd., Orpington, UK). Aged
aggregates were washed twice in milliQ water and isolated by
centrifugation. Three independent samples were investigated (64
scans, 2 cm−1 resolution). The secondary structure was estimated
using OPUS 5.5. If needed, the presence of water vapor was corrected
for by subtraction of a fresh vapor spectrum or the inbuilt atmospheric
compensation function. Peaks were assigned from the 2nd derivative
and deconvolution of spectra [16]. The non-deconvoluted spectra
were fitted using the Levenberg–Maquardt method, the areas of
individual peaks calculated and the secondary structure content
estimated.
Fig. 1. Primary structure of wildtype Bri (wtBri), ADan and SerADan peptides. #:
Location of pyroglutamate found in physiological aggregates of ADan peptide. ⁎:
Mutation of cysteine to serine. ¤: Mutation of phenylalanine to tryptophane. -:
Elongation found in physiological aggregates of ADan peptide.
85L. Nesgaard et al. / Biochimica et Biophysica Acta 1794 (2009) 84–93
The Molecular Basis of Familial Danish Dementia
73
2.6. Fluorescence spectroscopy
Time-resolved fluorescence spectroscopy was performed on a
Cary Eclipse fluorometer (Varian, Palo Alto, CA), excitation at
290 nm and emission measured at 350 nm. Freshly thawed peptide
stock was diluted to 10–50 μM in buffer with or without lipid (LP
0.1–10). Aggregation was monitored for 30 min in 10 s increments
and for the following 600–1200 min in 1 min increments. Initial
reaction rates were calculated by linear regression as the slope of
the timecurve over the initial 10 min. Emission spectra were
obtained at start and at end points before and after vigorous
agitation of the sample to resuspend sediments. Time resolved
emission spectra were recorded similarly on a LS55 fluorometer
(Perkin-Elmer, Wellesley, MA), excitation at 290 nm, emission
310 nm–390 nm.
2.7. Dynamic light scattering
Time-resolved estimates of the hydrodynamic radius were
obtained by dynamic light scattering on a PDDLS/CoolBatch+90T
system (Precision Detectors, Bellingham, MA). Buffers were filtrated to
remove dust particles. Samples were prepared by dilution of freshly
thawed and centrifuged peptide stock into buffer (50 μM peptide,
50 mM Tris, pH 7.5) with or without freshly prepared and centrifuged
lipid vesicles (LP 0.1–10). Temperature was held at 22.5 °C and Rhyd
estimates were obtained every 2–3 min.
2.8. Electron microscopy
Electron microscopy was performed as described [17] by placing
5 μL aliquots on 400-mesh carbon-coated, glow-discharged grids for
30 s followed by washing with distilled water and staining with
phosphotungstic acid (pH 6.8). Samples were visualized using a Jeol
1010 transmission electron microscope. For time-based electron
microscopy on the hour timescale, aliquots were removed directly
from the aging sample. For longer experimental periods, the aliquots
were flash-frozen in liquid nitrogen and stored at −80 °C.
3. Results
3.1. SerADan is sparsely soluble and quickly forms β-rich but
non-amyloid aggregates
The serine-variant of the short non-toxic wildtype Bri peptide
(SerBri) readily dissolves in dilute buffer to adopt a predominantly
random coil-like structure when examined with circular dichroism
(data not shown). In contrast, the longer SerADan peptide forms large,
insoluble aggregates when diluted from 10 M urea to 0.2 M urea at pH
5.0 (Fig. 2) and 7.5 (Fig. 3) as shown by time-resolved electron
microscopy. The aggregates can be observed within minutes of
dilution (Figs. 2A–B, 3A) and have μm-scale dimensions, consisting
of thin filaments that persist over the entire visualized time-span of
5 days (Figs. 2D, 3C, E). At pH 5.0, a more electron-dense and less
organized morphology can be observed for samples obtained 19 min
after dilution, but not for later time points. Smaller, transient
amorphous structures were also present during the first hour of
aggregation (Fig. 3B, shown for pH 7.5 only) but slowly disappeared.
When studied by attenuated total reflection infrared spectroscopy
(ATR-FTIR, Fig. 4A) the secondary structure of aged (12 h) and washed
samples, which are structurally stable over a period of several days,
appear rich in β-sheet with similar sheet content for pH 5.0 and 7.5
(34–36%). Circular dichroism spectra (Fig. 4B) show that β-structure
with a characteristic minimum around 215 nm appears within a few
minutes of dilution from the stock solution (within the dead-time of
themeasurement), suggesting that the peptide rapidly collapses into a
β-rich structure in solution. Over time, the spectra diminish in
intensity, particularly within the first 100 min of incubation (insert to
Fig. 4B), but retain the overall β-sheet appearance. At pH 7.5 there is a
lag phase of around 30 min before the ellipticity starts to decline,
while the lag phase is absent at pH 5.0.
Fig. 2. Time-resolved electron micrographs of 50 μM SerADan at pH 5.0. Black bar corresponds to 400 μm. (A) Thin filaments observed within the method deadtime (2–3 min). (B)
Same sample as A. but showing a more electron-dense morphology. (C) Sample obtained after 19 min showing dense, less organized morphology, which coexisted with the type of
structures shown in B. (D) Sample obtained after 2 h and frozen for later imaging. Morphology consists of long, thin filaments. (E) Sample obtained and frozen after 5 days aging. The
shown morphology coexists with thin filaments.
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The fibril-like structure and β-sheet signature are amyloid hall-
marks. However, no binding of Congo Red or Thioflavin T can be
observed (data not shown), just as reported for wildtype ADan
deposits [2,3]. This indicates a different arrangement of the β-
structure within the observed filaments. Our previous X-ray fiber
diffraction data show a strong signal at 4.76 Å arising from the
distance between adjacent β-strands [18]. However, signals at 10–11 Å
(which are strong in regular amyloid fibrils and reflect inter-sheet
distances) are essentially absent for pH 7.5 aggregates and very diffuse
for the pH 5.0 aggregates [18], indicating a lack of organized higher-
order structure.
3.2. Time-resolved fluorescence data shows two distinct phases
The images obtained by EM show that the aggregates formwithin a
very short time span of a few minutes. The Phe11Trp substitution
provides a fluorescent probe to follow the time course of the aggregate
formation (Fig. 5A).
Fig. 4. Secondary structure of aggregated SerADan. (A) Fourier transform infrared spectroscopy of 10 and 50 μM SerADan at pH 5.0 and 7.5, aged for 12 h at 10 and 50 μMpeptide. The
aggregates were washed in water and found to be stable over several days. The secondary structure appears independent of pH and concentration. Table: Estimate of secondary
structure content by curve fitting. (B) CD spectra of 50 μM SerADan in 10 M urea (no buffer) and at pH 5.0 and 7.5 after 50-fold dilution into 0.2 M urea. Immediately after dilution,
there is a clear minimum around 215–220 nm, indicative of β-sheet structure. The spectra reduce in intensity over the next 12 h but retain minimum around 215–220 nm. Insert:
change in molar ellipticity at 215 nm over time when 50 μM SerADan is diluted into 0.2 M urea from 10 M urea, indicating that most of the ellipticity change occurs over the first
100 min. Ellipticity levels for the two runs have been offset for clarity. Note the lag phase at pH 7.5 which is absent at pH 5.0.
Fig. 3. Time-resolved electron micrographs of 50 μM SerADan at pH 7.5. Black bar corresponds to 400 μm. (A) Morphology after 6 min. (B) Amorphous structures observed after
24 min. Structures coexistent with structure of the type shown in A. (C) Sample obtained after 62 min contains filaments and amorphous elements. (D) Long, thin filaments of clear
morphology obtained after 2 h and frozen for later imaging. (E) Sample obtained and frozen after 5 days aging. Thin filaments persist as dominating structure.
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When 10–50 μM SerADan is incubated at pH 7.5 and 22.5 °C and
the fluorescence emission was monitored over time, we observe a
rapid and only slightly concentration-dependent ∼5–7% decline in the
signal over the first 5–10 min, followed by a ∼5% linear decline (∼5%).
After an additional 10–100 min (depending on concentration), there is
a very steep decline over 10–100min in emission down to ∼60% of the
initial fluorescence intensity, which slowly declines further by ∼20%
over the next 6–9 h. Incubation at pH 5.0 also leads to a similar 20%
decline in signal although the change is somewhat slower (Fig. 5A,
insert). In conjunction with the differences in the time-profile for the
CD signal between pH 5.0 and 7.5 (Fig. 4B), this suggests subtle
differences in the initial conformational changes at these two pH
values. The rapid fluorescence phase completed within 5–10 min at
pH 7.5 coincides with the formation of β-sheet structure within the
dead-time of the recording of the first CD spectrum (Fig. 4B). The
subsequent 5% signal change occurs over the next ∼100 min at 10 μM
peptide, and the rate of the linear decline (raw fluorescence emission
intensity per time unit) scales with protein concentrationwith a slope
of 1 in a log–log plot, indicating that this step does not involve a
change in the molecularity of the SerADan aggregate formed at this
stage (data not shown). However, the length of this phase (ending at
the onset of the steep fluorescence decline) is shortened dramatically
at 50 μM to around 15 min, indicating that the next step involves
aggregation. In fact we have two observations that indicate that the
large decline in emission to around 60% is simply caused by bulk
sedimentation of aggregated material. Firstly, there is no decline if the
experiment is performed with agitation, which prevents sedimenta-
tion (data not shown). Secondly, resuspension of the aggregates
returns fluorescence to the plateau value reached after the first 20%
decline in signal (data not shown).
Emission spectra recorded at different times at both pH-values
reveals that change in fluorescence signal within the initial exponen-
tial phase and slow linear decline (prior to the sedimentation step) is
due to changes in fluorescence intensity rather than a major shift in
maximum emission wavelength, since we only observe a slight blue-
shift from ∼353 nm to ∼350 nm (data not shown).
The rapid fluorescence decline to a 60% level (completed after
20 min at a concentration of 50 μM SerADan) is complemented by DLS
data for 50 μMSerADan at both pH 5.0 and 7.5 which showan increase
in particle size to a plateau level within 20–30 min (Fig. 5B). During
this period there is no change in the CD signal at 50 μm SerADan (Fig.
4B insert). Rather, the slow decline in CD signal seen for 50 μM
SerADan (Fig. 4B insert) coincides with the slower decay over several
hundreds of seconds from ∼60 to ∼40% intensity after the rapid
fluorescence decline. Thus there appears to be several phases in the
sedimentation process, of which only the last one is detected by CD. As
a reporter of tertiary and quaternary structure, Trp fluorescence is a
more sensitive reporter of protein changes than CD signal and it is
therefore not unexpected that more phases are revealed by the former
method.
Early onset of formation of large aggregates and thereby
sedimentation can also be triggered by addition of seeds of preformed
aggregates, which is a well-known characteristic of batch fibrillation
in vitro. Thus, addition of 1.5% seeds reduces the sedimentation half-
time from around 200 to around 120 min, while 15% seeds have little
further effect (data not shown).
3.3. SerADan interacts with the anionic lipid DOPG
Wildtype ADan is cytotoxic to the commonly used SH-SY5Y
neuronal cell line [8,9] in both oligomeric and more extensively
aggregated forms. The known interaction between cytotoxic peptides
and cell membranes prompted us to study the membrane interactions
of the SerADan peptide. Fibrillation of numerous proteins has
previously been shown to be stimulated by the presence of anionic
lipids [10–12,14] so we investigated the effect on aggregation by both
the zwitterionic DOPC and anionic DOPG. While little interaction was
observed with DOPC at both pH values (data not shown), DOPG
interacted strongly with freshly diluted peptide. The presence of
anionic lipid prevented the sedimentation of large aggregates (Fig.
6A). This effect was pronounced at even 1:10 lipid:protein ratios at pH
7.5 while 10:1 lipid:protein ratios were required at pH 5.0 (data not
shown). For pH 7.5, the anti-sedimentation effect was abolished for all
but the highest lipid concentration (LP 10) by the presence of 100 mM
NaCl, indicating electrostatic forces as an important factor in the
interaction. However, the lone tryptophan also appears involved in the
interaction as the peptide fluorescence spectrum shows a clear
blueshift from ∼353 nm to ∼340 nm when incubated with lipid
(Fig. 6B insert). In contrast, the far-UV CD spectrum has a minimum
around 210 nm (Fig. 6B) which is different from andmore intense than
that in the absence of lipid (Fig. 4B). Furthermore, it does not undergo
any significant band shifts or intensity changes over time. Interest-
ingly, the small pre-sedimentation exponential decay in emission
(within the first 20 min, Fig. 5A) is not affected by lipids, suggesting
Fig. 5. Aggregation behavior of SerADan at pH 7.5 and 22.5 °C. (A) Time-resolved intrinsic fluorescence (excitation 290 nm, emission 350 nm) at 10 μM,15 μM and 50 μM, respectively.
An exponential decline of ∼5–7% is followed by a linear decline of ∼5%, a steep drop of ∼30% and a slower decline of ∼20%. Insert shows a blow-up of the first 25 min of the reaction.
(B) Dynamic light scattering data for 50 μM SerADan at pH 5.0 and 7.5 followed over time. Note the immediate increase in particle size in contrast to the lag observed by CD and
fluorescence.
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that this conformational change is a prerequisite for lipid binding or
can occur on the lipid surface.
When examined at pH 7.5 by DLS, the formation of large species is
highly dependent on the presence of lipids (Fig. 6C). As described
previously the formation of large species is fast in the absence of
lipids, while the presence of small amounts (LP 0.1) slows the
formation of large species considerably. At higher lipid concentrations,
the formation of large species is negligible within the observed time
window. Electron microscopy of samples aged for 16 h or 6 days did
not show straight fibril-like structures but rather small amounts of
wool-like morphologies (Fig. 6D), suggesting mixed, amorphous lipid/
peptide material. This suggests that the presence of anionic lipid
prevents the formation of fibril-like aggregates instead of just
preventing their sedimentation.
3.4. SerADan affects release of calcein from vesicles in competition
with ageing
To investigate more closely the interactions of SerADan with
lipids, we studied the ability of the peptide to release calcein from
different vesicles. In this assay, calcein is initially trapped in vesicles
at self-quenching concentrations and subsequent release of calcein
leads to a large rise in fluorescence which for SerADan follows an
approximately exponential time course (Fig. 7A). This permeabiliza-
tion ability towards DOPG vesicles is maintained at peptide:lipid
molar concentrations down to 1:500 (Fig. 7B). SerADan's ability to
release calcein is highly dependent on its age. While SerADan
freshly diluted from a stock in 10 M urea is able to affect release of
almost 60% of all trapped calcein from 21 μM DOPG vesicles, this
figure drops precipitously to around 30% within 15 min of ageing
(Fig. 7C), and subsequently remains at a plateau until it drops
further after around 3 h of ageing (corresponding to the onset of
precipitation seen in Fig. 5A). Over the same 15 min ageing time
range, the rate constant at which calcein release occurs (approxi-
mated by a first order fitting to the release data) drops by around a
factor of 10, after which it remains at a very low value. The ability to
release calcein is also sensitive to vesicle type. SerADan diluted from
a stock in 10 M urea and aged for about 10 min is able to effect only
release of around 31% of the trapped calcein from pure DOPG
vesicles (Fig. 7A) over a period of about an hour, and the figure
Fig. 6. Spectroscopic and microscopic investigations of SerADan lipid interactions at pH 7.5 and 22.5 °C. (A) The effect of anionic lipid (DOPG) at high and low ionic strength on the
change in fluorescence signal (excitation 290 nm, emission 350 nm) of 10 μM SerADan over time. The presence of lipids prevents sedimentation but the effect is abolished by the
presence of 100 mM NaCl at lipid-to-protein ratios (LP) of 1 and below. (B) CD spectra for fresh (immediately after dilution from stock in 10 M urea) and aged (12 h after dilution)
SerADan (10 μM) in the presence of DOPG, LP 10 at pH 7.5 (no NaCl). Fresh spectrum in absence of DOPG (from Fig. 4B) included for comparison. Insert: Emission spectra showing
significant blue-shifting. (C) Time-resolved DLS of 10 μM SerADan showing inhibition of aggregation at LP 1 and 10. (D) Electron micrograph of 50 μM SerADan with DOPG (LP 10) at
pH 7.5 after 5 days aging. Black bar corresponds to 400 μm. The previously observed thin filaments are absent in favour of amorphous material.
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declines to around 13 and 8% for 1:1 DOPG:DOPC vesicles and pure
DOPC vesicles, respectively. Just as high NaCl concentrations abolish
the interaction between lipids and SerADan (Fig. 6A), they also
prevent SerADan from permeabilizing vesicles (Fig. 7D).
4. Discussion
4.1. The multifaceted nature of SerADan aggregation
SerADan is an interesting model aggregation system for several
reasons. Firstly, the close similarity to the original ADan peptide
provides a direct link to aggregation processes occurring in vivo.
Secondly, despite the preponderance of β-sheet structure and the
overall amyloid-like appearance of the aggregates at longer time
points, it presents no bona fide amyloid structure (according to
both tinctorial assays and X-ray fiber diffraction studies). Diffraction
data [18] indicate that the peptide is able to form organized β-
stranded structure at the local level, but cannot assemble the
ensuing β-sheets into supramolecular structures that are suffi-
ciently organized to provide binding sites for amyloid-specific dyes
such as Thioflavin T and Congo Red. In this sense SerADan occupies
an intermediate position between classical amyloid and more
diffuse protein aggregates, which may occur naturally as reversible
associations in secretory granules [19]. These less well organized
structures can be stabilized by local interactions in competition
with proper amyloid structures [20] or may be held together by e.g.
complementary charges mediated by detergent molecules [21].
The conformational and functional transitions identified for
SerADan based on the use of 6 different techniques (circular
dichroism, FTIR, Trp fluorescence, dynamic light scattering, electron
microscopy and the release of calcein entrapped in vesicles) indicate
that non-fibrillar aggregates can also assemble in numerous steps. We
can thus build up a rather detailed picture of the different steps
involved in SerADan aggregation after it has been diluted out from
10 M urea into buffer (summarized in Fig. 8). The following data
pertain to behavior at pH 7.5 but are essentially the same at pH 5.0
unless indicated otherwise. SerADan is calculated to have a negative
charge of −1 to −2 at pH 7.5 and ∼+1 at pH 5, but the minor difference
in behavior at these two pH values reveals that the overall charge does
not play a significant role.
Fig. 7. Ability of SerADan to permeabilize vesicles at pH 7.5 and 22.5 °C. (A) Time profile of the release of calcein from 21 μMof vesicles of different compositions by 1 μMSerADan (50-
fold diluted from a 50 μM solution in 0.2 M urea that had been aged for an hour after 50-fold dilution from a 2.5 mM stock in 10 M urea). Lines indicate best fits to single exponential
decays. The fit is not particularly good for DOPG, but the associated rate constant and amplitude provide useful (if approximate) measures of the efficacy of permeabilization. (B)
Ability of different concentrations of freshly diluted SerADan to permeabilize 21 μMcalcein-filled DOPG vesicles. SerADanwas first diluted from 2.5mMpeptide in 10M urea to 50 μM
peptide in 0.2 M urea, and then immediately diluted to the indicated concentrations in the presence of vesicles. SerADan permeabilizes a significant proportion of the vesicles at
molar protein:lipid ratios down to 1:500. (C) Effect of ageing on ability of SerADan to permeabilize DOPG vesicles, measured in terms of the rate constant and amplitude of calcein
release (derived from exponential decays as in panel A). SerADan was aged at a concentration of 10 μM in 0.04 M urea (diluted 250-fold from a 2.5 mM stock in 10 M urea) and
subsequently diluted to 1 μM in the presence of 21 μM DOPG. The time profile thus reports on the ageing at 10 μM concentration. (D) Effect of ionic strength on ability of 1.0 μM
SerADan to permeabilize 21 μM DOPG vesicles, measured as in panel A.
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Within the first 5–10 min, there is a small (∼15%) concentration-
independent decline in Trp fluorescence; concomitantly a large
amount of β-sheet structure forms rapidly according to circular
dichroism, after which it stabilizes temporarily. In this period,
SerADan's ability to permeabilize calcein-loaded membranes declines
50% in terms of the amount of calcein that can be released and
around 10-fold in terms of the rate constant of permeabilization. This
initial Trp decline is not so evident at pH 5.0, and at this pH the CD
signal starts to decline straight away, suggesting that the rearrange-
ment step occurs more rapidly at pH 5.0 or is bypassed to some
extent. Over the next 5–100 min (depending on peptide concentra-
tion), there is a minor (∼5%) linear and concentration-independent
decline in fluorescence which may indicate a modest conformational
rearrangement, but no change in permeabilization efficiency or CD
signal at pH 7.5. Compared to the initial non-aggregated species
which can permeabilize up to 60% of the vesicles, the aggregates
present at this stage have a two-fold reduced membrane permeabi-
lization activity, perhaps based on a limited ability to dissociate and
re-aggregate productively in the membrane environment. Alterna-
tively, these aggregates do not rearrange in the membrane, but
simply possess a more modest permeabilization activity than the
aggregated species formed by assembly of monomers in the
membrane environment; the assembly process in the membrane is
likely to be different from that in solution and also leads to β-sheet
assemblies with stronger CD signals and more blue-shifted Trp
fluorescence than in solution. In this time range, we also observe a
marked growth in aggregate size by dynamic light scattering and the
transient appearance and disappearance of amorphous aggregates
according to electron microscopy. Although we do not include this as
a separate step, it is likely that there is a gradual build-up of soluble
species of increasing size in this period. From 2 h onwards, fibril-like
aggregates (which already appear after a few minutes but not as the
major species) dominate the EM images and there is a marked
increase in aggregate size (probably due to the formation of
intermeshed structures), leading to precipitation from solution and
the complete loss of membrane permeabilization activity. This
aggregation process is complex and proceeds in several stages; the
steep drop in fluorescence to around 60% of the initial value (which is
not paralleled by CD changes) is followed by a more measured
fluorescence decline towards 40% over the next 2–10 h as well as a
decline in CD signal. Although EM provides no categorical distinction
between the different levels of aggregation on these time scales, the
final decline is nevertheless accompanied by the consolidation of
large filament-like structures by EM (Fig. 3). No major rearrange-
ments occur over longer time intervals at the level of secondary
structure (FTIR) or ultrastructure (EM). The modest decline in
fluorescence prior to precipitation can be viewed as an apparent
lag phase, as it represents the time required for accumulation of
aggregates of a certain size. Similar to other nucleation-limited
process, precipitation can be accelerated by the addition of
preformed aggregates around which the smaller aggregates can
coalesce as well as by an increase in the protein concentration.
In the presence of sufficient amounts of lipids, and provided
there is not significant amount of electrostatic screening, there is
only a small decline in Trp fluorescence (i.e. no precipitation) but a
marked increase in β-sheet structure compared to the absence of
lipids. Nevertheless EM does not indicate formation of straight
fibril-like structure in lipids but rather wool-like threads. The
decline in Trp fluorescence is accompanied by a ∼13 nm blueshift,
suggesting direct hydrophobic interaction between the aromatic
residue and lipid. In contrast, the lipid-free process associated with
the 15% Trp fluorescence decline gives rise to a negligible shift.
Thus there is a kinetic partitioning between lipid binding and
aggregation. In fact the inability of fresh SerADan to permeabilize
vesicles 100% could be due to dead-time formation of aggregated
species. Aggregation will dominate under physiological conditions
(cfr. the screening effect of 100 mM NaCl), but permeabilization is
not completely abolished and will be facilitated by higher lipid:
peptide ratios, so that its effects may accumulate over longer time
spans.
Fig. 8. Model of the different aggregation steps for SerADan and its interaction with lipids. Times indicate the approximate lengths required to complete the step in question (at
concentration ranges spanning 10–50 μM SerADan). The first phase (first 10 min) involves formation of β-sheet structure, a ∼5% loss in Trp fluorescence, initial aggregation and ∼50%
loss of permeabilization ability. Over the next 10–100 min aggregation levels increase, leading eventually to a multi-step sedimentation of large aggregates with loss of
permeabilization ability, CD and Trp signals. Calcein-containing vesicles are denoted by circles. The different shades of grey indicate different levels of ability of SerADan aggregates to
permeabilize the vesicles.
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4.2. Similarities between SerADan and ADan
The previous studies of the reduced form of ADan showed no
formation of amyloid-like structures but did demonstrate the presence
of a dimer in fresh samples, which aggregated over several days [8,9]
into an electron-densematrix. Thatmatrix shares somemorphological
similarities with the electron micrographs we present here although a
stronger similarity can be seenwith so-called immature fibers formed
by oxidized ADan [9]. However, the kinetics of SerADan aggregation at
pH 5.0 and 7.5 alike are an order of magnitude more rapid than those
previously measured for the cysteine-containing ADan variants. This
acceleration of aggregation is unexpected given the nature of the
substitutions (Cys→Ser and Phe→Trp). These donot significantlyalter
the β-sheet propensity [22,23] or, in the case of F15W, the propensity
for β-aggregation [24]. For C5S and C22S, the substitution theoretically
lowers the β-aggregation propensity rather than increasing it.
However, due to the proximity to the theoretical pKa for cysteine
(∼8.0),∼17% of the Cys residues in reduced ADanwill be charged at pH
7.5. In principle, the elimination of charge by themutations in SerADan
could play a role at pH 7.5, but not at pH 5.0 where only 0.1% of the Cys
residues will be charged. However, since the kinetics are rapid at both
pH 5.0 and 7.5, we conclude that charge elimination by the Cys-Ser
mutations will not contribute significantly. An alternative explanation
for the effect of the mutations is that the elimination of cysteine
prevents shuffling and formation of intermolecular disulphide bonds
that could trap the peptide in ‘aggregation-protected’ conformations.
Thus the mutations in SerADan allow us to filter out the covalent
interactions and focus entirely on hownon-covalent interactions affect
the aggregation process.
4.3. SerADan interacts strongly with anionic phospholipids
SerADan shows the preference for anionic lipids that is seen for
most other lipid-interacting aggregating proteins. These interactions
are mediated by electrostatics, as they are reduced at medium ionic
strength. At pH 7.5, the charge is predicted to be −1 to −2, leading
to overall repulsion from anionic lipid membranes. Inspection of the
primary structure does not reveal an obvious basic region that could
account for the interaction with the negatively charged lipid.
However, several authors have attempted molecular modeling of
the ADan peptide based on (a) the 101–123 segment of transthyr-
etin [9] or (b) a previous model for the related ABri peptide [8,25].
The former (a) resulted in a double-stranded β-sheet stabilized by
disulphide and hydrogen bonding and terminating in a long loop
with the C-terminal tyrosine residue hydrogen bonded to the β-
sheet. The latter (b) showed a triple β-sheet in which strands one
and two are similar to the double-stranded model while the third
strand consist of the C-terminal region. Both of these models are
interesting in that they largely isolate the charged residues at one or
both ends of the β-sheet albeit not in a manner that creates a clear
cationic region. In addition, the peptide contains two histidine
residues and local environmental effects could very well shift the
effective pKa of this group. The residue corresponding to the single
tryptophan in SerADan is also located at one end of both models.
Together with the observed strong blueshifting of the emission
spectrum in SerADan, it is tempting to speculate that Trp is buried
within the core or border region of the membrane while a local
basic region of the peptide interacts with the lipid head group; this
whole interacting region is located at one end of a double- or triple-
stranded β-sheet.
4.4. SerADan share characteristics with antimicrobial peptides
The rapid release of calcein from vesicles demonstrates that
SerADan (and by implication ADan) has a potent perturbing effect
on lipid membranes at molar peptide:lipid ratios down to 1:500,
which is comparable to bona fide antimicrobial peptides [26]. Unlike
small antimicrobial peptides such as Novispirin [27], lipid-bound
SerADan does not contain notable amounts of α-helical structure.
However, amphiphilic antimicrobial peptides forming β-hairpins in
the active form have been identified such as the cationic β-
defensins and bactenecin [28,29], and self-assembling β-sheet
peptides are able to form transient pores in membranes [30].
Furthermore, formation of α-helix structure is not a prerequisite for
the ability of Novicidin to permeabilize e.g. zwitterionic lipids (B.S.
Vad and D.E. Otzen, unpublished observations).
SerADan's predilection for β-sheet structure in lipids is in
marked contrast to IAPP, which in the presence of anionic lipids is
able to form α-helical assemblies that lead to membrane leakage
and subsequent fibril assembly through α-to-β conversion within
the α-helical assembly [31]. Similarly, the fibrillating polypeptides
α-synuclein [32] and Aβ [33] both form α-helical structures in lipid
bilayers which may be intermediates in fibril formation [34].
Although programmes such as TANGO [35] predict Aβ to have a
significantly higher β-sheet propensity in buffer than SerADan
(whose propensity in turn is much higher than that of IAPP), this
may be overruled by the pronounced tendency of SerADan to
associate rapidly by a more general collapse. SerADan's inability to
form highly organized fibrillar structures may thus reflect that it is
quickly trapped in locally well-organized aggregates that are unable
to reorganize at the molecular level to make regular β-sheet
contacts. It is tempting to speculate that the swiftness with which
these oligomeric structures are formed in solution and in lipid
bilayers is a key factor that will facilitate an aggressive behavior
towards cellular membranes at the monomeric and early oligomeric
level.
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3.2 Discussion of Paper 1
3.2.1 SerADan aggregates by a step-wise mechanism
The aggregation of SerADan was followed by several methods (table 11), which
in collaboration demonstrate an assembly mechanism that falls in several steps.
The earliest detectable event in the assembly process, occurring within the first
minute, is the collapse from a random coil structure into a β-rich conformation
following dilution from 10M to 0.2M urea (paper 1/figure 4). Considering the
intrinsic Trp fluorescence, the assembly of SerADan aggregates takes place in
three roughly defined phases (figure 33, paper 1/figure 5). During the initial phase,
the fluorescence intensity declines by approximately 20% associated with a mini-
mal peak blue-shift (~353nm to ~350nm). For pH 7.5, the reduced intensity can
be further divided into two sub-phases as discussed in section 3.2.4. The length
of phase I varies with the initial peptide concentration between ~20 and ~160
minutes for 50μM and 10μM peptide, respectively. During this phase, DLS shows
a steady increase in particle size starting immediately after dilution and into the
second phase observable by Trp-fluoresence (paper 1/figure 5.B). The eventual
plateau in particle size, which for a peptide concentration of 50μM is reached
after approximately 40 minutes, is rather due to limitations imposed by instru-
ment settings than a genuine arrest of aggregate growth. This is consistent with
sedimentation as the cause of the abrupt reduction in Trp fluorescence to ~60%
of the initial emission intensity. The role of sedimentation is also supported by
the absence of phase II and III in continuously stirred samples (figure 34.A) and
the recovery of emission intensity by agitation of quiescent samples (figure 34.B).
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In parallel with aggregate growth observed by DLS and indirectly by Trp fluores-
cence, EM shows the transient appearance of amorphous structures followed by
very large particles composed of tightly interwoven linear, fibre-like aggregates
(figure 35.A, paper 1/figure 2). Nevertheless, linear filaments are observable in
the very earliest EM images albeit as a minor species and with less well-defined
and uniform structure, which could suggest that they function as precursors to
the mature, linear aggregates. However, the obtained EM images do not allow
discrimination between the observed structures with sufficient confidence to make
conclusions regarding their relative position on or off the aggregation pathway.
Based on these observations, a putative assembly mechanism can be draw up
(figure 35.B) consisting of an early collapse of the monomer into a β-rich confor-
Figure 35. (A) Exam-
ples of morphology by
EM for aggregation of
50μM SerADan at pH
7.5. Scale bars corre-
spond to 400nm. (B)
Putative mechanism of
SerADan aggregation
and lipid interaction.
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mation followed by association of monomers into oligomers and later aggregates
of increasing size. The onset of sedimentation appears to correlate with the for-
mation of increasingly large aggregates of closely intertwined fibres with fibril-
like appearance. A more detailed description of the steps involved in the assem-
bly process is not possible, but it is likely that the early phase of aggregation
involves gradual build-up of soluble and insoluble oligomers in equilibrium with
the amorphous structures observed by EM. Aspects of this assembly mechanism,
the structure of SerADan aggregates and the circumvention of aggregation by
liposome binding are discussed in the following.
3.2.2 SerADan forms linear, β-rich, non-amyloid aggregates
The assembly of SerADan aggregates is rapid with formation of the final mature
structures accomplished within a few hours depending on concentration. A minor
fibrous species emerges for pH 5.0 within a few days, but overall stable and static
mature aggregates are established within the initial few hours whether in second-
ary structure or in the observable morphology. The final fibre-like, ThT and CR
Figure 36. Topology by
AFM of SerADan fibres
(50μM, pH 7.5). Image
area is 4.82x482μm
and z-range 44.4nm.
Cross-sections 1-4
(below) are marked
with white lines (1-4).
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negative structures are highly curved and intertwined to the point of preventing
imaging of single fibres although sonication prior to imaging for some samples
was found to cause shearing of the micron-scale aggregates allowing AFM im-
ages to be obtained along their edges. The final fibre-like structures are of vari-
able length but reasonably consistent height in the 3-5nm range (figure 36). The
estimated dimensions and the curvilinear appearance are suggestive of the
protofibrillar aggregates described as intermediates during the fibrillation of many
polypeptides including oxADan [547]. It is worth noticing that protofibrils in
general have little or no affinity for CR or ThT, which is consistent with the
binding model of CR and ThT that places the dye molecules parallel along the
fibril axis and bound in groves between protofilaments. According to this model,
binding of the dyes would not expected for fibrous structures without such
multifilament substructure. However, a possible structural relationship between
SerADan fibres and protofibrils must remain a suggestion in the absence of more
detailed structural information.
The fibres are undoubtedly composed of β-sheet organised to form linear aggre-
gates, but the supramolecular arrangement is puzzling. Our initial observations
by X-ray fibre diffraction, included in paper 2, did show a reflection at 4.8Å in
agreement with the interstrand distance in regular β-sheets but absent or very
diffuse reflection as higher distances inconsistent with cross-β structure and
strongly suggesting the absence of supersecondary structure (figure 37). It must
be noted that the overall signal intensity was very low, possibly due to poor align-
ment of the fibres.
Martin Jeppesen and Daniel Otzen continued this work by X-ray fiber diffraction
on recombinant SerADan, in collaboration with Kim Hein and Poul Nissen, al-
lowing collection of high quality X-ray diffractograms (figure 38.A). The pep-
tide preparation and aggregation conditions were somewhat different [573]. The
SerADan peptide was expressed as a SUMO fusion product in E. coli,
disaggregated in HFIP and could be induced for form ThT-binding aggregates at
25μM peptide and pH 5.5, 37ºC with vigorous shaking9. Aggregation at other pH
values in the range 4.8-7.5 showed less or no binding of ThT. However, despite
the affinity for ThT, the appearance in EM was not one of linear, fibril-like struc-
tures but rather short strands intermixed with amorphous material (figure 38.B).
The complex diffraction pattern showed several reflections including the charac-
Figure 37. X-ray fibre
diffractograms of alig-
ned SerADan fibres
formed at pH 5.0 and
7.5. Adapted from
paper 2/figure 10,
9 Aggregation of synthetic SerADan was independent of temperature between 13ºC and 40ºC.
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teristic peak at 4.67Å, but only a single reflection at 11.5Å in the 10-11Å region
expected for cross-β organisation. However, the multiple reflections do suggest
significant supersecondary structure and illustrates that SerADan has capacity
for forming regular structures with a high degree of intermolecular organisation.
As discussed in section 1.2.5, several structures have been suggested as alterna-
tives to the canonical fibril model, in which the fibril is composed of multiple
protofilaments of cross-β structure. A particularly interesting alternative in light
of the SerADan X-ray diffraction data is the nanotube model suggested by Max
Perutz for polyglutamine fibrils [129]. Rather than a semi-flat continuous β-sheet,
the nanotube model describes a continuous β-helix with 20 residues per turn
forming a water-filled tube with a mean diameter of 20Å. In this model, the 3.2Å
and 3.6Å reflections observed for polyglutamine were interpreted as side-chain
repeats along the inner and outer cylindrical phases, respectively.
The observation of β-rich, linear fibres is not limited to structures with the clas-
sical amyloid-like characteristics of dye binding, linear morphology and cross-β
organisation. Natural fibres such as spider drag line silk are composed of highly
organised β-sheets while β-rich fibres without classical cross-β organisation has
also been described for e.g. domain-swapped fibres of cystatin C or ribonuclease
A [574, 575] as well as edge-associated superoxide dismutase (SOD-1) [576].
These structures contain a large degree of preserved native structure. In all, pres-
ervation of native structure appears to be a more common feature for protein
aggregation than previously believed. We have in our group demonstrated that
ribosomal subunit S6 from Thermus thermophilus can be induced to aggregated
in a quasi-native state by electrostatic attraction mediated by the anionic deter-
gent SDS [577]. A certain degree of structural specificity has also been observed
for secretory granules [578]. An interesting example of the balance between na-
tive and β-rich aggregate structure was described by Alakoskela et al. [579] who
demonstrated heterogeneity along the long axis of fibres formed by cytochrome
c in the presence of anionic lipids varying from near-native to classical cross-β
amyloid-like organisation. This highlights the possibility of structural polymor-
phism, not only between fibrils formed of the same polypeptide under differing
circumstances but also within the same sample. It also speaks to the plasticity of
the polypeptide backbone when moving from globular protein folding, with its
dependence upon sequence as described by Anfinsen [155], to the apparently
Figure 38. (A) X-ray
fibre diffractogram of
ThT-positive aggrega-
tes of recombinant
SerADan, disaggrega-
ted in HFIP, incubated
at pH 5.5 with shaking.
(B) Aggregate morpho-
logy by EM. Scale bar
corresponds to 90nm.
Adapted from [573]
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generic ability of proteins to form aggregates and fibrils [10], which in the ab-
sence of evolutionary pressure gives rise to wide-ranging structural polymor-
phism dependent on external conditions [114].
Based on these reflections, it is possible that the β-rich and linear but non-amy-
loid fibres observed here for SerADan could represent an intermediary between
conventional amyloid structure and one or more alternative linear arrangements
of β-sheets. The obtained results suggest that the linear SerADan arrangement is
considerably less organised than that of amyloid, and lacks the surface character-
istics required for CR and ThT binding. The exact structural properties of such
alternative structures is of great interest and could provide a greater understand-
ing of β-sheet interaction in linear aggregates as well as their assembly. Struc-
tural studies with the potential to answer these questions are currently underway.
3.2.3 The onset of sedimentation is accelerated by seeding
The rapid decline in intrinsic Trp fluorescence (phase II) can be ascribed to sedi-
mentation of very large aggregates and as a result, the kinetic behaviour of
SerADan cannot be followed reliably by Trp fluorescence beyond the early stages
of aggregation. Nor is DLS suitable since even low concentrations of large ag-
gregates skewer the results towards high particle size and polydispersity. In the
absence of more specific time-resolved methods, inferences must be made based
on indirect methods.
The addition of 1.5% sonicated, preformed, mature aggregates to 10μM SerADan
approximately halves the apparent lag phase (T0.5), here defined as the time-point
corresponding to a normalised emission intensity of 0.5 (figure 39.A-B). Further
addition to 15% seeds did not considerably shorten the delay before onset of
sedimentation. Whereas this could be interpreted as the circumvention of nuclea-
tion during growth of the fibres and thereby as an indirect sign of a nucleated
growth process, a different interpretation is likely. It must be expected that the
period required for formation of sedimentation-prone particles would be short-
ened by the presence of large particles at the onset of aggregation around which
smaller oligomeric species can coalesce. However, process of seeding in forma-
tion of ordered aggregates, e.g. during fibrillogenesis, is complex and poorly
understood. Dobson and co-workers [188] observed that a tandem repeat of the
SH3 domain of the α-subunit of bovine phosphatidyl-3'-kinase forms amorphous
oligomers of various sizes at pH 3.6 by a down-hill oligomerisation process and
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that oligomers over a certain size efficiently seed amyloid-like fibrils at pH 2.3.
The authors attributed this activity to a structural conversion within the amor-
phous oligomers to form curly fibrils. Similar seeding of ABri fibrils was de-
scribed when spherical aggregates formed at pH 7.3 was transferred to pH 4.9
[548]. In all, the underlying role of amorphous structures in seeding is unre-
solved, but seems to involve internal structural conversion, seeding via surface
structures of amyloid-like conformation or a role as reservoir for aggregation-
prone monomers [188, 208, 209, 580]. The mature SerADan aggregates do not
appear to have classical amyloid-like structure and the function of preformed
aggregates in acceleration of the assembly of sedimentation-prone aggregates
could involve a number of such mechanisms.
3.2.4 Charge may play a role in the early aggregation phase
The difference in pH does not result in significant disparities in later phases of
aggregation in terms of secondary structure, gross morphology or in the time-
profiles obtained by fluorescence and dynamic light scattering. However, clear
differences can be observed in intrinsic Trp fluorescence in the initial phases
immediately following the collapse into from random coil to β-structure. At pH
7.5, an initial ~15% decline in emission intensity can be observed over 5-10
minutes (phase Ia, figure 33) followed by a less steep, linear reduction of ap-
proximately 5% (phase Ib). The normalised data sets, used for easy comparison,
do not demonstrate concentration dependence of phase I, but when the non-nor-
malised time-courses are examined, a different picture emerges (figure 40).
At pH 7.5 a log-log plot of the initial reaction rates10 versus initial monomer
concentration yields a reaction order in peptide concentration of ~1.3 (figure 40,
10 Initial reaction rates were obtained as the initial slope by linear regression over the first five minutes of non-normalised
emission intensity per time unit.
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insert). This value is more consistent with a complex reaction than a simple
monomeric collapse or dimerisation. In contrast, this sub-phase division is ab-
sent at pH 5.0 for which a single linear reduction to ~80% of the initial intensity
can be observed. The first 4-5 minutes at pH 5.0 are marked by significant noise
of unknown origin preventing the direct calculation of initial reaction rates. How-
ever, under the assumption that the following linear decline is representative, the
slopes of the curve versus peptide concentration in a log-log plot yields a reac-
tion order of approximately 1, similarly to phase Ib for pH 7.5, suggesting an
unchanged aggregate molecularity. Similarly, time-resolved CD shows distinct
differences over a comparable time period. While the decline in intensity of the
β-component of the spectrum begins immediately after dilution at pH 5.0, the
time profile for pH 7.5 shows a lag phase. In all, these results are suggestive of
subtle differences between the aggregate assembly mechanisms with particular
emphasis during the initial phase. Given the differing predicted charges at pH 5.0
and 7.5, the pH-dependence of the time profiles points towards an electrostatic
cause for the disparity in assembly, e.g. by charge repulsion or alternative elec-
trostatic interaction for the β-rich monomeric conformation or within oligomeric
structures. However, this charge dependency also speaks to the possible effects
of the C5S and C22S mutations. While cysteine is neutral at pH 5.0, pH 7.5 is
sufficiently close to the theoretical pKa for cysteine that a considerable propor-
tion of the residues (~17%) will be negatively charged at pH 7.5. It must be
emphasised that this difference between redADan and SerADan may make the
kinetic observations of early aggregation irrelevant for the biological peptide.
In addition to the possible charge-related effects on the early events in aggrega-
tion of the Cys-to-Ser substitutions, the absence of the intramolecular disulphide
must be considered. It is possible that the disulphide maintain the ADan peptide
in a aggregation-protected conformation that only slowly converts to a more ag-
gregation-prone conformation. The absence of the disulphide would allow the
SerADan peptide to sample possible conformation, including aggregation-prone
ones, more rapidly thereby significantly increasing the observable aggregation
rate in spite of the lower predicted β-aggregational propensity. In the light of the
solution condition-dependent partitioning between fibrillation and amorphous
aggregation described for monoclonal human immunoglobulin light chain [581],
this line or reasoning also offers a possible rationalisation for the transition from
amorphous aggregates observed for ADan to the linear aggregates described here
for SerADan. Slow conversion to the aggregation-prone conformation combined
with rapid aggregation of the ADan peptide could lead to kinetic trapping of the
peptide in β-rich but amorphous aggregates with limited ability to structurally
reorganise into ordered, linear aggregates. In contrast, the lowered aggregational
propensity predicted for SerADan could permit formation of repeatable intermo-
lecular contacts and thereby linear aggregates without permitting formation of
canonical fibrils. It is possible that further mutational studies could tune the in-
trinsic aggregational propensity of SerADan to allow formation fibrils with clas-
sical tinctorial, structural and morphological characteristics.
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3.2.5 SerADan interacts with anionic lipids by a combination of factors
The presence of anionic lipids dramatically alters the aggregational properties of
SerADan. Whereas the early changes in fluorescence appear conserved, the later
sedimentation phase is effectively prevented within the monitored time frame
(paper 1/figure 6). Similarly, DLS shows that formation of large aggregates is
either prevented (lipid-to-protein, LP, ratios of 1 mole/mole or higher) or signifi-
cantly delayed (LP 0.1). The fibrous aggregates are also absent in EM and AFM
in favour of amorphous, wool-like structures, which show a combination of char-
acteristic lipid and protein bands in the amide-sensitive 1750-1500cm-1 region in
FTIR (figure 41). The appearance in FTIR is of a β-rich polypeptide similarly to
the CD spectra, which suggest that the lipid-bound peptide contains significantly
more β-structure than in the absence of lipid. This β-rich conformation is estab-
lished within the first few minutes and on a similar timescale as the β-structure
observed in the absence of lipid. Despite the higher β-content, the elements in-
volved in peptide-peptide interaction (i.e. a form of monomer-level aggregation
nucleus similar to the folding nucleus described for folding of globular proteins)
may well be similar. The reaction is associated with a strong peak blue-shift (353nm
to 340nm) within the dead time of the fluorescence measurement that remains
stable throughout the monitored time window. In all, it is likely that the peptide
interacts with lipid vesicles in a manner that leads to a highly ordered β-rich
structure at the monomer level associated with partial or complete burial of the
Trp residue within the membrane. However, the presence of NaCl in the physi-
ological range re-establishs the formation of large aggregates and this combined
with the preference for anionic over zwitterionic lipids clearly indicate a strong
electrostatic component to the interaction between lipid and peptide. It thus ap-
pears that the interaction of SerADan with lipids occurs as a combination of both
electrostatic and hydrophobic factors, which is intuitively consistent with a pep-
tide containing both predominantly hydrophobic and highly charged regions.
3.2.6 Membrane permeabilisation and aggregation are kinetically partitioned
The strong effect of the anionic lipid DOPG, particularly at pH 7.5, led us to
further investigate the interaction during early stages of aggregation at this pH
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value by calcein release, which shows a strong dependence of sample ageing on
the effectiveness of vesicle permeabilisation. Addition of freshly diluted peptide
to calcein-containing vesicles allows release of nearly 60% compared to levels
obtained by addition of detergent (paper 1/figure 7). The membrane-disturbing
effects can be observed down to a lipid-to-peptide ration of 500:1, which makes
SerADan a very effective membrane de-stabiliser on par with the efficiency of
antimicrobial peptides [582]. However, within the initial 15 minutes, the rate
constant of the time course of calcein release11 decreased rapidly while the ob-
tained final emission level drops to a plateau of ~30% before decreasing to prac-
tically nil concurrent with the onset of precipitation12.
The distinct three-phased dependence upon sample ageing suggests that whereas
the peptide becomes effectively sequestered in the mature aggregates of linear
fibres, earlier forms of the peptide fall in two classes. The most effective agent or
agents of liposome permeabilisation are the earliest and presumable smallest and
least structurally complex species. The second class of oligomers may have an
observable but lower intrinsic permeabilisation activity. However, an alternative
and fascinating interpretation is that peptides aggregating in the absence of
liposomes attain a stable, energetically favourable or kinetically trapped struc-
ture for which some degree of structural rearrangement is required for
permeabilisation to occur. However, despite the dead time peak blue shift, the
early fluorescence time course is preserved both in terms of time and emission
intensity scales indicating that the freshly dissolved and thereby effectively pen-
etrating peptide does display some degree of oligomerisation with similarities to
the process under lipid-free conditions. Alternatively, the conformational transi-
tion associated with the decreased emission intensity could be a prerequisite of
membrane binding rather than a process occurring both on- and off-membrane. It
thus appears that peptide oligomerisation, membrane interaction and
permeabilisation is a complex process composed to two competing and partially
overlapping but kinetically partitioned pathways in the presence or absence of
anionic lipids. Interestingly, the permeabilisation of the calcein-containing vesi-
cles by freshly dissolved peptide is not complete when compared to the effect of
detergent and in the kinetic partitioning scenario, this could be due to limited but
significant formation of stable lipid-free aggregates. It is possible that addition of
pre-incubated peptide/non-calcein vesicle samples to calcein-containing liposomes
could illuminate the structural dynamics of the lipid-bound peptide ensemble,
e.g. whether the membrane-bound and permeabilisation-competent peptide is
effectively immobilised or capable of transfer to the calcein-containing vesicles.
3.2.7 Membrane interaction inhibits aggregation rather than enhancing it
The cessation of large-scale aggregation in the presence of anionic liposomes
suggests that the lipid association plays a pivotal role in effectively preventing
self-association of the peptide into large aggregates although formation of smaller
oligomers appears preserved as judged by the early fluorescence changes. This is
in contrast to the majority of observations for the interaction of amyloidogenic
11 The release of calcein fits well with a single exponential decay.
12 The sample was agitated so the decreasing permeabilisation is not due to disappearance of peptide from solution.
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polypeptides and anionic lipids for which membrane interaction results in accel-
eration of fibril formation. However, inhibitory effects of anionic lipids have
been demonstrated for Aβ and α-synuclein purportedly due to burial of hydro-
phobic segments within the membrane protecting these aggregation-promoting
regions from protein self-association (see section 1.4.3).
A similar scenario could be relevant for the non-amyloidogenic SerADan given
the central hydrophobic region, which could be involved in such interaction [583],
and the likely membrane insertion of the Trp residue suggesting that the lipid
interaction of SerADan is dependent upon a combination of electrostatic and
hydrophobic effects. However, the general lack of effect of zwitterionic lipids
demonstrate that the mere availability of a hydrophobic environment is not suffi-
cient for binding to occur whereas the electrostatic interaction appears crucial. A
recent study from our group [584] demonstrated the dependence of membrane
surface electrostatics. Using a simple but descriptive binding-and-folding model
Lars Kjær et al. showed that the membrane association and folding of α-synuclein
into an α-rich conformation is highly dependent upon lipid gel-to-liquid disor-
dered phase transition but also that the binding and folding was critically de-
pendent upon the presence of anionic lipids of sufficient charge density. The
kinetic partitioning between strong membrane interaction and aggregation is also
curious in the light of the pH preference for membrane interaction. A signifi-
cantly stronger anti-aggregational effect of the negatively charged lipids at pH
7.5 (predicted charge -1) compared with pH 5.0 (predicted charge +1). The blue-
shift in Trp-emission is indicative of direct membrane contact, but an inspection
of the adjacent protein sequence does not suggest an obvious and intuitive way
for such charge-dependent interaction to occur. Rather, the peptide consists of
the hydrophobic region with high predicted aggregational propensity flanked by
two zwitterionic segments predicted to be overall neutral at pH 7.5.
A survey of literature reveals two proposed structural models for the oxADan
peptide in the aggregate form (figure 42). Surolia et al. [551] modelled a double-
stranded β-sheet (model 1) based on the 101-123 segment of transthyretin whereas
Austen and co-workers [557] based their triple-stranded β-sheet (model 2) on a
previously model of oxABri, which in turn was derived from multiple alignment
secondary structure predictions yielding a β-strand-turn-β-strand motif for the
N-terminal residues 1-23 [546]. The two models are similar for these initial 23
residues but whereas model 1 suggests a loosely coordinated loop for the 11 C-
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terminal residues, model 2 describes a third anti-parallel β-strand stabilised by
van den Waals interactions and electrostatic attraction between K14 and the C-
terminus. Despite the differences in peptide composition as well as the absence
of the intramolecular disulphide, it is interesting to speculate that the membrane-
bound peptide exists in such a β-rich conformation, which allows partly or com-
plete burial or W15 as well as interaction with the negatively charged lipid
headgroups via a localised positively charged patch. Model 2 in particular de-
scribes the concentration of several charges at one end of the structure and in
vicinity of the F15W mutation, which is interesting in light of the preference of
aromatic residues for the membrane interface region [585, 586]. The charge state
of histidine is malleable to the surrounding electrostatic environment, e.g. in the
dipole charge stabilisation at the C-terminus of α-helices [587], and charge-
stabilisation specific to the structure formed at pH 7.5 beyond the nominal pKa
could conceivably explain the peculiar preference for neutral over acidic pH.
However, in the absence of conclusive experimental information, it must be pre-
sumed that the residue has neutral charge at pH 7.5 and under such circumstances
neither model adequately explains the preference for anionic lipids. An alterna-
tive and attractive possible explanation is that the interaction with anionic lipids
is dependent upon a delicate balance between charge and hydrophobicity push-
ing the peptide towards lipid binding when the hydrophobicity increases as histi-
dine is deprotonated without increasing the hydrophobic effect to the point where
interaction with zwitterionic membranes becomes favourable. Studies of oligomer/
detergent complexes are ongoing and could potentially shed light on the struc-
tural characteristics of these kinetically trapped species.
3.2.8 Mechanisms of increased membrane permeability
A simple structural model of SerADan binding to liposomes could involve bind-
ing of monomeric or oligomeric species to the membrane surface. In contrast to
the many amyloidogenic polypeptides, which have preference for anionic
liposomes, the increased concentration at the membrane surface, neutralisation
of repulsive charges, non-random orientation and other surface-specific effects
that could be expected from such binding does not lead to acceleration of nuclea-
tion or elongation of linear fibres. However, the structure of the membrane-bound
monomer or oligomer may very well differ from the aggregation-prone species
found in solution and furthermore homogeneous orientation of the peptide by
membrane binding cannot be assumed. An alternative mechanism to surface
membrane binding is lipid-mediated formation of size-limited β-rich oligomeric
structures with burial of the Trp residue within the lipid/peptide structure. These
mechanisms are both consistent with the permeabilisation of vesicles observed
by calcein-release. In the former case, direct membrane permeabilisation could
occur by a pore-like mechanism or by non-specific alteration of membrane per-
meability, which has been extensively described from amyloidogenic polypeptides.
In the latter case, IAPP could serve as an instructive example. It has been pro-
posed that extraction of lipid molecules could directly cause membrane leakage
[356], but a recent study of permeability changes associated with on-membrane
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fibril growth [588] suggests that it is the growth itself which disturbs the mem-
brane, possible due to bilayer perturbation and distortion associated with peptide
structural rearrangement within the membrane leading to increased membrane
permeability. On-membrane fibre growth has not been observed for SerADan,
but it is possible that structural rearrangement or lipid extraction could play a
similar role as for IAPP.
The proposed mechanisms of SerADan-induced membrane instability share many
similarities with the antimicrobial peptides (AMPs), a class of small (10-40AA)
and amphipathic peptides that often, but not exclusively, are positively charged
and preferentially bind to anionic membranes [589, 590]. Unlike SerADan, the
majority of AMPs are random coil in solution but form amphipathic α-helices
upon membrane binding with concomitant increased membrane permeability.
However, there does not seem to be a single unified mechanism behind the action
of AMPs. While some AMPs appear to form well-defined transmembrane pores
or ‘helical bundles’ [591, 592], antimicrobial activity has been demonstrated for
both natural AMPs and synthetic peptides in parallel orientation to the membrane
[593], which is inconsistent with such pore models. For these peptides, the in-
creased membrane permeability has been suggested to arise from transient chan-
nel formation via a combination of mechanisms, e.g. ‘carpet’-like membrane bind-
ing and disruption, transient perturbation of lipid packing and membrane stabil-
ity by diffusing peptides or detergent-like lipid extraction and membrane disinte-
gration [591, 594-597]. Despite the prevalence of α-helical structure, a smaller
subset of β-rich AMPs have been identified such as the β-hairpin forming
bactenecin or the mammalian defensins (figure 43.A), which bind to membranes
as triple-stranded β-sheets stabilised by several disulphide bonds [590, 598].
It is possible that the β-rich AMPs have similar mechanisms of action as the α-
helical AMPs [598]. Similarly, self-assembled, β-rich channels are well-known
for toxins such as α-latrotoxin and α-haemolysin [599-601] while formation of
transient transmembrane pores have been demonstrated for β-hairpin forming
peptides [602]. In general, the physiochemical properties of the lipid or deter-
gent, e.g. charge, strongly influence the structural preferences for AMPs and the
disruptive effect of AMPs hinges on a combination of electrostatic interactions
and the hydrophobic effect related to the burial of hydrophobic residues in the
membrane proper [589, 603-605]. While SerADan does not share e.g. the ca-
nonical multiple-cysteine defensin motif or an overall positive charge (figure
43.B), the peptide does share the strong preference for anionic lipids, the impor-
tance of electrostatic attraction in the lipid-peptide interaction, the likely burial
of hydrophobic residues and, interestingly, the low concentration threshold for
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membrane activity. The pore-forming ability of ABri and ADan have previously
been described [202, 550], but such structures could not be identified by EM or
AFM in the samples examined here However, it is conceivable that SerADan
affects membrane integrity by one or several AMP-like mechanisms such as for-
mation of well-defined channels or by less specific membrane perturbation. As
such, SerADan does not only occupy an interesting position between amorphous
and fibrillar aggregates but also between aggregating polypeptides and the anti-
microbial peptides. Further studies of the mechanisms and effects the analogous
serine-mutants of the ABri peptide in vitro and in vivo are currently in the early
stages under the direction of Dr Jorge Ghiso (Departments of Pathology and Psy-
chiatry, New York University, New York, NY, USA) and in collaboration with
our group.
3.2.9 The relevance of the SerADan peptide
The balance between self-association in the form of large aggregates or mem-
brane association and permeabilisation appears controlled by solution conditions
via charge screening at close to physiological ion concentrations. This curious
characteristic does suggest that the biological activity of the relevant ADan pep-
tide may be similarly affected in tissue although this does assume that the obser-
vations for the SerADan peptide carries physiological relevance. My initial inter-
est in ADan as an aggregation model system was through the combination of
predominantly non-amyloid deposits in vivo and the aggressive nature of the
disease. The design of the SerADan peptide does raise obvious questions about
the biological validity of the results, but it does provide a direct link to aggrega-
tion processes occurring in vivo. Furthermore, the SerADan peptide combines a
number of highly interesting properties. It is both capable of forming organised,
linear, β-rich but non-amyloid aggregates with a puzzling lack of supersecondary
structure based on our results and the ability to effectively and specifically
permeabilise anionic liposomes during the very early phases of aggregation. In
this light, I would argue that the peptide has proven to be of interest in its own
right. The putative mechanism of SerADan aggregation in vitro demonstrates
that mature aggregates that do not bind ThT and CR, and therefore cannot be
classified as amyloid-like, can occur as a step-wise assembly process and have
ordered, linear appearance.
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3.3 Introduction to Paper 2
Nesgaard, L.W., Hoffmann, S.V., Andersen, C.B., Malmendal, A., Otzen, D.E. Characterization
of dry globular proteins and protein fibrils by synchrotron radiation vacuum UV circular dichr-
oism. Biopolymers (2008) 89 p. 779-95.
The mature linear aggregates formed by SerADan do not share classical amyloid
characteristics, but seem to occupy a intermediate position between β-rich amor-
phous aggregates and canonical fibril structure. It is likely that more refined struc-
tural methods such as solid phase NMR [573] will yield more detailed structural
information, but my structural analysis was restricted to gross morphology and
secondary structure estimation. For the latter purpose, I used ATR-FTIR, which
showed negligible variation among samples, and solution far-UV circular dichr-
oism, which is somewhat unsuitable for insoluble aggregates due to scattering
effects as well as the inherent non-uniform concentration throughout solution.
3.3.1 Features of circular dichroism
The circular dichroism signal is measured as the difference, rather than the ratio,
between left and right circularly polarised light making the signal particularly
sensitive to noise at low light intensities [606]. At wavelengths below ~190nm,
the absorbance of the polypeptide, solvent and solutes increases beyond the lim-
ited light intensity of commercially available instruments fitted with xenon lamps
although the practical cut-off may be well above 200nm in the presence of e.g.
chloride ions or, as the case is here, urea. The 250-190nm spectral window pro-
vides a great deal of information about secondary structure, and should allow
distinction between 4-5 structural elements [607, 608]. A light source with higher
intensity is required to permit more detailed structural characterisation by ex-
tending the spectral window further into the far-UV range. High-flux synchro-
tron radiation allows spectral collection down to 160-175nm [609] (figure 44),
which allows full recording of the nπ* transition and perpendicular and parallel
exciton peaks of the πnbπ* transition as well as the interamide charge transfer
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transitions around 180nm. The high light influx and well-defined characteristics
makes it well-suited to the purpose, but the production of high-energy synchro-
tron radiation requires access to expensive and technically complex accelerator
equipment. Currently, only a handful of centres are exploiting synchrotron radia-
tion for CD studies world-wide including the ASTRID (Aarhus STorage RIng in
Denmark) facility at Aarhus University, Denmark. In cooperation with Dr Søren
V. Hoffmann, I was given the opportunity to record synchrotron radiation vacuum
UV CD (SRCD) spectra of mature SerADan aggregates. While the more detailed
spectra did not lead to new extensive and conclusive structural information about
the SerADan aggregates, it was the beginning of an exciting collaboration.
3.3.2 Synchrotron radiation vacuum ultraviolet circular dichroism
The information content of CD spectra dramatically increases as the spectral
window is extended further into the far-UV region. Whereas spectra in the 250-
190nm range only allow discrimination between four to five structural elements
[608, 611], extension to 178nm could increase the information content sufficiently
to allow for seven to eight structural classes (e.g. α-helix, 310-helix, β-sheet, ran-
dom coil, various turns), which should suffice for meaningful estimates of sec-
ondary structure content [607]. This approach assumes highly standardised spec-
tral contributions for each structural element. However, the practical analysis of
protein β-sheet content presents a special challenge, which must be considered
for β-rich structures such as fibrils or the linear SerADan aggregates. Firstly,
proteins with predominant β-sheet structure but differing fold can be highly di-
verse in their circular dichroism [607]. The splitting of the πnbπ* band at ~190nm
into two apparent components is a known spectral deviation observed to varying
degree for e.g. immunoglobulin-like folds [612]. The nature of this variation could
be unusual negative spectral contributions from e.g. aromatic residues [613, 614]
or attributable to variations in β-sheet twist. The β-sheet geometry has also been
implicated in the intensity differences observed for the nπ* (~215nm) and πnbπ*
(~198nm) bands [615] with higher relative intensity of the πnbπ* band for highly
twisted β-sheets. Secondly, the β-sheet CD signal has a significantly lower inten-
sity than several of the other common structural elements [607, 610]. This im-
pedes accurate estimation of the spectral β-sheet contribution proteins of e.g.
mixed α/β or α+β, but also influences the spectra obtained for proteins otherwise
identified as β-rich from their crystal or NMR structures. This is demonstrated
by the subdivision of all-β spectra into βI and βII types [616]. While βI-type
spectra are similar to those for model β-sheets, βII-type spectra resemble those
obtained for unordered polypeptides, which in turn have great similarity with
poly(L-proline) II helix-like P2-type spectra (figure 45). Sreerama and Woody
[616] showed that the partitioning between βI- or βII-type spectra depends on the
relative content of β-sheet (fβ) and P2 (fP2) structure, the latter of which can ac-
count for a considerable fraction of the secondary structure of globular proteins
[617]. At low ratios (fP2/fβ < 0.4), β-sheet dominates the spectrum but this contri-
bution is counteracted by the higher intensity P2 contribution at higher ratios.
Spectral perturbations can also come from the intrinsic CD of aromatic residues
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and disulphide bonds above 225nm [614], which can distort the low-intensity β-
type spectra significantly. As a result, the extraction of structural characteristics
of β-rich proteins may be poor from spectra with atypical properties despite the
otherwise powerful tool provided by e.g. secondary structure estimation using
reference data sets. One such example comes from jacalin, which shows a strong
negative contribution at ~190nm resulting in particularly inaccurate estimation
of the β-sheet content [618]. Extension of the spectral window into the vacuum
ultraviolet (VUV) range could provide further structurally sensitive bands for
analysis and thereby allow more accurate analysis of rare protein folds as well as
potentially offer information on super-secondary and tertiary structure [609, 619,
620]. The prospect of additional spectral information allowing characterisation
of subtle alterations in secondary as well as higher levels of structure is of par-
ticular interest for fibrils in light of the polymorphism in structure and stability
that appears to be a common phenomenon for numerous proteins and peptides.
3.3.3 Experimental approach to synchrotron radiation vacuum UV CD
The absorbance of UV light by water below ~160nm limits solution synchrotron
vacuum UV CD to this wavelength and acquisition of CD spectra at higher ener-
gies requires either the substitution of water for an alternative non-absorbing
solvent or drying of samples. Spectra have been recorded at wavelengths down
to ~130nm using fluorinated alcohols, e.g. trifluoroethanol (TFE) and HFIP, as
solvents but these alcohols have also been implicated in denaturation of globular
and membrane proteins [621, 622] as well as modulation of fibrillation [623] and
aggregation, as we have shown for several α-helical and β-barrel membrane pro-
teins [624]. This effect likely arise from the reduction in relative solvent dielec-
tric constant and associated mimicry of membrane-surface conditions [625, 626].
In contrast, amyloid, amyloid-like fibrils and other aggregates types are gener-
ally robust and studies by Dobson and co-workers [126] have shown that fibrils
tolerate dehydration well without significant structural alteration. We therefore
decided to use samples dried on a MgF2 plate, which only absorb light below
125nm, in a manner similar to that used for FTIR and AFM for which a small
volume was air dried or dried under a gentle nitrogen stream. Because of the
relatively larger volume, the process was accelerated by placing sample under
approximately ~100mbar vacuum during drying.
Figure 45. Examples of
α-, β- and P2-type CD
spectra deconvoluted
from a reference pro-
tein set (A) or model
polypeptides (B).
Adapted from [616].
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To allow meaningful interpretation of low wavelength features for fibril spectra
if was necessary to obtain spectre for a range of globular proteins of known struc-
ture in the dry phase. For this purpose, a selection of 13 globular model proteins
was chosen based on relevance, availability and the need for sufficient structural
diversity to cover a range of all-α, αβ and all-β proteins. Although the former
two groups are included in the selection, special emphasis was placed on β-rich
proteins in light of the predominance of β-sheet in fibrils and aggregates and the
structural diversity of all-β proteins. The model proteins were dried and other-
wise treated similarly to fibril and aggregate samples for the dry phase spectra.
Globular proteins are less tolerant towards drying and dehydration than aggre-
gates although the preservation of native-like structure under ambient tempera-
ture is a recurrent observation [627-629]. As the primary purpose of the study
was to obtain information about structurally sensitive features below ~160nm,
elucidation of the overall preservation of spectral features upon drying became a
secondary purpose. To this end, spectra for both model proteins and aggregate or
fibril samples were obtain for in aqueous solution (or ‘wet phase’) using quartz
cuvettes, which are opaque below 165nm, as well as in the dry phase.
ASTRID has several beamlines including the custom-built synchrotron vacuum-
UV CD (SRCD) facility (figure 46) using the high-flux UV1 beamline [630].
Briefly, the highly linear polarised UV1 beam was converted to circularly polar-
ised light with alternating left- and right-handed orientation at a frequency of
50Hz by a CaF2 Photo Elastic Modulator (PEM, model I/CF50, Hinds Instru-
ments, Hillsboro, Oregon, USA). The light beam was passed through the sample
and sample chamber, which was continuously purged with nitrogen to limit ab-
sorbance from atmospheric oxygen, and detected with a UV-sensitive
photomultiplier tube (PMT, model 9402B, Electron Tubes, Uxbridge, UK) and
lock-in amplifier. The pre-use calibration with camphor sulphonic acid (CSA),
baseline and sample spectrum acquisition as well as post-acquisition data treat-
ment was similar for wet and dry phase with exception of a lower wavelength
end-point for the dry phase spectra. For comparison between wet and dry phase
spectra, the concentration-sensitive detector voltage for the protein-specific peak
at 190nm was used for normalisation of the dry phase spectrum to the known
concentration for the wet phase spectrum.
Figure 46. Schematic
overview of SRCD
instrumentation on  the
UV1 beamline
(www.isa.au.dk/
facilities/astrid/
beamlines/uv1/)
Linearly polarised
monochromatic SR
Sample
cell
Modulated
RH and LH
components
Photoelastic
modulator
Photomultiplier
tube
CD spectrum
Lock-in
amplifierDrive unit
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INTRODUCTION
T
he deposition of soluble proteins or peptides in the
form of insoluble amyloid plaques is associated with
many systemic and neurodegenerative diseases such
as Alzheimer’s disease, Parkinson’s disease and Type
II diabetes mellitus.1 Because of their insolubility,
amyloid-like fibrils do not lend themselves easily to struc-
tural studies, but some insight has been gleaned from e.g.
cryo-electron microscopy and X-ray diffraction studies of
model fibrils formed in vitro.2–5 These methods offer detailed
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ABSTRACT:
Circular dichroism using synchrotron radiation (SRCD)
can extend the spectral range down to 130 nm for dry
proteins, potentially providing new structural information.
Using a selection of dried model proteins, including a-
helical, b-sheet, and mixed-structure proteins, we observe
a low-wavelength band in the range 130–160 nm, whose
intensity and peak position is sensitive to the secondary
structure of the protein and may also reflect changes in
super-secondary structure. This band has previously been
observed for peptides but not for globular proteins, and is
compatible with previously published theoretical
calculations related to p-orbital transitions. We also show
that drying does not lead to large changes in the secondary
structure and does not induce orientational artifacts. In
combination with principal component analysis, our
SRCD data allow us to distinguish between two different
types of protein fibrils, highlighting that bona fide fibrils
formed by lysozyme are structurally more similar to the
nonclassical fibrillar aggregates formed by the SerADan
peptide than with the amyloid formed by a-synuclein.
Thus, despite the lack of direct structural conclusions, a
comprehensive SRCD-based database of dried protein
spectra may provide a useful method to differentiate
between various types of supersecondary structure and
aggregated protein species. # 2008 Wiley Periodicals, Inc.
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structural information, but are technically demanding and
not well suited for high-throughput studies. In contrast, sev-
eral spectroscopic methods allow fast and reliable estimation
of secondary structure. Among the commonly used methods
are infrared, Raman, and far-UV circular dichroism spectros-
copy (CD).6 Each method has advantages and drawbacks.
Infrared spectroscopy, usually in the form of Fourier-trans-
form infrared spectroscopy (FTIR), is useful for secondary
structure characterization, but high confidence estimates
require spectra of high quality, whose acquisition is compli-
cated by the presence of strongly absorbing water as solvent
and vapor. This demands meticulous sample handling and
use of deuterium oxide or dried protein films.7,8 Circular
dichroism offers simpler sample handling and experimental
conditions closer to physiological values. The method, when
using conventional lamp-based CD instruments, is highly
useful for a-rich proteins but has lower accuracy for proteins
with a low a-helix content due to a number of factors such as
presence of aromatic residues and the relatively lower signal
intensity of b-sheet compared to a-helix above 190 nm.9,10
Circular dichroism is measured as the difference in
absorption of left- and right-handed circularly polarized light
(DA 5 AL 2 AR) and commonly expressed as mean residue
molar ellipticity. The magnitude of the difference is small for
protein samples leading to the need for high light influx. A
commercially available instrument equipped with a xenon
arc lamp typically gives meaningful information down to
190 nm although the spectral window can be further lim-
ited by the presence of species that absorb strongly in the far-
UV range such as chloride ions.11 This only allows distinction
between a handful of structural classes, but extension of the
spectral window into the vacuum ultra violet (VUV) range
would provide additional information about secondary
structure and potentially allow assessment of super-second-
ary and tertiary structure information.12–14 Synchrotron
radiation is eminently suited for this purpose given its high
intensity and well-defined electromagnetic characteristics
and has been used successfully to increase the accuracy of
secondary structure prediction by allowing spectra to be
measured down to 160 nm. The lower limit for synchrotron
radiation CD (SRCD1) is dictated by the presence of water.10
This is not a major problem for protein fibrils and aggre-
gates, because sample heterogeneity and insolubility makes it
more appropriate to study them in the form of thin protein
films.15–17 By eliminating water, it should be possible to
extend the available spectral range down to 130 nm and
thereby obtain additional structural information.
Based on these considerations, we here present the use of
circularly polarized far-UV synchrotron radiation (SRCD)
on dried protein samples.
To elucidate the usefulness of the method, thirteen globu-
lar model proteins were selected with varying structural
motifs (Table I). The list of potential model proteins was
winnowed down based on availability and relevance to
include proteins with a-rich, mixed a-b, and b-rich struc-
tures. Spectra were obtained for both solubilised proteins
and dried proteins films to assess the advantage of extending
the spectroscopic window weighed against the risk of struc-
tural rearrangement of proteins due to altered hydration.
Structural effects of drying have previously been
described,18,19 suggesting that drying at ambient tempera-
tures preserves structure whereas e.g. freeze-drying might
lead to conformational changes. In this study our concern is
to elucidate whether the drying process perturbs the CD
spectra to an extent that prevents a meaningful interpretation
of the spectra for dried samples.
We used an over representation of b-rich proteins to allow
further examination of various b-sheet configurations, par-
ticularly sandwiched sheets. The characterization of b-rich
proteins was of special importance because of the wide range
of structural motifs observed in b-sheet globular proteins
and the prospect that information could be gleaned from
spectra features at lower wavelengths, which could assist in
differentiating structural motifs. Including a high number of
b-rich proteins was also of interest for the characterization of
protein fibrils, which are known to have high b-sheet con-
tent. Nevertheless, although all fibrils display a characteristic
stacking of b-strands, there is an increasing number of
reports of fibrillar polymorphisms, which include subtle var-
iations in secondary structure and associated stability.20–22
This is substantiated by recent X-ray microcrystal structures
revealing several different types of b-strand arrangements in
fibrils.23 Our results suggest that SRCD may provide a
method for more detailed classification of such polymor-
phism.
RESULTS
Spectral Features Are Preserved for
Dry Phase Spectra
Denaturation caused by disruption of native protein-sol-
vent interactions is a major concern when protein samples
are dried to form protein films. It has previously been
shown for globular proteins (including serum albumin,
ConA, trypsin, and lysozyme) that secondary structure
maybe preserved during film-formation and that protein
films can be used for structural studies.17,24 To investigate
whether protein films retain the same structure as in solu-
tion under the conditions of our experiments, we recorded
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spectra for both wet samples and dried proteins films.
Since the conversion of spectral raw data to mean molar
ellipticity is dependent on knowledge of the protein con-
centration, the dried spectra were normalized by compari-
son of the protein absorbance at 190 nm.
For a-helical and mixed a-b proteins (see Figure 1), the
main spectral difference lies in the relative intensities of the
three np* and pp* bands, which lie approximately at the
well-known values of 222, 208, and 190 nm. The spectra
display a minimum at 160–170 nm and, for ACBP and se-
rum albumin, a weak shoulder at 180 nm. Spectral fea-
tures in this area have previously been ascribed to np* or
pp* charge transfer transitions for a-helical and b-sheet
geometries, respectively.25–27 Only limited band shifting can
be observed, predominantly for the perpendicular exciton
peak (190 nm) for which a slight red-shift occurs upon
drying. There is no clear tendency in the intensity differen-
ces. This suggests that the shift and intensity differences are
protein-specific rather than a general effect of the drying
process.
The same overall preservation of spectral features can be
observed for the b-rich protein concanavalin A (ConA)
and thaumatin (see Figure 2). Both represent nonimmuno-
globulin-like sandwich architectures. Although drying
mainly affects the relative intensities for ConA, thaumatin
shows a slightly larger red-shift of the np* band (215
nm) than ConA. As previously described,28 thaumatin also
displays a positive band at 230 nm, consistent with the
presence of aromatic side-chains and disulfide bonds.29
The band is preserved upon drying, although an apparent
baseline shift can be observed. Spectral artifacts due to
unavoidable scattering in the protein film were minimized
by a short sample to detector distance of less than 30 mm.
Since any possible scattering increases at lower wavelength,
the spectra were recorded up to 330 nm, to ensure
that any discrepancy between the baseline and the sample
Table I Model Proteins and Fibrillar Samples Used for Wet and Dry Phase Synchrotron Circular Dichroism
Protein/Peptide Class Architecture Topology Remarks Pdb
Acyl-CoA-binding protein
(ACBP, bovine)
Mainly a Up-down bundle ACBP 1HB6
a-lactalbumin (bovine milk) Mainly a Orthogonal bundle Lysozyme 1HFX
b-galactosidase (Escherichia coli) a b Complex Complex, multidomain
protein.
Predominantly b
1DP0
Carbonic anhydrase (bovine) a b Roll Carbonic anhydrase II Single sheet, 10 strands.
Predominantly b
1V9E
Concanavalin A (ConA,
Canavalia ensiformis)
Mainly b Sandwich Jelly roll Sandwich, 12 strands in two
sheets, complex topology
1NLS
Jacalin (Artocarpus integrifolia) Mainly b Aligned prism Vittelline 1KU8
Porcine serum albumin (PSA) Mainly a Orthogonal bundle Serum albumin 1HK1
S6, ribosomal subunit
(Thermus thermophilus)
a b 2-layer sandwich a-b plaits 1RIS
Tenescin, third fibronectin
type III repeat
(Tnfn3, human)
Mainly b Sandwich Immunoglobulin-like
(Fibronectinv type III)
7 strands in two sheets 1TEN
Thaumatin
(Thaumatococcus danielli)
Mainly b Sandwich Thaumatin 11 strands in two sheets 1RQW
Titin, Ig repeat 27
(TII27, human)
Mainly b Sandwich Immunoglobulin-like
(Immunoglobulins)
7 strands in two sheets 1TIT
Transthyretin (human) Mainly b Sandwich Immunoglobulin-like
(Transthyretin)
7 strands in two sheets 1F41
Trypsin (bovine pancreatic) Mainly b b-barrel Thrombin 6-stranded barrel 5PTP
Alpha synuclein (human) N.A. Fibrils, two forms N.A.
Lysozyme (hen egg white) N.A. Fibril N.A
SerADan N.A. b-rich aggregates with
linear structure,
two types
N.A.
Model proteins are described using CATH classification. N.A, not applicable.
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spectra were due to properties of the protein film, and not
an instrumental artifact.
The presence of a similar strong, positive band at higher
wavelengths (230 nm) combined with a relatively weak np*
band can be observed for the immunoglobulin-like proteins
(see Figure 3). This unusual appearance of the typical b-sheet
spectrum is well known for Bence Jones-like structures and
likewise attributed to side-chain interference.30,31 A compa-
rable shift in baseline, which partially obscures the presence
of aromatic side-chains, combined with a striking shift in rel-
ative peak intensities can also be seen for the immunoglobu-
lin class. In addition there is a significant red-shift of the np*
band, while the pp* band remains largely unaffected, in
contrast to the band-shifts observed for predominantly a-
helical proteins. Splitting of the pp* band at 200 nm (Fig-
ures 3A and 3B) has also been observed for some immuno-
globulins.32
The remaining four globular proteins, carbonic anhy-
drase, trypsin, jacalin and b-galactosidase, represent b-rich
structural classes that differ from the immunoglobulin-like
proteins and, in the case of b-galactosidase, is of a highly
complex nature including both b-sandwich and other archi-
tectures (see Figure 4). For all proteins, the recorded wet
phase spectra correspond well to known spectra obtained
from literature.12,14,33,34 While carbonic anhydrase is classi-
fied as a mixed a-b-protein, the predominant structure type
FIGURE 1 Wet and dry phase CD spectra for mainly a-helix and mixed a1b structural classes.
A. Acyl-CoA-binding protein (ACBP) with peaks corresponding to np* and pp* electronic transi-
tions marked. B. Porcine serum albumin. C. a-lactalbumin. D. S6.
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is b-sheet and has a spectrum similar to the classical bI-sheet
spectrum.9,33 Drying causes a similar shift towards negative
ellipticity and red-shift of the negative np band as observed
for sandwich-type folds. A comparable baseline shift is
observed for the aligned prism jacalin. This protein is charac-
terized by the atypical negative band at 190 nm, which has
been speculated to be an effect of local environment or b-
sheet twisting.35 A less pronounced but similar splitting is
also observed for the two immunoglobulin-like proteins
Tnfn3 and TII27.
The only significant red-shifts for jacalin are observed for
the bands at 202 nm and 182 nm. In contrast, trypsin
shows red-shift of both positive and negative peaks, similar
to what is observed for the large and complex b-galactosi-
dase, although this protein shows little variance in peak
intensities upon drying.
Overall, we observe preservation of spectral features upon
drying for all structural classes, which reassures us that the
protein films have not undergone significant structural
changes compared to the solution state.
Proteins Do Not Significantly Order Within Film
The extent of absorbance for any single chromophore within
a protein will depend on the orientation with respect to the
direction of polarization of light. For a film with a high
degree of cooperative organization between proteins, i.e.
organized or maybe even crystalline films, the orientation
could have a significant effect on the obtained spectrum with
artifacts arising from a potentially very strong linear dichro-
ism signal. To ensure that no in-plane molecular alignment
occurred due to the drying process of making the protein
film, spectra of dried samples were obtained before and after
rotation by 908 of the MgF2 plate upon which a sample had
been dried. No significant difference was observed when the
sample plate was rotated (data not shown), indicating that
the observed spectrum predominantly demonstrated biologi-
cally relevant structural data rather than orientation-related
artifacts.
Estimates of Secondary Structure Show Good
Correspondence with Known PDB Structures
The general preservation of spectral features prompted us to
estimate the secondary structure of the globular model pro-
teins for both the wet and dry phase spectra using the
CDSSTR program and reference sets available at DICHRO-
WEB (Table II). CDSSTR is intended for analysis using water
as solvent, but the spectral similarities indicated its potential
usefulness in analysis of the dried protein films as well. Val-
ues for native secondary structure were extracted from crystal
structure data using the DSSP algorithm and grouped by
simple partitioning into a-helical, b-sheet and other struc-
ture as described by Oberg et al.,36 which has previously been
used successfully for comparison of CD and PBD data.37 We
cannot exclude that a different grouping of assignments
might lead to differences in the analysis, but that is outside
the scope of this article. We are here concerned with overall
similarity to crystal structure.
For the majority of spectra, both wet and dry phase
yield estimates the approximate values obtained from crys-
tal structures. The main inaccuracy is related to estimates
FIGURE 2 Wet and dry phase CD spectra for non-immunoglobulin-like sandwich architectures.
A. Concanavalin A (ConA) with peaks corresponding to np* and pp* electronic transitions marked.
B. Thaumatin.
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predicting a small presence of b-sheet in predominantly a-
helical proteins or vice versa. For the immunoglobulin-like
proteins, the estimates have a higher deviation from the
crystal structure predictions, which is expected, given the
side-chain interference superimposed on a low-intensity b-
sheet signal. Curiously, transthyretin shows good agreement
for the wet phase and PDB data, but with little similarity
to the values obtained for the dry phase. The estimates for
jacalin are also predictably poor because of the atypical
spectra. Overall the correspondence between PBD and CD
data is sufficient to determine the structural class for both
solubilised protein and protein film with the exception of
dry phase transthyretin.
A subset of the model proteins was also investigated in the
dried state using ATR-FTIR (see Figure 5) followed by sec-
ondary structure estimation (Table III). These were com-
pared to data for the native structures obtained as described
above. FTIR and PDB values correspond reasonably well for
b-galactosidase, carbonic anhydrase, serum albumin, and
thaumatin, but with lower accuracy for a-lactalbumin
although the protein is estimated to have mixed a/b-content.
In all cases, the content of the predominant structural class
was overestimated at the expense of loops and other struc-
tural elements.
The various structural elements do not give rise to well-
separated structural bands in infrared spectroscopy but rather
to a single, relatively featureless overall band, which can only
be cautiously analyzed by use of Fourier self-deconvolution.
A likely reason for the inconsistency in the data for a-lactal-
bumin is this overlap between the bands corresponding to
FIGURE 3 Wet and dry phase CD spectra for immunoglobulin-like folds.
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individual structural elements. Overall, the data obtained by
FTIR support our previous conclusion from CD spectra that
drying does not cause significant loss of structure.
Principal Component Analysis of Wet and Dry
Spectra Correspond Well to Estimated
Structural Content
To obtain correlations which are not obvious from the gen-
eral structural analysis, we performed principal component
analysis (PCA) for wet and dry spectra. PCA provides a
ranked series of components that describe the changes
among a collection of spectra. The first principal component
accounts for the great majority of the spectral variance, but
useful modulations within this variance may be provided by
the second component. Spectra were analyzed both as sepa-
rate data sets and as a combined wet and dry data set. For all
data-sets, the first principal component (PC 1) was found to
correlate well with estimated helical content (see Figure 6).
The correlation was best for the combined wet and dry data
set (R2 0.9499) and weaker for the isolated wet and dry data
sets. The b-sheet content of globular proteins correlates with
a-helix content because these two constitute the major struc-
tural classes so that low b-sheet content corresponds to high
a-helix content. PC 1 was therefore found to correlate well
also with b-sheet content. The subsequent components did
not show correlation with estimated structural content of less
abundant structural classes such as turns. This could be due
to the low frequency of residues in such conformations, lack
of well-defined spectral characteristics for the structural type
or the actual PCA method used.
For more in-depth analysis, subsequent PCs were plotted
against the primary principal component for the isolated wet
FIGURE 4 Wet and dry phase CD spectra for other mainly b folds and complex structures.
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and dry data sets. If the second principal component (PC2)
is plotted against PC1 (Figures 7A and 7B), a clear separation
is seen based on structural class. a- and a/b proteins, with
the exception of the dry-phase values for the complex b-
galactosidase, lie in two groups separate from the larger
area containing b proteins. However, there is an interesting
variance within the b-protein group. In the wet phase, the
three Ig-like folds Tnfn3, TII27, and transthyretin have simi-
lar PC1 values but highly different PC2 values. In the dry
phase, both PC1 and PC2 differ but in a similar pattern with
Tnfn3 lying close to the main b-protein area and transthyre-
tin furthest away. This variance could illustrate a structural
difference but could also be due to the positive aromatic and
cysteine signal at 230 nm, which is strong for these folds.
However, it should be mentioned that transthryretin does
not have an apparent strong aromatic signal for either wet or
dry phase. If the third principal component (PC3) is plotted
against PC1 (Figures 7C and 7D), the observed clustering is
similar to that observed for PC2 although the Ig-fold var-
iance is not observed. Overall, the PCA yields a meaningful
clustering of structural classes for both wet and dry phases,
further affirming that drying does not significantly alter
structure.
Low Wavelength Features Correlated to Structural
Class and Architecture
Drying of samples expanded the spectroscopic window
towards 130 nm and revealed new spectral features. For the
majority of proteins, the spectrum climbs from the negative
band at 160–175 nm for a-helical proteins and 170–180
nm for b-sheet proteins to a well-defined positive band cen-
tered at 140–160 nm. The positive band has previously been
observed for UVCD studies of a-helical oligomers or cyclic
amino acid dimers in halogenated alcohols or dried films38–40
(see DISCUSSION). However, the band has not been
correlated with other structural features of either peptide or
globular proteins. To elucidate this in more detail, we have
therefore recorded spectra down to 130 nm for a number of
Table II Structure Estimates from Circular Dichroism and
Crystal or NMR Structure
Model Protein a-helixa b-sheeta Othera NMRSDa
ACBP 0.56 0.10 0.34 0.022
0.72 0.01 0.27 0.012
0.64 0 0.36
a-lactalbumin 0.31 0.14 0.56 0.012
0.35 0.13 0.51 0.025
0.29 0.08 0.63
b-galactosidase 0.15 0.32 0.53 0.033
0.08 0.40 0.52 0.053
0.10 0.38 0.51
Carbonic anhydrase 0.05 0.37 0.58 0.043
0.07 0.32 0.61 0.049
0.08 0.29 0.63
ConA 0.06 0.44 0.49 0.045
0.08 0.39 0.53 0.026
0 0.46 0.54
Jacalin 0 0.44 0.53 0.190
0.05 0.40 0.54 0.052
0 0.62 0.38
Serum albuminb 0.64 0.05 0.29 0.009
0.59 0.13 0.28 0.007
0.66 0 0.34
S6 0.19 0.29 0.51 0.027
0.28 0.24 0.49 0.017
0.26 0.28 0.47
Tnfn3 0.01 0.43 0.55 0.111
0.07 0.37 0.57 0.022
0 0.53 0.47
Thaumatin 0.03 0.42 0.54 0.028
0.07 0.39 0.53 0.088
0.11 0.36 0.54
TII27 0 0.47 0.50 0.098
0.06 0.35 0.60 0.143
0 0.33 0.67
Transthyretin 0.05 0.46 0.48 0.018
0.34 0.29 0.38 0.009
0.06 0.48 0.46
Trypsin 0.03 0.33 0.62 0.043
0.06 0.34 0.58 0.075
0.07 0.32 0.61
a 1st row, wet phase CD; 2nd row, dry phase CD; 3rd row, estimate from
DSSP.
b Both human and porcine types of serum albumin were analyzed and
gave similar values.
FIGURE 5 Representative ATR-FTIR spectra of model proteins
shown for the structurally sensitive amide I area. a-helical signals
predominate at 1655 cm21 and b-sheet signals between 1622–
1638 cm21.
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globular proteins covering a wide range of structures. Interest-
ingly, the position of the 140–160 nm band appears to be
associated with secondary structure as discussed below (sum-
marized in Table IV). However, there is no clear correlation
between the intensity of this band and bands at higher wave-
lengths, although the bands largely fall within the same inten-
sity range, i.e. a-helical proteins show higher intensity than b-
sheet proteins.
Proteins containing significant a-helical structure (i.e.
[25%) have a common band position at 140–142 nm
(Figure 8A). In the case of S6, which contains similar frac-
tions of a-helix and b-sheet, the spectrum also displays a
shoulder at 160 nm, which could be attributable to the
mixed structure since the b-rich proteins show bands at
higher wavelengths. For both immunoglobulin-like and
other sandwich architectures, the band is centered at higher
wavelengths, such as 149–152 nm for ConA, thaumatin,
TII27 and Tnfn3 and 157 nm for transthyretin (Figure 8B).
The third group of proteins, mainly b-sheet with more com-
plex architectures, shows a wider variety of spectral features
as expected (Figure 8C). Jacalin and trypsin both have well-
defined bands located at 147-148 nm. It is possible that a
similar band could be observed for carbonic anhydrase, but
the considerable increase in background absorbance from
145 nm onwards, possibly because of opacity of the dried
film, interferes with the spectrum. As a result, the spectrum
for carbonic anhydrase could not be quantified below 147
nm. This is also likely to be the cause of the final shape of the
spectrum for TII27. The final example, b-galactosidase, has
the highest band position among the model proteins at 166
nm (Figure 8D), which is a sufficiently high wavelength that
the tail of the peak is also detectable on the wet phase spec-
trum. This high position could be caused by a number of fac-
tors including the tertiary structure of the 116 kDa protein,
which is a combination of several structural motifs including
immunoglobulin-like b-sandwich and triosephosphate
isomerase a/b-barrel-like folds. Contributions from aro-
matics and cysteines, which are known to affect the region
around 240–220 nm, could also play a part.29
Fibril Spectra Show Spectral Features Similar to
b-Rich Globular Proteins
Spectra of protein aggregates and fibrils of various types were
obtained in wet and dry phase to acquire both far-UV and
VUV-range structural information. One of the well-known
in vitro models of amyloid is lysozyme fibrillated at low pH,
for which there is good correspondence with the typical bI-
sheet spectrum (Figure 9A). The low-wavelength band at 145
Table III Structure estimates from AT-FTIR and PDB file
Model Protein a-helixa b-sheeta Othera
a-lactalbumin 0.54 (0.04)
0.29
0.06 (0.03)
0.08
0.40 (0.02)
0.63
b-galactosidase 0.19 (0.03)
0.10
0.37 (0.02)
0.38
0.44 (0.03)
0.51
Carbonic anhydrase 0.08 (0.04)
0.08
0.29 (0.02)
0.29
0.63 (0.03)
0.63
Serum albumin 0.75 (0.04)
0.66
0.01 (\0.01)
0
0.24 (0.03)
0.34
Thaumatin 0.10 (0.04)
0.11
0.54 (0.02)
0.36
0.36 (0.03)
0.54
a 1st row, FTIR (1/2 s.e.m.); 2nd row, estimated from DSSP.
FIGURE 6 Correlation between a-helical content and first princi-
pal component for three data sets: Wet phase spectra only, dry phase
spectra only and wet and dry phase spectra combined. All three
datasets show similar linear correlation between the fraction of
a-helical structure and PC1.
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nm is located slightly lower than the 149–152 nm seen for
the b-rich model protein spectra described above, although
not as low as the a-rich proteins. In contrast, fibrils formed
by a-synuclein, which is the predominant protein isolated
from the insoluble amyloid found in Parkinson’s disease,
shows a low-wavelength peak at 151 nm, similar to the b-
rich proteins. The fibrils, which are formed in the presence of
phosphate and NaCl, show the same features in wet and dry
phase (Figure 9B).
The third example of fibril or aggregate structures is for
the nonamyloidogenic peptide SerADan (Figure 9C). The
peptide is derived from the parent peptide ADan by substi-
tuting the two Cys residues (positions 5 and 22) with Ser to
prevent covalent crosslinking. This is justified by the observa-
tion of ADan aggregates in the reduced state. In addition,
Phe11 is replaced by Trp to provide better quantitation and
monitoring of its behavior. ADan does not bind the fibril-
specific dyes Congo red and Thioflavin T in its reduced
form41 and the same is observed for SerADan (L.W.N. and
D.E.O. unpublished observations). However, AFM (Figure
9D) and ATR-FTIR (data not shown) indicates that SerADan
forms b-rich, linearly structured aggregates indicative of a
fibril-like superstructure. This is further corroborated by a
distinctive X-ray fiber diffraction pattern that is characteristic
for amyloid-like fibrils in Figure 10. Despite long accumula-
tion times, diffraction patterns were weak, possibly owing to
the fact that fibrils were aligned in solution by centrifugation
in a capillary tube. Nevertheless, the X-ray fiber diffraction
FIGURE 7 Clustering of model proteins into structural classes from primary (PC1) and second-
ary (PC2) or tertiary (PC3) principal components. Fibril and aggregate samples are circled.
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patterns have sharp diffraction peaks at 4.76 Å (typical of the
inter-strand distance in b-sheets). In well-organized fibrils,
the inter-sheet distance gives rise to a sharp peak at 10–11 Å,
but in the case of SerADan, the diffuse peaks at 10–13 Å sug-
gest only partly aligned fibrils. There were subtle differences
between the fibrils formed at the two pH values, as indicated
by the shoulder around 5.0–5.5 Å for the pH 7.5 (but not pH
5.0) fibrils, and the greater intensity of the 10–15 Å diffrac-
tion peaks for pH 5.0 fibrils compared to the pH 7.5 fibrils.
The pseudo-fibril properties of SerADan made it particularly
interesting to examine these fibrils by VUV-CD. The aggre-
gates were formed at two pH values and spectra were col-
lected for both wet and dry phase. All peaks corresponded
well with b-rich structures. Interestingly, the dry-phase spec-
tra show pH-dependent splitting of the positive band at 190
nm similar to that observed for some immunoglobulin-like
folds, corroborating the pH-dependent differences observed
in fiber-diffraction data. Furthermore, the low-wavelength
band lies in the area populated by b-rich proteins with values
of 149 nm for pH 5 and 148 nm for pH 7.5. These peak posi-
tions are midway between those of lysozyme and a-synuclein.
We calculated the PC values for the fibril spectra (in Fig-
ure 7) based on the PCA analysis of the globular proteins.
When the fibril values (represented by circled entries) are
included in Figure 7, an interesting pattern emerges. The val-
ues for SerADan aggregates and lysozyme fibrils fall at the
centre of the main b-protein area for all plots. However, a-
synuclein fibrils lie outside the main b-protein area with PC1
values similar to mixed a/b-proteins, possibly indicating a
biologically relevant structural difference. This distribution
of points is virtually identical to that obtained if the spectra
for the fibrils and globular proteins are combined and used
in a new PCA analysis (data not shown).
Overall, the fibril and aggregate sample all have the
expected b-rich characteristics, but varying intensities of the
low-wavelength band compared with the intensity of the pos-
itive pp* band particularly for a-synuclein fibrils. This is also
observed for the globular model proteins.
DISCUSSION
Drying Has Limited Effect on Protein Structure
A key objective of the present study is to examine the VUV
spectral region for bands potentially carrying structural in-
formation. Our strategy was to use a number of model pro-
teins including both a- and b-rich structural classes as well as
mixed a/b species. b-rich proteins are over represented to
allow subsequent analysis of b-rich fibrils. Since this region is
only accessible by removal of water, it is assumed that gentle
drying of proteins into film form does not cause significant
loss of secondary structure, which would negate any advan-
tages that removal of water might bring. How well is this
assumption borne out? Previous studies have suggested that
gentle drying does not lead to major structural changes,18,19
but we found it necessary to investigate the extent to which
the synchrotron radiation spectra were affected to support
the validity of our conclusions. Overall, the spectral elements
are well preserved when aqueous samples and dried films are
compared, although red-shifting and changes in relative in-
tensity of bands were observed for some samples in a manner
that could not immediately be correlated to structure class.
The normalization procedure used for the dried spectra uti-
lized the protein absorbance at 190 nm for the dry and wet
phase spectra and includes the assumption that drying does
not affect the absorbance, which could conceivably be inac-
curate. This normalization procedure makes it clear that dry-
Table IV Spectral Features and Bands Observed at Low Wavelengths
Model Protein Structure Class/Architecture Observed Low-Wavelength Features
ACBP Mainly a, up-down bundle Peak at 140 nm
a-lactalbumin Mainly a, orthogonal bundle Peak at 141 nm
b-galactosidase a b, complex Peak at 166 nm
Carbonic anhydrase a b, roll, predominantly *b-sheet Shoulder at 157 nm, increases towards 145 nm
without reaching max
ConA Mainly b, sandwich, jelly roll Peak at 150 nm
Jacalin Mainly b, aligned prism Peak at 148 nm
Serum albumin Mainly a, orthogonal bundle Peak at 141 nm
S6 a b, 2-layer sandwich Peak at 142 nm with shoulder at 150–160 nm
Tnfn3 Mainly b, sandwich, immunoglobulin-like Peak at 152 nm
Thaumatin Mainly b, sandwich Peak at 149 nm
TI27 Mainly b, sandwich, immunoglobulin-like Peak at 152 nm
Transthyretin Mainly b, sandwich, immunoglobulin-like Peak at 157 nm
Trypsin Mainly b, b-barrel Peak at 147 nm
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ing led to changes in relative peak intensity, as previously
reported.17
Analysis by conventional secondary structure analysis
tools revealed that both wet and dry phase spectra corre-
spond well to the secondary structure obtained from PDB
data with the exception of transthyretin in the wet phase and
the unusually structured jacalin. It should be mentioned that
such tools are designed specifically for use on spectra
obtained for aqueous samples of soluble globular proteins.
FTIR secondary structure analysis of a subset of proteins like-
wise showed correspondence between spectral data collected
for dried films and native structure with the main structural
elements either estimated accurately or overestimated. Simi-
larly, the PCA yielded structurally relevant correlations for
both wet and dried samples as well as for fibril samples.
Interestingly, the immunoglobulin-like folds appeared partic-
ularly sensitive in the analysis with transthyretin as the
extreme outlier. This could be due to loss of structure but
also underlying structural differences or the effect of the
presence of aromatic and cysteine residues. Otherwise, the
proteins were found to cluster according to structural class.
Overall, this indicates that drying does not cause wide-
spread protein denaturation and the proteins can be accu-
rately associated with the correct structural class. However, it
cannot be ruled out that local denaturation occurs either due
to loss of hydration, protein–protein interactions within the
FIGURE 8 Spectral features at low wavelengths correspond to secondary structure. (A) Mainly
a-helical and a-b-proteins. (B) Sandwich architectures. (C) Mainly b-sheet proteins with more com-
plex architectures. Note that while carbonic anhydrase is classed as a-b, it is contains mainly b-sheet.
790 Nesgaard et al.
Biopolymers
The Molecular Basis of Familial Danish Dementia
113
film or interaction with the surface upon which the film is
formed although the latter would be limited to the protein
interacting with the surface and therefore small compared to
the total thickness of the film.
Spectral changes accompanying drying might be caused
by local changes in hydration. The films are formed under
vacuum but subsequently exposed to moist room air before
being placed in the dry N2 atmosphere of the sample cham-
ber. It is therefore not possible to give a precise description of
the hydration level of the protein film. Loss of direct interac-
tions with water could alter the spectral characteristics, but
one could speculate that removal of water could conceivably
lead to local or global structural changes without signifi-
cantly disturbing the secondary structure content. Although
structure appeared well preserved for our model proteins,
studies have demonstrated the risk of structure alterations
for e.g. freeze-dried samples,42,43 which indicates that sec-
ondary structure perturbations upon drying cannot generally
be discounted. Addition of saccharides to protect native sec-
ondary structure could be considered in such situations
although the additive must allow the formation of transpar-
ent protein films. The challenge of structural preservation
upon drying is well known in the field of drug stability and
delivery.44 In contrast, a recent study showed very little effect
of drying on structure for fibrillar samples,45 highlighting the
usefulness of the technique for such samples.
Calculations on oligopeptides and proteins have previ-
ously suggested a connection between b-sheet twisting and
the magnitudes of the 215 nm np* and 198 nm pp*
bands.46 Such disturbances of individual secondary structure
FIGURE 9 A–C. Dry phase CD spectra for fibril and aggregate samples. D. AFM of SerADan
aggregates formed at pH 7.5, white bar is 1 mm.
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elements could potentially be a cause of spectral distortion
for film samples. However, the spectral content obtained for
the dry phase does appear to be consistent with known struc-
tural data. Consequently, the information obtained from the
VUV range is expected to be structurally relevant, although
further investigations must be conducted to elucidate the
exact nature of the observed structural distortions.
Low-Wavelength Band Is Sensitive to
Secondary Structure and May Be Related
to a p-Orbital Transition
The second central issue is whether VUV bands confer addi-
tional structural information on top of the information pro-
vided by the conventional far-UV spectra. The position of
the low-wavelength band, observed in the 140–160 nm
region, appears sensitive to secondary structure. Both a-rich
and mixed a/b proteins showed a low-wavelength band cen-
tered at 140–142 nm. However, for b-rich proteins, the band
was shifted to higher values, which varied from 147 to 157 nm
for different proteins. In addition, the low-wavelength band
was either absent from the spectrum for the structurally com-
plex b-galactosidase or positioned very high at 166 nm. Inter-
estingly, the relative intensity of the band was not correlated to
the intensity of other bands, suggesting that it may serve as an
independent structural indicator, though its direct structural
significance remains unclear. Some clues may be obtained
from previous studies. In a study on poly-c-methyl L-gluta-
mate (PMG) in hexafluoro-2-propanol (HFIP) published 35
years ago, Johnson and Tinoco described a spectrum for the
a-helical species containing a negative peak at 159 nm and a
positive maximum below 140 nm.38 Similarly, a well-defined
positive band centered at 140 nm has been observed for
poly(L-alanine) in the form of a dry film produced by evapora-
tion of trifluoroethanol (TFE)39 although no such band was
observed for a poly(L-proline) film formed from water.47
Instead, the spectrum appeared typical for the polyproline II
conformation and showed a negative band was centered at
145 nm and with a positive band below 135 nm. Bowman et
al.40 measured the circular dichroism of cyclic amino acid
dimers, which likewise showed a strong, positive band at 140
nm, although cyclic, constrained dimers are geometrically dis-
similar to biologically relevant protein structures. One might
expect exciton-splitting of the transition between the p-bond-
ing and p-antibonding orbitals (pbp*) for a-helical proteins in
a manner similar to that observed for the pnbp* transition, but
the transition is nonetheless energetically relevant. Serrano-
Andrés and Fülcher48 calculated the transition energies for
several small amides to lie within 9.6–10.5 eV (118–129 nm).
Similarly, calculations on formamide and N-methylacetamide
(NMA) by Besley et al.49 showed that the pbp* transition
occurs at 9.4–9.6 eV (129–132 nm) for NMA and 10.4eV (119
nm) for formamide in water. These energies are within the
same range as the VUV band albeit somewhat higher. The
VUV band could arise from the pbp* transition but other con-
tributions such as Rydberg states should be considered
although an in-depth analysis falls outside the scope of this
work. However, based on the present experimental data, the
involved transitions must be sensitive to the secondary struc-
ture of the proteins’ backbone.
The protein distribution in the PCA plot was broadly
retained whether based on wet or dry spectra, but there were
clear shifts among different proteins due to the inclusion of
the VUV band. The position and intensity of the VUV band
also appears useful in differentiating between different types
of aggregates. For a-synuclein, the band position was within
the range described by the b-rich globular proteins, while
that of lysozyme was shifted to a lower wavelength. Both Ser-
ADan spectra had band positions that fell in between. Never-
FIGURE 10 X-ray diffractograms of partly aligned SerADan sam-
ples formed at (A) pH 5 and (B) 7.5. (C) The diffractograms show a
distinct diffraction peak at 4.76 Å and diffuse diffraction peaks at
10–13 Å. The fibrils were aligned in solution in a capillary tube to
avoid diffraction from buffer salts, and this accounts for the
relatively weak diffraction.
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theless, the SerADan fibrils showed relative and absolute
peak intensities much closer to those of lysozyme than of a-
synuclein, leading to a close clustering of SerADan and lyso-
zyme in the PCA plots in Figure 7.
Protein fibrils and aggregates are well-suited for study in
film form and detailed study of these and other aggregate
structures might reveal underlying structural differences in
otherwise similar fibrillar samples. We are currently investi-
gating a number of different fibrillar states by SRCD in order
to elucidate potential changes in super-secondary or tertiary
structure and anticipate that the present study will be the
start of a comprehensive database for the classification of
aggregated protein species.
MATERIALS AND METHODS
Materials
a-lactalbumin, b-galactosidase, carbonic anhydrase, jacalin, hen
egg-white lysozyme, porcine serum albumin, thaumatin, transthyre-
tin, trypsin, Thioflavin T and other chemicals were from Sigma
(Sigma-Aldrich, St. Louis, MO). Concanavalin A was obtained from
CalBioChem (La Jolla, CA). Acyl-CoA-binding protein was purified
as described in Ref. 50. S6 was purified as described in Ref. 51.
Tnfn3 and TII27 were purified as described in Ref. 52. Expression
and purification of wild-type a-synuclein was performed according
to Ref. 53. SerADan peptide (EASNSFAIRH FENKWAVETL
ISFNLFLNSQ EKHY) was obtained [90% pure from EZBiolab
(EZBiolab Inc., Westfield, IN).
Sample Preparation for Wet and Dry Phase
Model proteins were used without further purification. For dried
samples, the proteins were weighed and dissolved in water and in
6M guanidine followed by spectroscopic concentration measure-
ment at 280 nm using extinction coefficients available in literature
or predicted using the ProtParam tool (http://www.expasy.org/
tools/protparam.html). The weighed amount was found to be in
agreement with the spectroscopically determined concentration for
all proteins within a margin of 5%. For proteins supplied in the liq-
uid phase, only spectroscopic concentration measurements were
used. Dried proteins were dissolved in either fresh milliQ water or
dilute phosphate buffer (20 mM, pH 7.5). Proteins supplied as dis-
solved stocks were dialyzed for [2 h against the dilute phosphate
buffer to remove traces of chloride ions and other contaminants.
Instrument Preparation
The spectra were recorded at the SRCD facility at the UV1 beam-
line54 on the storage ring ASTRID at Institute for Storage Ring
Facilities (ISA), University of Aarhus, Denmark. The light exiting
UV1 through a CaF2 window was passed into the custom built CD
instrument, which was constantly purged with nitrogen to avoid
absorption from atmospheric oxygen. In the CD instrument the
highly linear polarized light from UV1 was converted into alternat-
ing left and right handed circularly polarized light with a CaF2
Photo Elastic Modulator (PEM) [model I/CF50, Hinds Instruments,
USA] at a frequency of 50 kHz. The modulated light was passed
through the sample and detected with a UV-sensitive photomulti-
plier tube (PMT) [model 9402B, Electron Tubes, UK]. The 50 kHz
CD signal from the PMTwas detected using a lock-in amplifier. The
instrument was carefully calibrated with respect to CD signal mag-
nitude using camphor sulfonic acid (chemical shift anisotropy
[CSA]) after each daily beam fill of the storage ring.
Circular Dichroism for Wet Samples
All wet sample spectra were recorded using a 0.1 mm path length
quartz SUPRASIL cell (Hellma GmbH, Germany), over a wave-
length range of 260–170 nm in 1 nm steps and a dwell time of 3 s
per wavelength point. The sample cell was carefully cleaned with
milliQ water or HCl if needed and dried before recording of a base-
line spectrum (average of three single spectra) of the relevant sol-
vent. The cell was cleaned again and loaded with 15 lL sample solu-
tion and the sample spectrum collected (average of five individual
spectra). The protein concentration was adjusted until a detector
voltage of 800–900 V was obtained at the 190 nm protein absorp-
tion peak, corresponding to a sample absorbance of about 0.8. The
cell was cleaned and filled with solvent before a second baseline
spectrum was obtained for comparison.
Circular Dichroism for Dry Samples
Quartz cuvettes are opaque below 165 nm, so all measurements
with dry samples were performed using MgF2 plates, which only
absorb below 125 nm. For the dry spectra, one MgF2 plate was fitted
to be used at stable orientation to the incident light. The plate was
carefully cleaned with milliQ water and dried before a baseline spec-
trum was collected as above. A 15-lL sample was applied as a drop-
let of approximately ellipsoid shape. The sample was dried under
low vacuum (about 100 mbar) for 10 min and visually inspected
for particles or opaque areas. The sample was transferred to the CD
instrument and a sample spectrum was obtained as described above.
After cleaning of the plate, a second baseline spectrum was obtained.
For comparison of the wet and dry spectra, the detector voltage for
the polypeptide specific peak at 190 nm was used to normalize the
dry phase spectrum against the known concentration of the wet
phase spectrum. Although the amount of protein transferred to the
MgF2 plate was known, local unavoidable variations in protein film
thickness made it necessary to perform this normalization.
Preparation of Aggregated Samples
Purified a-synuclein was dialyzed against milliQ water, lyophilized
and stored at 2208C. Protein stock solution was prepared according
to Ref. 55. Samples were prepared containing 1 mg/mL of protein
(20 mM phosphate, pH 7.4, 150 mM NaCl) and incubated as 1 mL
aliquots at 378C in a fluorometer (Cary Ellipse, Varian Inc., Palo
Alto, CA) with constant stirring. Addition of the fibril-specific flur-
ophore thioflavin T (ThT, 40 lM) allowed in situ monitoring of
fibril formation using excitation at 450 nm and emission at 485 nm.
Lysozyme fibrils (10 mg/mL protein) were formed in 500 mM
NaCl adjusted to pH 2 with HCl. Samples were incubated overnight
at 578C with mechanical agitation. Presence of fibrils was monitored
using ThT (emission 490 nm).
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Freeze-dried SerADan peptide was dissolved in 10M urea and
allowed to disaggregate overnight at room temperature. Concentra-
tion was monitored by absorbance at 280 nm and found to be
within 5% of the weighed amount. Stock concentration was
adjusted to 2.5 mM. Stock aliquots were fast frozen, stored at
2808C and thawed immediately before use. Aggregates were pre-
pared by dilution of the stock to 50 lM peptide (0.2M urea) in
50 mM sodium acetate (pH 5) or 50 mM Tris (pH 7.5) and incuba-
tion overnight at room temperature. Presence of aggregates was
verified by atomic force microscopy (AFM) and secondary structure
analyzed by ATR-FTIR.
X-Ray Fiber Diffraction
Fibrillated sample solution was pipetted into a thin glass capillary
sealed at one end and centrifuged at 4000g for several hours until a
visible precipitate had formed. Fibrils in the capillary tube are partly
aligned due to the centrifugation, and as the fibrils are still in solu-
tion, the buffer salts do not give rise to unwanted diffraction. The
capillary tube was sealed and mounted on a rotating anode setup
with a wavelength of 1.5418 Å and a Mar345 image plate detector
(Mar Research). The sample-detector distance was 35 and 40 cm for
the SerADan samples formed at pH 5 and 7.5, respectively. ‘‘Wet"
fibers diffract poorly, and to that end each diffractogram was col-
lected by accumulating data over night. A single data set consisted
of 40 or 100 images each accumulated over 10 min and averaged by
use of Marcombine (Mar Research). The diffractogram was radially
averaged by use of Datasqueeze (Datasqueeze Software).
Circular Dichroism for Fibril Samples
To separate protein fibrils or aggregates from the reaction solution,
the samples were centrifuged for 10 min before aspiration of the su-
pernatant. The pellet was washed in milliQ water and centrifuged
again before being resuspended in milliQ water. All aggregate and
fibrils samples used here were known to be stable over several hours
in water. Otherwise, the samples were treated as described for dry
phase spectra.
Analysis of Secondary Structure from
Circular Dichroism
The CDSSTR program,56 available at DICHROWEB,57,58 was used
to estimate secondary structure based on wet and dry phase spectra
employing the SP175 reference set35 when possible. The DSSP59
algorithm was used for assignment of secondary structure from
PDB files giving eight output classes, which were grouped in a sim-
ple manner to give a-helical (H), b-sheet (E), and ‘‘other’’ as dis-
cussed in Ref. 36.
Primary Component Analysis of Wet and Dry
Phase Spectra
PCA60 was conducted on data sets containing wet, dry, or wet and
dry spectra of globular proteins and of globular and fibrillating pro-
teins. The data was scaled to obtain unit variance (i.e. the intensities
at each frequency were divided by the standard deviation of the
intensities of that frequency within the entire data set) and then
centered. This scaling reduces the weight of stochastic large ampli-
tude variations and increases the weight of small correlated changes.
The resulting scores and loadings were then rescaled to the original
intensities. The PCA was performed using Simca-P (Umetrics,
Umeå, Sweden).
Fourier Transform Infrared Spectroscopy
Spectra were recorded on a Bruker Tensor 27 infrared spectrometer
(Bruker Optik GmbH, Ettlingen, Germany) with a Specac Golden
Gate single-reflection ATR unit (Specac Ltd., Orpington, UK). Pro-
teins were dissolved in milliQ water and 2 lg protein were dried
on the ATR element under a gentle stream of nitrogen. Three inde-
pendent samples were investigated (64 scans, 2 cm21 resolution).
The secondary structure was estimated using OPUS 5.5. If needed,
the presence of water vapor was corrected for by subtraction of a
fresh vapor spectrum or the built-in atmospheric compensation
function. Peaks were assigned from the 2nd derivative and deconvo-
lution of spectra.61 A fitting scheme composed of nine peaks of
mixed Lorentzian and Gaussian shapes was found to fit well for all
spectra. Of the eight peaks, six were assigned to amide band I, two
to amide band II and one to weak side-chain contributions between
the amide bands. The nondeconvoluted spectra were fitted using the
Levenberg-Marquardt method, the areas of individual peaks calcu-
lated and the secondary structure content estimated.
ACBP was kindly provided by Kell Andersen, TII27 and Tnfn3 by
Mette Nielsen and a-synuclein fibrils by Lise Giehm, Aalborg Uni-
versity. We thank Anders Svensson, Mathias Norrman and Gerd
Schluckebier at Novo Nordisk A/S for help with the collection of
fiber diffraction data.
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3.4 Discussion of Paper 2
3.4.1 Spectral features are generally preserved after drying
The aim of the present study was to investigate the 130-170nm range for structur-
ally sensitive bands. This required the use of dried samples and the recording of
spectra for a number globular model proteins (paper 2/table 1), which may not be
tolerant towards dehydration. However, we observed limited effect of dehydra-
tion for our model proteins, but there can be little doubt that the general sensitiv-
ity of globular proteins towards dehydration limits the applicability of the 130-
170nm region that we have explored here. Comparison of wet and dry phase
spectra for the model proteins as well as for protein aggregates or fibrils showed
that the structurally sensitive bands in the 170-230nm range were generally well-
preserved despite some changes in relative intensities and shifting of positions
for the nπ* and πnbπ* bands (paper 2/1-4). Fibril samples, which are generally
less sensitive to hydration state, displayed similar spectral effects of the drying
process. Similarly, principle component analysis (PCA) of wet and dry phase
spectra showed correlation between the first principle component (PC1) and the
α-helical content for the model proteins as well as structurally meaningful clus-
tering from PC1/PC2 and PC1/PC3 comparisons for both model proteins and
aggregate/fibril samples (paper 2/figure 6-7). We therefore believe that informa-
tion gleaned from the 130-170nm range contains meaningful information.
3.4.2 Drying reveals a novel structure-sensitive, low-wavelength band
The extension of the spectra into the higher-energy area accessible by drying
showed known negative bands at 162-171nm for all-α or mixed proteins or
~175nm for β-rich proteins followed by a positive band in the 140-160nm re-
gion. The position of this band is sensitive to protein structure (figure 47.A, pa-
per 2/figure 8) and while it is lower in intensity for β-rich proteins, its intensity
does not correlate with that of bands at lower energy suggesting a possible role as
an independent structural indicator. Whereas the proteins with predominant β-
helical structure (ACBP, α-lactalbumin and serum albumin) display a band cen-
tred at 141-142nm (figure 47.B no. 1-3), this position was red-shifted by ap-
proximately 10nm (mean value 151nm) for β-rich model proteins albeit within a
large range consistent with a more structurally diverse structural element. It is
noteworthy that the immunoglobulin-like folds (TI27, Tnfn3, transthyretin, no.
9-11) all fall above the mean at 151nm while the lowest values observed for β-
structure belong to the closed β-barrel of trypsin (no. 5) and the aligned prism of
jacalin (no. 6). It is possible the relative position and intensity of this band could
provide information about super-secondary structure, but further studies are needed
to elucidate of the relationship with protein architecture/fold. A second interest-
ing observation is that S6, which contains significant β-structure, shows α-heli-
cal characteristics at first glance, but the spectrum also contain a shoulder at 150-
160nm and a β-sheet-like negative band at ~170nm suggesting that structural
distinction of these predominantly a-helical and mixed structures may furthered
by information in this wavelength range. Similarly, jacalin contains clearly β-
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sheet-like bands below 170nm despite the atypical appearance in the 180-200nm
range.
The low-wavelength band has not previously been described for globular pro-
teins or aggregates. However, the study by Young and Pysh published in 1973
[631] of α-helical poly(L-alanine) in a film produced by TFE evaporation details
negative and positive bands at ~160nm and ~140nm, respectively. The sign and
position of these bands are in agreement with the spectrum of helical poly-c-
methyl L-glutamate (PMG) in HFIP by Johnson and Tinoco from 1972 [632],
which contains a negative peak centred at 159nm climbing to a maximum below
140nm, and the later study by Bowman et al. [633] of cyclic amino acid dimers
that showed a strong positive band at ~140nm. Cyclic amino acid dimers are
highly geometrically constrained and structurally unrelated to biological
polypeptides so the preserved band at 140nm speaks against structural sensitiv-
ity. However, the spectrum of a poly-(L-proline) film [634], formed by evapora-
tion of water, shows a P2-like spectrum in the 160-250nm range, but a negative
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band centred at 145nm with positive bands at ~165nm and below 135nm. The
same study by Young and Pysh [634] also shows that the poly-(L-proline) I helix
spectrum is essentially featureless below 190nm but that gradual conversion to
poly-(L-proline) II conformation is associated with emergence of the 145nm and
165nm bands. Based on these observations and the results from the present work,
it is plausible that the 135-160nm VUV region contains structurally sensitive
bands and could potentially aid in characterisation of protein structure by CD.
The origin of the low-wavelength band remains unknown, but it is worth noting
that Besley and Hirst [635] and Serrano-Andrés and Fülscher [636] calculated
the π-bonding-to-antibonding orbital transition (πbπ*) for a number of small
amides to fall within the 118-132nm region. It is possible that the low-wave-
length band originates from this transition although other contributions cannot
be ruled out.
3.4.3 Potential uses of the low-wavelength band in analysis of β-rich spectra
As summarised in section 3.3.2., all-β proteins are highly diverse in their spectral
properties. The intensity of the low-wavelength band is significantly lower for β-
sheet compared to the α-helical spectra, but it is possible that the separation into
distinct α- and β-regions, as the spectrum for S6 demonstrates, could aid in the
discrimination and characterisation of these two structural elements. This struc-
tural specificity of the 130-160nm region is also interesting in light of the alter-
native P2-like βII-type spectra, which were not included among the model pro-
teins. The exact spectral properties for βII-type all-β proteins in this region can-
not be predicted, but it would be reasonable to expect a negative band at or near
145nm by comparison to the previous P2-like film spectrum [634] and it is inter-
esting to speculate that this region could provide an unambiguous marker of β-
structure, which in not otherwise clearly visible in the βII-type spectrum.
The availability of an additional structurally sensitive band is also interesting for
fibril and aggregate samples, particularly because these typically are more toler-
ant to dehydration and harsh treatment than globular proteins. One of the central
characteristics of amyloid-like fibrils is their high β-sheet content, but widespread
heterogeneity has been described for secondary structure and particularly for CD
spectral properties. Using the well-characterised glucagon as example, this pep-
tide is capable of forming several types of fibrils with distinct structure and sta-
bility depending on conditions during fibrillogenesis [67, 92, 114] (also see sec-
tion 1.2.4). FTIR appears less sensitive to structural diversity and generally dis-
plays spectra consistent with a high β-sheet content, while the corresponding CD
spectra show much greater variety including spectra with characteristic for α-
helical or β-turn bands as well as typical β-structure. The underlying cause of
this diversity it most likely genuine structural variability combined with the low
relative intensity of the β-sheet bands. While FTIR provides a straightforward
method for estimation of the secondary structure content, it is possible that infor-
mation contained in the low wavelength band could aid in more sophisticated
structural analysis. The examination of fibril and aggregates samples by SRCD
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shows that the position and intensity of the low-wavelength band varies signifi-
cantly in a similar region and over a similar range as the globular model proteins
(figure 47.B, paper 2/figure 9). Whereas the position of the low-wavelength band
for fibril of lysozyme (no. 13) lies between the β-rich proteins and the α-helical/
mixed protein region, the position of the band for fibrils of α-synucleins (no. 16)
hints at structural similarities with the sandwich-like architectures, e.g. concana-
valin A. This is not inconsistent with the available models of sub-filament struc-
ture widely agree on a fibril structure consisting of two or more laminated, regu-
lar β-sheets with little or no twist. In contrast, the α-synuclein fibrils fall outside
the main β-rich area when examined by PCA suggesting subtle structural varia-
tions but highlighting the potential value of the low-wavelength band in analysis
of secondary and super-secondary structure. However, as for the globular model
proteins, a meaningful interpretation of the structural content of the structural
information contained in the low-wavelength band requires further studies and a
wider range of model as well as fibril structures.
3.4.4 SRCD reveals subtle pH-dependent differences for SerADan aggregates
The examination of secondary structure of the mature aggregates by FTIR showed
no significant variability depending on concentration or pH value indicating that
the secondary structure was similar and primarily dependent on peptide proper-
ties rather than solution conditions. Whereas the low-quality spectra obtainable
on our commercial CD spectrometer also showed minor variability, the high-
resolution spectra obtain by SRCD yielded spectra that included splitting of the
πnbπ* band at ~190nm, which has been described for proteins with immunoglobu-
lin-like folds but is also observed for e.g. jacalin, which has an aligned prism
architecture. Interestingly, the splitting of this band shows different intensity of
the two components depending on pH. The underlying differences that result in
observable spectral differences are not clear, but the difference in pH can be
assumed to alter the charge state of the peptide and it is likely that the underlying
structural cause is connected to differences in charge distribution. Curiously, the
low-wavelength bands for the SerADan aggregates fall within the β-rich region
and share overall position and shape, but vary in intensity. It is likely that the
ongoing effort in structural characterisation by solid state NMR [573] may pro-
vide answers to not only the differences observed by CD spectroscopy, but also
the overall question of the structure of the mature SerADan aggregates.
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4Cloning, expression andpurification of BriPP and variants
The biophysical and structural properties of BriPP and the two disease-related
variants, ABriPP and ADanPP, are of interest because of the possible effect of the
C-terminal elongations on stability and aggregational propensity. Consequently,
the gene encoding BriPP, ITM2B, was isolated from cDNA, the relevant muta-
tions introduced by site-directed mutagenesis and the coding sequences inserted
in an appropriate vector system (summary of constructs and vectors in figure 48).
Protein expression, in the form of inclusion bodies, was verified and a purifica-
tion protocol established followed by screening of refolding conditions.
pET3a
(4640bp)
pBR322 ori
NdeI
BamHI
bla
T7 transcription
elements
pET101/D-TOPO
(5753bp)
lacI
bla
pBR322 ori
TOPO
elements
pET30 Ek/LIC
(5439bp)
pBR322 ori
NdeI
BamHI
kan
lacI
Bpu1102I
T7 transcription
elements
B C D
pITM2B
pBriPP-FL
pOA-BriPP-SD
pBriPP-SD
T7 promoter and terminator elements
Intracellular and transmembrane domains
Extracellular domain
3’ untranslated region
His -tag6
Signal peptide
NdeI BamHI
NdeI Bpu1102I
NdeI BamHI Bpu1102I
A Figure 48. Overview of
constructs (A) and
empty vector maps of
pET3a (B), pET30Ek/
LIC (C) and pET101/D-
TOPO (D).
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4.1 Results and discussion
Isolation of ITM2B coding sequence from cDNA
ITM2B is ubiquitously expressed but has particularly high expression levels in
most regions of the CNS including cerebellum. Consequently, a cDNA library
obtained from human cerebellum (HL1128b, Clontech, Palo Alto, CA, USA) was
chosen for isolation of the ITM2B encoding sequence by polymerase chain reac-
tion (PCR). Based on the AY341247 genomic DNA sequence (www.ebi.ac.uk/
embl/), the forward and reverse primers (table 12) were designed to introduce
NdeI and BamHI restriction sites, respectively, and to allow inclusion of the ITM2B
3'-untranslated region, which is activated in the two disease-related mutants.
Despite repeated attempts, ITM2B could not be isolated from cerebellar cDNA
and the search was widened to include a comparable library from adult lung
tissue (Clontech), which yielded a fragment of approximately the expected size
Isolation of ITM2B+3’UTR from cDNA and insertion in pET3a
Forward 5'-aggccgcgcc atggtgaaggtgacgttcaa-3' T
1 5'-ggaattccat atggtgaaggtgacgttcaa-3'
Reverse 5'-aaacattattgaggaaaattaatat cacagcata-3' T
2 3'-tttgtaataactccttttaattata cctaggcgc-5'
Introduction of mutations in pITM2B
3 ABriPP 5'-ccgtggaaactttaatttgttct cgc acagtcaagaaaaacattattgag-3'
5'-ccgtggaaactttaatttgttct tga acagtcaagaaaaacattattgag-3' T
4 3'-ggcacctttgaaattaaacaaga gcg tgtcagttctttttgtaataactc-5'
5 ADanPP 5'-caaatttgccgtggaaactttaatttgttttaatttgttcttgaacagtc-3'
5'-caaatttgccgtggaaac          tttaatttgttcttgaacagtc-3' T
6 3'-gtttaaacggcacctttgaaattaaacaaaattaaacaagaacttgtcag-5'
Construction of OmpA signal sequence
7 5'-ggaattccatatgaaaaagacagctatcgcgattgcagtggcactggctgg-3'
8 3'-gtcaccgtgaccgaccaaagcgatggcaccgcgtccggcgacctagggcg-5'
Insertion of ITM2B, full length and soluble domain, in pET30Ek/LIC
Forward, full length 5'-taattttgtttaactttaagaaggagatatacatatg gtgaaggtgacgttcaac-3' T
9 5'-ggaattccatatgcatcaccatcaccatcacggtgct gtgaaggtgacgttcaac-3'
Forward, soluble domain 5'-cttgcaggcgttattctaggaggagcatacttg tacaaatattttgcacttcaa-3' T
10 5'-cgcggatcccatcaccatcaccatcacggggct tacaaatattttgcacttcaa-3'
Reverse 5'-cgtggaaactttaatttgttct tgaacagtcaagaaaaacat-3' T
11 BriPP 3'-gcacctttgaaattaaacaaga attattcgactcgccttaag -5'
5'-gaaaaacattattgaggaaaattaa tatggatccggctgcta-3' T
12 ABriPP 3'-ctttttgtaataactccttttaatt attcgactcgccttaag-5'
5'-ttgaacagtcaagaaaaacattat tgaggaaaattaatatggat-3' T
13 ADanPP 3'-aacttgtcagttctttttgtaata attattcgactcgccttaag-5'
Insertion of ITM2B, soluble domain, in pTOPO101/D
Forward 5'-tgcaggcgttattctaggaggagcatacttg tacaaatattttgcacttcaacc-3' T
14 5'-caccatgcatcatcatcatcatcatggtacc tacaaatattttgcacttcaacc-3'
Reverse 5'-cgtggaaactttaatttgttct tgaaca-3' T
15 BriPP 3'-gcacctttgaaattaaacaaga attatt-5'
5'-gaaaaacattattgaggaaaattaa tat-3' T
16 ABriPP 3'-ctttttgtaataactccttttaatt att-5'
5'-ttgaacagtcaagaaaaacattat tgagga-3' T
17 ADanPP 3'-aacttgtcagttctttttgtaata attatt-5'
Table 12. Primer and
other oligonucleotides.
T, target sequence.
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(856bp, figure 49). The pET3a plasmid (Novagen, Madison, Wisconsin, USA)
was chosen as template for vector construction. Rapid ligation at 22ºC was un-
successful but overnight ligation at 4ºC gave numerous colonies compared to
controls (insert or empty vector). Ten colonies were cultured for plasmid purifi-
cation and sequencing. Mutations were identified in all clones, but one of these
(pITM2B) contained only silent mutations (ggc-to-ggt at codon 67, cct-to-ccc at
codon 133 and gca-to-gcg at codon 138) and was chosen for further modifica-
tion.
Construction of recombinant expression vectors
The pITM2B plasmid contained not only the ITM2B coding sequence but also
sufficient 3'-UTR to allow introduction of the two disease related mutations di-
rectly on the vector by site-directed mutagenesis (SDM) as opposed to elonga-
tion of the 3' sequence by successive rounds of PCR. The forward and reverse
primers were designed for the two mutations (table 12). As expected, the method
yielded few colonies per mutation (3-5), all of which were picked for plasmid
amplification and sequencing using the T7 forward primer combined with a cus-
tom primer (table 12) allowing better visualisation of the 3'-region. Despite the
low number of colonies, correctly introduced mutations were identified in all but
one clone. The purpose of the introduction of the disease-related mutations was
to obtain templates for PCR amplification and modification to allow insertion in
an appropriate expression vector. To this end, a single clone was picked for each
mutation (pITM2B-AB and pITM2B-AD for ABriPP and ADanPP, respectively)
containing only the disease-related mutation and the three silent mutations.
BriPP is a predicted type I transmembrane proteins with a short 51AA N-termi-
nal cytoplasmic region, a 25AA transmembrane helix and a 190AA C-terminal
extra-cellular domain. To allow characterisation of both the full-length mem-
brane protein (FL form) and the presumably soluble extra-cellular domain (SD
form), two sets of expression vectors were designed based on the pET30Ek/LICS
plasmid (Novagen). This kanamycin-conferring plasmid was chosen to minimise
false-positive clones of pITM2B vectors, which carry ampicillin resistance. The
BriPP-FL, ABriPP-FL and ADanPP-FL constructs were designed to yield simple
N-terminally His-tagged proteins which would presumably form inclusion bod-
ies. The His-tag was introduced by PCR as an additional overhang and the cod-
ing sequence inserted between the plasmid NdeI and BlpI restriction sites. As for
pITM2B, rapid ligation yielded only colonies bearing the empty vector and simi-
lar results were obtained by cold overnight ligation. However, the addition of a
desphosphorylation step for the vector fragment prior to gel purification gave
multiple colonies of which 8 were picked for sequencing for each variant and one
chosen per construct (pBriPP-FL, pABriPP-FL and pADanPP-FL).
Figure 49. 1% agarose
gel of PCR from cDNA
of cerebellum (1) and
lung tissue (2).
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The BriPP-SD and variant constructs were initially designed for transport to the
periplasm by introduction of the OmpA signal sequence (OA, table 12) to allow
purification of native protein rather than inclusion bodies. The vector was to be
assembled in two steps: i) Insertion of the OA between plasmid restriction sites
NdeI and BamHI (pOA plasmid) and ii) insertion of the soluble domain coding
sequence including an 5' His-tag sequence between plasmid restriction sites BamHI
and BlpI (pOASS-<variant>-SD plasmids). However, while the signal sequence
was readily incorporated into the empty vector, the subsequent ligation of the
vector and SD domain (produced by PCR) proved difficult. Similar lack of re-
sults were observed for ligation of the SD-sequence into an unmodified vector
(pET3a and pET30Ek/LICS both). An alternative approach was chosen based on
the TOPO 101/D cloning system (Invitrogen, Carlsbad, CA, USA). The method
omits the use of restriction sites, restriction enzymes and conventional ligation.
The PCR product is cloned into the linear plasmid by the activity of covalently
linked topoisomerase I from the Vaccinia virus (figure 50).
Directional cloning is made possible by adding a 4bp, 5'-overhang during PCR
amplification. An N-terminal His6-tag introduced by PCR was preferred over the
C-terminal His-tags available on the vector due to the C-terminal localisation of
the two mutations. Therefore, the TOPO cloning primers included the cacc over-
hang for directional cloning, an N-terminal MH6T peptide, and a two C-terminal
stop codons (table 12). The colony-yield was low (with no control plate colonies)
but subsequent sequencing showed that the correct sequence had been obtained
for all three variants (pBriPP-SD, pABriPP-SD and pADanPP-SD).
Overhang invades double-stranded
DNA, displacing the bottom strand
Topoisomerase
Topoisomerase
----CCCTT
----GGGAAGTGG
CACC ATG NNN --- --- --- NNN
GTGG TAC NNN --- --- --- NNN TTC CC----
AAG GG----
Tyr-274
P
Tyr-274
P
Overhang
PCR product
----CCCTTCACC ATG NNN --- --- --- NNN AAG GG- ---
----GGGAAGTGG TAC NNN --- --- --- NNN TTC CC- ---
G
T
G
G
AAG GGC GAG CTC AAT TCG AAG CTT GAA GGT AAG CCT ATC CCT AAC CCT CTC CTC GGT CTC GAT TCT
ACG CGT ACC GGT CAT CAT CAC CAT CAC CAT TGA GTTTGA TCCGGCTGCT AACAAAGCCC GAAAGGAAGC
Lys Gly Glu Leu Asn Ser Lys Leu Glu Gly Lys Pro Ile Pro Asn Pro Leu Leu Gly Leu Asp Ser
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Figure 50. Principle of
TOPO cloning (A) and
sequence of the
cloning region (B)
(tools.invitrogen.com/
content/sfs/manuals/
pettopo_man.pdf).
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Verification of protein expression in rich and minimal medium
A series of culture experiments was designed to monitor expression of the solu-
ble domain (SD) of BriPP, ABriPP and ADanPP by E. coli BL21 (DE3) in rich
(LB) and minimal (M9) medium at 37ºC. Briefly, E.coli BL21 (DE3) cells trans-
formed with the appropriate plasmids were grown under batch conditions and
cell samples were removed at regular intervals for SDS-PAGE analysis (figure
51). Following induction, a band appears at approximately 30kDa with increas-
ing intensity. The apparent value is somewhat higher than the expected molecu-
lar weight of the soluble domain (23.4 kDa). This is the case for both rich (figure
51.A) and minimal medium (figure 51.D) and a similar behaviour can be ob-
served for the soluble domain of the mutant ABriPP and ADanPP (figure 51.B-
C). Since the protein was expressed to the cytoplasm, and appears to be present
in large amounts, it is reasonable to assume that the protein deposits as inclusion
bodies rather than as native protein.
To verify the presence of BriPP-SD, cells were harvested and the inclusion bod-
ies isolated and re-dissolved in 8M urea (20mM Tris, 8M urea, pH 7.4).
Unsurprisingly, the roughly purified inclusion bodies had a very intense band at
~30kDa (figure 52). The His-tagged protein was further purified by nickel affin-
ity chromatography (NAC). The resulting fractions were analysed on 15% SDS-
Figure 51. Expression
of BriPP (A), ABriPP
(B) and ADanPP (C) in
LB medium and BriPP
in M9 medium (D).
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PAGE (figure 53) and did show overall increased purity of the supposed
recombinant band (arrow) but also a marked degree of impurity including a strong
band at ~46kDa (arrowhead), which closely follows the supposed recombinant
band in intensity. The position corresponds to the expected dimer mass (46.6kDa)
although the monomer runs with a higher apparent mass. The two bands were
analysed by in-gel tryptic digestion and mass spectroscopy and both were identi-
fied as variants of the recombinant protein. The presence of a high-molecular
weight band of the recombinant protein suggests formation of a covalent dimer
by partially dithiothreitol (DTT)-resistant disulphide formed from any of the 5
cysteines. Indeed, incubation with 40mM DTT decreased the intensity of higher
order bands but did not entirely suppress the formation of dimers or higher
oligomers (figure 54).
Establishment of purification protocol
The initial purification experiment suggested that affinity-chromatography could
be an effective method provided that the formation of covalent dimers and higher
Figure 53. NAC-puri-
fied BriPP (15% SDS-
PAGE). Arrow, recom-
binant band; arrow-
head, contiminant
band.
Figure 52. Roughly
purified inclusion
bodies of BriPP at 1:2
and 1:500 dilutions
(15% SDS-PAGE).
Figure 54. Effect of
DTT on oligomerisation
of BriPP (15% SDS-
PAGE).
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oligomers could be suppressed and that the presence of additional impurities
minimised. To this end, an initial anion-exchange chromatography (AEC) step
was introduced using a high capacity SourceTM 15Q column. The AEC step did
improve overall purity but the highest-concentration fractions still required fur-
ther purification (fractions 35-37, figure 55). BriPP eluted at approximately
200mM NaCl, which allowed binding to the NAC matrix without intervening
dialysis. To limit cross-linking without reducing Ni2+, 25mM 2-mercaptoethanol
(2me) was added to the equilibration, wash and elution buffers. The resulting
fractions appear pure but low in concentration (figure 56). To asses the purity, the
highest-concentration fractions (2-3) were pooled and concentrated by ultrafil-
tration/centrifugation. By comparison to a samples purified only by NAC and in
the absence of 2me, the combination of the two methods appears to yield suffi-
ciently pure protein with limited disulphide cross-linking (figure 57).
Screening of refolding conditions
The attained purity cannot be said to be sufficient for advanced characterisation,
e.g. crystallisation, but was deemed sufficient for screening conditions under which
folding into a stable, supposed native-like conformation could be accomplished.
The micro-well plate method was adopted from [637] with special emphasis on
the effect of reducing (2me, GSH/GSSG) and stabilising agents (glycerol, glu-
cose, PEG 400 and 4000) as well as the effect of salts (KCl, NaCl). In addition, a
Figure 55. AEC-purified
BriPP.
Figure 56. BriPP purifi-
ed by NAC and AEC in
the presence of redu-
cing agents.
Figure 57. Concentrate
of purified BriPP in the
presence of 2me (2)
compared to the same
concentration of
protein purified by AEC
alone and in the
absence of reducing
agent.
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1 2 3 4 5 6 7 8 9 10 11 12
pH 4.0 pH 5.0 pH 6.0 pH 7.0 pH 8.0 pH 9.0
A N.a.a.
2me
Glycerol N.a.a.
2me
EDTA N.a.a. N.a.a. Cocktail N.a.a. 2-bme N.a.a. ----
B 0.1M KCl
2me
0.1M KCl KCl
2me
Glycerol 0.1M KCl 0.1M NaCl 2me 0.1M NaCl
2me
0.1M NaCl 0.1M NaCl
C EDTA
2me
0.1M NaCl 0.2M NaCl
2me
PEG 4000 EDTA 2me 0.2M NaCl
2me
0.1M NaCl 0.2M NaCl
0.1M NaCl
Glucose
0.1M KCl
Glucose
D Glycerol
2me
0.2M NaCl 0.1M NaCl
2me
PEG 400 Glucose 0.1M KCl
2me
EDTA Glucose 0.2M NaCl PEG 400
E
PEG 400
Glucose
2me
Glucose Cocktail
2me
0.1M NaCl Glycerol EDTA
EDTA
Glucose
Glycerol
F
PEG 4000
Glucose
Cocktail EDTA
2me
Glucose
EDTA
PEG 400 Glucose PEG 400 PEG 400
PEG 4000
Glucose
G 2-bme
2me
PEG 400
Glucose
2me
Glucose
EDTA
PEG 4000 Cocktail PEG 4000 PEG 4000 Cocktail Cocktail
H* 5mM GSH 5mM
GSSG
---- ---- ---- ---- ---- ----
*50mM Tris, pH 8, 150mM NaCl, 1mM EDTA. N.a.a. No additional additives; ----, used for background; 2me, 2-mercaptoethanol; GSH, glutathione;
GSSG, glutathione disulphide. Other concentrations: EDTA, 1mM ; glycerol, 20%(v/w); PEG 400 and PEG 4000, 0.5%(m/m); glucose, 500mM;
2me, 10mM. Cocktail: 50µM each of thiamine(HCl), CaCl , CuSO , Zn2 4 SO , NiCl .4 2
1 2 3 4 5 6 7 8 9 10 11 12
pH 4.0 pH 5.0 pH 6.0 pH 7.0 pH 8.0 pH 9.0
A 0.115 0.108 0.061 0.071 0.029 0.072 0.001 0.010 0.001 0.001 0.001 ----
B 0.122 0.102 0.097 0.047 0.069 0.074 0.001 0.001 0.002 0.001 0.001 0.002
C 0.121 0.104 0.095 0.069 0.033 0.029 0.013 0.002 0.001 0.002 0.001 0.001
D 0.103 0.096 0.095 0.060 0.025 0.027 0.003 0.001 0.002 0.001 0.001 0.001
E 0.106 0.102 0.058 0.088 0.033 0.029 0.001 0.002 0.001 0.001 0.001 0.001
F 0.105 0.110 0.057 0.059 0.037 0.031 0.001 0.002 0.001 0.001 0.001 0.001
G 0.105 0.037 0.054 0.030 0.033 0.033 0.001 0.001 0.001 0.008 0.008 0.001
H* 0.010 0.008 0.007 0.013 0.008 0.006 ---- ---- ---- ---- ---- ----
* pH 8.0; ----, Empty
1 2 3 4 5 6 7 8 9 10 11 12
pH 4.0 pH 5.0 pH 6.0 pH 7.0 pH 8.0 pH 9.0
A 0.117 0.110 0.063 0.073 0.030 0.075 0.001 0.007 0.001 0.001 0.001 ----
B 0.121 0.103 0.097 0.049 0.072 0.076 0.005 0.002 0.002 0.002 0.002 0.002
C 0.120 0.112 0.095 0.070 0.034 0.030 0.019 0.004 0.002 0.003 0.002 0.002
D 0.107 0.102 0.097 0.063 0.028 0.028 0.006 0.001 0.002 0.002 0.001 0.002
E 0.111 0.109 0.059 0.092 0.033 0.030 0.002 0.002 0.001 0.001 0.001 0.013
F 0.106 0.108 0.059 0.061 0.044 0.032 0.001 0.002 0.002 0.001 0.002 0.002
G 0.105 0.099 0.054 0.054 0.030 0.036 0.001 0.001 0.001 0.005 0.003 0.001
H* 0.015 0.007 0.010 0.013 0.010 0.007 ---- ---- ---- ---- ---- ----
* pH 8.0; ----, Empty
A
B
C
10mM
GSSG
5mM GSH
5mM
GSSG
5mM GSH
2mM
GSSG
2mM GSH
5mM
GSSG
2me
0.1M NaCl
2me
0.2M NaCl
Glucose
2me
Glycerol
2me
Glucose
2me
PEG 400
2me
Glycerol
2me
PEG 4000
2me
PEG 400
Glucose
2me
0.2M NaCl
Glucose
2me
Glucose
2me
Glycerol
2me
0.1M KCl
2me
0.2M NaCl
2me
EDTA
2me
0.1M NaCl
Glycerol
The Molecular Basis of Familial Danish Dementia
133
cocktail of trace metal ions was screened (table 13.A). The results showed a clear
tendency towards aggregation at low pH and high salt concentration (table 13.B-
C). The latter could be partially alleviated by the presence of glucose, but not
altogether abolished. After two weeks, the protein remained in solution in all
samples at pH 8.0 and 9.0 with exception of those containing 0.2M NaCl. No
clear effect was observed for other additives or trace metal ions.
Following 14 days of storage, the stability of the protein against tryptic digest
was estimated for aggregated and soluble samples at pH 6.0 and 8.0, respectively
(wells A5 and A9, figure 58), and compared to stability of the protein diluted
directly from 8M urea to comparable protein concentration in digestion buffer.
Both the soluble and aggregated protein were significantly more resistant to pro-
teolysis than the denatured form. It is expected that protein aggregates are pro-
tected from proteolysis. The somewhat lower but nonetheless apparent resist-
ance of the soluble form at pH 8.0 suggests that the protein is folded in what must
assumed to be a native-like conformation. Circular dichroism spectra were ob-
tained for protein freshly diluted into folding buffer at pH 8.0 and after overnight
folding (figure 59). The initial conformation appear β-like albeit with significant
Table 13 (opposite).
Refolding assay (A)
and OD340 after 15 min.
(B) and overnight sto-
rage (C) at 4ºC. Clas-
sification: ‘Soluble’
(bold) <0.01; ‘partly
soluble’ (italics) <0.03.
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Figure 59. CD spectra
of 5μM BriPP (A) in the
denatured, freshly
dissolved and aged
state. Insert: Thermal
scan of a similar
sample.
Figure 58. Trypsin
digest of urea-
denatued, aggregated
and ‘folded’ BriPP.
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noise. Over the longer folding period, the spectrum changes to a more α-like
appearance. However, following the CD-signal at 215nm during heating does
not reveal corporative loss of secondary structure suggesting a non-native con-
formation (figure 59, insert).
An important issue raised by the observations summarised above, is the forma-
tion of dimers and higher oligomers, presumably by disulphide cross-linking.
For long-term storage, including storage at -80ºC, neither DTT nor 2me was found
to suppress cross-linking while the addition of 25mM Tris(2-
carboxyethyl)phoshine (TCEP) was found to be more effective without suppress-
ing the cross-binding entirely. The role of cysteines is also of concern since the
protein largely aggregates in solution at pH-values below 8. The use of refolding
under basic conditions also leads to higher lability and shuffling of disulphide
bonds [638], which could aid in refolding by allowing a higher degree of confor-
mational freedom. However, considering the tendency towards cross-binding,
suppression of intermolecular disulphide formation may well be a requirement
for folding to occur and for long term stability of the protein in solution. Con-
versely, the high number of cysteines suggest a structural role of disulphide for-
mation and the suppression of oxidation could significantly and adversely affect
the stabilisation of the protein structure. Similarly, the in vivo quartenary struc-
ture of BriPP is not at all clear but potential dimerisation or higher oligomerisation
must be kept in mind particularly in light of the odd number of cysteines is found
in both the full-length protein and extra-cellular domain. A recent study by Tsachaki
et al. [639] on BriPP expressed in culture demonstrated the presence of BriPP
dimers formed by disulphide cross-linking at position 89 in the transmembrane
region. It is possible that prevention of intermolecular bonding could prevent the
protein from attaining native structure. As such, the highly reducing conditions
do not reflect biologically relevant conditions and any structural or functional
properties must be viewed with some doubt. One possible approach to elucidat-
ing the role of cysteines in BriPP folding and function would be a Cys-to-Ser
combinatorial mutational study.
4.2 Materials and methods
Materials
All chemicals were supplied by Sigma (St. Louis, MO, USA) unless otherwise
indicated. Medium components (tryptone, yeast extract, bacto-agar) were from
International Diagnostics Group (Bury, UK). NaCl was supplied by J.T. Baker
(Deventer, Holland). XL1 Blue and BL21 (DE3) cell lines were generic labora-
tory strains. QuikChange® Site-Directed Mutagenesis kit and ChampionTM Di-
rectional TOPO® 101/D expression kit including specific supercompetent cells
were from Strategene (La Jolla, CA, USA) and Invitrogen (Carlsbad, CA, USA),
respectively. pET3a and pET30Ek/LIC vector backbones were from Novagen
(Madison, WI). Lung tissue and whole cerebellum 5'-STRETCH cDNA libraries
(λgt11) were supplied by ClonTech (). Plasmids were purified using the
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GenEluteTM Plasmid Miniprep kit (Sigma, St. Louis, MO, USA). The NucleoSpin
Extract kit (Macherey-Nagel, Düren, Germany) was used for purification of PCR
products and agarose gel extraction of DNA. Primers were supplied by DNA
Technology (Aarhus, Denmark). The Taq and Herculase polymerases were from
New England Biolabs (Beverly, MA, USA) and Stratagene (La Jolla, CA, USA).
T4 DNA ligase and restriction enzyme NdeI were from New England Biolabs
(Beverly, MA, USA). Restriction enzymes BamHI and BlpI (isoschizomer of
Bpu1102I), shrimp alkaline phosphatase (SAP), sequencing reagents, DNA and
protein weight standards were supplied by MBI Fermentas (Hanover, MD, USA).
Acrylamide:bis-acrylamide (37.5:1, 30% solution) and sodium dodecylsulfate
(SDS) were supplied by AppliChem (Darmstadt, Germany). All lipids were from
Avanti Polar Lipids (Alabaster, AL, USA).
DNA-based methods
Polymerase chain reaction (PCR) was performed using 16nM of each primer,
0.2mM dNTP, 0.04units/100μL Taq or Herculase polymerase and 2μL template
(plasmid or λ phase cDNA). Templates, primers, temperatures and cycle lengths
are summarised in table 14. All PCR products were visualised on 1% agarose and
purified before further use.
The appropriate and purified PCR fragment was sequentially digested according
to manufacturer’s recommendations followed by a second round of gel purifica-
tion. Vector DNA was treated similarly but also dephosphorylated (SAP) prior to
gel purification. Ligation using T4 ligase was performed either for 1 hour at 22ºC
or overnight at 4ºC according to manufacturer’s protocol. For each ligation, a
maximum of ten colonies were picked for analysis by PCR using insert-specific
primers. Positive colonies were further analysed by sequencing. The alternative
TOPO method was performed according to the supplied protocol, but otherwise
analysed similarly. Site-directed mutagenesis on the pITM2B plasmid was per-
formed using the Quik-Change® method (Stratagene) according to manufactur-
er’s protocol.
Relevant colonies were picked for plasmid purification and used as PCR tem-
plate with specific sequencing primers followed by treatment with SAP and exo-
nuclease I. Dye terminated fragments were obtained by second PCR using dye-
dNTPs. The dye-terminated fragments were separated by capillary chromatogra-
phy (Megabace, GE Health Care, Little Chalfont, UK)
Growth and expression of BriPP and variants
Chemically competent E.coli BL21 (DE3) cells were transformed with the ap-
propriate plasmid and plated on LB-agar under selection pressure (100μg/mL
ampicillin). Single colonies were picked for overnight starter cultures (37ºC, LB
or M9 medium, table 15). Growth batch cultures were inoculated with 5% starter
culture and grown to an optical density at 600nm (OD600) of ~0.2 before induc-
tion with 0.5mM IPTG. Cell samples were removed at regular intervals, OD600
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measured and aliquots centrifuged and stored at -20ºC for subsequent analysis.
All cell samples were re-dissolved in PBS buffer to similar OD and aliquots were
mixed with SDS-PAGE sample buffer (0.2M Tris, 2% (w/v) SDS, 20% (v/v)
glycerol, 40mM DTT, pH 6.8) and heated (60 seconds, 95ºC). Samples were
analysed by Laemmli-type SDS-PAGE [640] (4% stacking, 15% separation gels).
Proteins were visualised by Coomassie staining.
Inclusion body purification
Cells were harvested by centrifugation (8000rpm, 10 minutes, Sorvall® RC5C
Plus, SLA3000 rotor, Kendro Laboratory Products,Newtown, California, USA).
The pelleted cells were re-suspended in 50mL PBS and lysed by repeated sonica-
tion (10 x 60 seconds with 30 second intervals) on ice. Inclusion bodies and
remaining whole cells were isolated by centrifugation (5800rpm, 2 hours, SS34
rotor, Kendro Laboratory Products). The pellet was resuspended in 20mL TEN-
Triton buffer (50mM Tris, 1mM EDTA, 100mM NaCl, 1mM DTT, 2% (w/v)
Triton X100, pH 8) and incubated overnight at 37ºC, 150rpm shaking. The sam-
ple was centrifuged (5800rpm, 20 minutes, SS34 rotor), the pellet re-suspended
in 20mL TEN buffer (without Triton) and centrifuged again under the same con-
ditions. The pellet was re-suspended in 20mL TN buffer (50mM Tris, 100mM
NaCl, 1mM DTT, pH 8.8 for AEC and pH 7.4 for NAC) and mixed with 4 vol-
umes TN buffer with 10M urea. The inclusion bodies were allowed to dissolved
for 3 hours at 37ºC before removal of remaining whole cells and non-inclusion
body cellular debris by centrifugation (19000rpm, 20 minutes, SS34 rotor). The
supernatant was decanted, fast-frozen and stored at -80ºC. Samples taken during
the purification and the final supernatant were analysed by 15% SDS-PAGE and
visualised by Coomassie staining.
Anion-exchange chromatography
Anion-exchange chromatography was performed on an ÄKTAexplorer system
(GE Healthcare, Little Chalfont, UK) fitted with a 30mL SourceTM 15Q anion
exchange column (GE Healthcare). Due to the high back pressure cause by run-
ning in 8M urea, flow was restricted to 0.5mL/minute. The column material was
equilibrated in buffer AEC A (20mM Tris, 8M urea, 10mM DTT, pH 8.8). Protein
(5mL) was loaded on the column and washed with two column volumes of buffer
AEC A. Elution was performed as a linear 0-500mM NaCl gradient (0-50% buffer
AEC B, 20mM Tris, 1M NaCl, 8M urea, 10mM DTT, pH 8.8) over two column
volumes and the eluent collected as 0.5mL fractions. The elution was followed
by absorbance at 280nm and selected fractions were analysed by 15% SDS-PAGE.
Nickel affinity chromatography
The HIS-SelectTM Nickel Affinity gel (Sigma) was chosen for the NAC step. The
tolerance of the binding capacity towards reducing agents was examined prior to
use. DTT reduced Ni2+, while 2me could be used up to a concentration of ~30mM.
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The Ni2+-charged agarose gel beads were drained and equilibrated (20mM Tris,
6M urea, 20mM 2me, 100mM NaCl, which was omitted when binding AEC sam-
ples). The slurry was mixed with four volumes of sample and left overnight at
4ºC with rotational agitation. The material was transferred to a column and washed
twice (20mM Tris, 100mM NaCl, 5mM imidazole, 6M urea, 20mM 2me) by
gravity draining. Protein was eluted in 10 x 5mL elution buffer (20mM Tris,
100mM NaCl, 250mM imidazole, 6M urea, 20mM 2me), which were analysed
by 15% SDS-PAGE. The relevant fractions were pooled and dialysed overnight
(20mM Tris, 8M urea, 30mM DTT or TCEB, pH 7.4) at 4ºC. The sample was
then concentrated (~10x) in a Centricon® YM10 filter (Millipore, Billerica, MA,
USA), aliquoted, fast-frozen and stored at -80ºC.
Refolding assay
Screening of refolding conditions was performed according to Vincentelli et al.
[637] with some modifications (assay summarised in table 13.A). The buffer con-
centration was 50mM of sodium acetate (pH 4.0), MES (pH 5.0 and 6.0) or Tris
(pH 7.0, 8.0 and 9.0). Buffers were prepared, filtered (0.22μM syringe filter,
Millipore) to prevent microbial growth and aliquots of 95μL were transferred to
a clear 96 microwell plate (Greiner Bio-One, Frickenhausen, Germany). The con-
centration of the dialysed protein was estimated from absorbance at 280nm (A280,
ε280=18130M
-1cm-1) and adjusted to a stock concentration of ~5mg/mL of which
5μL were transferred to each well to a concentration of ~0.25mg/mL (11μM).
The formation of protein aggregates was measured (U1500, Hitachi, Tokyo, Ja-
pan) as optical density at 340nm (OD340) after 15 minutes, overnight and 14 days
storage of the closed plate at 4ºC. Samples were classified as ‘soluble’ for OD340
at or below 0.01 and ‘partly soluble’ for OD340 between 0.01 and 0.03.
Trypsin stability assay
For examination of protein stability towards trypsin digest, protein samples were
mixed with 1:1 with trypsin digest buffer (50mM sodium phosphate, pH 7.6)
containing 0.1, 1 and 10μM freshly prepared and chilled trypsin. Sample were
incubated at 37ºC for 15 minutes. Proteolysis was stopped with 1mM
phenylmethanesulphonyl fluoride (PMSF) and samples examined by 15% SDS-
PAGE. Protein diluted directly from 8M urea into trypsin digest buffer was in-
cluded as control and otherwise treated similarly.
Circular dichroism
Circular dichroism (CD) spectra were recorded using 5μM protein on a Jasco J-
810 spectropolarimeter (Jasco, Hachioji, Tokyo, Japan; 1mm 110-QS cuvette,
Hellma, Müllheim, Germany) with averaging over 10 scans, resolution 0.1nm,
response time 2s. Thermal scanning was monitored at 215nm for every 0.2ºC
with linear ramping from 20 to 95ºC at a speed of 90ºC/hour (resolution 2nm,
response time 2s).
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Abstract
Anionic surfaces promote protein fibrillation in vitro and in vivo. Monomeric SDS has also been shown to stimulate this process. We describe
the dynamics of conformational changes and aggregative properties of the model protein S6 at sub-micellar SDS concentrations. S6 exhibits a rich
and pH-sensitive diversity in conformational changes around 0.2–2 mM SDS, in which several transitions occur over time scales spanning
milliseconds to hours. Monomeric SDS readily precipitates S6 within minutes at pH-values of 5 and below to form states able to bind the fibril-
specific dye thioflavin T. At pH 5.5, the process is much slower and shows a mutagenesis-sensitive lag, leading to different forms of organized but
not classically fibrillar aggregates with native-like levels of secondary structure, although the tertiary structure is significantly rearranged. The
slow aggregation process may be linked to conformational changes that occur at the second-time scale in the same SDS concentration range,
leading to an altered structure, possibly with unfolding around the C-terminal helix. The S6 aggregates may be differently trapped states,
equivalent to pre-fibrillar structures seen at early stages in the fibrillation process for other proteins. The low quantities of anionic species required
suggest that the aggregates may have parallels in vivo.
© 2007 Elsevier B.V. All rights reserved.
Keywords: Aggregation; Kinetics; SDS; Anionic surface; Unfolding
1. Introduction
Protein aggregation is a ubiquitous problem with deleterious
consequences from both a medical [1] and industrial [2] per-
spective. In particular, an increasing number of both neurode-
generative and systemic diseases are known to be associated
with the formation of ordered needle-like aggregates known as
amyloid fibrils. It has been proposed that the ability to aggre-
gate to well-ordered structures is a generic property of proteins
[3]. However, amyloid formation is specific (i.e. unrelated pro-
teins do not cross-seed each other's fibrillation) and sequence-
dependent [4], and there are numerous examples of deposition
diseases caused by single amino acid substitutions which have a
dramatic effect on aggregation. Recent studies suggest that this
intrinsic aggregation propensity can be rationalized on simple
physical–chemical properties, making it possible to predict the
fibrillogenic effect of different mutations [5–7]. In addition to
intrinsic changes in the protein sequence, external factors can
contribute. A protein can be induced to aggregate and fibrillate
if it is cleaved proteolytically into smaller unstable fragments.
This occurs for e.g. the Aβ peptide involved in Alzheimer's
disease [8], gelsolin [9,10] and ABri/ADan [11]. Aggregation
can also be encouraged if the protein concentration increases, as
seen for secondary amyloidoses, where chronic inflammation
can increase serum concentrations of SAA (serum amyloid A)
by a factor of 1000, facilitating amyloid formation [12].
Changes in the environment can also play an important role. In
vitro fibrillation is often favoured by conditions which stabilize
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a flexible yet partially folded state, typically favoured by low
pH (S6, [13]), structure-inducing solvents such as trifluoroetha-
nol and hexafluoroisopropanol (β2-microglobulin, [14]) or
negatively charged surfaces (α-synuclein, [15]). Living organ-
isms harbour many fibrillogenic anionic molecules. For
example, many proteins including tau fibrillate preferentially
in the presence of the anionic proteoglycan heparin [16], while
negatively charged lipid vesicles stimulate fibrillation of islet
amyloid polypeptide (IAPP) [17,18], whose aggregation is
central to non-insulin dependent diabetes mellitus (NIDDM).
Similar effects by anionic lipids have been seen for common
proteins not associated with disease [19]. Exposure of anionic
lipids may in fact be associated with cell dysfunction and thus
stimulate binding and aggregation of proteins. For example,
during apoptosis, the anionic phosphatidylserine lipids, which
normally reside in the inner leaflet, become accessible at the cell
surface [20], while anionic lipids accumulate during NIDDM
and upon glucose stimulation [21,22]. Polyanion-binding
proteins may even constitute a functional network of interac-
tions [23].
The anionic surfactant sodium dodecyl sulphate (SDS), al-
though not found in vivo, is a widely used mimetic of anionic
lipids. Above its critical micelle concentration (cmc), which is
around 1 mM under physiological conditions, it mainly exists as
micelles. SDSmicelles have excellent solubilizing properties due
to the electrostatic inter-micellar repulsion, which counteracts
their ability to stimulate aggregation. Nevertheless, just around
the cmc, SDS micelles stimulate formation of amyloid-like fibers
of Aβ which form after passing through a stage of initial amor-
phous aggregates [24]. However the resulting fibrils were not able
to seed subsequent fibrillation of Aβ monomers, and did not
form at higher micelle concentrations. Sub-micellar SDS is
also known to stimulate aggregation, for example when mixed
with cationic peptides such asNovispirin [25]. Goto et al. showed
that SDS' ability to stimulate elongation of β2-microglobulin
fibrils [26] and induce fibrillation of aβ2-microglobulin fragment
[14] peaked just below the cmc, and similar observations have
been made for collagen [27] and a peptide from human com-
plement receptor 1 [28], while fibrillation of lysozyme is sti-
mulated by sub-mM (and thus monomeric) SDS concentrations
[29]. Nanomolar concentrations of SDS may also affect cal-
citonin's ability to interact with lipid membranes [30]. In addi-
tion, the temperature at which Fusarium solani pisi cutinase
aggregates decreases from 70 to 60 °C between 0 and 0.5 mM
SDS at pH 7 [31].
It has been suggested that anionic surfaces may stimulate
protein aggregation simply by concentrating proteins within a
small area [17,24], rather than by altering the proteins' con-
formational properties. This may be true for inherently flexible
peptides such as Aβ and IAPP, but larger proteins are likely to
undergo coordinated conformational changes which can have
profound bearings on their aggregation. To attempt to shed more
light on this, we report a study on the structural basis for sub-
micellar SDS' general ability to stimulate protein aggregation.
As model protein we use the ribosomal protein S6 from Thermus
thermophilus, which has been shown to fibrillate upon pro-
longed incubation at low pH and high salt concentrations [13].
Under these conditions, S6 remains overall native-like but a part
of the protein becomes more flexible, and this may be the basis
for the subsequent fibrillation. S6 unfolds rapidly in micellar
SDS in a manner which is sensitive to mutagenesis [32,33], but
its conformational and aggregative behaviour in monomeric
SDS has not been investigated in detail. We find that S6 ag-
gregates in a narrow SDS concentration interval, leading to
seeding-competent aggregates in a sigmoidal time-profile that is
responsive to mutagenesis. However, these aggregates are not
classical fibrillar and may represent trapped states that are
equivalent to early stages in the fibrillation process.
2. Materials and methods
Sodium dodecyl sulfate (SDS), 8-anilino-1-naphthalenesulfonic acid (ANS),
Thioflavin T (ThT) and N-phenyl-1-naphthylamine (NPN) were from Sigma-
Aldrich (St. Louis, MO). S6 wildtype and mutants were prepared and purified as
described [34,35].
2.1. Fluorescence-based equilibrium titration of S6
Buffers used were as follows: 20 mM Tris (pH 8) and 20 mM sodium acetate
(pH 5.5 or 4.0). All experiments were done at 25±1 °C. 2 μM S6 was incubated
with different concentrations of SDS for at least 1 h before measuring fluo-
rescence on an LS-55 Luminescence spectrometer (Perkin-Elmer Instruments,
Welleslay, MA), using an excitation wavelength of 295 nm and measuring the
emission between 315 and 375 nm. Measurements were obtained using a 10 mm
quartz cuvette (Hellma,Müllheim, Germany) from an average of three scans with
a slit width of 8 nm and a scanning speed of 300 nm/min. For solubility studies,
20 μM S6 (or other proteins examined) was incubated with different SDS
concentrations for at least an hour. Fluorescence intensities of the supernatant
were recorded before and after spinning down 15min at 14,000 rpm, and the ratio
of the two measurements used as a measure of solubility.
2.2. Circular dichroism
Far-UV CD spectra were recorded in a 1 mm quartz cuvette on a J-810
spectropolarimeter (Jasco Spectroscopic Co. Ltd., Hachioji City, Japan) equip-
ped with a PTC-423S temperature control unit. Wavelength scans were recorded
from 250 to 195 nm using 25 μM S6 in 20 mM Tris pH 8.0 (preincubated for an
hour before measurement) with a band width of 2 nm and a scanning speed of
50 nm/min. Five accumulations were averaged to yield the final spectrum. Near-
UV CD spectra were recorded from 320 to 260 nm using 60 μM S6 in a 10 mm
quartz cuvette with the same settings as for far-UVCD.Due to the high amount of
protein required and limited availability, this was performed as a titration
experiment with a single S6 solution. After each SDS aliquot, the sample was
equilibrated for 10 min before spectra were recorded. In both cases, background
contributions from the buffer were subtracted.
2.3. Determination of cmc
This was done in three different ways, namely using NPN fluorescence,
interfacial tensiometry and pyrene fluorescence.
2.4. NPN fluorescence
5 μM NPN was incubated with different concentrations of SDS and the
fluorescence (excitation 350 nm, emission 430 nm, slits 10 nm) recorded.
Inclusion of NPN into the micelles results in an increase in the fluorescence
intensity of NPN. Fluorescence intensity was plotted against surfactant
concentrations, and the cmc was estimated from the break-point of the curve.
2.5. Tensiometry
Interfacial tension was measured with an EZ-PI interfacial tensiometer
(Kibron Inc., Finland). A known volume of sample was introduced in the cuvette
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and placed onto the cuvette holder. Before starting measurements, the instrument
was calibrated with Milli-Q water.
2.6. Pyrene fluorescence
In the presence of bulk micelles or hemi-micellar aggregates on e.g. protein
surfaces, pyrene undergoes a shift in the emission intensity at 383.5 nm (I3) and
372.5 nm (I1), allowing us to use the I3/I1 ratio to measure the cmc value [36]
and the formation of surfactant aggregates on surfaces. Pyrene was added to a
final concentration of 0.2 μM (from a 20 μM stock solution in ethanol) to a
solution containing 0–12 mM SDS and 0 or 2 μM S6. The solution was excited
at 335 nm and the emission between 350 and 440 was monitored. Each
measurement was recorded as an average of three emission scans in a 10 mm
quartz cuvette. Subsequently the I3/I1 ratio was plotted versus SDS concentra-
tion. The cmc in the absence of S6 could be estimated by the break-point as for
NPN.
2.7. Plate-reader assays
These were recorded on a SpectraMax Gemini XS (Molecular Devices,
Sunnyvale CA) fluorescence plate reader at 42 °C using 100 μM S6. Samples
were incubated in triplicate in 96 well black polystyrene microtiter plates
(Greiner Bio-one, Frickenhausen, Germany). Tryptophan emission intensities at
330 nm and 355 nm (both with excitation at 295 nm) were read every 15 min.
Each reading was preceded by 150 s of automixing. To prevent evaporation
during long incubations, the microtiter plates were covered with Crystal Clear
Sealing Tape (Hampton Research, Aliso Viejo, CA), which absorbs only a small
fraction of UV light. For time profiles showing lag phases, the lag time was
estimated as the interpolated time point for the intersection of the pre-
aggregation baseline and the tangent to the elongation or ramp phase.
2.8. ANS and ThT fluorescence
S6 was incubated with 40 μM ANS or 40 μM ThT (in both cases prepared
from 100 mM stock solutions in ethanol). ANS was excited at 375 nm and
emission recorded at 470 nm. ThTwas excited at 450 nm and emission recorded
at 485 nm.
2.9. Solubility studies
20 μM S6 or hen egg white lysozyme (Sigma-Aldrich) was incubated in
20 mM buffer with different concentrations of SDS at 25 °C for 1 h. Samples
were spun down for 15 min at 14,000 rpm. The fluorescence of the supernatant
was measured as described above using excitation at 280 nm and emission at
350 nm.
2.10. Stopped flow kinetics
Unfolding kinetics were monitored on an SX18MV stopped-flow micro-
analyzer (Applied Photophysics, Leatherhead, UK) in a thermostatically
controlled sample-handling unit. S6 and surfactant were mixed 1:10 to a final
protein concentration of 2 μM, samples were excited at 280 nm and the emission
above 320 nm was monitored using a cut-off filter.
2.11. Isothermal titration calorimetry
The calorimetric measurements were conducted on a VP-ITC (MicroCal
Inc., Northampton, MA). The reference cell was filled with water and in a
typical experiment, the sample cell was loaded with a solution of 0.1–0.4 mg/ml
S6. The cell solution was titrated with aliquots of 2.5–4 μl of 99 mM SDS in
10 mM Tris, pH 8. All experiments were done at 22 °C, where SDS demi-
cellization gives a minimal thermal signal [37]. Therefore the enthalpic contri-
bution from demicellization of SDS upon injection can be neglected in data
analysis. The obtained heat signals from the ITC were integrated using the
Origin software supplied by MicroCal Inc.
2.12. Electron microscopy
Electron microscopy was carried out as described [38]. Briefly, a 5 μl aliquot
of BSA was placed on a 400-mesh, carbon-coated, glow-discharged grid for
30 s. Grids were washed in two drops of double-distilled water and stained with
1% (w/v) phosphotungstic acid (pH 6.8) and blotted dry on filter paper. Samples
were viewed with a Jeol 1010 transmission electron microscope (JEOL, Japan).
2.13. FTIR spectroscopy
Spectra were recorded on a Bruker Tensor 27 infrared spectrometer (Bruker
Optik GmbH, Ettlingen, Germany) with a Specac Golden Gate single-reflection
ATR unit (Specac Ltd., Orpington, UK). Aggregates were allowed to sediment
in the eppendorf tube and samples for FTIR were removed from the bottom of
the tube. Approximately 1–3 μg protein was dried under a gentle stream of
nitrogen. Three independent samples were investigated (64 scans at 2 cm−1
resolution). If needed, the presence of water vapour was corrected for by sub-
traction of a fresh vapour spectrum. Peaks were assigned from the 2nd derivative
and deconvolution of spectra. Amide bands I and II of the non-deconvoluted
spectra were fitted using the Levenberg–Marquardt method to 7 Lorentzian
peaks of which 4 were assigned to secondary structure elements and 3 to modes
in amide band II.
2.14. Atomic Force Microscopy
The solution was centrifuged at 14,000 rpm for 10 min. The supernatant was
removed by aspiration and the pellet washed in water. 100 μL of 0.5 μM protein
was applied to freshly cleaved mica and dried at 80 °C. Samples were imaged in
contact mode on a PicoSPMI (Molecular Imaging, Tempe, Arizona) using
silicon nitride cantilevers (BudgetSensors, Sofia, Bulgaria) with force constant
0.27 N/m.
2.15. Limited proteolysis and N-terminal sequencing
10 μM S6 was incubated with 10 nM alcalase (kindly provided by Ture
Damhus, Novozymes A/S) in 20 mM NaOAc pH 5.5 or 20 mM Tris–Cl pH 8.0
in 1.5 mM SDS for 30 min at 25 °C. The stacking gel was allowed to polymerize
one day prior to electrophoresis and samples were heated in SDS-PAGE loading
buffer for 3 min at 80 °C only before loading on the gel. After electrophoresis,
selected S6 bands were transferred to a polyvinylidene diflouride membrane
(Immobilon-P, Millipore, Bedford, MA) in 10 mM CAPS, 10% (v/v) methanol,
pH 11 as described [39]. Samples were analyzed by automated Edman degra-
dation using a Procise amino acid sequencer (Applied Biosystems, Foster City,
CA) with on-line phenylthiohydantoin analysis by HPLC.
3. Results
3.1. S6 undergoes significant multi-step conformational
changes at sub-micellar concentrations
The purpose of this study was to investigate the conforma-
tional changes of relevance for aggregation processes that sub-
micellar SDS concentrations can induce in a model protein. We
start by titrating in SDS at low concentrations, monitoring the
process through S6′ single Trp residue (Trp 62). Under our
buffer conditions (20 mM Tris pH 8), the cmc of SDS is around
2.5–3.3 mM (Fig. 1A and 4A) according to three different
assessment methods (see legend to figure).The tryptophan
signal undergoes several changes below 6 mM SDS, leading to
a general decline in intensity and a slight blue-shift in the peak
position (Fig. 1B insert). Monitoring the emission intensity at
the emission peak around 350 nm (typical of exposed Trp
residues), there is a lag region between 0 and 0.25 mM SDS
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before the signal rises to a maximum around 1.5 mM SDS and
then declines to a plateau level around 4 mM SDS, where it
remains up to 10 mM SDS (Fig. 1B). The same behaviour is
seen using emission at 330 nm (typical of buried Trp residues).
The ratio between these two intensities also shows the same
type of behaviour, although the maximum signal is reached
around 1.9 mM SDS (rather than 1.5 mM SDS) and the signal
change is greatest for the first phase (0.3–1.9 mM) rather than
the second (1.9–6 mM). Although the ratio between two
wavelengths may not always be as quantitative a measure of
conformational changes as the actual intensities, it provides a
useful trend for the changes that occur.
Although Trp fluorescence is generally a highly sensitive
probe of conformational changes, it will also be influenced by
changes in the polarity of the medium due to binding of sur-
factant molecules. Near-UV CD spectroscopy, although requir-
ing ∼1000-fold more sample, only reflects changes in the
conformational freedom of the aromatic side chains and was
used to investigate whether both transitions seen in Fig. 1B are
associated with changes in the mobility of the aromatic side
chains (due to conformational changes) rather than just sur-
factant binding. Addition of SDS effectively abolishes the near-
UV spectral features (Fig. 1C insert), and the concentration
dependence nicely correlates with Trp fluorescence (Fig. 1C):
there is a steep rise up to ca. 1.6 mM, commensurate with the
first Trp transition, and a less steep rise up to around 2–3 mM,
corresponding to the second Trp transition. Thus both tran-
sitions reflect conformational changes.
When we monitor changes in secondary structure using far-
UV circular dichroism, we see changes in the relative intensities
of the two minima around 220 and 206–209 nm (Fig. 1D
insert). At increasing SDS concentrations, the second minimum
blue-shifts from 209 to 206 nm and the ratio of the intensities at
206 and 220 nm rises steeply to a plateau around 1.6 mM SDS,
after which no further changes occur (Fig. 1D). This suggests
that the changes in secondary structure only occur in one
transition from around 0.2 to 1.6 mM SDS. Although the spec-
tra retain their overall α-helical appearance, the change in
intensity ratios suggests that the helices dissociate from each
other to form more isolated entities (cfr. [40–42], which is
entirely consistent with the loss of tertiary structure seen in this
transition according to Trp fluorescence and near-UV CD.
Thus interaction of S6 with low concentrations of SDS at pH
8 appears to involve at least two conformational transitions
below cmc. The first change (up to around 1.5–2 mM SDS)
involves changes in both secondary and tertiary structure, while
the second change primarily involves changes in tertiary struc-
ture. The second change is completed just before the formation
of micellar structures around 3 mM.
To probe whether the second change is connected with
micelle formation, we titrated S6 fluorescence in the presence of
0.1–0.8MNaCl, which leads to a strong reduction in cmc. At all
concentrations, we see the same general trend, namely a short
lag phase before a rise in intensity followed by a steep decline
(Fig. 1E). The position of the signal maximum always occurs at
slightly higher concentrations whenmeasured by emission ratios
rather than actual emission values (data not shown). Importantly,
Fig. 2. (A) ITC enthalpograms of the interaction of SDS with different con-
centrations of S6 in 20 mM Tris pH 8.0 at 22 °C. The sections A–D denote
regions with different types of interactions between SDS and S6. (B) SDS
concentrations and (C) enthalpy values at which the four characteristic tran-
sitions in Fig. 2A occur, plotted versus S6 concentration. Data are summarized
in Table 1.
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although the position of the SDS maximum does shift to lower
values with increasing [NaCl], the maximum does not decrease
as strongly as the cmc value (Fig. 1F). This suggests that the
second step reflects an independent conformational change ra-
ther than a trivial fluorescence change caused by the binding of
micelles to S6.
3.2. Isothermal titration calorimetry experiments reveal several
binding regions
To complement our spectroscopic studies on the binding of
SDS to S6, we turned to ITC, which is a sensitive method that
may monitor and quantitate spectroscopically invisible binding
of SDS to proteins. When we titrate different concentrations of
S6 with SDS, we obtain enthalpograms which change in a
characteristic fashion (Fig. 2A). These enthalpograms may be
divided into four sections (A–D). Section A shows a significant
exothermic (negative) heat flow, which peaks at low concentra-
tions (0.3–0.5 mM SDS. referred to as minimum I). This is
followed by a plateau up to around 2 mM SDS (section B), after
which there is a steady linear decrease in the signal until it forms
a small but distinct peak (section C). This peak has been seen for
a number of other protein–SDS systems, and has been assigned
to the (endothermic) enthalpy change of protein denaturation
[43–45]. Subsequently, the system undergoes a marked exo-
thermic effect in section D, reaching a minimum around 3–
4 mM SDS (minimum II). This is also a general observation in
ITC studies on protein–SDS interactions, and it most likely
reflects the association of SDS and denatured protein [43]. The
saturation of this binding occurs around the inflection point
(around 3.5–4.5 mM SDS). This also corresponds to the
apparent critical micelle concentration (cmcapp) in the presence
of protein [37]. SDS injected beyond this point mainly remains
in micellar form and has far fewer protein molecules to interact
with [43,46]. Finally, at high SDS concentrations, the heat flow
levels out, indicating that the injected SDS remains in a micellar
form and interacts only weakly with the existing protein–SDS
complex.
To estimate the number of surfactant molecules bound to S6
at various stages in this process, we can plot the total SDS
concentrations ([SDS]tot) at these stages against the correspond-
ing protein concentration. Provided that the SDS concentration
is low enough to neglect SDS in bulk micellar form (a safe
assumption when working below 4–5 mM SDS and at protein
concentrations sufficient to bind a substantial amount of SDS),
SDS binding at each peak can be expressed by the mass balance
equation [31]:
SDS½ tot ¼ SDS½ aq þ protein½ ⁎N ð1Þ
where [SDS]aq denotes aqueous (non-bound) SDS and N is the
average number of bound SDS per protein molecule [37]. The
plots for the transition points illustrated in Fig. 2A give satis-
factory linear relationships (Fig. 2B) and the parameters are
summarized in Table 1. At minimum I (interpreted as the bind-
ing of non-denaturing SDS), 8.1±1.6 molecules of SDS bind S6
in the presence of 0.29±0.04 mM free SDS. This corresponds
nicely to the lag region seem from fluorescence titration, sug-
gesting that the SDS molecules bind at different places on S6
without any significant conformational changes. At the end of
the plateau region, an additional 4 molecules have bound, lead-
ing to 0.32 g SDS/g protein which is comparable to the 0.4 g
SDS/g protein reported by Reynolds and Tanford for a number
of proteins just below the cmc [47]. However, at this stage in our
Table 1
Interactions between S6 and SDS in 20 mM Tris pH 8.0 at 22 °C as determined
by isothermal titration calorimetry
Position Slope (SDS molecules
bound per S6)
[SDS]o
(mM)
Slope (cal/
mol/mM S6)
ΔHo
(cal/mol SDS)
Minimum
I
8.1±1.6 0.29±0.04 −12.7±2.4 −43±57
Plateau 12.4±0.1 1.94±0.01 −2.1±0.5 −117±12
Minimum
II
30.56±1.22 3.21±0.03 −4.4±1.3 −66±31
Inflection 36.5±2.6 3.75±0.06 −2.85±0.23 69±6
Fig. 3. Kinetics of unfolding of 2 μM S6 in SDS in 20 mM Tris pH 8 at 25 °C.
Parameters are obtained by fitting the data to the appropriate number of
exponential decays. (A) Rate constants. (B) Relative amplitudes.
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experiments, the free SDS concentration has risen to 1.94 mM
which is still well below cmc. The small increase in the amount
of bound SDS over a fairly wide SDS concentration range may
explain the lack of a discernible signal in this plateau region,
alternatively the SDS molecules bind in a way that does not
elicit a strong enthalpic signal.
31 molecules SDS bind at minimum II, leading to a free SDS
concentration of 3.21 mM SDS. Finally, at binding saturation
(inflection point), 37 molecules of SDS have bound and the free
SDS concentration (cmc) is 3.75 mM. This binding corresponds
to 1.05±0.07 g SDS per gram protein, only slightly lower than
the 1.17 g SDS per gram protein seen for many other proteins
[47]. The binding data are summarized in Table 1.
The enthalpy associated with the four different points also
scales linearly with protein concentration, although data are
slightly more scattered (Fig. 2C and Table 1).
3.3. Multiphasic relaxation phases coincide with hemi-micelle
formation on S6
We can analyse this phenomenon in more detail by following
the kinetics of these conformational changes. Changes in fluo-
rescence caused by simple binding of SDS micelles, and con-
comitant change in the polarity of the Trp environment, should
be virtually instantaneous, while conformational rearrangements
tend to occur on a slower time-scale. Interestingly, at SDS con-
centrations between 0.75 and 1.75 mM, corresponding to the
first conformational change seen in equilibrium titrations, we
observe three conformational changes (Fig. 3A). Of these, the
fast phase with rate constants around 2–8 s−1 and the inter-
mediate phase with rate constants 0.1–0.4 s−1 disappear around
1.75 mM SDS, slightly below the onset of micelle formation.
The slow phase dominates in terms of amplitude (Fig. 3B), and
the log of the slow rate constant increases linearly with in-
creasing [SDS] until it reaches a plateau around 4 mM SDS,
Fig. 4. (A) Pyrene fluorescence (ratio of intensities at 373 and 383 nm) as a
function of SDS concentration in the absence and presence of 2 μM S6 in
20 mM Tris pH 8.0 at 25 °C. Based on the break-point in the curve in the
absence of S6, we estimate the cmc to be around 3.3 mM SDS. (B) Equilibrium
denaturation of 2 μM S6 wildtype (●), LA30 (○) and VA6/LA30 (×) as a
function of SDS monitored using emission at 330 nm in 20 mM Tris pH 8.0 at
25 °C.
Fig. 5. (A) Solubility of 20 μM S6 as a function of SDS at pH 3–11. Solubility
measured as the ratio of the Trp emission intensity of the supernatant (excitation
280 nm, emission 350 nm) before and after centrifugation. Solubility of
lysozyme (lys) at pH 4 also shown. (B) ThT fluorescence of pellets obtained
from panel A (excitation 350 nm, emission 485 nm) by centrifugation and
resuspension in the same volume and same buffer as in (A) but without SDS.
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coinciding with the plateau in equilibrium fluorescence. We
have described its subsequent dependence on SDS concentration
in detail elsewhere [32,33]. Thus kinetics also illuminate a fun-
damental distinction in the behaviour of S6, namely a multi-
phasic change below cmc versus single-step unfolding above the
cmc.
Next we wanted to probe whether SDS remains monomeric
when interacting with S6 below the cmc. It is possible for SDS
to form aggregates termed hemi-micelles on protein surfaces
which provide binding sites for multiple SDS molecules. This
can be investigated using the probe pyrene whose fluorescence
(quantified as the ratio of the two emission bands at 383 and
373 nm) changes in a micellar – as well as a hemi-micellar –
environment [36], making it a useful tool to determine cmc
values. In the absence of protein, pyrene shows a rise in the I3/I1
ratio from ca. 2 mM SDS onwards. However, in the presence of
S6, there is an intermediate rise in the I3/I1 ratio already around
0.6 mM SDS, which only converges with the protein-free
pyrene data around 4 mM SDS (Fig. 4A). This is evidence that
SDS forms organized structures on the S6 surface in the
concentration range 0.5–2 mM SDS, and the formation of these
organized structures leads to multiphasic conformational
changes. Note that since these hemi-micelles only form on the
surface of the protein (they are not observed in the absence of S6
in Fig. 4A), they do not exist as bulk species but form part of the
mass balance described in Eq. (3), and therefore do not violate
the underlying assumption of this equation.
Note that pyrene does not appear to bind to native S6, since
S6 does not lead to any change in the I3/I1 ratio at 0 mM SDS. It
cannot be excluded that pyrene can bind to S6 once it has
undergone conformational changes in the presence of SDS
(giving rise to the increase in the I3/I1 ratio around 0.6 mMSDS),
but we consider this somewhat less likely for several reasons:
First of all, there are already 8–12 SDS molecules bound at this
stage according to ITC, which provide ready binding sites for
pyrene. Secondly, there are no additional changes in the I3/I1
ratio in the region around 1–4 mM SDS, where up to 18 addi-
tional SDS molecules bind, potentially providing new binding
sites for pyrene if it was previously bound to S6.
We then sought to elucidate whether the early stages in the
SDS-S6 interactions were sensitive to protein global stability.
We compared the SDS-titration of S6 wildtype with two de-
stabilized S6 mutants, namely LA30 (the change in free energy
of unfolding compared to wildtype ΔΔGD–N=2.6 kcal/mol
[35]) and the double mutant VA6/LA30 (ΔΔGD–N=5.9 kcal/
mol [48]). All three variants showed very similar titration curves
(Fig. 4B), with even a hint that the first conformational transition
of LA30 occurs at slightly higher SDS concentrations than that
Fig. 6. Equilibrium titration of 2 μM S6 with SDS in 20 mM sodium acetate at (A) pH 5.5 and (C) pH 4. Kinetics of unfolding as a function of SDS concentration in
20 mM sodium acetate at (B) pH 5.5 and (D) pH 4.
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of S6 wildtype. This indicates that the equilibrium binding of
monomeric SDS to S6 is not coupled to global stability.
3.4. Precipitation of S6 by SDS under acidic conditions
SDS–protein interactions are likely to be mediated to a sig-
nificant extent by electrostatic interactions which will be altered
by changes in pH. Upon incubation of S6 with sub-micellar
[SDS] at pH-values below 5, we noticed that the solution be-
came turbid at some concentrations. We systematically analyzed
this by incubating 20 μM S6 with 0–6 mM SDS in the pH range
3.5–11 for an hour. Trp fluorescence was then measured before
and after spinning down insoluble material, leading to solubility
curves (Fig. 5A). These indicated that whereas S6 remains
soluble at all SDS concentrations at pH 6 and above, solubility
decreases to almost 0% at pH 5 between 0.4 and 0.8 mM SDS;
at pH 4.5 and below, solubility is very low between 0.5 and
1 mM SDS, and only recovers to 100% from 5 mM SDS on-
wards. Interestingly, the spun-down pellet gave rise to a sig-
nificant rise in the fluorescence of the fibril-sensitive dye
Thioflavin T (Fig. 5B). This suggested that SDS might be able
to precipitate S6 to orderly aggregates at low pH. The ability of
SDS to precipitate proteins appears to be a general feature, as
we also observe precipitation of all other proteins we have
tested at sub-micellar SDS concentrations at pH 4, including
hemoglobin, hen egg white lysozyme, Acyl Co-A binding pro-
tein and the all-β sheet protein TNfn3 (data not shown).
To investigate the changes at low pH more systematically,
we first carried out equilibrium titrations of S6 at pH 4 and pH
5.5 at a protein concentration where no measurable precipitation
occurs at pH 4 (2 μM). At pH 5.5, we see the same increase in
intensity followed by a decrease as at pH 8; however, the lag
region before the initial rise has essentially disappeared for both
absolute intensity values as well as ratios between 320 and
360 nm (Fig. 6A). Similar behaviour is seen at pH 4 (Fig. 6C),
although the peak region has broadened to span 0.6–2 mM
SDS. In addition, the intensity at pH 4 increases around 8-fold
upon addition of SDS. This reflects the fact that Trp fluo-
rescence is severely quenched in the native state below pH 5
(data not shown). In terms of kinetics, the main change is that
the dominant phase which persists at higher concentrations
remains the fastest phase throughout. At pH 5.5, there is one
dominant relaxation phase which increases linearly with [SDS]
in a log–log plot and then reaches a plateau, while a minor
and slower phase is only observed around 0.25–0.5 mM SDS
(Fig. 6B). This latter phase corresponds to the peak region in the
equilibrium titration, just as at pH 8. At pH 4, two slow phases
are observed only at concentrations up to the end of the peak
(2 mM), above which a very fast phase takes over (Fig. 6D).
3.5. Slow precipitation processes with lag phases at pH 5.5
Thus at low pH we still observe the same general con-
formational changes on the second-to-minute time-scale as at
neutral pH, although there are variations in the nature and
number of phases. To investigate possible slower processes, we
monitored the process in a plate reader where samples were
incubated with shaking at 42 °C over a period of several days. At
pH 4 and 8, we observe up to 50% increase in Trp fluorescence
over a time scale of around 10 h (Fig. 7A). These signal changes
Fig. 7. Plate-reader measurements of S6 emission intensity at 330 nm in
(A) 20 mM Tris pH 8 and (B) 20 mM sodium acetate pH 5.5 at the indicated
SDS concentrations using 100 μMS6 at 42 °C. (C) ThT fluorescence of samples
from the termination of the plate reader assays in (A) and (B). ANS fluorescence
of freshly prepared S6 in 20 mM Tris pH 8 in different concentrations of SDS at
25 °C are also shown.
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only occur within a narrow range of SDS concentrations, corre-
sponding to the concentration range where a large signal change
is seen under equilibrium titrations; at lower and higher SDS
concentrations, there is no development. The data fit well to
single or double exponential functions. Thus the signal changes
monitored by fast reaction kinetics are only the first in a series of
Fig. 8. (A) Electron microscopy images of S6 samples from plate reader in Fig. 6B (20 mM sodium acetate pH 5.5) at (left) 0 and (right) 0.6 mM SDS. No aggregates
were seen at 5 mM SDS. The scale bar represents 100 nm. (B) AFM images of S6 after 7 day s of incubation at 42 °C at (left) 0.4 and (right) 1.5 mM SDS in 20 mM
sodium acetate pH 5.5. The bottom panel shows the height sampled by the green line. (C) SDS-PAGE analysis of proteolytic degradation of 10 μM S6 in 20 mM Tris
pH 8 and 20 mM sodium acetate 5.5 in 1.5 mM SDS (30 min at 25 °C), using the protease Alcalase (10 nM). “C” is undegraded S6.
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rearrangements at low concentrations. However, at pH 5.5, a
more unusual development is observed between 0.2 and 0.6 mM
SDS, in which there is a lag phase of 20–40 h before the signal
decreases to a plateau level of around 40% of the original value
(Fig. 7B). This time course is similar to that observed for many
proteins undergoing fibrillation and has also been observed for
S6 fibrillating at pH 2 [13]. However, there are some differences
compared to the conventional fibrillation time profiles. Firstly,
when Thioflavin Twas added at the end of the reaction, the ThT
fluorescence peaked around 1 mM SDS and was quite low at the
SDS concentrations where the lag phase was observed (Fig. 7C).
Furthermore, when the fibril-specific dye Congo Red was added
at the end of the reaction, it failed to undergo the spectral band-
shift characteristic of the fibril-bound state. In contrast, the
hydrophobic probe ANS binds with particular affinity to S6
between 0.2 and 0.8 mM SDS even without prior long-term
incubation of S6 with SDS (Fig. 7C).
We next sought to analyze the structure of the aggregates
formed in this way. At pH 5.5, electron microscopy pictures
reveal no persistent aggregate structure at 0 and 5mMSDS but at
0.6mMSDSwe observe a few cases of ordered structures similar
to fibrils (Fig. 8A), although we did not find many examples and
the putative fibrils were difficult to visualize clearly. Atomic
force microscopy reveals a compact but non-fibrillar state at
0.4 mM SDS and only scattered aggregates at 1.5 mM (Fig. 8B)
(these states were observed consistently and were not observed
in the absence of SDS). At both pH 4 and 5.5, Fourier transform
infrared spectroscopy of the pelleted aggregates formed at
different time points revealed only minor changes in overall
secondary structure at different SDS concentrations and as a
function of time compared to the native state (data not shown).
Thus the aggregates formed by low concentrations of SDS do not
appear to contain elevated amounts of β-sheet structure
compared to the SDS-free samples. In addition, under all long-
time runs, the ratio between emission at 330 and 355 nm remains
constant, unlike the case for S6 fibrillation at pH 2, where the
ratio increases from 1 to around 1.6 [13].
To compare the flexibility of the structures of S6 at pH 5.5 and
8.0, populated at the onset of the reaction prior to aggregation,
we subjected S6 to limited proteolysis at both pH-values in
1.5 mM SDS using the SDS-robust protease Alcalase which is
able to cleave after essentially all amino acids, although it shows
a preference for hydrophobic amino acids. SDS-PAGE revealed
in both cases the formation of a band migrating just below the
intact protein (Fig. 8C), which N-terminal sequencing revealed
to consist of the sequence 8/9–101 (middle of the first β-strand).
The complementary peptide (1–7/8) was too small to be detec-
ted on the gel. At pH 8, an additional band, corresponding to
a molecular weight around 6 kDa on the SDS gel, was observed
with an N-terminus at position 38 and 39 in β-strand 2, (the
complementary sequence 1–38/39 was not observed as it was
presumably rapidly degraded). At pH 5.5, a major band around
6 kDa and a very faint band around 3 kDa were observed, with
N-termini at residue 43 (β-strand 2) and 76 (middle of α-helix
2). This suggests that low concentrations of SDS at both pH-
values renders regions of β-sheet 1 and 2 more flexible; at pH
5.5, the region around α-helix 2 also becomes more flexible.
It thus appears that S6 assumes a partially folded state at very
low SDS concentrations, which makes it particularly prone to
subsequent aggregation, but no significant structural changes
occur at the monomer level during the aggregation process.
3.6. Side-chain sensitivity and seeding ability of S6 aggregates
The lack of evidence for well-defined fibrillar structuresmight
be taken to indicate that the aggregates formed at intermediate
SDS concentrations lacked specific interactions between pro-
teins. To investigate this further, we monitored the aggregation
kinetics of 11 different S6mutants over longer time scales using a
plate reader. Of these, 7 show the characteristic lag phase-de-
crease in fluorescence; all do so only at pH 5.5 (not at pH 5 and to
amuch less pronounced extent at pH 6) and in a relatively narrow
SDS interval. However, the range of the SDS interval varies quite
considerably among the mutants (Table 2), spanning the whole
range of 0.4–2 mM for the mutant IA8 and only occurring at a
Table 2
SDS concentrations at pH 5.5 at which lag phase aggregation is observed for
different S6 mutants and their associated lag times (in minutes) a, b
[SDS]→ 0.2 mM 0.4 mM 0.6 mM 0.8 mM 1 mM 1.5 mM 2 mM
Mutant↓
IA8 – 550 2800 ND 3300 3950 4000
FA60 350 1560 3700 – – – –
Wildtype 1275 2030 ND 2600 – – –
LA19 – – – – – 2150 –
LA52 750 – – – – – –
VA9 150 – – – – – –
VA90 – – – 2150 – – –
IA26 125 – – – – – –
–: no lag phase observed; ND: not determined.
a All experiments in 20 mM NaOAc pH 5.5 and 42 °C using 100 μM protein.
Lag times (in minutes) determined as described in Materials and Methods.
Standard deviations (from duplicates) 20–30%.
b No lag times observed at any SDS concentration for the mutants LA21,
VA65,VA37 and IA25.
Fig. 9. Plate-reader assay of the seeding of IA8 S6 in 1.5 mM SDS using 1–10%
IA8 aggregate from a previous aggregation reaction in 20 mM sodium acetate
pH 5.5 at 42 °C. Insert: Lag time of fibrillation as a function of aggregate
concentration.
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single measured concentration for several other mutants. The
breadth of the SDS interval does not correlate with the lag time,
however, suggesting that aggregation versatility and rapidity of
aggregation are different phenomena.
A classical test of the specificity of an aggregation reaction is
the ability to seed the reaction by the addition of small amounts
of pre-formed aggregates. We see a reduction in aggregation lag
time by around 25% when as little as 1% aggregate is added
(Fig. 9), although no further effect is observed at higher con-
centrations (Fig. 9 insert).
4. Discussion
4.1. Three different sub-micellar concentration regimes with
different modes of protein–SDS interactions
The purpose of this study was to obtain a better under-
standing of the ability of sub-micellar SDS to stimulate protein
aggregation, previously reported for only a small number of
proteins. At the very onset, it is obvious from our data that there
is a rich complexity of interactions between S6 and SDS at sub-
micellar concentrations. Over time scales spanning seconds to
hours, we observe a number of transitions involving changes in
conformation and levels of association. These interactions vary
significantly as a function of SDS concentration. We can divide
the observations into at least 3 concentration regimes:
4.2. Regime 1: Below 0.2 mM SDS
In this range, we observe no binding or conformational
changes according to either fluorescence or CD. ITC data in-
dicate that 8 molecules of SDS bind in this concentration region,
but clearly this is not sufficient to cause detectable conforma-
tional changes. This suggests that the monomers bind separately
and loosely on the S6 surface.
4.3. Regime 2: 0.2–2 mM
This region, which is still below the cmc, is the richest in
terms of conformational changes. Although the total number of
bound SDS molecules only rises to 12 (ITC data, Table 1), our
pyrene experiments (Fig. 4A) suggest that they undergo a
significant rearrangement to form hemi-micellar aggregates on
the protein surface. The total number of aggregated molecules
of SDS on BSA increases from 29 to 82 between 17 and
105 mM [49], and in view of of the 6-fold larger size of BSA
compared to S6, it would seem quite plausible to have 12
molecules of SDS aggregated on S6. Binding of this number of
SDSmolecules is sufficient to cause significant changes in both
secondary (CD) and tertiary (fluorescence) structure (Fig. 1).
As shown in Fig. 7C, the ensuing state is sufficiently flexible
over a wide pH-range to bind the probe ANS (or to allow ANS
to insert into the hemi-micellar aggregate). The population is
probably quite heterogeneous and fluctuating, since absolute
fluorescence intensities do not coincide exactly with fluores-
cence intensity ratios (Fig. 1A). Several mechanistic steps are
involved in this change. On the second scale, 2–3 phases are
observed (Fig. 3), while even slower phases can be seen over
several hours (Fig. 7A). For these very slow phases, there is no
change in the ratio of the emission intensities at 330 and
350 nm, suggesting that only subtle changes in conformation or
association occur. The main changes are related to protein
solubility. Above pH 5.5, these slow phases do not lead to
visible aggregation and are characterized by a (relatively small)
increase in fluorescence (Fig. 5A). Only a small amount of
aggregate is formed, leading to a slight increase in thioflavin T
fluorescence. In contrast, at pH 5.0–5.5 over a narrow con-
centration range (0.2–0.6 mM SDS), a time profile with a
characteristic lag phase is observed (Fig. 7B), leading to states
which can be spun down and lead to a significant increase in
thioflavin T fluorescence (Fig. 7C). The single slow second-
scale phase observed around pH 5.5 by stopped-flow kinetics
(Fig. 6A) would appear to be a prerequisite for this aggregation,
since both phases are only seen over a narrow concentration
range. Interestingly, at pH 8.0, two slow second-scale phases
are observed by stopped-flow kinetics in the very same con-
centration range (0.8–2 mM SDS) where the hour-scale increase
in fluorescence occurs. This suggests these two pairs of phases
are also linked mechanistically, although they must differ
qualitatively from the reactions at pH 5.5 where there is a
decrease in fluorescence in the same time-scale phase. Below pH
5.0, precipitation happens much faster and is only observed on
the hour-scale at SDS concentrations that are either low or close
to the cmc. Thus SDS can propel S6 in a number of different
conformational directions, depending on pH and concentration.
Limited proteolysis data suggest that S6 partially unfolds in
the β-sheet region around strands 1 and 2 at both pH-values
(Fig. 8C); in addition, the region around the C-terminal helix is
rendered more flexible at pH 5.5. The added unfolding in this
region may be the basis for the increased aggregation propensity.
We have in a previous study identified regions of S6 which
appear to be the first sites of unfolding in the presence of low
(mode 1) and high (mode 2) concentrations of SDS micelles at
pH 8.0 [33]. Interestingly, the region around strand 1 is targeted
by SDS in both modes while the C-terminal helix only becomes
exposed to SDS in mode 2, leading to rapid unfolding [33]. This
suggests that the C-terminal helix is an important determinant of
structural integrity in an amphiphilic environment.
4.4. Regime 3: Ca. 2–5 mM
This is a straight-forward transition to the micelle-unfolded
state, accompanied by the binding of a large number of SDS
molecules, leading eventually to 36 SDS molecules per S6
molecule. We observe an overall decrease in equilibrium fluo-
rescence which stabilizes at plateau level before the cmc is
reached (Fig. 1A). The kinetics are simple, since only a single
fast relaxation phase is seen, without any further changes over
longer time scales and no aggregation occurring (Fig. 3A).
In all cases, these transitions are uncoupled from the con-
formational stability of S6 measured in the absence of SDS
(Fig. 3B). Thus the SDS-induced conformational changes are
not coupled to the intrinsic stability of the protein but involve
specific ligand-type interactions.
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4.5. Ability to precipitate protein requires titration of acidic
residues
SDS is known to precipitate proteins under certain con-
ditions, although the basis for this has not been discussed in
detail. At pH 3.3 and 90 μM protein, completely soluble SDS-
lysozyme complexes are only formed above 5 mM SDS, i.e. an
SDS:protein molar ratio of 60 [50,51]. This corresponds to an
SDS concentration of ca. 1.2 mM in the presence of 20 μM
protein (the protein concentration used in our studies). At
20 μM protein and pH 4.0, we see full resolubilization of
lysozyme at 2.5 mM SDS (Fig. 5A), in good agreement with
this report. Under the same conditions, complete solubilization
of S6 is achieved at a slightly higher concentration (5 mM
SDS). At pH 4.5 and below, precipitation happens over a re-
latively broad range (0.5–5 mM SDS), while it is not detectable
at pH 6 and above. The pH region 5–6 thus forms a transition
region. What is the basis for this precipitation? S6 has an ex-
perimentally determined isoelectric point around 6.5 [32], but
other proteins with much higher pI values (e.g. lysozyme, pI
10.8) also precipitate below pH 5, excluding a simple iso-
electric effect. We have previously reported that the kinetics of
unfolding of S6 titrates strongly with pH, increasing 100-fold
as we decrease pH from 8 to 5 with an apparent pKa of around
5.5 [32]. We attributed this effect to the titration of the acidic
residues Asp and Glu, whose pKa values will be increased in the
apolar environment provided by the SDS alkyl side chains. In
the absence of acidic side chains, this pH-dependence dis-
appears; for example, the anti-microbial peptide Novispirin
which only has a C-terminal carboxyl group to offset 4 Lys and
3 Arg, is precipitated by SDS at neutral pH [25]. Although our
solubility experiments on S6 were conducted below cmc and
thus at most in the presence of hemi-micelles rather than mi-
celles proper, the effect on the pKa of Asp and Glu are most
likely similar. We therefore consider it likely that the elec-
trostatic repulsion of SDS by deprotonated side chains limits
the ability of SDS to bind to the protein. Once this can be
overcome at sufficiently low pH-values, SDS can bind to the
cationic regions and presumably act as a charge neutralizer that
allows protein monomers to attach to each other.
4.6. Submicellar SDS induces aggregates but not fibrils in S6
The question now is what kind of aggregates is formed. They
possess some of the characteristics of fibrils, increasing the
fluorescence of Thioflavin T and forming with a characteristic
lag phase. Furthermore, pre-formed aggregates can to some ex-
tent accelerate the process for a new batch when added as seeds.
The aggregates probably possess some degree of side-chain
specificity, since different S6 mutants show considerable dif-
ferences in their lag phase behaviour. Side-chain sensitivity is
even more marked for bona fide fibrils of S6 formed at low pH,
and mark out a contiguous region which we have suggested to
be a flexible domain that is central to the fibrillation process
[13]. However, for SDS-induced aggregation, mutant data are
somewhat more scattered and do not identify a specific region in
the protein. In fact the SDS-induced aggregate is unlikely to be a
proper fibril for a number of reasons. Firstly, the increase in
Thioflavin T fluorescence is fairly low (Fig. 5B), contrasting
with the many orders of magnitude increase that e.g. glucagons
fibrils can elicit [52]. Secondly, there is no shift in the Congo
Red shift. Thirdly, EM and AFM data do not reveal needle-
shaped fibril structures (Fig. 8), although the aggregates have a
certain degree of regular order. Finally, the FTIR data do not
indicate any overall change in secondary structure in the
presence of SDS, with little increase in β-sheet signal. So what
kind of aggregates has been formed? S6 already possesses
extensive β-sheet structure (4 β-sheets as well as 2 α-helices)
which could presumably engage in intermolecular contacts. We
have persuaded S6 to form tetramers which interface via ap-
propriate mutations in the outward β-strand [53], and it is
possible that this can also be exploited by SDS. It is tempting to
speculate that such contacts could be further consolidated by
hemi-aggregates on different S6 molecules linking up to form
micellar structures with alkyl chains facing away from the S6
surface and bridging S6 molecules.
Just as the engineered tetramer represented an association
that was trapped at an early stage, it could be imagined that the
aggregates represent structures that are trapped at intermediate
concentrations en route to the actual fibril, because they lack
sufficient conformational flexibility to undergo the major struc-
tural changes needed to fibrillate. Trapping could occur at se-
veral levels. Thus the precipitates at pH 5.5 that lead to the
highest ThT signal (around 1.5 mM SDS, which we term Agg2)
show less organized structure than those formed around 0.4–
0.6 mM SDS (and which have a lag phase, termed Agg1). It is
possible that Agg1 represents a more structured aggregate than
Agg2 which is nevertheless trapped in a pre-fibrillar structure or
which will rearrange to fibrils over longer time scales than
tested in the present study. There is precedence for such semi-
trapped states: Aβ makes a transition from quasi-amorphous to
fibrillar structure over 4 days in the presence of 2 mM SDS. For
β2-microglobulin, agitation-induced amorphous aggregates are
an important early step in the aggregation process [54–56].
Incomplete conversion to β-sheet conversion has also been
reported for the synthetic insulin variant miniproinsulin [57]
which aggregates to non-fibrillar structures, but also shows
seeding ability. Unlike human insulin fibrils, MPI shows less
than 2-fold increase in ThT fluorescence and also very low ANS
binding. Thus it has certain elements in common with SDS-
aggregated S6.
In summary, it is notable that we observe a significant change
in the properties of the states formed at the very low SDS versus
cmc-level concentrations. It is possible that the state formed at
very low concentrations is sufficiently “poised” towards flexi-
bility, yet not blocked too much by bound SDS, to allow it to
aggregate through slow conformational changes. Despite the
unphysiological nature of SDS, the richness of the conforma-
tional changes induced in S6 by this molecule over a narrow
range of concentration and pH suggests that its cellular equi-
valents such as free fatty acids may exert considerably influence
on protein aggregation behaviour. In this sense, the SDS-bound
state could be a model for other slowly aggregating protein
species in the cellular cytosol.
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ABSTRACT: Alcohols modulate the oligomerization of membrane proteins in lipid bilayers. This can occur
indirectly by redistributing lateral membrane pressure in a manner which correlates with alcohol
hydrophobicity. Here we investigate the direct impact of different alcohol-water mixtures on membrane
protein stability and solubility, using the two detergent-solubilized R-helical membrane proteins DsbB
and NhaA. Both proteins precipitate extensively at intermediate concentrations of alcohols, forming states
with extensive (40-60%) -sheet structure and affinity for the fibril-specific dye thioflavin T, although
atomic force microscopy images reveal layer-like and spherical deposits, possibly early stages in a fibrillation
process trapped by strong hydrophobic contacts. At higher alcohol concentrations, both DsbB and NhaA
are resolubilized and form non-native structures with increased (DsbB) or decreased (NhaA) helicity
compared to the native state. The alternative conformational states cannot be returned to the functional
native state upon dilution of alcohol. The efficiency of precipitation and the degree to which DsbB is
destabilized at low alcohol concentrations show the same correlation with alcohol hydrophobicity. Thus,
in addition to their effect on the membrane, alcohols perturb membrane proteins directly by solvating the
hydrophobic regions of the protein. At intermediate concentrations, this perturbation exposes hydrophobic
segments but does not provide sufficient solvation to avoid intermolecular association. Resolubilization
requires a reduction in the relative dielectric constant below 65 in conjunction with specific properties of
the individual alcohols. We conclude that alcohols provide access to a diversity of conformations for
membrane proteins but are not a priori suitable for solution studies requiring reversible denaturation of
monomeric proteins.
To remain soluble in the native state, membrane proteins
(MPs)1 need an amphiphilic environment, which can be
provided by detergents or lipids. R-Helical MPs typically
contain long consecutive sequences of hydrophobic amino
acids in the transmembrane segments that allow the helices
to dock against each other, stabilized through van der Waals
interactions (1-3). -Barrel MPs are made up of alternating
hydrophilic-hydrophobic sequences that alternatively point
into the protein interior and out toward the hydrophobic
environment (4). As a consequence, it is actually possible
to solubilize -barrel membrane proteins in high concentra-
tions of chemical denaturants such as guanidinium chloride
and urea (5-7), where they remain in an extensively
unfolded state. In contrast, R-helical MPs generally resist
this treatment and are most commonly denatured in SDS (8-
11), in which they retain significant amounts of residual
helical structure. Thus refolding of -barrel MPs can be
followed by diluting the protein from high concentrations
of denaturant into lipids or detergents (6), whereas R-helical
MPs are typically refolded from SDS. The SDS-denatured
state of many water-soluble proteins has been the subject of
numerous structural studies (12-15) and appears to consist
of isolated detergent-decorated helices joined by more
flexible regions. A quantitative way to reversibly denature
membrane proteins is to add increasing amounts of SDS in
the presence of a constant concentration of a nonionic
detergent such as dodecyl maltoside (DM) (9, 10). There
appears to be an empirical linear relationship between the
SDS mole fraction and the log of the refolding and unfolding
rates (11, 16). This relationship also extends to thermal
stability, provided account is taken of the micellar rather than
bulk composition of detergent (17).
The SDS-denatured state retains significant residual struc-
ture (11, 18). This may be analogous to the structure of
nascent membrane proteins prior to lipid insertion (19).
Nevertheless, recent reports indicating that this state may
have native-like compaction (20) have led to the suggestion
that the action of SDS may just as well be modeled by simple
ligand binding rather than unfolding (21). This makes it
relevant to look for alternative means of denaturation of
membrane proteins.
One possibility is provided by alcohols, which are am-
phiphilic and contain a hydrophilic headgroup as well as a
hydrophobic segment of varying lengths. Alcohols’ denatur-
ing action toward soluble proteins (22, 23) is related to their
reduction of the relative solvent dielectric constant εr, which
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may mimic conditions near the membrane surface (24-26).
Increasing the alcohol concentration generally leads to a
uniform increase in R-helicity (24, 27-30). The reason for
this is not entirely clear (31), although the lowered εr could
conceivably strengthen internal hydrogen bonds which can
be formed by isolated sequences in the R-helical conforma-
tion. However, trifluoroethanol can also induce the ac-
cumulation of -sheet-rich aggregation-prone structures at
intermediate (20-40%) concentrations and only induce
R-helix structures at higher concentrations (32). As a further
testimony to the versatility of alcoholic conformational
switches, methanol but not longer chain alcohols has very
recently been reported to induce -sheet structure in an all-
R-helix protein (33).
This then leads to the interesting question of whether
alcohols can be used to reversibly denature membrane
proteins for subsequent folding studies. The environment of
the membrane protein stabilizing the native state can play a
role in the protein’s response to alcohols. Previous studies
on the Streptomyces liVidans potassium channel KcsA have
shown that the stability of the tetramer in lipids is reduced
by molar concentrations of alcohols in an indirect manner
which can be related to their ability to alter the lateral
membrane pressure and permeabilize the membrane (34, 35).
When KcsA is dissolved in detergents and TFE subsequently
added, a partially and reversibly unfolded monomeric state
is formed at intermediate TFE concentrations, but at higher
TFE concentrations this state converts into an irreversibly
denatured form (36). KcsA is an unusually stable R-helical
MP which resists denaturation in SDS, making it possible
to monitor its state of oligomerization on SDS-PAGE.
Extrapolating on this, a recent study combines 2D gel
electrophoresis with exposure to TFE or HFIP (hexafluor-
oisopropyl alcohol) to identify stable oligomeric membrane
protein complexes, based on the criterion that they withstand
exposure to SDS and only dissociate in alcohols (37). The
quoted studies have focused on oligomeric proteins, and
while many membrane proteins are found integrated into
complexes, a significant number are monomeric. We would
like to address the question how monomeric membrane
proteins respond to alcohols, more specifically whether they
can be unfolded to the same or greater extent by alcohols
such as TFE and how reversible this behavior is.
Here we study the response of two R-helical membrane
proteins to alcohols, namely, the four-transmembrane helix
176-residue disulfide-exchanging protein DsbB and the 388-
residue sodium-hydrogen antiporter NhaA (38), both from
the inner membrane of Escherichia coli. Both proteins can
be unfolded in SDS (39), and in the case of DsbB, the protein
can be reversibly folded into DM micelles as monitored by
stopped-flow kinetics (11, 16). We report that incubation with
alcohols generally leads to precipitation at intermediate
concentrations and the formation of a -rich structure, which
at higher concentrations is replaced by a soluble state with
altered secondary structure. Both processes are irreversible,
precluding the use of this approach for renaturation studies.
The alcohols’ ability to precipitate proteins, as well as their
destabilizing properties at very low concentrations, is directly
related to their hydrophobicity. We conclude that alcohols
affect intrinsic membrane protein properties as well as
exerting an effect via the membrane.
MATERIALS AND METHODS
DsbB (11), DsbA (40), NhaA (39), and AIDA (41) were
purified as described. The buffer used in all experiments was
25 mM Tris, pH 8, and 0.1 M NaCl. This buffer, including
different concentrations of detergent, was completely mis-
cible with all of the alcohols analyzed in this study within
the concentration range probed; turbidity was only observed
above 40% (v/v) HFIP, 55% TFE, or 75% isopropyl alcohol.
Note that the alcohols are expected to alter the pKa of Tris
by little more than 0.1 pH unit (cf. ref 42). Given that DsbB
retains full solubility in detergent over the pH range 3-10
and has unaltered stability over the pH range 8.5-6.5 (data
not shown), these small changes in pKa will not affect
solubility or stability by themselves.
Equilibrium Denaturation Experiments. DsbB or NhaA
(1.8 μM) was incubated in buffer with 5 mM DM (unless
otherwise indicated) and varying concentrations of alcohol
in a total volume of 150 μL. Following at least 30 min
incubation at room temperature, the solution was centrifuged
for 10 min at 14000 rpm and the fluorescence of the
supernatant measured by excitation at 295 nm and emission
between 310 and 400 nm with slit widths of 8 nm for both
excitation and emission, using a LS55 fluorometer (Perkin-
Elmer, Wellesley, MA). By using Trp fluorescence for these
measurements, we were able to monitor conformational
changes in addition to changes in solubility, as well as taking
advantage of the superior sensitivity of fluorescence com-
pared to absorbance.
Circular Dichroism. Typically 5 μM protein was incubated
in buffer with 5 mM DM and different concentrations of
TFE. Circular dichroism spectra were recorded between 195
and 250 nm on a J-810 spectrometer (Jasco Spectroscopic
Co. Ltd., Hachioji City, Japan) after at least 30 min of
incubation using 1 mm cuvettes and an accumulation of three
scans recorded at 20 nm/min with 1 nm bandwidth.
Thermal Scans by CD. These were performed with 5-
10 μM protein as described (16), following the change at
ellipticity at 220 nm as a function of temperature in the
presence of different concentrations of alcohols at a con-
centration range where precipitation did not occur to a
significant extent.
Stopped-Flow Kinetics. DsbB in 5 mM DM and buffer
was mixed 1:10 with TFE to a final concentration of 2.1
μM DsbB, 5 mM DM, and 20% TFE on an SX18MV
stopped-flow microanalyzer (Applied Photophysics, Surrey,
Leatherhead, U.K.) at 25 °C. The reaction was followed by
exciting at 280 nm and measuring emission above 320 nm
using a glass cutoff filter.
DsbB ActiVity Assays. These were performed essentially
as described (40, 43). Typically, 1 μM DsbB was mixed with
10 μM reduced DsbA (from a 167 μM stock where the
Cys49-Cys52 bond was reduced in the presence of 10 mM
DTT, desalted to remove excess DTT, and stored at
-80 °C in 1 mM EDTA to avoid reoxidation) and 30 μM
decylubiquinone (from a 0.1 M stock in DMSO) in 300 mM
NaCl and 50 mM sodium phosphate, pH 6. Emission was
followed at 360 nm with excitation at 295 nm over 1 min.
The linear decline in emission, caused by the formation of
the Cys49-Cys52 disulfide bond in DsbA by the disulfide
bonds in DsbB (40), was used as a quantitative measure of
DsbB activity.
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ThioflaVin T Fluorescence. Following incubation with
alcohols as described above, the solution was centrifuged
for 10 min at 14000 rpm, the supernatant was removed by
aspiration, and the pellet was resuspended in 120 μL of buffer
containing 40 μM thioflavin T. Fluorescence was measured
by excitation at 440 nm and emission at 385 nm using slits
of 8 nm.
FTIR Data Acquisition. Spectra were recorded on a Bruker
Tensor 27 infrared spectrometer (Bruker Optik GmbH,
Ettlingen, Germany) with a Specac Golden Gate single-
reflection ATR unit (Specac Ltd., Orpington, U.K.). Fol-
lowing incubation with alcohols as described above (40%
for MeOH and EtOH, 30% for iPrOH, and 20% for TFE
and PrOH), the solution was centrifuged for 10 min at
14000 rpm, the supernatant was removed by aspiration, and
the pellet was resuspended in MilliQ water. Protein (2 μg)
was dried under a gentle stream of nitrogen. Three indepen-
dent samples were investigated (64 scans at 2 cm-1 resolu-
tion). One spectrum was collected for TFE. When necessary,
we corrected for the presence of water vapor by subtracting
a fresh water vapor spectrum. Peaks were assigned from the
second derivative and deconvolution of spectra. The non-
deconvoluted spectra were fitted using the Levenberg-
Maquardt method to seven Lorentzian peaks, of which six
were assigned to secondary structure elements and one low-
intensity peak was assigned to contributions from side chains.
Atomic Force Microscopy. NhaA (5.4 μM) was incubated
for 30 min in buffer with 2.8M TFE before centrifugation.
The supernatant was removed by aspiration and the pellet
washed twice in water. Protein (100 μL of 0.5 μM) was
applied to freshly cleaved mica in a sample chamber, dried
in an oven at 80 °C (typically 2-3 min), and removed from
the oven as soon as the sample had dried. The elevated
temperature was required to enable rapid drying and avoid
leakage from the sample chamber. This handling does not
appear to destroy, e.g., protein fibrils since it allows us to
image fibrils of R-synuclein (data not shown). Samples were
imaged in contact mode on a PicoSPMI apparatus (Molecular
Imaging, Tempe, AZ) using silicon nitride cantilevers
(BudgetSensors, Sofia, Bulgaria) with a force constant of
0.27 N/m.
RESULTS
Our initial interest was to analyze whether it was possible
to reversibly and cooperatively denature DsbB in the
fluorinated alcohol TFE to provide an alternative denaturation
method. This would facilitate refolding experiments to
compare with refolding from the SDS-denatured state, which
is highly structured and contains approximately the same
level of R-helicity as the state in DM (11).
DsbB Undergoes a Two-Step IrreVersible Spectroscopic
Change in the Presence of Increasing Concentrations of TFE,
InVolVing Precipitation Followed by Resolubilization. A
useful signature for cooperativity is a sigmoidal unfolding
curve over a relatively narrow denaturant concentration
interval [although sigmoidal unfolding curves can also be
obtained from cooperatively and strongly binding ligands
(21)]. We had failed to observe such cooperative unfolding
of DsbB and NhaA when exposed to chemical denaturants
in the presence of 5 mM DM. A linear decrease in the ratio
of the Trp fluorescence emission at 335 and 350 nm was
observed in response to increasing concentrations of guani-
dinium chloride (0-7 M) and urea (0-9 M) (data not
shown). The ratio between these two wavelengths is often
taken as a measure of the unfolding of a protein, since
unfolding usually leads to a red shift of the emission
spectrum (44).
We therefore turned to alcohols for denaturation. However,
when DsbB was incubated with 0-55% TFE, we saw visible
cloudiness over a relatively broad concentration interval.
Upon centrifugation, sedimented pellets were observed
predominantly around 10-35% TFE. The fluorescence of
the supernatants showed a characteristic pattern: the intensity
level remained unchanged up to 3% TFE, after which it
plunged to around 25% of the original level as the TFE
concentration was increased to 12%. The fluorescence
remained at a low level up to around 30% TFE and then
slowly increased to a level close to two-thirds of the original
(Figure 1A). In parallel with this, the 335/350 nm emission
ratio remained relatively constant around 1.1 to around 20%
TFE, after which it fell to a new level around 0.95 where it
remained as the TFE concentration increased to 50%.
The low concentration of DsbB made it unfeasible to use
absorption at 280 nm as a measure of solubility. In order to
obtain a more direct measure of the solubility of DsbB, we
instead measured the ratio of the fluorescence of each sample
before and after centrifugation and obtained a profile which
was very similar to that of the absolute fluorescence
spectrum, except that some lack of solubility was already
observed at low concentrations of alcohol and the solubility
at high alcohol concentrations reached close to 100%
(Figure 1B). For the subsequent analysis, we will use the
unprocessed fluorescence emission values for the supernatant
rather than the ratio between the solution emission before
and after centrifugation, due to problems with light scattering
in the presence of suspended precipitates.
As might be expected, the presence of detergents has a
significant impact on the ability of TFE to precipitate the
protein. If the concentration of DM is decreased from 5 to
1 mM, the midpoint of precipitation is lowered by a factor
of at least 2, while replacing DM with SDS increases the
midpoint around 3-fold (data not shown). Nevertheless, the
same profile involving precipitation and resolubilization was
observed under all circumstances. In the following experi-
ments, we kept the DM concentration constant at 5 mM to
allow comparison between different alcohols.
CD spectra showed the expected typical R-helical structure
in the absence of TFE, but at 20% TFE this is replaced by
an essentially featureless spectrum due to extensive precipi-
tation, while the spectrum in 50% TFE (where the solution
is visibly clear and precipitation is insignificant; cf.
Figure 1B) reveals a state with even higher R-helicity than
the native state (insert to Figure 1A). Analysis of the CD
spectra by the k2d algorithm (45) predicts an R-helix content
of 59% (ca. 104 residues) in 0% TFE and 85% (ca. 150
residues) in the presence of 50% TFE, corresponding to an
increase in helicity encompassing 46 residues. The trans-
membrane helices are modeled to consist of ca. 80 residues
(46), accounting for the majority of the native state helicity.
As the two cytoplasmic termini account for only around 25
residues, the increased helicity is most likely to reflect an
increase in helicity in the two periplasmic loops as the protein
goes from 0 to 50% TFE. We have in a recent thermody-
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FIGURE 1: (A) Emission at 335 nm and the ratio of emission at 335 and 350 nm for DsbB incubated in different concentrations of TFE.
After incubation in TFE for 30 min, the protein solution was spun down and the emission of the supernatant measured. Insert: Far-UV CD
spectra of DsbB in the presence of 0-50% TFE. (B) Solubility of DsbB and NhaA at different TFE concentrations. The apparent fluorescence
emission at 335 nm of the solution was measured before and after centrifugation. Light scattering due to aggregates contributes to emission
before but not after centrifugation. (C) Emission of DsbB at 335 nm as a function of different alcohol concentrations. (D) Midpoint of
precipitation [Ppt]50% for DsbB and NhaA versus alcohol hydrophobicity plotted on a semilogarithmic scale (data for HFIP excluded from
the fit). The slopes of the fitted straight lines are -1.53 ( 0.15 (DsbB) and -1.58 ( 0.05 (NhaA). Insert: [Ppt]50% versus midpoint of
resolubilization for DsbB. (E) Ratio of emission at 335 and 350 nm for DsbB incubated at different concentrations of alcohols. (F) Data
in (C) plotted versus relative dielectric constant εr rather than alcohol concentration. Concentrations were converted to εr values based on
data in ref 48.
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namic study concluded by indirect means that residues in
the periplasmic loop in the native state are essentially
unstructured (16), which ties in well with these observations.
The helically enriched species observed in 50% TFE
represents a trapped state. If DsbB is transferred from 0 to
4.5% TFE, the protein retains around 80% of its biological
activity, i.e., its ability to oxidize the periplasmic chaperone
DsbA (see Materials and Methods). This agrees well with
its solubility level in 4.5% TFE (Figure 1B). However,
transfer from 50% to 4.5% TFE does not restore activity or
the original low-TFE CD spectrum with reduced R-helix
signals. As expected from the extensive precipitation, no
activity was observed in 20% TFE.
On the basis of these observations, it appears that DsbB
is not structurally perturbed by TFE until around 3% TFE,
after which it starts to precipitate significantly. The soluble
state present to a decreasing extent between 3% and 20%
TFE appears to be native-like judged by the rather crude
measure of the 335/350 nm ratio, but at higher TFE
concentrations this is replaced by a state which according
to both CD and 335/350 nm is soluble but irreversibly
denatured to a non-native state, similar to the membrane
protein KcsA (36).
Correlation between Hydrophobicity and Precipitation.
The precipitation at intermediate TFE concentrations had not
been observed for KcsA. We therefore decided to character-
ize the precipitation behavior in more detail, focusing on
(a) the role of general hydrophobicity in precipitating DsbB,
(b) the nature of the precipitated state, (c) the mechanism of
precipitation, and (d) the generality of this behavior.
We repeated the titration of DsbB using the alcohols
methanol (MeOH), ethanol (EtOH), n-propyl alcohol (PrOH),
isopropyl alcohol (iPrOH), and hexafluoroisopropyl alcohol
(HFIP) (listed according to increasing hydrophobicity). In
all cases, we saw a characteristic decrease in supernatant
fluorescence at relatively low alcohol concentrations. Except
for MeOH, which is the least hydrophobic of all the solvents
tested, this was always followed by a rise in fluorescence to
levels approaching (or in PrOH’s case exceeding) that of
the native state (Figure 1C). Let us define [Ppt]50% as the
alcohol concentration at which the protein is halfway to the
minimal fluorescence level starting from the alcohol-free
level; this value can be obtained for each alcohol by
simple interpolation. Provided we exclude data for HFIP,
Figure 1D shows a clear linear relationship between log
[Ppt]50% and alcohol hydrophobicity [defined by their par-
titioning between water and octanol (47)]. This is similar to
the observations made for membrane-embedded KcsA (34).
However, the slope of the plot for DsbB (-1.53 ( 0.15) is
significantly higher than that seen for KcsA using the same
hydrophobicity values (slope estimated by us to be around
-0.67) (34).
Let us similarly define [resolubilization]50% as the alcohol
concentration where the protein is halfway to the highest
fluorescence level attained at high alcohol concentration. If
the interactions responsible for precipitation and resolubili-
zation are similar in nature, we would expect this parameter
to correlate with [Ppt]50%. There is a reasonable linear
relationship between the two 50% values (Figure 1D insert),
although this may not be significant as the points cluster in
one group with a single outlier. The variation in the 335/
350 nm ratio with alcohol concentration (Figure 1E) shows
a strong correlation with the fluorescence emission intensi-
ties: the ratio stays constant until the protein starts to
resolubilize, reinforcing the conclusion made from the TFE
and activity data that the soluble fraction of the protein
remains native-like until it enters the resolubilization range.
As an alternative to alcohol hydrophobicity, we replotted
the data in Figure 1C versus the relative dielectric constant
εr of the alcohol-water mixtures, using data from ref 48 to
convert concentration to εr. We see a convergence but not
complete coalescence for data between the different alcohols
(Figure 1F), suggesting that simple reduction in solvent
polarity cannot explain our observations entirely. In particu-
lar, it is clear that the resolubilization step differs greatly
among alcohols under conditions of comparable polarity.
Aggregation Is Initiated by a Dimerization Reaction. We
noted that the final appearance of the titration profile of DsbB
in TFE was attained very quickly; overnight incubation did
not alter the fluorescence emission levels in the supernatant
(data not shown). This indicated that the aggregative
processes happened very quickly. We therefore performed
stopped-flow experiments to follow the process in more
detail, using apparent Trp fluorescence as a sensitive measure
of aggregation (similar effects were seen by absorbance
changes at 400 nm, but the signal-to-noise ratio was lower).
When DsbB is transferred into TFE, there is a lag phase of
a few seconds before the (apparent) fluorescence levels rise
to a plateau level (Figure 2A). The length of the lag phase
is inversely correlated to protein concentration (Figure 2B).
In a log-log plot, there is a good linear relationship with a
slope of -1.01 ( 0.09. If aggregation is assumed to involve
a preequilibrium corresponding to the formation of an
oligomeric nucleus, followed by irreversible polymerization,
then the first derivative in this log-log plot equals -n*/2,
where n* is the nucleus size (49). Our data thus suggest that
dimerization is the first step in the aggregation process.
Intermediate Alcohol Concentrations Reduce Membrane
Protein Stability. It was of interest to analyze the stability
of DsbB at low alcohol concentrations, where a significant
fraction of the protein remains soluble and native-like, to
see how stability may be coupled to the precipitation process.
Thermal stability of DsbB may be monitored via the change
in ellipticity at 220 nm (16), which provides the midpoint
temperature of denaturation tm. Although DsbB starts to
precipitate at the higher end of the alcohol concentration
range in these scans, the soluble fraction of DsbB whose
stability could be measured by CD-based thermal scanning
retained a native far-UV CD spectrum (data not shown). This
correlates well with the observation that the 335/350 nm
fluorescence emission ratio of the soluble fraction remains
roughly constant up to 20% TFE (Figure 1A). Scans at
increasing concentrations of different alcohols reveal a linear
decline in tm with alcohol concentration over a restricted
concentration range (Figure 3A) (we were unable to obtain
satisfactory thermal scans in HFIP). Using the slope of this
decline as a measure of the destabilizing influence of the
alcohol, we obtain a monotonic and slightly curved relation-
ship with hydrophobicity, which illustrates the clear cor-
relation between increased hydrophobicity and increased
destabilizing propensities (Figure 3B). Alternatively, we can
estimate the alcohol concentration required to decrease the
melting temperature by 10 °C and plot this concentration
versus hydrophobicity (Figure 3B). Remarkably, this gives
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a linear correlation in a log-log plot with a slope of -1.49
( 0.17, identical within error to the slope for the precipitation
concentrations (Figure 1D). In both cases the slopes show a
correlation with hydrophobicity which is significant at the
99% level. This indicates that stability and precipitation are
very closely related.
The same relationship between tm and alcohol concentra-
tion was seen when the detergent DM was replaced with
octaethylene glycol mono-n-dodecyl ether, illustrating that
the nature of the detergent is not central in the effect of the
alcohol on protein stability (Figure 3C).
The R-Helical Membrane Protein NhaA, but Not the
-Barrel Membrane Protein AIDA, Follows the Same Two-
Step Change in Alcohols. To test the generality of alcohols’
ability to induce this characteristic sequence of precipitation
in membrane proteins, we also tested the behavior of the
388-residue sodium-hydrogen antiporter NhaA, a 12-trans-
membrane R-helix protein (38) which is considerably larger
than DsbB. The same general behavior is seen, in which
fluorescence decreased sharply at relatively low alcohol
concentrations, followed by a recovery (in the case of PrOH,
iPrOH, EtOH, and to some extent TFE) at higher alcohol
concentrations (Figure 4A). NhaA solubility increases in
FIGURE 2: (A) Time profile of aggregation of DsbB upon transfer
from 0 to 20% TFE. The process was followed by the apparent
change in fluorescence, but the magnitude of the signal indicates
that significant light scattering is occurring. The lag time tlag is
estimated by the intersection of the lag region and the growth region
as indicated. (B) Lag time of aggregation as a function of DsbB
concentration. The slope of the fitted straight line in the log-log
plot is -1.01 ( 0.09.
FIGURE 3: (A) Melting temperature tm of DsbB as a function of
different alcohol concentrations. The straight lines represent the
best linear fits to the data. (B) The slopes of the fits in (A), and the
alcohol concentration required for a 10 °C drop in thermal stability,
plotted versus alcohol hydrophobicity. The stippled line is a
polynomium intended to guide the eye through the plot of the
slope-hydrophobicity data, while the line is the best linear fit of
the 10 °C hydrophobicity data. The line has a slope of -1.49 (
0.17, identical within error to the linear plots in Figure 1D. (C)
Change in tm of DsbB as a function of TFE in two different
detergents, namely, DM and C12E8. Insert: Thermal scans for DsbB
in 0-0.56 M TFE in the presence of C12E8.
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parallel (Figure 1B). Again, we observe a linear relationship
between [Ppt]50% and alcohol hydrophobicity in a log-log
plot when HFIP is excluded, and the slope (-1.58 ( 0.05)
is identical within error to that of DsbB (Figure 1D). In the
case of NhaA, there is a very marked coalescence of data
from different alcohols in the precipitation region when
fluorescence data were plotted versus εr (Figure 4B). There
is more divergence in the resolubilization region. Unlike
DsbB, NhaA does not show an increase in R-helicity at
higher TFE concentrations; according to CD, the R-helical
content actually decreases from 41% in 0 M alcohol to 31%
in 7 M TFE (Figure 4C). This could partially be due to small
light scattering artifacts, since the solution showed a slight
opacity in 7 M TFE (data not shown). However, the spectrum
in 8 M PrOH (where no opacity is observed) is similar to
that in 7 M TFE, although it was not possible to deconvolute
it (Figure 4C). Although NhaA only has a slightly higher
proportion of transmembrane residues than DsbB [255
residues, corresponding to 66% (38)], the residues exposed
to the extramembraneous environment are predominantly
restricted to form turns between helices and so are presum-
ably less amenable to change to R-helical structures in TFE.
In contrast to the two R-helix membrane proteins DsbB
and NhaA, the -barrel outer membrane protein AIDA (17)
failed to show any visible precipitation at any TFE concen-
tration with essentially identical fluorescence intensities
before and after centrifugation (Figure 4D). Although there
was a clear decrease in fluorescence, the linear decline in
the 340/350 nm ratio suggested a noncooperative structural
transition (Figure 4D).
The Structure of the Precipitated State. It was not feasible
to obtain reliable structural information on the aggregates
from CD spectra due to excessive light scattering artifacts.
However, FTIR is insensitive to the physical state of the
FIGURE 4: (A) Fluorescence emission intensity of NhaA in different alcohols. Emission corresponds closely to solubility (cf. data for TFE
in Figure 1B). (B) Data in (A) plotted versus relative dielectric constant εr rather than alcohol concentration. Concentrations were converted
to εr values based on data in ref 48. (C) Far-UV CD spectra of NhaA in the native state (no alcohol), the precipitated state (2.8 M TFE),
and the resolubilized state (7 M TFE or 8 M PrOH). (D) Emission intensity and emission ratio for the outer membrane -barrel protein
AIDA as a function of TFE concentration.
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sample and provides a useful method to characterize these
aggregates. Spectra of the DsbB precipitates were recorded
at alcohol concentrations where precipitation was maximal.
For all alcohols, a clear contribution is observed in the lower
 region of the amide I band (Figure 5A). The deconvoluted
spectra and the second derivatives showed six contributions
for the secondary structure at similar frequencies. A seventh
low-intensity Lorentzian peak was added to the fit to account
for the contribution of side chains in the lower range of the
band. The fitted peaks were centered at 1627 ( 0.2 cm-1
(extended chain/-sheet), 1646 ( 1.0 cm-1 (disordered
structure), 1659 ( 0.9 cm-1 (R-helix), 1672 ( 1.2 and
1684 ( 1.1 cm-1 ( turns), and 1694 ( 1.0 cm-1 (-sheet).
In all alcohols, the -sheet structure clearly dominated at
the expense of R-helicity. iPrOH showed slightly less -sheet
structure than the other alcohols, with a corresponding
increase in the R-helix content as well as -turns
(Figure 5B).
Similar experiments performed for NhaA showed the
-sheet structure to assume an even more dominating role
(Figure 5C), with up to 60% -sheet as opposed to only
40-45% for DsbB.
The increase in -sheet structure upon incubation at
intermediate TFE concentrations raised the question whether
the aggregates contained an organized fibrillar structure as
seen for water-soluble proteins such as acylphosphatase
incubated at 20-30% (2.8-3.8 M) TFE (32) and the K3
peptide at 20% TFE (50). We therefore incubated samples
of DsbB and NhaA at 0.04 mg/mL (i.e., 1.9 μM DsbB or 1
μM NhaA) with TFE for several days, spun down the pellet,
and resuspended it in buffer containing the dye thioflavin T
(ThT). This dye is known to bind amyloid structures with
reasonable specificity (51). For both proteins, a significant
rise in the ThT signal was observed in the concentration
range where DsbB and NhaA precipitate (Figure 5C and
insert), although the increase was higher for NhaA. A similar
FIGURE 5: (A) FTIR spectrum of DsbB precipitated in 20% (2.8 M) TFE. The stippled lines indicate the deconvoluted peaks assigned to
secondary structure elements. (B) Distribution of different secondary structural elements in precipitates of DsbB formed in alcohol
concentrations corresponding to lowest solubility (Figure 1A), namely, 2.8 M TFE, 2 M PrOH, 2 M iPrOH, 6 M EtOH, or 15 M MeOH.
(C) As in (B) for NhaA in 2.8 M TFE, 15 M MeOH, 6.8 M EtOH, 4.4 M PrOH, or 4 M iPrOH. (D) Thioflavin T fluorescence in the
presence of precipitates formed upon incubation of DsbB in (b) TFE and NhaA in (O) TFE, (×) PrOH, (]) iPrOH, ([) EtOH, and (9)
MeOH at different concentrations. Insert: Correlation between NhaA solubility (b) and ThT fluorescence (O) as a function of TFE
concentration.
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analysis of NhaA’s structure in other alcohols revealed the
same general behavior, in which the ThT signal increases in
parallel with the amount of precipitated protein and then
declines at high concentrations where the protein becomes
resolubilized (Figure 5D).
Nevertheless, the increase in ThT signal is not unequivocal
evidence for fibril formation. ThT is also able to bind to
nonfibrillar structures, ranging from the acetylcholinerase
receptor (52) to amorphous aggregates (D. E. Otzen,
unpublished observations). Most fibrillation reactions proceed
over hours to days and are preceded by a lag time during
which nuclei can form (53). However, the kinetics of
formation of these ThT-positive structures is rapid and the
ThT fluorescence level stabilizes within at most 30 min; no
further change is seen upon incubation for several days (data
not shown). Stronger evidence for the lack of fibrillated
aggregates was provided by the amyloid-specific chro-
mophore Congo Red, which did not undergo any spectral
change in the presence of these aggregates (data not shown).
We used atomic force microscopy to visualize the aggregates
of NhaA formed in 2.8M TFE. Much of the mica surface
was covered by a layer of a uniform depth of approximately
10 Å (Figure 6A) which coexisted with circular aggregates
of varying sizes that were up to 100 Å tall (Figure 6B),
indicating a variety of different aggregate structures. How-
ever, no bona fide fibrils were observed.
DISCUSSION
We initially hoped to find means of reversibly denaturing
monomeric MPs in alcohols as an alternative to detergent
solubilization. While alcohols are very useful for reversible
dissociation of oligomeric complexes (36), it has not been
investigated in detail how they affect monomeric membrane
proteins. The aim was to be able to obtain reliable estimates
of membrane protein stability under conditions where the
denatured state is truly denatured and not just a slightly
expanded version of the native state, as has been suggested
to be the case for the SDS-denatured state (20). For the two
R-helical MPs tested here, we find no cooperative unfolding
in traditional chemical denaturants. In view of recent reports
on the ability of the fluorinated alcohol TFE to reversibly
denature the membrane protein KcsA at intermediate con-
centrations (36), we therefore decided to systematically test
several fluorinated and nonfluorinated alcohols for their
ability to induce reversible conformational changes. We find
that both proteins irreversibly precipitate at intermediate
concentrations of alcohol, and although they are solubilized
at higher concentrations of alcohol, dilution does not restore
activity. Resolubilization only occurs because the protein is
forced into a non-native state which can be more effectively
solubilized. These experiments all had to be done in the
presence of detergents, since their absence would only make
precipitation more pronounced. Thus, increasing detergent
concentration simply postponed precipitation to higher
alcohol concentrations. We therefore conclude that alcohols,
fluorinated or not, do not provide a useful general means of
inducing reversible unfolding of membrane proteins in
solution. Nevertheless, the conformational changes induced
by these alcohols are worthy of further comments.
Precipitation through Destabilization and Structural Frus-
tration. Let us start by focusing on the precipitation occurring
at low to medium alcohol concentrations. Cosmotropic salts,
such as sodium sulfate, precipitate proteins by hyperstabi-
lizing them; they are preferentially excluded from the protein
surface (54) and thus favor compact conformations with
minimized exclusion zones. At lower salt concentrations, this
FIGURE 6: Atomic force microscopy images of NhaA precipitates formed in the presence of 2.8 M TFE. The bottom panels display the
height profile of the green lines in the AFM images.
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will lead to a significant stabilization of the native state
relative to the denatured state (55), whereas higher salt
concentrations eventually induce precipitation of the native
state so as to minimize contact with solvent. The alcohols
precipitate membrane proteins by a mechanism which is
fundamentally different from this. Thermal scans with DsbB
indicate that destabilization of the native state of the protein
is a prelude to precipitation.
On the basis of this, we speculate that the alcohols are
able to bind to hydrophobic parts of the membrane protein
via their aliphatic groups, both on the surface-exposed parts
of the protein, which are normally sequestered by detergents,
and internally in the protein, disrupting tertiary helix-helix
contacts which are important stabilizing elements. This will
lead to structural frustration, since the alcohol disturbs the
normal protein-protein and protein-detergent contacts
which maintain the protein in a solubilized native state, while
being unable to provide a sufficiently effective solvent to
keep the protein in solution (Figure 7). This is corroborated
by several observations: First, the good correlation between
[Ppt]50% and hydrophobicity (Figure 1F) is evidence that the
more hydrophobic the alcohol, the higher affinity it has for
the hydrophobic patches on the protein. In addition, alcohol
hydrophobicity is linked to precipitation and destabilization
parameters by exactly the same slope (Figures 1D and 3A).
Second, the precipitation data for different alcohols converge
when plotted versus dielectric constant rather than molar
concentration, indicating that exposure of otherwise seques-
tered parts of membrane proteins to solvents with high
polarity will of necessity lead to precipitation. The conver-
gence is particularly clear for NhaA, which has a larger
proportion of transmembrane residues than DsbB and is
therefore a “cleaner” membrane protein. For water-soluble
proteins, where solubility is not such a sensitive issue, the
protein will typically respond to changes in εr by undergoing
conformational transitions at the monomeric level (48, 56).
Third, the low fraction of the protein population that remains
in solution at intermediate alcohol concentrations has native-
like fluorescence emission ratios (Figure 1), suggesting that
adoption of the non-native conformation induced by alcohols
is not compatible with staying in solution. Fourth, the
-barrel membrane protein AIDA remains solubilized through-
out the same alcohol concentration range that leads to
massive precipitation of DsbB and NhaA, supporting the fact
that the tertiary structure of helical membrane proteins is
predominantly stabilized by strongly hydrophobic contacts
between transmembrane helices that can be disrupted by the
alcohols (2, 3). -Barrel membrane proteins consist of
amphiphilic sequences which do not provide such suitable
binding sites. In addition to direct alcohol-protein interac-
tions, it could also be expected that the more hydrophobic
alcohols more strongly partition into the protein-detergent
complex. This could conceivably lead to early disruption of
micelles and subsequent precipitation. However, the fact that
AIDA, which also requires micellar detergent to stay in
solution (41), remains solubilized throughout the titration
argues that there is little actual stripping of detergents off
the membrane protein surface.
Rapid Formation of Stable but Nonfibrillar Precipitates
DriVen by Hydrophobic Effects. The structural frustration
induced by the alcohols leads to very rapid (second-scale)
precipitation, driven by the hydrophobic effect. It is a well-
defined process with a discernible lag phase where the rate-
limiting step is the formation of dimers. This leads to the
formation of thioflavin T-positive -rich precipitates with
organized but nonfibrillar structure that also shows great
variations in height, indicating a heterogeneous population
of aggregates (Figure 6). Thus, under these conditions,
formation of intermolecular -sheet structures is the most
effective way of satisfying hydrogen-bonding requirements.
Aggregation at intermediate TFE concentrations (peaking at
25%) is also seen for water-soluble proteins such as
acylphosphatase (32) and the K3 peptide from 2-microglo-
bulin (50). For AcP, aggregation initially leads to the
formation of relatively amorphous aggregates which only
form ordered structures over a time scale of many days (57).
No such transitions were observed upon longer term exposure
of DsbB and NhaA. Presumably, the strong hydrophobic
interactions between the membrane protein molecules ef-
fectively trap the precipitated state in a stable conformation
which cannot rearrange to other structures. This contrasts
with strongly fibrillating peptides such as the 42-residue
Alzheimer A peptide, whose C-terminal domain is a
fragment of a membrane-spanning helix while the N-terminus
is hydrophilic. Similarly, truncation of the transmembrane-
spanning part of glycophorin, making it unable to span the
membrane bilayer, induces fibrillation within a few days (58).
The key to their fibrillation propensity, in contrast to full-
length membrane proteins, probably lies in (a) their relatively
small size, making conformational changes more accessible,
and (b) a disruption (truncation) of the normal hydrophobic
interactions at a very fundamental level.
Resolubilization Follows Alcohol-Specific Patterns. As we
increase the alcohol concentration, it becomes possible to
resolubilize the -rich precipitates to structures rich in
R-helicity but with altered tertiary structure, as witnessed
by the change in the 335/350 nm emission (Figure 1). In
contrast to the alcohols’ general ability to precipitate DsbB
and NhaA at low concentrations, resolubilization does not
follow a simple pattern. To some extent, resolubilization
depends on hydrophobicity: the weakly hydrophobic alcohol
MeOH cannot resolubilize the precipitates, unlike EtOH,
PrOH, iPrOH, and TFE. MeOH, as opposed to other alcohols,
has also been shown to induce -rich structures in the all-
helical protein VlsE (33) and the R/ protein ervatamin (59).
However, plotting precipitation data versus εr (Figure 1D)
clearly reveals that changes in εr cannot explain the resolu-
bilization. In the same εr range where PrOH, iPrOH, TFE,
FIGURE 7: Proposed model for alcohol-induced destabilization,
precipitation, and resolubilization of membrane proteins. Alcohol
molecules may disrupt helix-helix contacts and displace detergent
molecules, leading eventually to destabilization and precipitation
to -rich structures, until sufficiently high alcohol concentrations
disrupt the -sheet structure and lead to non-native predominantly
R-helical (DsbB) or other non-native (NhaA) states.
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and EtOH achieve high solubilization (but starting at different
values of εr), neither MeOH nor HFIP shows any effect. The
fluorinated alcohol TFE does not distinguish itself from the
nonfluorinated alcohols in precipitation and resolubilization,
suggesting that the fluorinated groups do not play any
specific role in these phenomena. However, the “hyperflu-
orinated” alcohol HFIP is not as potent a denaturant as would
be predicted from its hydrophobicity. For example, it does
not decrease [Ppt]50% for DsbB and NhaA as much as
expected and does not show strong resolubilization proper-
ties. The basis for this decreased potency could be related
to the inability of fluorine groups in hemifluorinated sur-
factants to mix with lipids (60). On the other hand, HFIP
conforms to the general hydrophobicity-driven ability of
alcohols to dissociate KcsA tetramers in lipid membranes
(34). Thus resolubilization appears to be more sensitive to
the nature of the alcohol than precipitation, possibly because
the alcohol molecules have to bind well to the hydrophobic
surfaces to shield the protein against aggregation.
A thought-provoking study on the effect of alcohols on
the conformational transitions of the aggregation-prone
protein R-synuclein revealed that nonfluorinated alcohols led
to -rich oligomer formation, while HFIP and TFE led to
R-rich monomers (26). The authors suggested that MeOH
and EtOH mimic the environment near the membrane, and
TFE and HFIP mimic the environment in the membrane,
simply because TFE and HFIP are more hydrophobic. These
considerations are likely to apply for water-soluble proteins.
However, for membrane proteins, which are unequivocally
dependent on a membrane-like environment, TFE and HFIP
are clearly not sufficiently membrane-like to keep the
membrane protein in solution.
TFE and HFIP have also been shown to form higher order
clusters at concentrations around 15-65% (v/v) (48). How-
ever, these clusters cannot be instrumental in resolubilization.
TFE only solubilizes DsbB from around 35% onward,
whereas HFIP, which has a much greater propensity to form
these clusters, does not resolubilize to any significant extent,
and the nonclustering alcohol EtOH solubilizes just as
efficiently as TFE.
In conclusion, we have shown that alcohols can induce
numerous conformational changes in membrane proteins,
leading to destabilization, precipitation, and resolubilization.
Destabilization and precipitation correlate well with hydro-
phobicity, whereas resolubilization also involves effects
specific for each alcohol. These phenomena highlight the
fact that alcohols can exert an effect on membrane proteins,
not just by modulating the actual lipid environment (34) but
also by directly affecting the intrinsic stability of the
membrane protein. The effect on membrane protein stability
is comparable to the effect on lateral pressure, since the
change in the midpoint of precipitation of NhaA and DsbB
is more than twice as sensitive to alcohol hydrophobicity as
the dissociation midpoints for the KcsA tetramer.
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Abstract: We have studied the thermal stability of the triglyceride-hydrolyzing enzyme cutinase
from F. solani pisi at pH values straddling the pI (pH 8.0). At the pI, increasing the protein concen-
tration from 5 to 80 lM decreases the apparent melting temperature by 198C. This effect vanishes
at pH values more than one unit away from pI. In contrast to additives such as detergents and osmo-
lytes, the hydrophobic fluorophore 1,8-ANS completely and saturably suppresses this effect, restor-
ing 70% of enzymatic activity upon cooling. ANS binds strongly to native cutinase as a noncom-
petitive inhibitor with up to 5 ANS per cutinase molecule. Only the first ANS molecule stabilizes
cutinase; however, the last 4 ANS molecules decrease Tm by up to 78C. Similar pI-dependent
aggregation and suppression by ANS is observed for T. lanuginosus lipase, but not for lysozyme or
porcine a-amylase, suggesting that this behavior is most prevalent for proteins with affinity for
hydrophobic substrates and consequent exposure of hydrophobic patches. Aggregation may be pro-
moted by a fluctuating ensemble of native-like states associating via intermolecular b-sheet rich
structures unless blocked by ANS. Our data highlight the chaperone activity of small molecules with
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affinity for hydrophobic surfaces and their potential application as stabilizers at appropriate stoi-
chiometries. # 2006 Wiley Periodicals, Inc. Biopolymers 83: 619–629, 2006
This article was originally published online as an accepted preprint. The ‘‘Published Online’’ date
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mers editorial office at biopolymers@wiley.com
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INTRODUCTION
Temperature-induced protein aggregation has been
known for many years.1,2 The thermally denatured
state tends to contain significant amounts of residual
structure including contiguous hydrophobic patches
that provide contact points between the individual
protein molecules and subsequent aggregation. Con-
sequently, aggregation generally occurs above the
thermal denaturation temperature Tm. While it is rare
for the aggregation process to lower Tm, some pro-
teins aggregate well below Tm.
3 In some cases this
can be explained by the formation of partially folded
states.4,5 These states are much more susceptible to
aggregation than the native or completely unfolded
state, because of the exposure of contiguous hydro-
phobic regions that are buried in the native state or
absent in the denatured state. However, even at tem-
peratures where the protein retains its native structure
with intact tertiary interactions, aggregation can oc-
cur because of fluctuations in the native state ensem-
ble via transiently expanded conformational subspe-
cies6 that may require as little as 15% of the surface
area expansion required for unfolding.
Higher protein concentration will typically in-
crease aggregation due to simple mass action effects.7
Efforts to reduce aggregation include the addition
of polyols, sugars, polymers, amino acids, detergents,
and denaturants, which either stabilize the native
state or shield the denatured state against intermolec-
ular contacts.8–13 In general, these stabilizers work
through weak and nonspecific preferential exclusion,
although detergents may work by more specific
shielding of hydrophobic patches.14 Salts are less of-
ten used, since the effect of ionic strength is very pro-
tein dependent.15 The salt type can also make a sig-
nificant difference in protein aggregation.16
An alternative strategy is to target hydrophobic
patches on the protein surface with small water-solu-
ble molecules. For example, the fluorescent dye 1,8-
ANS has been shown to suppress thermal aggregation
of carbonic anhydrase when present in 150-fold
molar excess.17,18 ANS is traditionally used to detect
molten globules, i.e. partly folded proteins that accu-
mulate under mildly denaturing conditions. Binding
is believed to occur via solvent-exposed hydrophobic
patches, which are a particular characteristic of this
protein state.19 Certain proteins also bind ANS in the
native state, however, provided this conformation dis-
plays exposed hydrophobic sites,20–23 as shown ini-
tially by Weber in his classic study of ANS binding
to BSA.24 Binding of ANS may in some cases lead to
structural changes in the protein, rather than acting as
a simple lock-and-key mechanism.25 This property is
shown to even higher extent for the covalent ANS-
dimer bis-ANS20,26 (M.E. Reinau and D.E.O., unpub-
lished observations), although bis-ANS has also been
shown to suppress thermal aggregation27 as well as
aggregation of proteins and peptides involved in de-
mentia diseases.28,29
Proteins are generally most susceptible to thermal
aggregation around their pI, because of the lack of
overall electrostatic repulsion. In addition, aniso-
tropic charge distribution at the pI can give rise to
dipoles, encouraging intermolecular contacts and
aggregation.30 Therefore, inhibition of aggregation is
most efficiently tested around the pI. Here, we report
on the observation and inhibition of pronounced pI-
dependent aggregation properties of a cutinase from
Fusarium solani pisi. Cutinase is a compact one-do-
main 214-residue globular enzyme able to hydrolyze
both soluble esters and water-insoluble lipids such as
triglycerides. Cutinase has two disulfide bonds and 47
titratable residues, leading to an isoelectric point
between 7.8 and 8.0. We show that the thermal stabil-
ity of cutinase is very sensitive to protein concentra-
tion around the pI. Furthermore, we find ANS to be
the most efficient inhibitor of this aggregative desta-
bilization at stoichiometric concentrations, with a per
mole effect far exceeding that of more conventional
formulation agents such as amino acids or detergents.
We make similar observations for the lipase from
T. lanuginosus, another enzyme with hydrophobic
substrates. In contrast, lysozyme and porcine -amy-
lase, whose substrates are much more polar, are not
nearly as susceptible to aggregative destabilization.
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This highlights the potential of small molecules as ef-
ficient chaperones for proteins with ‘‘sticky’’ surface
patches.
MATERIALS AND METHODS
Materials
n-Octyl--D-maltoside was from Anatrace (Maumee, OH)
and n-dodecyl--D-maltoside was from Calbiochem (La
Jolla, CA). All other chemicals were from Sigma (St. Louis,
MO). All chemicals were of analytical or biological grade.
The following buffers were used, all at 50 mM: acetate (pH
4.0 and 5.0), citrate (pH 6.0), Tris-Cl (pH 7.0, 7.5, 8.0, and
8.5), and glycine (pH 9, 10, and 11).
Cutinase Expression and Purification
Cutinase from Fusarium solani pisi (SwissProt entry
P00590) was cloned and expressed in Escherichia coli WK-
6 strain, a kind gift from Corvas International N.V. (Gent,
Belgium). The recombinant enzyme was produced and
purified to >95% purity as described,41 subsequently dia-
lyzed extensively against water, and lyophilized. Hen egg-
white lysozyme (EC 3.2.1.17) and -amylase (EC 3.2.1.1)
were purchased from Sigma and used without further purifi-
cation. T. lanuginosus lipase was a kind gift from Kim
Borch, Novozymes A/S.
Protein concentrations were determined spectrophoto-
metrically using molar extinction coefficients of 10,853.5,
37,275, and 37,800M1 cm1 at 280 nm for cutinase, lipase
and lysozyme respectively. A stock solution of 0.2 mM -
amylase was prepared by weighing out the lyophilized pow-
der (EC 3.2.1.1) (MW ¼ 55,376 g mol1).
Fluorescence Spectroscopy
Thermal scans were performed on an RTC 2000 spectrome-
ter from Photon Technology International (Lawrenceville,
NJ) equipped with a 75-W xenon arc lamp. The wavelength
for tryptophan excitation and emission was set to 298 and
350 nm, respectively, in order to avoid contributions from
tyrosine fluorescence. The tryptophan fluorescence spec-
trum of cutinase is unusual in that the fluorescence in-
creases markedly upon unfolding, and this effect will be
obscured to some extent if the tyrosine fluorescence contri-
bution is included. The cuvette was thermostated with a
Peltier element and the temperature of the solution was fol-
lowed with a PT100-element submerged into the solution at
a scan-rate of 908C h1. Because of the highly sloping base-
line of the denatured state at high protein concentrations,
we found it most reliable to determine Tm as the position of
the peak of the first derivative curve. The same instrument
was used to measure SLS between 25 and 758C using exci-
tation and emission wavelengths of 500 nm and sample vol-
umes of 100 l.
Dye–Cutinase Interaction
A stock solution of ca. 100 mM 1,8-ANS in DMSO was
prepared and diluted into water. The concentration was
determined using the "water350 of 4990M
1 cm1.42 ANS fluo-
rescence measurements were carried out on an LS-55 Spec-
trofluorometer (Perkin-Elmer, Wellesley, MA) using an ex-
citation wavelength of 350 nm and emission at the maxi-
mum of fluorescence intensity in the range of 420–550 nm
with slit size of 10 nm. For thioflavin T measurements, cuti-
nase was incubated with 40 M thioflavin T, based on a
100 mM stock solution of thioflavin T in ethanol. Excitation
was at 450 nm and emission at 485 nm. For Congo red
measurements, cutinase was incubated with 20 M Congo
red in buffer and the absorption between 400 and 600 nm
recorded.
Far UV CD Spectroscopy
Far UV CD spectra of thermal scans of cutinase in 50 mM
Tris at pH 8 were performed on a JASCO J-810 spectropo-
larimeter with a JASCO PTC-348WI temperature control
unit and Neslab RTE-111 water bath. For the far UV and
near UV CD, ellipticity was measured in the wavelength
range of 200–250 nm with the following settings: resolu-
tion: 0.1 nm; bandwidth: 1.0 nm; sensitivity: 50 mdeg;
response: 2.0 s; speed: 50 nm min1. Six accumulations
were averaged to yield the final spectra. Cuvettes of 1 mm
path-length were used.
Thermal scans were performed with a scan rate of 908C
h1 at 223 nm. Raw CD data were fitted in KaleidaGraph
(Synergy Software, Reading, PA) to the following equation:43
 ¼ N þ NT þ ðD þ DTÞ  e
ðHTm ð1 TTmÞÞ=RT
1þ eðHTm ð1 TTmÞÞ=RT
ð1Þ
where  is the raw CD signal, N and D are the -values
for the folded and denatured states, respectively, at 298 K,
N and D are the slopes of the baselines of the native and
denatured states, respectively, and HTm is the enthalpy of
unfolding at the midpoint of denaturation, Tm. Note that this
equation is formally only applicable to a reversible two-
state unfolding process and not to an irreversible process.
However, in practice, the unfolding scans fit very satisfacto-
rily to Eq. (1). In any case, the Tm-values are strictly used
for comparative purposes.
RH ¼ kbT
6Dr
ð2Þ
where kb is the Boltzmann constant, T is the temperature in
Kelvin and  is the viscosity.
Dynamic Light Scattering
DLS experiments were carried out in triplicate between 25
and 758C using a Dyna Pro MSTC Dynamic Light Scatter-
ing Instrument (Protein Solutions, Charlottesville, VA).
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The samples were in-line filtered through a 0.02 m filter to
remove any dust particles and injected into a 50 l quartz
cuvette. Temperature was maintained with an accuracy of
better than 18C by the Peltier cell. The sample was equili-
brated for at least 5 min at each temperature before mea-
surement.
Fourier Transform Infrared Spectroscopy
FTIR was carried out on a Bruker Tensor 27 infrared spec-
trometer (Bruker Optik GmbH, Ettlingen, Germany) with a
Specac Golden Gate single-reflection ATR unit (Specac,
Orpington, UK). Aggregates were isolated by centrifugation
and resuspended in milliQ water. Samples were prepared by
drying on the ATR surface under a gentle stream of nitrogen.
Spectra were recorded with 128 accumulations and analyzed
for secondary structure content of the amide I band using
OPUS 5.5 software (Bruker Optik GmbH, Ettlingen, Ger-
many). Estimates of secondary structure were obtained by fit-
ting of Gaussian or Lorentzian curves. Briefly, the number
and positions of peaks were determined from the second de-
rivative spectrum and by Fourier self-deconvolution.44 Peaks
fitting was carried out using the Levenberg Maquardt
method. Peaks were assigned to secondary structure elements
and the relative peak area percentages were calculated. The
assignments were: extended chain/-sheet (1625 6 0.2 and
1693 6 0.6 cm1), -helix (1657 6 0.2 cm1), turns (1670
6 0.2 and 16816 0.2 cm1), and disordered structure (1643
6 0.2 cm1).
Enzymatic Activity Measurements
The enzymatic activity of cutinase was measured on a UVI-
KON 943 A (Bio-Tek Kontron Instruments, Milano, Italy)
spectrophotometer at 208C using p-NPB as substrate. Hy-
drolysis of p-NPB was monitored as the change in absorb-
ance at 400 nm corresponding to the absorption maximum
of the p-nitrophenolate anion. p-NPB was dissolved in pure
acetonitrile to a concentration of 80 mM and used at a final
concentration of up to 0.8 mM. The final enzyme concentra-
tion was 3 nM. All measurements were performed in
20 mM Tris-Cl pH 8 in a volume of 1500 l. As soon as the
enzyme had been added, the cuvette was capped with paraf-
ilm, the contents were mixed by gentle inversion, and linear
1 min time profiles were recorded. Time profiles of samples
containing different p-NPB concentration (0.1–0.8 mM)
and buffer without enzyme were subtracted as blanks for all
spectra to take into account p-NPB’s autohydrolysis in
water. Absorption changes were converted to concentration
changes using e400 ¼ 16.000M1 cm1. Data both in the ab-
sence and presence of ANS were analyzed in a double-re-
ciprocal Lineweaver-Burk plot where the x-axis intercept
was 1/KM and the y-axis intercept 1/vmax. As seen in
Figure 3B, ANS affects the slope but not the x-axis inter-
cept, which is an indication of noncompetitive inhibition. In
this case, vmax is lowered by a factor (1 þ [ANS]/KI), where
KI is the apparent inhibition constant.
RESULTS
Cutinase’s Thermal Stability Decreases
Strongly with Increasing Protein
Concentration Close to Its pI, and Is
Related to Aggregation
To elucidate the effect of protein concentration on
thermal stability of cutinase close to pI, a concentra-
tion-dependent thermal unfolding of 5–80 M cuti-
nase was monitored by fluorescence spectroscopy, cir-
cular dichroism (CD), and light scattering. The native
state fluorescence baseline is essentially flat (Figure
1A), in contrast to many other proteins where a strong
decrease in fluorescence with temperature is observed
because of dynamic solvent quenching. This corre-
lates with the fact that cutinase’s single Trp residue is
almost totally buried and excluded from solvent con-
tacts in the native state. With increasing protein con-
centration, the fluorescence unfolding curves change
from a typical sigmoidal shape curve to a Gaussian-
type curve (Figure 1A). This is suggestive of aggrega-
tion and subsequent decline in fluorescence after
denaturation (cf. similar data in Ref. 31). It is clear
that the Tm decreases with increasing protein concen-
tration (Table I). CD thermal scans (Figure 1B) gave
Tm values identical to those obtained by fluorescence
(Table I). Far UV CD spectra reveal a significant loss
of secondary structural elements upon heating from
25 to 708C (insert to Figure 1B), although the protein
clearly retains a very significant amount of structure.
We used fluorimeter-based static light scattering
(SLS) to monitor aggregation associated with thermal
denaturation. A concentration-dependent increase in
the intensity of scattered light at 500 nm upon ther-
mal unfolding is observed (Figure 1C). At 5 M cuti-
nase, we only see a 7.4% increase in the intensity of
scattered light after protein unfolding, but this
increases to more than 100% at 20–60 M. At 20 and
40 M, the abrupt increase in intensity occurs above
508C, while at 60 M it already starts above 458C.
Thus, thermal denaturation, as monitored by CD and
fluorescence, is accompanied by aggregation.
Aggregation Is Suppressed at Low pH
and by a Mutation Altering the pI
Comparison of the Tm of cutinase at 5 and 80 M
between pH 4 and 11 reveals that concentration-depend-
ent lowering of the Tm only occurs in a narrow pH
range around the pI (Figure 1D). Outside this range, the
solutions remain clear upon heating, indicating no mac-
roscopic aggregation. This is confirmed by dynamic
light scattering (DLS), which reveals that outside the pI,
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RH only increases from 2.4 to 2.8 nm upon thermal
denaturation (insert to Figure 1C), consistent with a sin-
gle conformational change from native to unfolded. Fur-
thermore, the mutant E44A, whose pI is shifted upward
to 9.5, does not show any aggregation behavior at pH
8.0 between 5 and 80 M protein, where the Tm-values
are 47.3 and 48.08C, respectively (data not shown).
Fourier Transform Infrared Spectroscopy
and Dye-Binding Data Suggest that the
Aggregated State Is Rich in b-Content
Thermal aggregation of cutinase leads to temperature-
dependent differences in secondary structure according
to Fourier transform infrared spectroscopy (FTIR; Fig-
ure 2A). As the aggregation temperature increases, a sig-
nificant increase in the area of the low -sheet peak at
1625 cm1 is observed (total amount of -sheet struc-
ture at 808C: 55%), both compared to the lowest aggre-
gation temperature (48% -sheet structure) and to the
native structure (data not shown). The native state shows
predominantly -helical structure, consistent with 41%
-helix, 17% -strand, 16% -turns, and 27% disor-
dered in the crystal structure (e.g. PDB file 1CEX). The
high extended chain peak (1692 cm1) does not seem to
be influenced by the change in temperature, possibly
due to the low intensity. This is also the case for the
peak corresponding to disordered structure (1643 cm1).
Overall, the -sheet content of the aggregated form is
far higher than the content for the native protein. In par-
FIGURE 1 A: Thermal stability of 5–80 M cutinase as monitored by fluorescence spectroscopy
at pH 8.0. B: Thermal stability of 5–80 M cutinase as monitored by CD at 223 nm at pH 8.0. Inset:
far-UV CD spectra of 5 M cutinase at pH 8.0 and 258C (solid lines) versus 708C (broken lines).
C: SLS of 5–60 M cutinase at pH 8.0 as a function of temperature. Inset: plot of RH versus tem-
perature of 60 M cutinase at pH 4.0 and 8.0. The error bars denote the standard deviation deter-
mined for three experiments. RH is calculated using Eq. (2). D: pH profile of cutinase as a function
of DTm (805 M) as monitored by CD at 223 nm. The solid lines are drawn to guide the eye.
Error bars are obtained from the fit.
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allel to the increase in -content with increasing aggre-
gation temperature, the remaining peaks decrease in in-
tensity although this change is most pronounced for the
-helix peak (1657 cm1). It is possible that the increase
in -structure is due to exposure of the core -sheet dur-
ing thermal unfolding followed by cross -sheet aggre-
gation and recruitment of neighboring residues into the
-sheet.
The small molecule dyes thioflavin T and Congo red
are known to bind to proteins in the misfolded -sheet
rich fibrillated state.32,33 Incubation with the heat-aggre-
gated state of cutinase (formed by incubation of 80 M
at pH 8.0 at 50–708C) leads to a distinct red-shift in the
Congo red absorption spectrum and a marked increase
in thioflavin T fluorescence (Figure 2B), consistent with
a high -sheet content of the aggregates.
Suppression of Cutinase Aggregation by
Additives such as Urea, Detergents, and
L-Arginine Is Coupled to Destabilization
and Irreversible Denaturation
We next investigated the extent to which various
additives could reduce the protein’s aggregation-
induced destabilization. Nonionic detergents, the sta-
bilizing amino acid arginine, and the denaturant urea
largely suppressed concentration-dependent destabili-
zation, but all these reagents lowered the thermal sta-
bility of cutinase significantly (Table II). Cutinase is
known to be destabilized by anionic detergents,10,34
but nonionic detergents also appear somewhat sur-
prisingly to play a similar role (P. Sehgal and D.O.,
unpublished observations). In addition, unfolding was
far from reversible under these conditions: precipita-
tion above the Tm was observed for detergents, while
in urea, the native-level ellipticity was only partially
regained upon cooling (data not shown). Thus, deter-
gents could only suppress the aggregation events
prior to denaturation but could not keep it in a state
able to refold.
Micromolar Concentrations of ANS
Efficiently Suppress Aggregation
We reasoned that a probe binding to and shielding
exposed hydrophobic regions might suppress the ther-
mal aggregation of cutinase. An obvious candidate is
the fluorescent probe 1,8-ANS. We measured the Tm
of 80 M cutinase as a function of ANS concentra-
tion, and found that ANS increases the Tm in a hyper-
bolic fashion, which empirically fits to a simple bind-
ing curve. The fit predicts that the Tm-values
approach a final value of (63.5 6 1.0)8C with an
apparent dissociation constant KM of 8.6 6 1.1 M
(Figure 3A). Importantly, cutinase heated in the pres-
ence of ANS retains around 70% of its activity upon
cooling, in contrast to cutinase heated in its absence
(5% of residual activity), as shown in the insert to
Figure 3A. Concentrations up to 80 M of thioflavin
T and Congo red have no effect on the aggregation of
80 M cutinase (data not shown).
Given that cutinase has a hydrophobic binding
patch with an affinity for alkyl chains,35 it might be
expected that ANS could bind to the active site. How-
ever, enzymatic activity assays reveal that ANS in
fact acts as a noncompetitive inhibitor (i.e. binding
outside the active site) (Figure 3B) with unchanged
KD but reduced Vmax (Table III). The apparent KI is
62.5 6 12.5 M but this need not be identical to the
apparent KD of 8.6 M identified from thermal scans
Table I Melting Temperatures Tm of Cutinase, Lysozyme, and a-Amylase at Their Respective pI-Values Followed
by Fluorescence (FS) and CD
[Cutinase] (M)
Cutinase
(Tm (8C); pI ¼ 8.0)
Lipase
(Tm (
oC); pI ¼ 8.0)
Lysozyme
(Tm (
oC); pI ¼ 10.5)
Amylase
(Tm (
oC); pI ¼ 6.0)
FSa CDb FSa CDb FSa
0.1 59.3
5 59.3 59.5 74.4 71.9 58.2
40 57.3 57.2
60 52.0 51.4
80 40.3 40.3 68.9 75.7 61.5
DTm (80–5 M) 19.0 19.2 5.5 þ3.8 þ3.3
a Determined by fluorescence spectroscopy at a scan rate of 908C/h. Excitation for the fluorescence experiments was set at 295 nm and
emission at 350 nm. Tm is calculated as the position of the maximum of the first derivative curve for the thermal unfolding scans. Errors typi-
cally 0.18C.
b Tm derived from Eq. (1). CD was monitored at 223 nm. Errors typically 0.1–0.28C.
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(Figure 3A), since the KI only reports on the binding
to sites which directly affect enzymatic activity.
Direct addition of ANS to the native cutinase
reveals that ANS binds so tightly to cutinase that a
titration plot (with a break-point at saturation) rather
that a hyperbolic binding curve is obtained. Data
obtained at different cutinase concentrations suggest
a 5 ANS:1 cutinase stoichiometry (Figure 3C). Inter-
estingly, when cutinase is present at 4-fold higher
concentration than ANS, the protein is either stabi-
lized (pH 7.5–8.5) or not affected (outside pH 7.5–
8.5) (Figure 3D). However, when ANS is present in
4-fold excess, the Tm decreases at all pH values
(Figure 3D). This suggests that the first binding site
for ANS is stabilizing, whereas the occupation of sub-
sequent binding sites leads to destabilization of the
protein. This observation is vindicated by Figure 3E,
which shows how the Tm of cutinase at 5 M protein
actually increases in the presence of 5 M ANS but
subsequently declines.
Thermal Stability of Lipase, but not
Lysozyme and a-Amylase, Is Sensitive
to Protein Concentration at the pI
To test the generality of pI-enhanced thermal aggre-
gation and destabilization, we investigated the ther-
mal unfolding of T. lanuginosus lipase, lysozyme,
and -amylase at pH-values corresponding to their
respective pI-values (Table I). The Tm of lipase
decreased by 5.58C between 5 and 80 M. This
reduction in Tm was completely removed by ANS,
which in fact leads to a Tm of 75.88C at 80 M lipase,
which is 1.48C higher than the Tm at 5 M lipase in
the absence of ANS. However, for both lysozyme and
-amylase, increasing the protein concentration from
5 to 80 M resulted in a global thermal stabilization
of 3.8 and 3.38C, respectively, comparable to the sta-
bilization of cutinase by high protein concentrations
outside pH 7–9 (Figure 1D). Thus, the concentration-
Table II Effect of Additives on the Tm of 80 lM
Cutinase at pH 8.0
Additive Concentration
Tm (8C)
a
DTm (
oC)
80–5 M80 M 5 M
None – 40.3 59.3 19
Urea 2 M 47.5 47.5 0
DM 20 mM 53.8 54.9 1.1
OG 10 mM 52.1 53.1 –
OM 10 mM 52.5 54.65 –
L-Arg 0.5 M 55.2 56.4 1.2
a Unfolding followed by CD. Tm was obtained by fitting the data
to Eq. (1). Errors 0.1–0.28C.
FIGURE 2 A: Secondary structure content of aggregated cutinase at pH 8.0 based on FTIR
spectra. Cutinase (80 M) was incubated at 40–808C for 15 min. Insert: FTIR spectra of samples
incubated at 40 and 808C. B: Absorption spectra of Congo red alone (joined line) and in the pres-
ence of 80 M cutinase aggregated by exposure to 508C at pH 8.0 for 15 min (dashed line). Insert:
emission intensity of thioflavin T at 485 nm (excitation 450 nm) in the presence of 80 M cutinase
incubated at different temperatures for 15 min at pH 8.0.
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FIGURE 3 A: Tm of 80 M cutinase at pH 8.0 as a function of ANS concentrations. The solid
line is the result of the best fit to a simple binding equation. Inset shows the recovery of enzyme ac-
tivity after heating of 80 M cutinase at pH 8.0 in the presence and absence of 20 M ANS. Errors
ca. 5%. B: Double reciprocal plots of cutinase’s hydrolytic activity towards p-NPB at pH 8.0 in the
absence of ANS (filled circles) and in the presence of 20 M ANS (empty circles). C: Fluorescence
profile of cutinase titrated with ANS at pH 8.0 in 1–5 M cutinase. D: Effects of 20 M ANS on
the Tm of 80 and 5 M cutinase at different pH values. The solid lines are drawn to guide the eye.
E: Tm of 5 M cutinase at pH 8.0 at different [cutinase]:[ANS] values.
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destabilization effect, and its ability to be rescued by
ANS, appears specific for enzymes with hydrophobic
substrates, i.e. cutinase and lipase.
DISCUSSION
This work shows that the thermal denaturation of the
triglyceride-hydrolyzing enzyme cutinase from F.
solani pisi is particularly sensitive to aggregation
around the pI of the protein, where there is minimal
electrostatic repulsion. While it is not surprising that
protein unfolding around pI should lead to aggrega-
tion after thermal denaturation, it seems less obvious
why increasing the protein concentration from 5 to
80 M should decrease the melting temperature from
59.5 to 40.38C, since the protein is overwhelmingly
in the native state at 408C at low protein concentra-
tions. A simple explanation for such behavior could
be that a partially folded intermediate accumulates
around 408C. Intermediates tend to expose hydropho-
bic patches, which provide contact points to other
partially folded molecules, encouraging aggregation.4
Such an intermediate may accumulate for cutinase
under certain conditions. At pH 4.5, cutinase unfolds
via a transient unfolding intermediate in guanidinium
hydrochloride at 258C according to stopped-flow
experiments.36 In addition, there was a slight (ca.
0.1M) discrepancy between the changes in ANS and
Trp fluorescence upon equilibrium unfolding in
GdmCl, which is consistent with at least some degree
of formation of a partially unfolded state induced by
chemical denaturants.37 Nevertheless, the same study
concluded that thermal unfolding proceeded accord-
ing to a simple two-state model.37 A careful DSC
study on the unfolding of cutinase (conducted at pH 9
and at around 40 M cutinase, i.e. outside the region
of maximal aggregation) also concluded that cutinase
unfolding was more complex than a simple Lumry-
Eyring model for irreversible unfolding and the
authors invoked a thermal unfolding intermediate to
explain the discrepancy.10 However, they acknowl-
edged that there was no direct evidence for an inter-
mediate in the thermogram.
In our study, the perfect correspondence between
CD and fluorescence-based data for unfolding of cuti-
nase, the lack of an increase in the fluorescence of
ANS (which, in addition to its affinity for sticky
patches on native surfaces, should be expected to
have particular affinity for partially denatured states)
during the thermal scan, as well as the ability to fit
the data to a simple two-state unfolding model indi-
cate that a spectroscopically distinct intermediate
does not accumulate to any significant effect. On the
basis of the fact that the thermal aggregates are rich
in -sheet structure, we propose that aggregation
occurs because of fluctuations in the native state en-
semble, leading to transient interactions via exposed
-sheets that at high protein concentrations lead to
the formation of massive aggregates. This is similar
to a model proposed for interferon-.6 What is the na-
ture of these -sheet interactions? On the one hand,
the end-state of the aggregation process binds to the
(relatively) fibril-specific dyes thioflavin T and
Congo red, indicating the existence of relatively or-
dered -sheet structures. On the other hand, these pu-
tative -sheet contacts are unlikely to be as regular as
seen for the amyloid state, given that the dyes do not
have any effect on the aggregation process. One
might otherwise have expected that these dyes
could disfavor aggregation in view of their ability
to inhibit fibrillation of e.g. the A peptide and hun-
tingtin.38 It is possible that the well-organized -
sheet structures form at a later stage and the early
and rate-limiting formation of intermolecular con-
tacts is driven by more unspecific hydrophobic con-
tacts, such as surface patches found in the native
state. These patches are likely to be covered by
ANS, reducing the prevalence of intermolecular
contacts. Such patches are also found in lipase
because of its hydrophobic binding site for sub-
strates but are lacking in lysozyme and -amylase,
thus explaining the different behaviors of these pro-
teins close to their pI.
Aggregation occurs rather abruptly according to
SLS data, suggesting that the process may depend on
the formation of small nuclei whose formation then
lead to an onrush of aggregation. This is compatible
with the remarkable efficacy with which ANS sup-
presses aggregation of cutinase at molar ratios of less
than 1 ANS per cutinase molecule. Formation of a
propagation-competent aggregation nucleus will be
very sensitive to the presence of even small amounts
of ANS, which can interfere with the intermolecular
contacts, e.g. by binding in the interface between dif-
ferent cutinase molecules. It is also possible that
Table III Effect of ANS on Cutinase Activity
Towards p-NPB
[ANS] (M)
vmax
(DOD410 min
1
M1)1a,b KM (M)
a,b
0 0.6386 0.024 0.121 6 0.009
20 0.4836 0.015 0.135 6 0.008
a Experiments carried out at pH 8.0 and 208C using 3 nM cuti-
nase.
b Values obtained as described in Materials and Methods.
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binding of ANS (at least at low ANS:protein ratios,
see later) leads to an overall tightening of cutinase
structure, as seen for bovine serum albumin,25 and
suppressing the structural fluctuations that may en-
courage intermolecular contacts.
Kinetic studies on the aggregation of cutinase dur-
ing refolding from the chemically denatured state
suggest that the rate-limiting step is the formation of
dimers (R.B. and D.E.O., unpublished data). In con-
trast, a previous study on carbonic anhydrase only
saw an aggregation-suppressing effect at 150-fold
molar excess of ANS, and only a miniscule fraction
of activity was retained upon cooling.17 The key to
this difference may be that carbonic anhydrase does
not have any obvious binding sites on the surface,
since its substrate (hydrated carbon dioxide) is not a
large hydrophobic molecule. In contrast, ANS binds
so strongly to cutinase that we observe a titration
rather than a binding isotherm. The hydrophobicity is
so pronounced that several molecules of ANS are
able to bind, and this eventually destabilizes the pro-
tein when ANS is present in excess, possibly because
binding occurs in a cooperative fashion, leading to
the partial exposure of otherwise buried parts of the
protein and thus an interference with otherwise stabi-
lizing side-chain contacts. Similarly, the dye bis-
ANS, consisting of two fused ANS molecules, is able
to induce conformational changes and destabilization
upon binding.20 Thus, ANS is not a universal pana-
cea against aggregation of proteins, but appears to be
most appropriate when the protein is able to bind the
dye in the native state. At the more general level,
1,8-ANS may prove to be a useful aggregation-sup-
pressor for the large number of proteins, which bind
hydrophobic or amphiphilic substrates, including
both lipolytic enzymes and lipid-transporter mole-
cules. In the case of cutinase, ANS should only be
used at equimolar concentrations to avoid destabili-
zation of the protein, but the optimal stoichiometric
ratio must be obtained empirically from protein to
protein. At low and high pH where aggregation of
cutinase does not occur, osmolytes such as trehalose
can be used as stabilizers. At these pH values, cuti-
nase stability increases steadily with increasing tre-
halose concentrations and this effect has been
assigned to a shift in the equilibrium towards the
native state.39,40
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ABSTRACT: Novispirin G-10 is an 18-residue designed cationic peptide derived from the N-terminal part
of an antimicrobial peptide from sheep. This derivative is more specific for bacteria than the parent peptide.
We have analyzed Novispirin’s interactions with various amphipathic molecules and find that a remarkably
wide variety of conditions induce R-helical structure. Optimal structure induction by lipids occurs when
the vesicles contain 40-80% anionic lipid, while pure anionic lipid vesicles induce aggregation. SDS
also forms aggregates with Novispirin at submicellar concentrations but induces R-helical structures above
the cmc. Both types of aggregates contain significant amounts of -sheet structure, highlighting the peptide’s
structural versatility. The cationic detergent LTAC has a relatively strong affinity for the cationic peptide
despite the peptide’s net positive charge of +7 at physiological pH and total lack of negatively charged
side chains. Zwitterionic and nonionic detergents induce R-helical structures at several hundred millimolar
detergent. We have solved the peptide structure in SDS and LTAB by NMR and find subtle differences
compared to the structure in TFE, which we ascribe to the interaction with an amphiphilic environment.
Novispirin is largely buried in the SDS-micelle, whereas it does not enter the LTAC-micelle but merely
forms a dynamic equilibrium between surface-bound and nonbound Novispirin. Thus, electrostatic repulsion
can be overruled by relatively high-detergent concentrations or by deprotonating a single critical side
chain, despite the fact that Novispirin’s ability to bind to amphiphiles and form R-helical structure is
sensitive to the electrostatics of the amphiphilic environment. This emphasizes the versatility of cationic
antimicrobial peptides’ interactions with amphiphiles.
Widespread use of conventional antibiotics has resulted
in an increasing number of multiresistant microorganisms
that pose a problem when dealing with infections and sepsis.
In the search for alternatives to traditional antibiotics,
antimicrobial peptides (AMPs)1 have emerged as a possible
solution (1). These peptides are a part of the innate immune
system of almost all kingdoms, ranging from bacteria to
animals, indicating that AMPs are an important part of
evolution (2). The AMPs offer a quick immune response to
a broad range of microbes. This is important because the
activation of the pathogenic immune response is slow
compared to microbial proliferation (3). AMPs show enor-
mous sequence diversity but have been classified into four
groups. These include linear peptides with or without a
hydrophobic C-terminus which form R-helices upon binding
to membranes, peptides containing a rigid antiparallel -sheet
held together by disulfide bonds, and linear peptides rich in
one or two amino acids such as Trp, Pro, or Arg (2).
Whatever their structure, AMPs tend to be both amphi-
pathic and cationic. Amphipathicity increases their affinity
for biological membranes, while the positive charge increases
their specificity toward negatively charged bacterial mem-
branes, instead of the more neutral membrane surrounding
eukaryotic cells. Interestingly, this preference for negatively
charged membranes is also seen for aggregating proteins such
as R-synuclein (4), and the ability of such proteins to bind
and permeabilize membranes has been suggested to be a
central phenomenon in the development of Parkinson’s
Disease and other dementias (5). Unfortunately, several
AMPs have shown cytotoxic and hemolytic effect. Current
models of AMP action suggest that the peptides bind and
disrupt the cell membrane, either by forming holes through
† Daniel E. Otzen is supported by the Villum Kann Rasmussen
Foundation and the Danish Research Foundation. Financial support from
the Obel Foundation to both R.W. and D.E.O. is gratefully acknowl-
edged.
* To whom correspondence should be addressed. E-mail: dao@
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1 Abbrevations: 2QF-COSY, double quantum filtered correlation
spectroscopy; AMP, antimicrobial peptide; ATR, attenuated total
reflection; CD, circular dichroism; CMC, critical micelle concentration;
DM, dodecyl maltoside; DOPC, 1,2-dioleoyl-sn-glycero-3-phospho-
choline; DOPE, 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine; DOPG,
1,2-dioleoyl-sn-glycero-3-[phosphor-rac-(1-glycerol)]; DPS, 3-(dode-
cyldimethylammonio)propanesulfonate; EDTA, ethylenediamine tet-
raacetate; HPLC, high-performance liquid chromatography; IPTG,
isopropyl--D-thiogalactopyranoside; KSI, kesteroid isomerase; LTAB,
lauryl-trimethylammonium bromide; LTAC, lauryl-trimethylammonium
chloride; MALDI-TOF, matrix-assisted laser desorption ionisation-time-
of-flight; NOESY, nuclear Overhauser effect spectroscopy; NPN, 1-N-
phenylnaphthylamine; PAGE, polyacryl gel electrophoresis; PBS,
phosphate buffer saline; PFG, pulsed field gradient; SDS, sodium
dodecyl sulfate; TFA, trifluoro acetic acid; TFE, 2,2,2-triflour ethanol;
TOCSY, total correlation spectroscopy.
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the membrane (the barrel-stave model) or by disturbing the
lipid arrangement in the outer leaflet (the carpet model),
leading to growth inhibition or lysis (6-8). Until now, only
very little resistance has been observed against AMPs (9),
and the few reported cases involve a reduction in the amount
of acidic lipids or the production of specific digestive
proteases (2).
Besides their direct antimicrobial effect, the AMPs have
also proven to have other important roles such as stimulation
of adaptive immunity by recruiting memory T-cells and
immature dendrite cells (10), binding to and inactivating toxic
bacterial lipopolysaccharides (11), and binding to cellular
receptors and activating signaling pathways (12).
A number of biophysical features have emerged that
influence the interaction between AMPs and membranes.
First, electrostatic attraction is very important for initial
binding to the membrane surface. Work with synthetic
liposomes suggest that negative lipids must be included to
achieve high affinity, while screening charge by the presence
of salt can reduce or destroy AMP antimicrobial activity
(13-15). Second, interactions with the hydrophobic parts
of the membrane are important for the energetics of pore
formation. The specific composition of the membrane can
be expected to affect the energetics of pore formation through
parameters such as bilayer thickness and degree of order,
curvature strain, and adsorption energy (8, 16, 17). Thus,
incorporation of PE lipids, which leads to reduced strain in
the surface-bound peptide-lipid complex, increases the
[peptide]/[lipid] ratio needed for pore formation (18), while
DOPC encourages membrane insertion to a larger extent than
the thinner DLPC (19). In addition, physiological features
such as membrane proteins, periplasmic components, mem-
brane potential and pH gradients, efflux pumps, and so forth
(20) can also influence the process of membrane insertion.
Detergents mimic the amphiphilic nature of lipids, but do
not provide the bilayer environment needed for pore forma-
tion by AMPs. Thus, the interaction between detergents and
R-helical AMPs allows us to focus on the first stage of the
pore-forming process, namely, binding and formation of
R-helical structure. Because of the cationic nature of the
AMPs, the anionic detergent SDS is the most popular deter-
gent for such studies (21), although a zwitterionic detergent
like dodecylphosphocholine can also induce R-helical struc-
ture at similar detergent concentrations (22). In contrast,
nonionic detergents are generally not so effective at inducing
structure (23), and cationic detergents have, to our knowl-
edge, not been reported to interact significantly with cationic
microbial peptides (24).
Micellar SDS has, for a long time, been known to stabilize
R-helical conformations, even in peptides derived from
-sheet structures (25). For cationic sequences, this has been
shown to be mediated by stable salt bridges between
positively charged amino acids and the sulfate group of SDS
(26), while more hydrophobic sequences probably penetrate
into the hydrophobic micellar core (27). Because of the
specific interactions involved, detergent chain length and
headgroup structure can influence the degree of R-helicity
of the bound peptide. For example, the helical part of a 15-
residue membrane targeting peptide was one residue shorter
in sodium nonanesulfonate and 3 residues shorter in sodium
hexanesulfonate than in SDS (28); SDS was also shown to
lead to a structure closest to that observed in the presence
of the short chain lipid didecanoyl phosphocholine. The small
size of the peptide relative to the detergent means that the
micelle size is hardly influenced by the peptide (28).
Novispirin is a synthetic peptide (sequence KNLRR IIRKI
IHIIK KYG), developed in several steps from the N-terminal
part of the 29 residue R-helical AMP SMAP-29 found in
sheep. SMAP has shown unusually potent antimicrobial
activity (29), but its haemolytic and cytotoxic properties have
excluded use in humans. Therefore, residues have been
introduced which enhance helix stability and create a more
pronounced gradient of hydrophobicity along the backbone.
This resulted in enhanced bacterial activity and salt tolerance,
and the additional Ile f Gly mutation in position 10
decreased haemolytic activity sufficiently to make it a
suitable candidate for human use (30). The structure of
Novispirin in 40% TFE reveals an R-helix from residue 3
to 11, a hinge formed by His12 and Ile 13, and a 310 helix
from residue 14 to 16 (30). Alcohols such as TFE are known
to stimulate R-helix formation (31, 32), probably due to the
decrease in solvent polarity which strengthens hydrogen
bonding, as well as direct binding to the peptide or protein.
Here, we describe structural studies on the AMP Novispi-
rin G-10 in the presence of different lipids and detergents.
The objective was to obtain a better understanding of the
relative contributions of electrostatic and hydrophobic effects
when Novispirin folds in an amphiphilic environment. Not
surprisingly, zwitterionic lipids alone are not able to induce
an R-helical structure in Novispirin at experimentally ac-
cessible concentrations, unless at least 20% anionic lipid is
included. Zwitterionic and nonionic detergents induce an
R-helical structure, albeit several orders of magnitude more
weakly than SDS. Interestingly, the cationic detergent LTAC
is able to induce R-helical structure in Novispirin at detergent
concentrations comparable to SDS, although there were
subtle changes in the far-UV CD spectrum. We therefore
carried out a comparative analysis of the structure and micelle
interactions of Novispirin in SDS and LTAB by NMR
spectroscopy. To our knowledge, this is the first atomic-
level study to address interactions between cationic detergents
and antimicrobial peptides.
The peptide formed a helical secondary structure in both
SDS and LTAB, although the [detergent]/[peptide] ratio
needed to induce secondary structure formation was much
higher in LTAB than in SDS. Several NMR techniques were
applied to gather information about the relative positioning
of the peptide within/on the detergent micelle: HN-exchange,
NOE cross-peaks between the peptide and the lipid, and the
addition of paramagnetic ions. These techniques revealed that
Novispirin is, to a good part, buried in the SDS-micelle,
whereas it does not enter the LTAB-micelle but forms a
dynamic equilibrium between surface-bound and nonbound
Novispirin. Such a dynamic equilibrium can explain how
detergents can override electrostatic repulsion at sufficiently
high-detergent concentrations.
MATERIALS AND METHODS
Materials. All lipids, namely, DOPC, DOPE, and DOPG,
were from Avanti Polar Lipids (Alabaster, AL). Sodium-
dodecyl-d25-sulfate, LTAC, DPS, NPN, and Lipopolysac-
charide EH100 from Escherichia coli were from Sigma. DM
was from Calbiochem and TFE from Aldrich. All chemicals
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were of the highest grade available. LTAB-d25 (deuterated
only on the dodecyl chain but not on the methyl groups)
was obtained from QMX Laboratories (U.K.). Note that
LTAB-d25 was only used for NMR experiments, where
deuterated detergent was necessary due to the availability
of the deuterated form; for other experiments, LTAC was
used due to its lower absorption in the far-UV area.
Cloning, Expression, and Purification of NoVispirin G-10.
For economy of scale, Novispirin G-10 (KNLRRIIRKGI-
HIIKKYG) was produced recombinantly in E. coli as
inclusion bodies. This was achieved through gene-fusion with
a fragment of KSI using the commercially available plasmid
pET31b+ (www.novagen.com). To facilitate downstream
processing and recovery of Novispirin G-10, the Novispirin
G-10 gene was preceded by an aspartate-proline (DP)
dipeptide, followed by an aspartate-glutamate dipeptide
(DE). Thus, the gene-fusion construct encodes the follow-
ing: KSI-D-P-D-E-NovispirinG-10. The DP dipeptide
is prone to mild acid hydrolysis at elevated temperatures (33,
34), and the glutamic acid residue located immediately
upstream of the Novispirin G-10 is substrate of a glutamyl
endopeptidase I.
The expression plasmid was constructed using the fol-
lowing oligonucleotides encoding Novispirin G-10: (5′-ATT
ATT CAG ATG CTG GAT CCG GAC GAA AAA AAC
CTG CGT CGC ATT ATC CGC AAA GGC ATC CAT
ATC ATT AAA AAA TAT GGC TAA TAA CTC GAG
ATT ATT-3′ and 5′-AAT AAT CTC GAG TTA TTA GCC
ATA TTT TTT AAT GAT ATG GAT GCC TTT GCG GAT
AAT GCG ACG CAG GTT TTT TTC GTC CGG ATC
CAG CAT CTG AAT AAT-3′). Enzymatic digestion of
introduced flanking restriction endonuclease sites (AlwNI/
AvaI) enabled the cloning of the synthetic gene as a fusion
construct in pET31b+ (standard procedures as described by
the manufacturer (New England Biolabs, Inc., MA)). All
standard protocols have been described elsewhere (35).
Recombinant pET31b+ was transformed into E. coli
Novablue as described by the manufacturer (Novagen).
Plasmids were recovered by QIAprep Mini Columns
(QIAGEN, Inc., CA) and sequenced by automated sequenc-
ing using plasmid-specific primers (5′-TGC TAG TTA TTG
CTC AGC GG-3′ and 5′-ACC GTA GTT GCG CCC ATC
G-3′). Recombinant plasmid was transformed in E. coli BLR-
DE3 according to the manufacturer (Novagen). Bacteria were
cultivated in LB media to OD600 ∼ 0.8, and recombinant
protein synthesis was initiated by 1 mM IPTG. Three hours
after induction, bacteria were harvested, resuspended in 1/10
volume buffer A (50 mM Tris-HCl, 1 mM EDTA, and 100
mM NaCl, pH 8), and lysed by pressure disruption (1500
mbar). The DPDE-Novispirin G-10 is located in inclusion
bodies, which were isolated by centrifugation at 24 000g for
2 h. The resulting inclusion body pellet was washed twice
in buffer B (50 mM Tris-HCl, 10 mM EDTA, 0.5% Triton
X-100, and 100 mM NaCl, pH 8). All standard protocols
have been described elsewhere (35).
The PDE-Novispirin G-10 was liberated from the inclu-
sion bodies by hot acid hydrolysis, which cleaves specifically
between Asp-Pro. This sequence was introduced between
the KSI (ketosteroid isomerase) fusion partner and N-
terminally to the synthetic gene encoding Novispirin G-10.
For hot acid hydrolysis, inclusion bodies were resuspended
in 100 mM sodium phosphate (pH 2.3) and incubated
overnight at 85 °C. Resulting supernatant contained PDE-
Novispirin G-10. The sample was neutralized by adding 100
mM sodium phosphate (pH 12.3). The peptide was matured
with a glutamyl endopeptidase I from Bacillus licheniformis
(36) produced by Novozymes A/S.
The matured octadecapeptide was purified by cation-
exchange chromatography, as follows. The Novispirin G-10
and glutamyl endopeptidase mixture was adjusted to pH 6
and 7 mS/cm prior to application to a CM-sephadex column
(Amersham Biosciences). Novispirin G-10 was eluted with
a 0-1 M NaCl gradient in 50 mM malonic acid, pH 6, over
10 CV. The fractions were analyzed by MALDI-TOF mass
spectrometric analysis (for Novispirin identification) and
SDS-PAGE (for high MW impurity detection). The selected
fractions were pooled and desalted on Sephadex-G10 column
(Amersham Biosciences) equilibrated with PBS, pH 7.4 (50
mM phosphate buffer and 150 mM NaCl). Again the
fractions were analyzed by MALDI-TOF mass spectrometric
analysis and pooled. The Novispirin G-10 pool was analyzed
for purity by SDS-PAGE and RP-HPLC (Jupiter, 5 μm,
C18 300 Å, 150 mm × 2 mm, 50 min gradient from 8 to
80% acetonitrile in 0.1% triflouric acid, flow of 0.15
mL/min, λ ) 214 nm). The identity of the peptide was
determined by automated N-terminal sequencing using a
Procise automatic sequencer (Applied Biosystems Division,
Perkin-Elmer), and the concentration was determined by
amino acid analysis performed on a Biochrom 20 Plus
(Biochrom, Ltd.).
MALDI-TOF Mass Spectrometric Analysis. A 0.5 mL
sample was spotted onto a stainless steel target plate. A
volume of 0.5 μL of 10 mg/mL 4-hydroxy-R-cyano-cinna-
pinic acid (HCCA) in 50% acetonitrile and 0.1% TFA was
subsequently mixed with the sample on the target plate. The
sample spots were allowed to dry at room temperature before
analysis (dried droplet method). MALDI analyses were
performed on a Voyager DE Pro mass spectrometer with
delayed extraction technology and a 337 nm N2 laser
producing 3 ns pulses with a repetition rate of 20 Hz (Applied
Biosystems). The instrument was run in reflective mode with
positive ionization. External calibration was applied using
CalMix2 (Applied Biosystems).
Preparation of Vesicles. Synthetic lipid samples were
mixed from stock solutions of lipids dissolved in methanol
and dried overnight in a Heto VR-1 centrifuge vacuum drier.
Lipids were then resuspended by vortexing in 20 mM sodium
phosphate, pH 7.5, to a final concentration of 5 g/L (∼7
mM), exposed to at least seven cycles of freezing in liquid
nitrogen, followed by thawing in a 55 °C water bath, before
extrusion through a 100 nm pore filter (Nucleopore track
etch membrane (Whatman)) 12 times using a 10 mL
thermobarrel extruder (Northern Lipids, Vancouver, Canada).
Vesicle sizes were confirmed by dynamic light scattering
(DynaPro 99, ProteinSolutions). All extruded vesicles were
used within 2 days of production. E. coli total lipid extract
was not extruded due to its high content of phosphoethano-
lamine lipids but was subjected to 60 min of sonication in a
sonication bath after the freeze-thaw step. This yielded a
clear solution of vesicles with a hydrodynamic radius of
around 75 nm as measured by dynamic light scattering.
CD Spectroscopy. All experiments were carried out in 20
mM sodium phosphate, pH 7.5, at 25 °C unless otherwise
stated. Experiments at pH 11 were carried out using 20 mM
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Gly as buffer. Equilibrium circular dichroism studies were
performed on a Jasco J-810 spectropolarimeter (Jasco
Spectroscopic Co., Hachioji City, Japan) with a Jasco PTC-
348W1 temperature control unit. At least four scans were
averaged to yield the final spectrum. Unless otherwise stated,
the peptide concentration was 40 μM, and a 1 mm quartz
cuvette was used.
FTIR Spectroscopy. All experiments were carried out in
20 mM Tris, pH 7.5, at 25 °C and at a peptide concentration
of 40 μM. Fourier transform infrared spectroscopy was
carried out on a Bruker Tensor 27 infrared spectrometer
(Bruker Optik GmbH, Ettlingen, Germany) with a Specac
Golden Gate single-reflection ATR unit (Specac, Ltd.,
Orpington, U.K.). The peptide was precipitated in 0.75 mM
SDS or 1 mM DOPG. Aggregates were isolated by cen-
trifugation and resuspended in 0.75 mM SDS or 0.2 mM
DOPG. Samples were prepared by drying on the ATR surface
under a gentle stream of nitrogen. Spectra were recorded
with 128 accumulations and analyzed using OPUS 5.5
software (Bruker Optik GmbH, Ettlingen, Germany). For the
DOPG samples, a DOPG spectrum was collected and
subtracted from the sample spectra to remove the CdO peak
at 1740 cm-1. Estimates of secondary structure were obtained
by fitting of Gaussian curves by the Levenberg Maquardt
method. The number of bands and the positions were
determined from the second derivative spectrum and by
Fourier self-deconvolution as described (37). Bands were
grouped by secondary structure type, and the relative band
area percentages were calculated.
For comparison with results from CD spectroscopy,
transmission spectra were recorded in D2O using 2 mg/mL
Novospirin in 85 mM SDS and 20 mM Tris, pH 7.5.
Determination of Critical Micelle Concentration (Cmc).
Cmc was determined by monitoring the conductivity as a
function of detergent concentration in the appropriate buffers
using a CDM210 conductivity meter (Radiometer, Denmark).
The cmc was defined as the detergent concentration where
the increase in conductivity with detergent concentration
kinks to a lower slope.
Data Analysis. To obtain a quantitative measure of the
affinity of Novispirin for different lipids and detergents,
titration data (CD signals versus detergent or lipid concentra-
tion) were fitted to the following equations.
(1) Hyperbolic binding (only for LPS, DM, DPS, and
LTAC):
where ΔS is the signal change between the free and bound
Novispirin and Kd is an apparent binding constant.
(2) Cooperative binding (sigmoid curve):
where Sstart and Send are the CD values at low- and high-
lipid concentrations, respectively, concentration L, L50% is
the concentration at which the transition is halfway to
completion, and c is the cooperativity constant. The lower c
is, the more gradual the transition.
NMR Recording. All NMR spectra were recorded on a
BRUKER DRX600 spectrometer operating at a field strength
of 14.1 T, equipped with a TXI(H/C/N) probe with triple-
axis gradients. Spectra were processed using XWinNMR 2.6
and 3.6.
Titration of NoVispirin in LTAC. 1. Constant pH. A sample
of novispirin was dissolved in 550 μL of a solution
containing 80 mM NaCl, 3 mM NaN3, 20 mM phosphate
buffer, and 5% D2O. The peptide concentration was 2.5 mM.
The pH was adjusted to 5.7 by addition of 1 M H3PO4. Solid
LTAC was added in small amounts directly into the NMR
sample tube. The volume increase (20% at 1 M LTAC) was
estimated by help of a graduated sample tube; LTAC
concentrations were corrected for the increase in volume.
No measures were taken to keep the peptide or salt
concentrations unchanged. For each concentration of LTAC,
a 1D NMR spectrum and a diffusion spectrum were
measured. The 1D NMR spectrum was measured using
excitation-sculpting water suppression (38) and selective
excitation of the region from 6 to 9 ppm by an off-resonance
Q5 pulse (39) of 3.14 ms duration. This ensured maximum
sensitivity on the peptide HN/aromatic signals by leaving
detergent magnetization in the longitudinal state. Experi-
mental details of the diffusion measurements are described
below.
2. Constant [LTAC]. A sample of novispirin was dissolved
in 550 μL of a solution containing 270 mM LTAC, 80 mM
NaCl, 3 mM NaN3, 20 mM phosphate buffer, and 5% D2O.
The peptide concentration was 2.5 mM. The pH was brought
to 9 by addition of 1 M NaOH; thereafter, pH was brought
to 4.6 in steps of approximately 0.5 pH units by addition of
1 M H3PO4. A 1D NMR spectrum was measured using
excitation-sculpting water suppression (38) and selective
excitation of the region from 6 to 9 ppm by an off-resonance
Q5 pulse (39) of 3.14 ms duration at each pH value. The
solution was diluted by approximately 7% in the course of
the titration; no action was taken to compensate for this.
Structure Determination. 1. SDS. The NMR sample was
prepared by dissolving novispirin in 350 μL of a 300 mM
SDS-d25 (Sigma-Aldrich), 300 mM NaCl, 3 mM NaN3, and
20 mM phosphate buffer solution containing 5% D2O. The
pH of the solution was brought to 4.6 by addition of 1 M
H3PO4. A 2D NOESY spectrum with 70 ms mixing time
was recorded with a WATERGATE water suppression (40).
[1H,1H]-TOCSY spectra with 40 and 80 ms mixing time,
respectively, were recorded using the clean-TOCSY sequence
(41) with a 15 kHz spin-lock and a WATERGATE water
suppression. In addition, a 2QF-COSY experiment was
recorded. The assignment was obtained by following the
sequential assignment procedure outlined in ref 42. Spectral
analysis was performed with XEASY (43) and its PC version
NEASY. The temperature for the experiments with SDS was
chosen to be 50 °C, since signal intensities at lower
temperatures were dissatisfactory, probably due to fast
transverse relaxation brought about by high correlation times
of the large micellar particles.
2. LTAB. The NMR sample with LTAB was prepared by
adding LTAB-d25 to a final concentration of 1 M to a solution
of 3.1 mM Novispirin in 20 mM phosphate buffer containing
80 mM NaCl and 3 mM NaN3. The pH was brought to 5.7
by addition of 1 M H3PO4. The necessary concentration of
LTAB had been determined by titrating a Novispirin sample
S ) Sstart + ΔS
[det]
[det] + Kd
(1)
S )
Send + Sstart10
-c(L-L50%)
1 + 10-c(L-L50%)
(2)
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with LTAC until the amide protons of Novispirin showed a
satisfactory chemical shift dispersion (see Results). A 2D
NOESY spectrum with 70 ms mixing time was recorded with
a WATERGATE water suppression (40). [1H,1H]-TOCSY
spectra with 40 and 80 ms mixing time, respectively, were
recorded using the clean-TOCSY sequence (41) with a 15
kHz spin-lock and a WATERGATE water suppression. In
addition, a 2QF-COSY experiment was recorded.
NMR experiments with LTAB were conducted at 25 °C,
since higher temperatures led to a loss of amide proton
signals, presumably due to fast chemical exchange with the
solvent.
Detergent-Peptide Interactions. To investigate interac-
tions between detergent and peptide, 2D NOESY spectra
were recorded on samples with nondeuterated SDS and
LTAC, but otherwise identical conditions as for the structure
determination. In these spectra, the third (and last) 90° pulse
was replaced by an off-resonance Q5 pulse (39) of 3.14 ms
duration selectively exciting a region from 6 to 9 ppm. This
leaves the magnetization of water and detergent nuclei in a
longitudinal state thus minimizing the signal obtained from
them. The remaining water signal was further suppressed
by a WATERGATE element.
HN Exchange. For the experiments determining the HN
exchange, the pH of the sample in SDS-d25 used for the
structure determination was brought up to pH 5.7, which did
not cause large changes in chemical shift. The sample of
Novispirin in LTAB-d25 was used as for the structure
determination. [1H,1H]-TOCSY spectra with 75 ms mixing
time were recorded using the clean-TOCSY sequence (41)
with a 15 kHz spin-lock and a WATERGATE water
suppression. The sample of Novispirin in SDS-d25 was
measured at 50 °C, the sample of Novispirin in LTAB-d25
at 25 °C. As a control, an identical TOCSY spectrum was
recorded on a sample of 2.5 mM Novispirin at pH 5.7
containing 80 mM NaCl and 3 mM NaN3 but no detergent.
The control spectrum was recorded at 50 °C.
Diffusion Measurements. All diffusion measurements were
performed at 17 °C to minimize convection in the sample
tube.
1. SDS. The diffusion constant of Novispirin in SDS was
measured by the convection-compensated, double-stimulated
echo sequence (44). A diffusion delay of 100 ms was
employed. Sine-shaped gradient pulses of 10 ms duration
and 16 different, linearly spaced, strengths ranging from 2.4
to 48 Gcm-1 were used. Unlike the case of LTAB-d25, there
is no strong protonated signal available from SDS-d25.
Therefore, a sample of Novispirin in 284 mM SDS-d25 and
16 mM SDS was prepared for these measurements. The
regions from 3 to 3.2 ppm (Novispirin arginine Hδ2,3) and
1.0-1.4 ppm (SDS 3-11-CH2 with a minor contribution of
Novispirin isoleucine Hγ12) were integrated at each gradient
strength. The latter signal contains contributions from both
SDS and Novispirin (Hγ12 of Ile side chains). Under these
conditions (284 mM SDS-d25 with a degree of deuteration
of 98%, 16 mM SDS, and 2.5 mM Novispirin), assuming
18 SDS H-atoms (3-11-CH2) and 5 novispirin atoms (Hγ12
of Ile side chains) to have their resonance in this area, the
total contribution of the 1H on SDS to this signal is 97%,
while the Novispirin signals only contribute with 3%.
2. LTAC. Diffusion constants of Novispirin in solutions
with increasing amounts of LTAC were measured by the
convection-compensated, double-stimulated echo sequence
(44).
A diffusion delay of 200 ms was employed. Sine-shaped
gradient pulses of 4 ms duration and 16 different, linearly
spaced, strengths ranging from 2.4 to 48 Gcm-1 were used.
The signals at 6.76 ppm (Novispirin Y17 Hε1,2) and 3.05
ppm (LTAC N-(CH3)3) were integrated at each gradient
strength. Diffusion constants were obtained from the fitting
routine in XWinNMR2.6 and 3.6.
Probing Micelle Penetration with Paramagnetic Reagents.
For the experiments with the paramagnetic reagents a
[1H,1H]-TOCSY spectrum with 20 ms mixing time was
recorded using the clean-TOCSY sequence (41) with a 15
kHz spin-lock immediately before the addition of MnCl2 (to
a concentration of 0.5 mM for the sample with SDS and 4
mM for the sample with LTAB) and subsequent recording
of an identical [1H,1H]-TOCSY spectrum. The mixing time
was chosen in order to maximize the intensity of the HN/HR
cross-peaks. The sample of Novispirin in SDS-d25 was
measured at 50 °C, the sample of Novispirin in LTAB-d25
at 25 °C. Identical rectangular regions were integrated in
both spectra, and the integral ratios were determined. Thirty
rectangular regions in empty parts of the spectra were
integrated, and a standard deviation of the integrals was
determined. This was assumed to be the error of the
integration. The error of the ratio was determined from the
errors of the single values as outlined in ref 45.
1. Structure Calculation. NOE cross-peaks were identified,
integrated, and assigned in the aforementioned NOESY
spectra using the program XEASY (43) and the NEASY
subroutine of CARA (46). Backbone torsion angle re-
straints were obtained from secondary chemical shifts using
the program TALOS (47). TALOS-derived angle constraints
were only accepted for residues, where all the 10 best
database hits were situated within the same region of the
Ramachandran plot. A deviation from the TALOS-derived
value of (30° was allowed. The CALIBA (48) subroutine
in CYANA was used to convert cross-peak intensities from
NOESY spectra into distance constraints. The CYANA
subroutine FOUND (49) was used to add angle restraints.
On the basis of this input, the structure was calculated using
the torsion angle dynamics program CYANA (50). Structure
calculations were started from 100 conformers with random
torsion angle values. The 20 conformers with the lowest final
CYANA target function values were embedded in a water
shell of 8 Å thickness and energy-minimized against the
AMBER force field (51) with the program OPALp (52).
No further refinement was performed. The structures were
checked by PROCHECK_NMR (53).
Viscosity Measurements. LTAC micellar diffusion con-
stants were calculated according to the following equation:
where Dobserved is the measured diffusion constant of LTAC,
Dmonomer is the diffusion constant for monomeric LTAC, c is
the concentration of LTAC, and cmc is the critical micelle
concentration (13 mM). Diffusion constants are converted
to hydrodynamic radii by help of the Stokes-Einstein
Dmic )
Dobserved -
cmc
c
Dmonomer
1 - cmc
c
(3)
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equation to account for changes in sample viscosity at
different detergent concentrations:
where Rh is the hydrodynamic radius, k is the Boltzmann
constant, T is the absolute temperature, η is the kinematic
viscosity of the solution, and D is the diffusion constant.
The kinematic viscosity of aqueous solutions of LTAC (0
M e [LTAC] e 1 M) was determined by a Brookfield
Digital Viscosimeter DV-II with a UL adapter. Over the
interval 0-1 M, the viscosity of LTAC solutions could be
fitted to a quadratic curve (data not shown):
RESULTS
Importance of Electrostatic Interactions in NoVispirin-
Lipid Interactions. The first objective of this study was to
compare the ability of lipids and detergents to induce the
R-helical structure observed for Novispirin in TFE (30). This
process is followed by far-UV CD spectroscopy. A repre-
sentative overview of far-UV CD spectra of Novispirin in
different amphiphiles and TFE is shown in Figure 1A,B. We
start by determining optimal conditions for lipid interactions.
In buffer alone, Novispirin only has a weak signal in the
far-UV CD spectrum (Figure 1A), indicative of a very low
degree of organized structure. Pure zwitterionic DOPC lipid
vesicles do not lead to an appreciable increase in Novispirin
structure. This is not surprising, as Novispirin has a net
charge of +7 at pH 7.5 and would be expected to require
negatively charged lipids to bind to vesicles. Nevertheless,
vesicles with 10% DOPG do not alter the Novispirin structure
compared to DOPC alone. However, this changes as we
increase the fraction of anionic lipid. Vesicles containing
20-80% DOPG all show similar spectra with minima at 222
and 209 nm, which are typical of R-helical structure (cf.
spectra shown in Figure 1A). There is a cooperative increase
in CD signal between 0.5 and 1 mM lipid, after which it
reaches a plateau level (shown in Figure 1C for the lipid
mixture containing 80% DOPC and 20% DOPG and sum-
marized in Table 1), corresponding to essentially 100%
R-helix, according to the deconvolution program Continell
(54). There is no isodichroic point (data not shown),
suggesting that the transition involves more than two states.
Thus, the signal changes at the two minima, 207 and 222
nm, though similar, do not coincide completely when plotted
versus lipid concentration (Figure 1C). Note the cooperative
nature of the transition.
In 100% DOPG, Novispirin forms visible aggregates and
the corresponding CD spectrum is significantly altered
FIGURE 1: (A and B) Representative far-UV CD spectra of Novispirin in different amphiphilic environments. The spectrum in 80% DOPC/
20% DOPG is shown in both spectra for ease of comparison. (C) Molar ellipticities of Novispirin at 222 and 207 nm as a function of the
concentration of the lipid mixture 80% DOPC/20% DOPG. Data fitted to eq 1 (as shown in Table 2). (D) Secondary structure of the
Novispirin aggregates formed in 1 mM DOPG (white columns) or 0.75 mM SDS (black column).
Rh )
kT
6πηD
(4)
η(cLTAC) ) 1.13 + 1.23cLTAC + 1.04cLTAC
2 (5)
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(Figure 1A). This structural change already occurs at low
DOPG concentrations, after which no further change is seen
(data not shown). Due to light-scattering artifacts, CD is not
appropriate to analyze protein aggregates. However, an
analysis of the aggregated state by FTIR shows that the
R-helix content is reduced to around 50% with a compensat-
ing rise in -sheet and turns (Figure 1D). FTIR analysis of
Novispirin in solution with SDS shows very little or no
-structure (data not shown). Interestingly, the CD spectrum
in DOPG is very similar to that of Novispirin in E. coli total
lipid extract, which contains around 60% PE lipids and 18%
PG lipids (data not shown). PE lipids do not appear to play
a large role in this structure-induction, since synthetic DOPC
lipids containing 10-20% DOPE showed no increase in
Novispirin structure compared to pure DOPC (data not
shown).
The strong effect of including DOPG clearly indicates
electrostatic interactions between Novispirin and lipids. This
is confirmed by the screening effect of high ionic strength.
In 200 mM NaCl, lipids containing 20% DOPG are unable
to induce R-helical structure in Novispirin, whose far-UV
CD spectrum under these conditions is identical to that in
buffer (data not shown).
Different Modes of Binding of NoVispirin to LPS and TFE.
Previously, it has been shown that components of the cell
wall of Gram-negative and Gram-positive bacteria, namely,
lipopolysaccharides from Pseudomonas aeruginosa and
lipoteichoic acid from Staphylococcus aureus, respectively,
are able to induce R-helical structure in Novispirin at 1 mg/
mL (30). However, it is not clear whether this concentration
is sufficient to saturate the level of helicity. A more
quantitative analysis of the interaction using 0-0.9 mg/mL
LPS from E. coli EH100 (spectrum shown in Figure 1B)
leads to an isodichroic point around 203 nm, suggesting a
simple two-state binding-and-folding model (data not shown).
Fitting the data to this model using three different wave-
lengths (eq 1 and Figure 2A) leads to an apparent Kd of
0.7-1.1 mg/mL, indicating that the structural transition is
around 60% complete at 1 mg/mL (Table 2). The cmc of
LPS is in the low μg/mL range (55), indicating that the
interactions with Novispirin only involve LPS micelles. It
is noteworthy that the affinity of LPS for Novispirin is
comparable to that of DOPC/DOPG vesicles; in both cases,
the transition nears completion around 1 mg/mL LPS or lipid.
For similar quantitative reasons, we titrated Novispirin with
TFE. TFE (33-40%) has been shown to be sufficient to lead
to R-helix formation in Novispirin (30). The spectra between
0 and 60% TFE reveal a very clear isodichroic point around
202 nm (data not shown; spectrum in 60% TFE shown in
Figure 1B) with a cooperative change in the CD signal at
different wavelengths (Figure 2B). A plateau is reached
around 30% TFE with a midpoint around 16-18% (Table
1), indicating that 33-40% TFE is an appropriate condition
for analyzing the NMR structure of Novispirin.
Effect of SDS on NoVispirin. The interaction of Novispirin
with detergents is interesting, since these substances are lipid-
mimetic but more amenable to studies by NMR. Of these,
SDS is particularly appropriate due to its well-documented
ability to induce R-helical structure. SDS also induces clear
R-helical structure in Novispirin in the low millimolar range
(Figure 1B). While the 190 and 222 nm data reveal a
cooperative transition which can be fitted to eq 2, the data
at 207 nm can be divided into three regions, namely, a
plateau around 0-0.5 mM, followed by a rather abrupt jump
to another plateau between 0.5 and 1.4 mM SDS, leading
via a broader transition to a plateau above ca. 2.4 mM (Figure
2C). The midpoint of around 1 mM is only about twice as
high as for the vesicles with the highest affinity for
Novispirin, namely, 20% DOPC and 80% DOPG (Table 1).
Since the cmc of SDS is 2.4 mM under our buffer conditions
(20 mM NaP, pH 7.5), SDS is predominantly monomeric in
all these regions. There is visible precipitation in the plateau
region between 0.5 and 1.4 mM SDS (where the [SDS]/
[Novispirin] goes from 12 to 35), confirmed in Figure 2D
where it was possible to spin down most of the protein in
this detergent range. An FTIR analysis revealed that the
R-helix content had decreased to around 40% together with
a similar amount of -sheet as well as some turns and
disordered structure (Figure 1D). This contrasts with an
R-helical content close to 100% at higher SDS concentrations
where Novispirin is soluble.
Unlike the case for lipids, the interaction between No-
vispirin and SDS must involve hydrophobic as well as
electrostatic interactions, since addition of up to 500 mM
NaCl had no significant effect (data not shown).
Neutral and Zwitterionic Detergents Induce Structure at
Higher Concentrations. Interestingly, the neutral detergent
dodecyl maltoside as well as the zwitterionic detergent DPS
(3-(dodecyldimethylammonio)propane sulfonate) induce R-he-
lical structure, although this requires much higher detergent
concentrations than SDS. Both detergents show dichroic
points around 204 nm (data not shown; representative spectra
shown in Figure 1A), and the solutions show no visible pre-
cipitation. Data follow a hyperbolic binding curve with a
midpoint around 140-210 nm (DM, Figure 3A) or 82-120
mM (DPS, Figure 3B), which is around 100-200 times as
high as for SDS, as well as being high above the cmc of
these detergents (0.17 and 4 mM for DM and DPS,
respectively).
Ability of LTAC To Induce Structure in NoVispirin and
Role of Electrostatics. Remarkably, the cationic detergent
LTAC clearly induces R-helical structure in Novispirin
(Figure 1B), even under conditions where there is a high
positive charge on the peptide. At pH 7.5 (overall charge:
ca. +7), salt reduces the binding and R-helical folding of
Novispirin, but at pH 11 (overall charge ca. +2), salt does
not have any significant effect. Helix formation occurs earlier
in the presence of salt at pH 11, but this partly reflects NaCl’s
Table 1: Cooperative Unfolding Parameters for Novispirin in
Different Environments
amphiphile
concentration
units
wavelength
(nm) ca L50%b
20% DOPC,
80% DOPG
mM 207 15.5 ( 4.9 0.53 ( 0.01
20% DOPC,
80% DOPG
mM 222 8.0 ( 3.2 0.45 ( 0.02
TFE % (v/v) 222 0.12 ( 0.04 16.6 ( 1.5
TFE % (v/v) 207 0.13 ( 0.06 17.7 ( 0.4
TFE % (v/v) 190 0.11 ( 0.04 18.0 ( 060
SDS mM 222 1.33 ( 0.36 0.98 ( 0.09
SDS mM 207 4.8 ( 4.3 1.94 ( 0.09
SDS mM 190 0.68 ( 0.25 1.31 ( 0.17
a The cooperativity constant (eq 2). The lower c is, the more gradual
the transition. b The concentration at which the binding transition is
halfway to completion (eq 2).
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reduction of LTAC’s cmc due to its ability to reduce
electrostatic repulsion between headgroups (Figure 3C, Table
3). As seen for the zwitterionic and nonionic detergents, there
is a dichroic point and no precipitation (data not shown).
NMR Assignment and Structure Calculation. A comparison
of the far-UV CD spectra of Novispirin in different detergents
and solvents reveals that, although the same overall helical
structure is observed, there are subtle changes in the
distribution of minima (Figure 1B). The spectra in SDS, LPS,
and lipid fall in one class, whereas those in LTAC and TFE
fall into their own separate classes. Since only the structure
of Novispirin in TFE is known in any detail, we have
determined the structure of Novispirin in deuterated SDS
and LTAB to analyze the effect of detergents on Novispirin
structure in more detail. Note that LTAB was only used for
NMR experiments that require deuterated detergents, due to
the availability of the deuterated form; for all other experi-
ments, LTAC was used because of the prohibitively high
absorption of LTAB in the far-UV area.
The concentration of LTAC necessary for helix formation
strongly depends on the pH. The presence or absence of
secondary structure can be assessed from the HN region of
a 1H NMR spectrum. A high dispersion of chemical shifts
as found in the spectrum of Novispirin in 1030 mM LTAC
at pH 5.7 (Figure 4) is indicative of the presence of secondary
structure, while a low dispersion of chemical shifts as found
in the spectrum of Novispirin at pH 5.7 in the absence of
LTAC (Figure 4) points at a random-coil structure. The NMR
spectrum of Novispirin in 270 mM LTAC at pH 7.5 clearly
indicates the presence of secondary structure. This structure
is lost upon titration toward the acidic range (Figure 4 and
CD, data not shown). This loss of secondary structure can,
however, be reversed by adding larger quantities of LTAC
(Figure 3C and Figure 4). We therefore chose pH 5.7 and
1030 mM LTAB-d25 as suitable conditions for determining
Novispirin’s structure by NMR.
In SDS, Novispirin retains the same helix-rich CD signal
down to pH 3 unaltered (data not shown). NMR analysis
FIGURE 2: (A) Molar ellipticity of 40 μM Novispirin as a function of lipopolysaccharide from E. coli. Data fitted to eq 1 (results in Table
3). (B) Molar ellipticity of 40 μM Novispirin as a function of TFE. Data fitted to eq 2. (C) Molar ellipticity of 40 μM Novispirin as a
function of SDS. Data for 190 and 222 nm are fitted to eq 2, while data at 207 nm are joined up for clarity. Data are restricted to 0-3 mM
for clarity; there are no further transitions beyond 3 mM SDS. Increasing the Novispirin concentration to 400 and 1140 μM leads qualitatively
to the same transitions, although the spectral changes occur later at higher SDS concentrations. (D) Solubility of 40 μM Novispirin as a
function of SDS concentration. Novispirin was incubated at different SDS concentrations and centrifuged, and the absorbance (joined lines)
and ellipticity at 207 nm (stippled lines) of the supernatant were measured.
Table 2: Kd Values for Binding of Novispirin to Detergents
Showing Hyperbolic Unfolding Curvesa
wavelength LPS (mg/mL) DM (mM) DPS (mM)
222 0.67 ( 0.94 190 ( 50 120 ( 20
207 0.80 ( 0.90 210 ( 160 110 ( 25
190 (195.4) 1.15 ( 0.60 140 ( 30 82 ( 22
a Kd is defined in eq 1.
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was carried out at pH 4.7. The 1H atoms of Novispirin in
SDS could be assigned with the following exceptions: K1
(all protons), N2 HN, K9, K15, and K16 side-chain atoms
(H,Hγ,Hδ,Hε,H). All lysine signals were extremely weak;
some lysine side-chain signals could be found but not
unambiguously assigned. A set of 20 structures was calcu-
lated. Table 4 lists some quality criteria for the structure.
The structure shows two well-defined helical regions, whose
orientation toward each other was not defined (see Figure
5A). The first helix stretches approximately from residue 2
to 9, the second helix from residue 12 to 17. Residues 10
and 11 form a hinge. From the sequence plot (Figure 6A), it
can be seen that helix 1 is well-defined with many dRN(i,i+3)
FIGURE 3: (A) Molar ellipticity of Novispirin as a function of DM.
Data fitted to eq 1. (B) Molar ellipticity of Novispirin as a function
of DPS. Data fitted to eq 1. (C) Titration of Novispirin with LTAC
under different conditions: pH 5.7, 0 mM NaCl (×); pH 7.5, 0
mM NaCl (b); pH 7.5, 200 mM NaCl (O); pH 11, 0 mM NaCl
(9); pH 11, 200 mM NaCl (0). Asterisks indicate cmc of LTAC
under the various experimental conditions. Note the logarithmic
scale.
Table 3: Interactions between Novispirin and LTAC at Different
pH Values and Ionic Strengths
pH
[NaCl]
(mM)
CMC
[mM] Ca
L50%a
(mM)
[θ]end (deg cm2
dmol-1 residue-1)
5.7 0 14.3 -b -b -b
7.5 0 16.8 0.17 ( 0.02 17.3 ( 0.3 -19.5 ( 0.3
7.5 200 8.4 (low) 40.5 ( 4 -23.5 ( 0.5
11 0 23 0.20 ( 0.02 17.3 ( 0.2 -25.8 ( 0.3
11 200 7 0.49 ( 0.03 7.0 ( 0.07 -26.4 ( 0.2
a Defined in legend to Table 1 and eq 2. b Transition not complete.
FIGURE 4: HN/aromatic region of the 1H NMR spectrum of
Novispirin. Left panel: constant 270 mM of LTAC, decreasing
pH. Right panel: constant pH 5.7, increasing concentrations of
LTAC. The spectra were obtained using excitation-sculpting water
suppression (38) and a selective Q5 pulse of 3.14 ms duration
exciting only the region from 6 to 9 ppm.
Table 4: Quality Criteria for the Calculated Novispirin Structures
detergent SDS LTAB
number of distance constraints 168 131
- of which intraresidual 96 77
- of which sequential 37 35
- of which medium-range (2 e Δres e 4) 35 19
number of angle constraintsa 20 18
- of which φ 10 9
ψ 10 9
CYANA residual target function 1.0 ( 0.05 Å2 0.11 ( 0.02 Å2
distance restraints violated by
more than 0.2 Åb
0 0
angle restraints violated by more than 5°b 0 0
backbone rmsd values residues 2-9c 0.66 ( 0.25 0.30 ( 0.09
backbone rmsd values residues 12-17c 0.37 ( 0.12 0.23 ( 0.14
Ramachandran plotd
% of residues in most favored regions 78.3% 76%
% of residues in less favored regions 20.3% 22.5%
% of residues in generously allowed
regions
1.4% -
% of residues in disallowed regions - 1.5%
a Only those derived by TALOS (47). b Per molecule. c As calculated
by MOLMOL (64) from the pairwise rmsd values of each of the 20
structures against a mean structure. d As calculated by PROCHECK
_NMR (53) excluding Gly residues.
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cross-peaks, whereas helix 2 is only defined by relatively
few cross-peaks. However, in addition to those shown in the
sequence plot, there are interactions between the aromatic
ring protons of Tyr 17 and the side chain of Ile 14. This is
also reflected in atypical chemical shifts of the side-chain
protons of Ile 14. The helicity of these regions is also
corroborated by strong sequential HN-HN NOEs. At present,
we are unable to decide whether the lack of structural
information around residue 12 actually reflects mobility or
is caused by an artifact (e.g., lack of NMR signals in this
region).
In LTAB, the 1H atoms of Novispirin could be assigned
with the following exceptions: K1 (all protons) and N2 HN.
Quality criteria are listed in Table 4. As in SDS micelles,
the structure shows 2 helical stretches, but in contrast to the
structure in SDS, the kink between the two helices is well-
defined and the whole structure (Figure 5B) can be aligned
simultaneously. The sequence plot (Figure 6B) clearly shows
the presence of two helical stretches.
Micelle Penetration InVestigated by Paramagnetic Re-
agents. In addition to obtaining the structure of Novispirin,
it is of interest to investigate to which extent the peptide is
buried in the micellar environment or exposed to the
surroundings. We have used four complementary techniques
to obtain more information on this, namely, quenching of
signals by paramagnetic reagents, NOEs between peptide and
detergent, PFG-diffusion measurements, and finally HN
exchange.
Paramagnetic reagents such as Mn2+ are useful probes of
the solvent-accessibility of different parts of a protein or
peptide (56). When Mn2+ ions come into close proximity
with protons, their nuclear magnetic relaxation will be
enhanced, leading to signal broadening.
1. SDS. Upon addition of 500 μM MnCl2, several signals
of Novispirin were weakened or vanished altogether, whereas
others were affected much less. Table 5 and Figure 7 show
the results of these experiments. Because of electrostatic
interactions, it is assumed that most of the Mn2+ is localized
on the negatively charged surface of the SDS micelles. The
presence of Mn2+ ions has only little effect on resonances
FIGURE 5: Structure of Novispirin in the presence of (A) SDS and
(B) LTAB. The aligned bundle of the 20 structures with the lowest
residual target function is shown. In the left panel, N, C, and CR
atoms of residues 2-9 are aligned; in the right panel, N, C, and
CR atoms of residues 12-17 are aligned. In the case of LTAB, a
central panel with an alignment of N, C, and CR atoms of residues
2-17 (i.e., the combination of the helical two regions) is also
included.
FIGURE 6: Sequence plot of Novispirin NMR data (A) for
Novispirin in SDS at 50 °C and (B) for Novispirin in LTAB at 25
°C. The sequential NOE connectivities dRN, dNN, and dN are
indicated with black bars of a thickness that corresponds to the
strength of the NOEs. The medium range connectivities dRN(i,i+3)
and dR(i,i+3) are shown by lines starting and ending at the
positions of the residues related by the NOE. Residues whose φ
and ψ angles were constrained based on output from TALOS are
underlined. The line CSI gives the chemical shift index. A “+”
indicates that the chemical shift of the HR is larger than the random-
coil chemical shift +0.1 ppm; a “-“ indicates a HR chemical shift
lower than the random-coil chemical shift -0.1 ppm. A “0”
indicates a shift that is within 0.1 ppm from the random-coil value.
Random-coil values were taken from ref 40.
Table 5: NOESY Cross-Peaks Found between SDS and Novispirina
SDS-atom
Novispirin 1-CH2 2-CH2 3-CH2 4-11-CH2 12-CH3
R4/R5b Hε ? x
R8 Hε ? x x
H12 Hδ2 ? x x
H12 Hε1 ? x
Y17 Hδ1,2 x x
Y17 Hε1,2 x ? x
a Peaks are denoted with an “x”. A “?” denotes cases where neither
the absence nor the presence of the peak can be proven unambiguously
because of spectral overlap with other cross-peaks. b The Hε of R4 and
R5 have the same chemical shift; the cross-peak can, therefore, not be
assigned to only one of the two atoms.
490 Biochemistry, Vol. 45, No. 2, 2006 Wimmer et al.
Paper 6
214
of residues 2-6 and 8 forming the first helix. A medium
effect on residue 7 could be observed. Data on residue 9
have been omitted due to a standard error of more than 100%.
Resonances from residues 10 and 11 have disappeared
completely, and a moderate effect of the Mn2+ ions on
residues 12 and 13 can be observed. The resonance of residue
14 has vanished, while that of residue 15 is not affected at
all. No data can be obtained on residue 16, and the
resonances of the last two residues, 17 and 18, vanish upon
addition of Mn2+.
2. LTAB. Upon addition of 4 mM MnCl2, most Novispirin
signals diminished or vanished altogether. The fact that a
much larger Mn2+ concentration was needed to observe an
effect compared to SDS micelles is ascribed to the charge
of the micellar surface that attracts Mn2+ ions in the case of
SDS but repels them in the case of LTAB. The data are
presented in Table 5 and Figure 7. The only HN/HR signals
remaining are those of the hydrophobic residues Ile 6, Ile
13, and Ile 14. The signals of the aromatic protons of Tyr
17 remain visible, although its HN/HR cross-peak does not.
NOEs between Detergent and NoVispirin Molecules. 1.
SDS. The 2D-selective NOESY spectrum revealed several
cross-peaks from Novispirin side-chain atoms to SDS atoms.
The found cross-peaks are summarized in Table 5. No cross-
peaks were found from backbone HN atoms of Novispirin
to SDS atoms. Because of severe spectral overlap, only side-
chain atoms with a chemical shift >5.5 ppm could be
investigated. Neither the presence nor the absence of NOEs
between other side-chain atoms, notably Ile and Leu methyl
groups, and SDS can be proven. In addition to the cross-
peaks given in Table 5, a number of cross-peaks were found
that could not be assigned to any peptide atom. They could
possibly belong to Lys H atoms, but as none of them are
assigned, this cannot be confirmed.
2. LTAC. No NOEs between any Novispirin atom with a
chemical shift >5.5 ppm and LTAC atoms could be detected.
NOEs between other Novispirin side-chain atoms and LTAC
cannot be ruled out, but they cannot be observed due to
spectral overlap.
HN Exchange in SDS and LTAB. Figure 8 shows the
HN/HR regions of TOCSY spectra with 75 ms mixing time
obtained from Novispirin in SDS, in LTAB, and in the
absence of detergents, all at pH 5.7. Although Novispirin in
SDS was measured at 50 °C while Novispirin in LTAB was
measured at 25 °C, there are numerous HN/H2O exchange
peaks in the LTAB solution and only a few in the SDS
solution. The latter can be attributed to exchangeable arginine
side-chain atoms, while not a single HN exhibits exchange.
In LTAB, there is more exchangesonly Ile 6, Ile 13, Ile 14,
Lys 16, Tyr 17, and Gly 18 HN definitely do not yield an
exchange peak. A control experiment with Novispirin at pH
5.7 and 50 °C in the absence of detergent showed strong
backbone HN exchange. The F2-rows of the TOCSY spectra
are shown along with the 1D NMR spectra to demonstrate
that the cross-peaks originate from chemical exchange and
not from a combination of F1-ridges and insufficient water
suppression. Weak examples for the latter can be seen but
are having opposite sign to the “true” exchange peaks in the
spectra of Novispirin in both detergents.
NoVispirin-Micelle Association Probed by PFG Diffusion
Experiments. The results of the previous three techniques
make it reasonable to infer that Novispirin, at least in part,
is buried in the SDS micelle, whereas it is questionable
whether Novispirin is at all associated with LTAC micelles
(see Discussion). Measurement of the diffusion constant for
Novispirin could provide more insight. In the case of SDS,
diffusion constants obtained from Novispirin and SDS are
equal within the accuracy of the measurement. Under the
conditions mentioned above, the diffusion constant for both
Novispirin and SDS is 0.11 × 10-10 m2 s-1, where free
Novispirin in water diffuses with 1.75 × 10-10 m2 s-1. The
contribution of monomeric SDS to the measured diffusion
constants is negligible at the high salt concentrations used.
The diffusion constants obtained from Novispirin and LTAC
with increasing amounts of LTAC present are given in Table
6. They show that the diffusion constant of Novispirin drops
with increasing LTAC concentration. This is converted to
hydrodynamic radius using the Stokes-Einstein equation (eq
4), which also takes into account changes in the viscosity of
the solution with increasing LTAC concentration (see
Materials and Methods). Diffusion constants of LTAC
micelles are higher than those of SDS micelles, which is in
agreement with the fact that SDS micelles are larger than
LTAC micelles (57).
FIGURE 7: (A) Influence of paramagnetic Mn2+ ions on relative
signal intensity of Novispirin in SDS at 50 °C (closed squares)
and LTAB at 25 °C (open diamonds). The top graph shows IMn/I0
plotted vs the peptide sequence, where IMn is the signal intensity
in a clean-TOCSY spectrum (41) of 20 ms mixing time with a 15
kHz spin-lock and a WATERGATE water suppression (40) after
addition of 0.5 mM Mn2+, and I0 is the signal intensity before
addition of Mn2+. The highest ratio occurring in each of the samples
was normalized to 1, since no comparisons of absolute signal
intensity between two different samples could be made. In general,
signal intensity ratios are far weaker for LTAB than for SDS. (B)
Visualization of the data using the structures for Novispirin in SDS
(left) and LTAC (right). The backbone is represented by a spline
function, whose radius is proportional to the IMn/I0 value plotted in
the top graph. The thinner the curve, the more this individual residue
is influenced by Mn2+ ions.
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The hydrodynamic radii of LTAC and Novispirin versus
LTAC concentration are plotted in Figure 9. The data show
that the apparent hydrodynamic radius of Novispirin remains
essentially unchanged up to approximately 630 mM, after
which it begins to increase. This is in contrast to the NMR
spectra measured at different concentrations of LTAC (Figure
4) which already show signs of chemical shift dispersion of
HN atoms, pointing at the formation of stable secondary
structure elements at LTAC concentrations as low as 200
mM. We interpret the data as a sign of beginning secondary
structure formation, as detergent concentrations increase,
maybe aided by transient interactions with the LTAC
micelles. However, the association/dissociation equilibrium
at low LTAC concentrations is still shifted toward the free
form of Novispirin.
DISCUSSION
In the present work, we have investigated the influence
of different detergents and lipids as well as TFE on the
secondary structure of Novispirin G-10. For two detergents,
SDS and LTAB, we have determined the structures of the
peptide by solution-state NMR and obtained information on
how the peptide is oriented relative to the detergent micelle.
Different Binding Modes of NoVispirin. The titration of
Novispirin with different additives clearly follows different
binding modes. For lipids, TFE, SDS, and LTAC, there is a
cooperative transition, while LPS and the detergents DM and
DPS elicit a hyperbolic binding curve. Hyperbolic binding
occurs well above the cmc of the detergents in all three cases,
suggesting a simple equilibrium between free and micelle-
bound peptide. TFE’s cooperative transition is a simple
consequence of a linear relationship between the free energy
of folding and TFE concentration (31), similar to that seen
for denaturants (58). In the case of SDS, the cooperative
binding is completed below bulk cmc, and this indicates that
SDS monomers must cluster at the Novispirin surface. When
a cluster of sufficient density has formed, it presumably
generates enough anionic surface area to contact other
Novispirin molecules (see below). For LTAC, the cooperative
transition overlaps with the cmc under all conditions tested,
suggesting that monomers may cluster to a small extent on
Novispirin but are superseded by micelles above the cmc.
This confirms that a supramolecular structure is required to
overcome the electrostatic repulsions between positive side
chains and the cationic headgroup of LTAC. The cooperative
nature of Novispirin structure formation as a function of lipid
FIGURE 8: HN/HR regions of TOCSY spectra with 75 ms mixing time of Novispirin in (A) the absence of detergent, (D) SDS, and (G)
LTAB micelles. The spectra were recorded using the clean-TOCSY sequence (41) with a 15 kHz spin-lock and a WATERGATE water
suppression (40) with selective pulses. The chemical shift of water is 4.76 ppm in the spectrum of Novispirin in LTAB (recorded at 25 °C)
and 4.50 ppm in the spectra recorded in the presence of SDS and in the absence of detergents (recorded at 50 °C), respectively. The
F2-rows of the TOCSY spectrum at the chemical shift of water are presented (B) in the absence of detergent, (E) in SDS micelles, and (H)
in LTAB micelles. The bottom line shows 1D NMR spectra recorded using excitation-sculpting water suppression (38) and selective excitation
of the region from 6 to 9 ppm by an off-resonance Q5 pulse (39) of 3.14 ms duration. Spectrum C is from Novispirin in the absence of
detergents, spectrum F from Novispirin in SDS, and spectrum I from Novispirin in LTAB.
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concentration is less straightforward to explain, since the
amount of peptide is not limiting for Novispirin oligomer
formation at the vesicle surface at low-lipid concentrations.
We can only speculate that extensive coating of the vesicle
surface with Novispirin at very low-lipid concentrations can
actually block structural transitions for steric reasons.
The Aggregated State: An AlternatiVe to the Random-
Coil and R-Helix. Pure DOPG leads to the formation of
water-insoluble, -sheet-rich aggregates with Novispirin. The
same happens with SDS at certain protein/detergent ratios,
although the Novispirin-SDS precipitate can be redissolved
by adding more detergent. Variations in the amount of
secondary structure in DOPG and SDS can be ascribed to
differences in the concentrations of detergent versus lipid.
LPS, however, which contains a small number of negative
charges distributed in a matrix of neutral saccharides, is able
to induce structure in its pure form at very low concentrations
without forming precipitates to the same extent (although
there may be a small amount of aggregation around 0.075
mM LPS, as the CD spectrum at this concentration does not
cross the isodichroic point, unlike all other LPS concentra-
tions). Thus, the ability to form aggregates is most likely
promoted by electrostatically complementary “sandwich”
structures between positively charged Novispirin and nega-
tively charged lipids/detergents. For SDS, this is only
possible at relatively low concentrations; at higher SDS
concentrations, Novispirin becomes diluted out by SDS
molecules, and SDS micelles form, which by themselves are
solubilizing due to their high concentration of negative
charge. Because of the high degree of light-scattering of
DOPG vesicles, we were unable to determine whether higher
concentrations of DOPG likewise lead to Novispirin solu-
bilization and R-helix formation.
The aggregation phenomenon is unlikely to have biological
significance, since uniformly anionic vesicles do not occur
in nature. Nevertheless, it demonstrates that amphiphilic
molecules not only necessarily just induce R-helical structure
when bound to proteins but also allow them to access other
conformational states, depending on the ratio between
protein/peptide and amphiphile. SDS at submicellar concen-
trations has been shown to stimulate fibrillation of proteins
(59, 60), and anionic lipid vesicles stimulate the fibrillation
of globular proteins and peptides, which at sufficiently high
concentrations can even take up and incorporate the lipid in
the fibril structures (61, 62).
NoVispirin Shows a Versatile Ability To Form Helical
Structure in Detergents. Novispirin is able to form regular
secondary structures in both anionic, zwitterionic, nonionic,
and cationic detergents and phospholipids. The formation
of secondary structure proceeds readily if the amphiphilic
compounds are negatively charged. Both anionic detergents
as SDS and anionic lipids as DOPG can induce secondary
structure formation at relatively low concentrations; the latter
however only if “diluted” by the zwitterionic DOPC.
The affinity of Novispirin toward negatively charged
surfaces is not surprising, since Novispirin at pH 7.5 carries
eight positive charges opposed by only one negative charge.
Interestingly, Novispirin needs at least 20-40% anionic
lipids to form secondary structure, which covers the fraction
(around 25%) of anionic lipids present in E. coli inner
membranes. Our lipid compositions deviate from bacterial
membranes in that we used phosphatidylcholine rather than
phosphatidylethanolamine due to phosphatidylcholine’s su-
perior bilayer-forming properties and the inability to extrude
vesicles with high fractions of phosphatidylethanolamine.
However, 10-20% of the latter lipid does not affect
Novispirin structure.
The pure zwitterionic lipid (DOPC) is not able to induce
structure in Novispirin. Uncharged (DM) and zwitterionic
(DPS) detergents, however, do induce secondary structure
in Novispirin. More counterintuitively, the cationic detergents
LTAC and LTAB can likewise induce the formation of
secondary structure. The LTAC/LTAB concentration needed
to induce structure is strongly pH-dependent. At pH 7.5, a
far lower amount of detergent is sufficient than at pH 5.7
(Figure 4). This indicates that the histidine side chain plays
an important role in this interaction, since it is the only group
titrating in this pH area. In 270 mM LTAC, the chemical
shift of the two imidazole protons (Hδ2 and Hε1) titrate with
pH to give an apparent pKa of 6.37 (data not shown). The
chemical shift changes are likely to arise from a combination
of protonation-deprotonation, association-dissociation, and
Table 6: Diffusion of Novispirin (c ) 2.5 mM) in LTAC, pH 5.7
cLTACa
(mM)
ηb
(mPa s)
Dobs,novic
(10-10 m2 s-1)
Dobs,LTACd
(10-10 m2 s-1)
Rhe
Novispirin
(nm)
Rh LTACf
micelles
(nm)
0 1.13 1.75 1.10
18 1.15 1.84 3.20 1.03
97 1.26 1.65 1.39 1.05 1.46
174 1.37 1.47 1.13 1.08 1.54
247 1.50 1.32 0.99 1.10 1.56
322 1.63 1.33 0.89 1.00 1.57
395 1.78 1.19 0.80 1.04 1.57
478 1.96 1.09 0.74 1.03 1.53
575 2.18 0.94 0.66 1.07 1.53
639 2.34 0.87 0.60 1.07 1.56
711 2.53 0.71 0.55 1.22 1.59
798 2.78 0.60 0.44 1.31 1.80
880 3.02 0.55 0.41 1.31 1.75
1000 3.40 0.46 0.37 1.40 1.74
a Concentration of LTAC in millimoles per liter. b Viscosity of LTAC
solution as calculated from eq 3. c Observed Novispirin diffusion
constant. d Observed LTAC diffusion constant. e Hydrodynamic radius
of Novispirin calculated from the Stokes-Einstein equation. f Hydro-
dynamic radius of LTAC micelles calculated from the Stokes-Einstein
equation separating the contribution of the monomeric LTAC and the
micellar LTAC by eq 4.
FIGURE 9: Hydrodynamic radii of Novispirin (filled diamonds) and
LTAC micelles (filled squares) calculated from the diffusion
constants by applying the Stokes-Einstein equation versus the
concentration of LTAC. Open squares indicate the apparent
hydrodynamic radius for LTAC, which is a population-weighted
average of monomeric and micellar form.
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folding-unfolding equilibria. However, the protonation-
deprotonation generally give rise to the largest shift changes,
making the value of 6.37 a reasonable estimate of the
imidazole ring’s pKa. Since no positively charged biological
membranes are known, the biological significance of this
behavior is unknown. However, the observations reveal a
surprisingly broad susceptibility of small peptides to form
helical structures in micellar environments.
Structure Comparison. CD spectra of Novispirin in SDS,
LTAC, and TFE revealed subtle differences. Access to
atomic-level structures could elucidate the basis for these
differences. Since only the structure in TFE is available (30),
we have determined the high-resolution NMR structures of
Novispirin in two different micellar solutions: SDS and
LTAB. In both cases, there are well-defined helical re-
gions interrupted by a less well-defined region around
residues 10-12, in agreement with the TFE structure. While
the kink in the helix is very well-defined for Novispirin in
TFE, it is less so in SDS. This might reflect actual mobility,
since the spectra were recorded at 50 °C. Also, recently
published molecular dynamics simulations (63) point at a
higher flexibility of Novispirin G-10 in SDS micelles. It has
been pointed out that in the structure of Novispirin in TFE,
I13 fills a void in the hydrophobic face of the molecule
caused by the I10G mutation (30). Such an interaction might
be the reason for the observed rigidity of the Novispirin
structure. In micellar environments, however, the hydropho-
bic chains of the detergent molecules can take over this role,
thus allowing a more flexible structure of the peptide itself.
The structure in LTAB is better-defined. A reason for this
might be that only certain orientations of the peptide back-
bone allow sufficient separation of the positive charges on
the peptide from each other and from the positively charged
micellar surface; thus, conformational freedom is severely
restricted. As noted above, the introduction of an additional
positive charge in the middle of the sequence by protonating
H12 (at lower pH) greatly reduces the formation of structure
at a given LTAC concentration. Figure 10A,B shows the
structures of Novispirin in SDS and LTAB. Besides illustrat-
ing the amphipathic nature of the helix, it also shows a much
narrower spatial distribution of the positively charged side
chains when in contact with LTAB.
Figure 10C shows an overlay of the structures of Novispi-
rin in SDS, LTAB, and TFE. It is evident that the structure
is better-defined in TFE than in LTAB and SDS. The
sequence plots (Figure 6 in this paper and Figure 2B in ref
30) suggest that Novispirin in LTAB consists of two distinct
helical regions of approximately the same number of amino
acids, whereas Novispirin in both SDS and TFE consists of
a well-defined N-terminal helix and a much less well-defined
and smaller (in terms of its number of amino acids)
C-terminal helix. The angle between the two helical frag-
ments is different in all three cases, which might be a
consequence of the special role of I13 (see above). Thus,
although the general structure of the peptide is very similar
under all three conditions, there are changes from one
structure to another, which reflect the subtle changes
observed in the far-UV CD spectra.
FIGURE 10: Novispirin in SDS (A) and LTAB (B). Contact surface. Green surface regions correspond to Ile and Leu residues, cyan corresponds
to Asn and Tyr, red denotes the negatively charged C-terminus, and blue denotes positively charged side chains. The amphipatic nature of
the Novispirin helix is evident. The spatial distribution of the positively charged side chains is much narrower in LTAB than in SDS. (C)
A superposition of Novispirin in SDS (red), LTAB (blue), and TFE (green). For each structure, a bundle of the 10 best structures is shown.
In the left panel, the N-terminal residues are superimposed; in the right panel, the C-terminal residues are superimposed.
494 Biochemistry, Vol. 45, No. 2, 2006 Wimmer et al.
Paper 6
218
NoVispirin Is Embedded in the SDS Micelle. It becomes
clear that the key to understanding Novispirin’s behavior lies
in its interaction with the detergent micelles. Three types of
experiments were performed to learn more about the relative
orientation of Novispirin and the micelle: the backbone HN
exchange was determined qualitatively from TOCSY spectra,
paramagnetic Mn2+ ions were added to the solution, and
NOEs between SDS and Novispirin were investigated.
The HN exchange data (Figure 8) revealed that not a single
backbone HN showed exchange with the bulk solvent. In a
control experiment under identical conditions but without
SDS, strong exchange peaks could be seen. Protection from
exchange can signify a very stable hydrogen bond brought
about by regular secondary structure or isolation from the
bulk solvent. The two short helical stretches observed here
are, however, unlikely to provide enough structural stability
to explain the absence of HN exchange by the existence of
very stable hydrogen bonds. It is more likely that the
backbone HN atoms are situated inside the micelle, away
from the bulk solvent. Only labile side-chain protons from
arginine could be found to exchange with the solvent. This
is indeed expected, since the positive charges in the vicinity
of these atoms are supposed to be situated at the surface of
the SDS micelle, where they can interact with the anionic
sulfate headgroup. No lysine H could be observed in any
of the spectra.
Additional evidence for a micelle-embedded conformation
comes from NOESY spectra with nondeuterated SDS. As
summarized in Table 5, cross-peaks could be detected from
Novispirin hydrogen atoms to SDS hydrogen atoms. No
NOEs could be detected from backbone HN atoms to SDS
atoms. However, nearly all visible side-chain atoms of
Novispirin with a chemical shift bigger than 5 ppm (R5,6,8
Hε, H12 Hδ2, Hε1, Y17 Hδ1,2, Hε1,2) showed cross-peaks to
SDS. Cross-peaks to the aliphatic side chains could not be
detected due to severe spectral distortion by the strong SDS
signals. Therefore, neither the absence nor presence of such
NOEs can be confirmed. Most NOEs show to the overlapping
CH2-group signals from CH2-4-11 of SDS. Only weak
interactions with 2-CH2 and 3-CH2 groups could be estab-
lished. This could be due to the fact that the first group of
signals yields a stronger cross-peak owing to the high amount
of hydrogen atoms contributing to this peak, while signals
observed from only one group are not strong enough. In a
mobile ensemble, cross-peaks to several different atoms can
be expected that do not necessarily point at short distances
that have to be fulfilled simultaneously. No cross-peaks could
be seen to SDS-CH3 group. This could point at the fact
that Novispirin does not protrude that deeply into the micelle
but could also just mean that signals are too weak to be
detected.
The visible cross-peaks, however, present strong evidence
for a micelle-embedded structure. Under the high-salt
concentration used for the NMR experiments, the cmc of
SDS (around 0.1 mM) is too low to allow monomeric SDS
to cause these cross-peaks.
The addition of paramagnetic Mn2+ ions gave another
indication as to where in the micelle Novispirin is situated.
Mn2+ was titrated into the solution until a relative difference
in the ratio of remaining-to-original signal intensity could
be seen between different peptide atoms. In the case of SDS,
this proved to be at 0.5 mM. Probably, the Mn2+ ions stick
to the surface of the SDS micelle and thus form a much
higher local concentration. The data recorded in the presence
of Mn2+ ions point toward a micelle-embedded structure,
with the first helical stretch being buried in the micelle, a
surface-exposed hinge around G10 and I11, and thereafter
the second helical stretch being oriented in parallel to the
surface, showing alternating protection and lack of it. The
C-terminal residues are not protected at the backbone level;
the presence of a negative charge at the C-terminus would
also suggest that the C-terminus points away from the anionic
micellar surface. The apparent low protection might also be
caused by Mn2+ ions interacting with the C-terminus. In
either case, the backbone of the C-terminus is exposed to
the bulk solution. However, the aromatic side-chain atoms
of Y17 are only moderately influenced by the presence of
Mn2+, which points at an interaction of the phenyl ring with
the micelle. This interaction is also corroborated by NOEs
from the aromatic protons of Y17 to SDS protons.
Finally, the diffusion constants obtained on Novispirin in
SDS and the SDS micelle in the same sample are equal,
which is strongly supporting a firm attachment of Novispirin
to the SDS micelle.
In summary, the data point at a conformation where amino
acids 2-8 (roughly speaking, the first helix) are buried in
the micelle, whereas amino acids 9-18 (the kink and the
second helix) are situated on the surface of the micelle.
NoVispirin Is Only Loosely Associated with the LTAC
Micelle. Similar experiments as those for Novispirin in SDS
were also conducted to investigate Novispirin in LTAC
micelles. The results, however, pointed in a very different
direction.
The HN exchange was likewise estimated qualitatively
from TOCSY spectra. Unlike SDS, several backbone HN
were found to exchange with bulk water in the presence of
LTAC micelles. The spectrum shown in Figure 8G,H exhibits
a range of exchange peaks. The only backbone HN atoms,
which definitely do not exchange, are from the three
hydrophobic residues I6, I11, and I13 and from the three
C-terminal residues K16, Y17, and G18. The labile side-
chain protons of arginine again showed exchange with the
solvent.
In LTAB, 8 times more Mn2+ was needed than in SDS to
elicit an effect on the peak signals, probably due to repulsion
between the cationic LTAC headgroup and Mn2+. Only very
few residues were protected against Mn2+, namely, I6, I13,
and I14.
A NOESY spectrum of Novispirin in nondeuterated LTAC
did not show any cross-peaks from Novispirin to LTAC. As
for SDS, neither the presence nor the absence of NOEs from
LTAC to aliphatic side-chain atoms could be unambiguously
proven due to signal overlap and severe spectral distortions
brought about by the high concentration of the detergent.
From the results of the three experiments (exchange,
addition of Mn2+, and NOESY), it is doubtful whether
Novispirin actually is bound to the LTAC micelle at all.
Therefore, diffusion measurements were conducted to in-
vestigate whether Novispirin is bound to the LTAC micelle
or whether it is free in solution. A number of pulsed-field
gradient NMR measurements were conducted to determine
the diffusion coefficient of Novispirin in the presence of
increasing concentrations of LTAC. At pH 5.7, it was found
that the apparent hydrodynamic radius of Novispirin remains
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constant up to approximately 600 mM LTAC; hereafter, it
increases. This points toward the formation of larger ag-
gregates, most probably peptide-micelle clusters. This is
further corroborated by the fact that also apparent micellar
hydrodynamic radii increase at this point. However, No-
vispirin still diffuses faster than the micelle and is thus not
tightly bound; otherwise, Novispirin’s and the micelle’s
diffusion coefficients and apparent hydrodynamic radii
should be equal. Comparing with the 1D NMR spectra at
different LTAC concentrations (Figure 4), it can be seen that
a dispersion of NMR signals begins already at lower levels
of LTAC. We suggest that there is an equilibrium between
a micelle-associated, folded and a free, unfolded form, that
gradually is shifted toward the micelle-associated, folded
form upon increasing detergent concentrations. This is in
agreement with far-UV CD titration experiments in up to 1
M LTAC at pH 5.7 which show that the degree of R-helicity
increases in an essentially linear fashion between 0 and 1 M
LTAC and has not yet reached a plateau level at 1 M LTAC
(Figure 3C).
Combining these pieces of information, it seems likely that
Novispirin is weakly associated with the micelle in equilib-
rium between bound and free form. However, even such a
weak association appears sufficient to induce an overall
folded structure. The induction of structure is not an artifact
of the high concentration of detergent used (e.g., through
reduction of water activity or binding of the counterion
bromide), since it is also observed at 20-40 mM LTAC at
pH 7.5 under CD conditions, that is, much lower peptide
concentrations; furthermore, halide ions at molar concentra-
tions do not by themselves induce helical structure in
Novispirin (data not shown). The strong increase in binding
affinity upon increasing the pH from 5.7 to 7.5, which is
accompanied only by the deprotonation of the single histidine
residue, also points to very specific interactions between
LTAC and Novispirin. The somewhat counterintuitive in-
teractions with a positively charged detergent are of great
principal interest. The fact that such interactions can be
observed might lead to a reevaluation of the driving forces
behind peptide/membrane association. Understanding these
driving forces will in turn be rewarded with the ability to
design target-specific antimicrobial peptides.
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